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Artificial sweeteners (AS) are synthetic sugar substitutes which are commonly consumed in 
the diet for their low-calorie profile. Recent studies have indicated considerable health risks; 
consumption of AS linked to metabolic derangements and gut microflora perturbations. 
Despite these studies, there is still limited data on how AS affects intestinal epithelium or 
impacts the commensal microbiota to cause pathogenicity. Furthermore, it is not well-
understood whether the orphan G-protein coupled receptor (T1R2/3), which binds AS, is 
responsible for these health risks. The current in vitro study sought to investigate the role 
of commonly consumed AS on: intestinal epithelial cell  function, gut bacterial metabolism 
and pathogenicity, and gut epithelium-microbiota interactions, using models of the intestinal 
epithelium (Caco-2) and microflora (Escherichia coli NCTC10418 and Enterococcus 
faecalis ATCC19433). 
 
To address these aims, Caco-2 and model gut bacteria (MGB) were exposed to different 
concentrations of the AS; saccharin, sucralose, aspartame and neotame; and various in 
vitro studies were performed. Saccharin, aspartame and neotame decreased cell viability 
at physiological concentrations, whilst all increased permeability across the intestinal 
epithelial monolayer at either physiological or sub-physiological concentrations. 
Interestingly, these damaging effects were mediated through a T1R2/3-independent 
pathway. In the MGB studied, AS exposure had no impact on metabolic parameters, but 
increased pathogenicity of E. coli as measured by biofilm formation. Furthermore, AS 
differentially increased adhesion and invasion of MGB into Caco-2 cells, which is indicative 
of a pathogenic response. Interestingly, inhibition of sweet sensing attenuated these 
pathogenic effects.  
 
These findings suggest that AS negatively impact gut physiology by directly damaging the 
intestinal epithelium and by increasing the pathogenicity of MGB. These outputs are linked 
with inflammation and potential development of metabolic diseases such as diabetes. 
Further investigations are, however, needed to utilise these findings to prevent AS-induced 
intestinal damage. Since AS consumption is so high in the population, understanding how 
this food additive affects gut health and how these damaging effects can be ameliorated is 
vital. 
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1 General introduction 
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1.1 Metabolic Diseases  
Metabolic diseases (MD) are physiological disorders that perturb normal metabolic 
processes on a cellular level and are associated with increased risk for the development of 
diabetes and obesity (Lai et al., 2014). Hanefeld and Leonhardt described metabolic 
syndrome in 1981 suggesting that genetic and environmental factors such as diet and 
physical activity lead to diseases like type 2 diabetes mellitus (T2D), hyperinsulinemia, 
obesity, hypertension, hyperlipidemia, gout and thrombophilia which are included in the 
umbrella term ‘metabolic syndrome’ (reviewed by Sarafidis and Nilsson, 2006). More 
recently, metabolic syndrome was defined as the combination of diabetes, hypertension 
and obesity (NHS, UK, 2019). The increasing incidence of MD and its strain on the 
healthcare service worldwide demand investigations in every aspect including the 
predisposing factors (fig.1.1.1).  
The actual understanding of metabolic syndrome was made in the early 1970s (reviewed 
by Sarafidis and Nilsson, 2006) however diabetes, one of the biggest contributors to 
metabolic syndrome, has a history dating back to ~1550 BC (Diabetes UK, 2019). In the 5th 
century, two types of diabetes were identified; one being associated with ‘wealthy, heavy 
people’ which we now believe to be T2D (Frank, 1957). However, type 1 and type 2 diabetes 
were only formally differentiated by research in 1936, which discovered that T2D was a 
result of insulin resistance rather than a deficiency (Himsworth, 1936). Initial investigations 
blamed pancreatic dysfunction (Halter and Porte, 1978), however, as research progressed 
our understanding of the responsible mechanisms became complex. Strong links between 
obesity and T2D have been found over the past few decades indicating that adipose 
dysfunction also plays a role in the pathophysiology of T2D (Esposito and Giugliano, 2004). 
Adipose dysfunction leads to dysfunctional hormone signalling and the production of pro-
inflammatory cytokines representing a state of chronic inflammation. This, in turn, is 
associated with metabolic syndrome and the development of a plethora of MD (reviewed in 
Schuster, 2010) (fig.1.1.1).   
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Figure 1.1.1: Risk factors associated with metabolic syndrome and the diseases.  
The individual risk factors for the occurrence and escalation of the metabolic syndrome are complex, 
however, there are general links among the risk factors and the diseases. In fact, there are important 
pathways that regulate the metabolism, and understanding the biological mechanisms and taking 
multidisciplinary approach could help to prevent and treat these diseases. TG = triglycerides; HDL-c 
= high-density lipoprotein cholesterol; PCOS = polycystic ovary syndrome; NASH = nonalcoholic 
steatohepatitis. Figure adapted from Mendrick et al. (2017). 
Diabetes is responsible for 1.5 million deaths worldwide and is estimated to be the 7th 
leading reason for global death by 2030 (Nettleton et al., 2016). In 2015 global prevalence 
of diabetes was 8.8% (415 million) of the total population, estimated to increase to 10.4% 
(642 million) by 2040 (IDF diabetes atlas). Further research is vital to reduce the huge toll 
on human health and healthcare providers.   
Chronic inflammation triggers metabolic syndrome by causing obesity, T2D, and 
cardiovascular diseases (Toubal et al., 2013). Worldwide, chronic inflammation-mediated 
MD are responsible for 3 in 5 deaths (Pahwa et al., 2019). Metabolic disorders and 
inflammatory stress are interlinked, with one condition enhancing the development or 
exacerbating others. For example, obese patients with metabolic syndrome also develop 
T2D due to persistent, low-grade inflammation seen in obesity (reviewed in Schuster, 2010; 
Esposito and Giugliano, 2004). Emerging research indicates that gut microflora (GM) 
dysbiosis and impaired IBF result in metabolic endotoxaemia which is closely related to 
inflammation, insulin resistance, and cardiovascular events in patients with T2D (fig.1.1.2) 
(Fukui, 2016). Impaired IBF is characterised by increased epithelial permeability allowing 
entry of antigens resulting in metabolic endotoxaemia (König et al., 2016). Also, high-fat, 
high-sugar diets increase intestinal permeability resulting in inflammation, leading to MD 
such as T2D (Fukui, 2016). Moreover, food additives such as emulsifiers was shown to 
cause gut barrier leak leading to metabolic syndrome (Chassaing et al., 2017). Therefore, 
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IBF is a primary site that regulate the metabolic disease development via inflammation 
(fig.1.1.2) and understanding the role of dietary components is timely. 
 
Figure 1.1.2: Interactions of gut microflora dysbiosis, intestinal permeability and 
endotoxaemia to the progression of metabolic diseases.  
Increased Intestinal epithelial barrier permeability along with gut microflora dysbiosis allows antigenic 
substances in the lamina propria provoking low-grade inflammation in various tissues. This 
eventually leads to insulin resistance on type 2 diabetes. In obese patients, fat cell chronic 
inflammation in the adipose tissue causes pro-inflammatory cytokinemia. Inflammation and insulin 
resistance ultimately impair the insulin signalling and cause β-cell dysfunction. Similarly, 
inflammatory changes in the blood vessels and liver lead to ischemic heart disease and chronic liver 
disease, respectively. NAFLD= non-alcoholic fatty liver disease, NASH= non-alcoholic 
steatohepatitis, SBIO= small intestinal bacterial overgrowth, PBMC= peripheral blood mononuclear 
cells. Figure adapted from Fukui, 2016. 
1.1.1 Risk factors of metabolic diseases 
Genetic factors influence the development of MD. Locke et al. (2015) conducted a genome-
wide association study (GWAS) and meta-analysis of body mass index in obesity-mediated 
metabolic disorders. They identified 150 genetic variants associated with obesity risk via 
insulin secretion/activity, energy metabolism, adipogenesis, and lipid biology (Locke et al., 
2015). Weiss et al. (1984) reviewed the relationship of genetic factors and prevalence of 
MD, finding that people originated from Amerindian and their hybrids are prone to diabetes 
due to genetic configuration and environmental condition. Amerindians had a three- to 
fivefold greater prevalence of diabetes than the mixed ancestry. In addition, females are 
more susceptible to MD and pregnancy might trigger the diseases. Although the genetic 
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component was not defined, the review clearly showed a direct relationship between 
Amerindian ancestry and metabolic disease prevalence (Weiss et al., 1984).  
Other than genetics, factors like lifestyle, diet, inflammation, microbiome, environmental and 
drug intake affects the development of MD. A sedentary lifestyle influences MD 
development greatly by increasing adipose tissue size, lowering high-density 
lipopolysaccharide (HDL) cholesterol levels, increasing triglyceride in the blood, glucose 
concentration and blood pressure, all of which are associated with the onset of 
cardiovascular disease (Eckel et al., 2010). Lipodystrophy (both genetic and acquired) and 
obesity are also associated with MD development and insulin resistance (Cornier et al., 
2008). Impaired glucose tolerance doubles the threat of developing T2D (Goldberg and 
Mather 2012). Among these factors, diet has an independent and rapid impact on intestinal 
epithelial cell (IEC), GM composition and function, thereby modulating inflammation and 
disease development (Sonnenburg and Bäckhed, 2016; Lewis et al., 2015).  
Inflammation in the liver, intestine, and adipose are major sites that lead to inflammation 
mediated MD (Mendrick et al., 2018). Furthermore, the microbiome also plays a major role 
in inflammation (Lewis et al., 2015). Association between the fecal microflora and MD was 
demonstrated using meta-GWAS (Korem et al., 2015). The role of the microbiome has been 
discussed in-depth (section-3.1.1). Therefore, it is important to recognise the modulatory 
factors of these metabolic conditions, especially the effect of different dietary components 
and how they impact inflammatory responses and therefore metabolic health. 
1.1.2 Role of diet on metabolic disease  
The link between MD and diet is widely accepted (Sonnenburg and Bäckhed, 2016). Diet 
is a key modulator of IBF, as the intestine is exposed to dietary components. Diet has 
regulatory effect on intestinal permeability by directly affecting IEC function, and indirectly 
via GM modulation. A study showed that high-fat diet in rodents significantly increased 
paracellular permeability immediately although the effect was reversible (Hamilton et al., 
2015). Also, the high-fat diet reduced interleukin-10 expression, and decreased the 
abundance of Clostridia (Hamilton et al., 2015). 
Dietary effect on loss of IBF through bacterial translocation was also reported in rats by 
Deitch et al. (1995). Rats exposed to parenteral nutrition solution had significantly higher 
intestinal barrier dysfunction therefore greater translocation of E. coli in comparison to 
animals on elemental- or chow-fed diet (Deitch et al., 1995).  
Interestingly, diet can be as effective as high concentration of steroids in subsidence of 
small intestinal Crohn’s disease (SICD) (Sanderson et al., 1987a). An elemental diet for six 
weeks improved intestinal permeability of fourteen children suffering from SICD (Sanderson 
et al., 1987b). The elemental diet not only increased barrier integrity but also improved other 
relevant disease indices such as ESR, body weight and disease activity score. 
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These studies provide an understanding of gut pathophysiology in diet-induced diseases 
and indicate its potential contribution in intestinal barrier impairment that lead to metabolic 
disorders. 
1.2 Intestinal barrier function 
1.2.1 Role of barrier in absorption 
Maintenance of a healthy intestinal barrier is important for efficient absorption of essential 
molecules whilst preventing the ingress of harmful antigenic particles (König et al., 2016; 
Hollander, 1999). The intestinal barrier is composed of specialised epithelial cells that play 
an enormous role in protection and absorption.  A single layer of columnar epithelial cells 
divides the lamina propria and the external environment in the intestinal lumen (fig.1.1.3). 
They are tightly adhered by tight junction (TJ) proteins and other intercellular junctional 
complexes to regulate paracellular permeability, crucial for IBF (König et al., 2016). The 
paracellular space is controlled by TJ proteins that control movement of water, nutrients 
and electrolytes into the lamina propria of the intestine (Madara and Pappenheimer, 1987). 
Besides, some specific water-soluble compounds that pass the epithelial barrier by the 
activity of protein carriers or through transport channels, most of the hydrophilic compounds 
rely on the paracellular space for movement into the lamina (Hollander, 1999). Impaired IBF 
plays an important role in the formation of various disorders such as inflammatory bowel 
diseases (IBD), irritable bowel syndrome, obesity, diabetes, celiac disease (König et al., 
2016; Ulluwishewa et al., 2011; Damci et al., 2003). 
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Figure 1.1.3: Barrier function of intestinal tight junctions.  
The intestinal epithelial cells inhibit noxious macromolecules to penetrate in normal condition. But 
when epithelium is impaired, luminal bacteria, toxins, antigens can pass causing the activation of 
mucosal immune cells and inflammation. Figure adapted from Suzuki, (2013).  
1.2.2 Tight junctions 
Intestinal permeability is mediated by tight junction proteins (TJ) in intestinal cells 
(enterocytes), which form homotypic interactions between adjacent epithelial cells. The TJ 
comprises of over 50 proteins (Ulluwishewa et al., 2011), the key ones are occludins, 
claudins and junctional adhesion molecules (JAM) (König et al., 2016; Furuse, 2010; Mitic 
et al., 2000) (fig.1.1.4). Expression of these proteins at the cell surface is mediated by 
intracellular trafficking whilst activity can be regulated by signalling proteins such as protein 
kinase C (PKC), mitogen-activated protein kinases, the Rho family of small GTPases and 
myosin light chain kinases (Fredriksson et al, 2015; Fletcher et al., 2014; Ulluwishewa et 
al., 2011; Findley and Koval, 2009). 
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Figure 1.1.4: The tight junction in paracellular pathway is composed of proteins like 
occludins, claudins and junctional adhesion molecules (JAMs).  
These proteins are linked to the cytoskeleton via scaffolding proteins like zonula occludens proteins, 
multi-PDZ domain protein-1 (MUPP1). Other proteins involved are Ras-related protein (Rab3b), 
atypical protein kinase C (aPKC) and protease activated receptor 3 (PAR-3) (Venkatasubramanian 
et al. 2015).  
 
Protein kinases are crucial mediators of fundamental intracellular signal transductions, 
transport and barrier permeability of the gastrointestinal epithelium (Farhadi et al., 2006; 
Song et al., 2001). PKC is a diverse subfamily of serine/threonine kinases that are 
categorised into 12 isoforms (Farhadi et al., 2006). These isoenzymes are classified into 
three subtypes depending on their sequence homology, sensitivity to activators and 
cofactors (Farhadi et al., 2006; Song et al., 2001; Davidson et al., 1994). In the intestinal 
epithelium, activation of PKC isoforms is linked with an increase in paracellular permeability 
through actin polymerisation, with pan-inhibition of PKC promoting the recovery of TJs from 
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lecithin-induced leak (Sawai et al., 2002; Fasano et al., 1995). Conversely, studies show 
that TJ proteins interact with PKC isoforms to initiate assembly of the TJ complex, resulting 
in enhanced barrier function (Gonzalez-Mariscal et al., 2008; Stuart and Nigam, 1995; 
Harhaj and Antonetti, 2004). However, the precise mechanisms of PKC regulation are not 
fully understood.  
1.2.3 The intestinal barrier and microflora 
The GI mucosa is the interface between the internal structure and the external environment. 
This IEC monolayer is exposed to diverse antigenic substances from food and gut 
microflora. The importance of commensal microbiota for intestinal epithelium function was 
demonstrated in germ-free mice that experienced a significant reduction in mucosal layer 
thickness and antimicrobial product levels (Nagai et al., 2016).    
IECs recognise microorganisms through pattern-recognition receptors (PRRs), such as 
Toll-like receptors (TLR) and nucleotide binding oligomerization domain (NOD) 1 and 2. 
Paneth cell along with NOD2 produce α-defensins when they sense bacterial invasion. A 
damaged NOD2 function has been linked to gut microbial dysbiosis leading to Crohn’s 
disease development (Nagai et al., 2016). 
The bacterial endotoxin lipopolysaccharide (LPS) enhances intestinal layer function at a 
moderate concentration (Petersson et al., 2010), however excess can cause inflammation 
and lead to septic shock (Patterson and Watson, 2017; Beutler and Rietschel, 2003). The 
IEC secretes alkaline phosphatase enzyme to detoxify LPS, thereby preventing 
inflammation and shock (Bates et al., 2007). In addition, TLR-5, another bacterial 
component was demonstrated to reduce host’s ability of controlling intestinal microbial 
community by decreasing innate immunity (Vijay-Kumar et al., 2010). Gut bacterial flagellin 
acts as ligand for TLR-5, and the component defend against infection and lack of TLR-5 is 
correlated to metabolic changes that cause serious dysbiosis and metabolic disease 
development. Microbiota transplantation from TLR-5 deficient mice to germ-free mice 
demonstrated these implications (Vijay-Kumar et al., 2010). 
Microbial metabolites also influence IBF. Microbial metabolites, especially short-chain fatty 
acids (SCFA) (e.g., acetate, butyrate and propionate) are important for barrier function and 
disease prevention. Other gut microbial metabolites (e.g., indole, lactate) influence IEC 
proliferation and barrier function (Nagai et al., 2016). Therefore, GM and their metabolic 
products play a significant role in host health and wellbeing through epithelial barrier 
function. 
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1.3 Regulation of intestinal barrier by diet and gut microbiota 
Diet have direct effect on intestinal barrier. Dietary components have demonstrated effects 
on the expression and distribution of TJ leading to intestinal permeability (Ulluwishewa et 
al., 2011). Diet also influences the microbiota surrounding the intestinal epithelium. Within 
the intestinal tract, there are more than a hundred trillion microbes such as bacteria, fungi, 
protozoa, and archaea (Ley et al., 2006); referred to as gut ‘microbiota’ or ‘normal flora’ 
(Fukuda and Ohno, 2014). Recent studies demonstrate crosstalk between GM and IBF 
(Nettleton et al., 2016; Wells et al., 2011).  ~60% of human GM is bacteria, comprising of at 
least 1000 species but diversity is limited (Schuijt et al., 2013) (fig.1.1.5).  
 
 
Figure 1.1.5: Major groups of intestinal microbiota.  
Around 80% of the intestinal microbiota can be classified into three phyla: Firmicutes, Bacteroides, 
and Actinobacteria, although interindividual and interpopulation differences in gut microbiomes exist 
(Yatsunenko et al., 2012). Other bacterial phyla include the Proteobacteria, including various 
pathogenic or inflammatory groups, and the Verrucomicrobia, the latter one solely represented by 
the mucus-utilizing Akkermansia spp. Figure adapted from (Schuijt et al., 2013).  
 
Of the ~28 phyla identified so far, only four phyla, Firmicutes, Bacteroidetes, Actinobacteria 
and Proteobacteria, make up the most of the GM (Nettleton et al., 2016; Fukuda and Ohno, 
2014).  
B. thetaiotaomicron, B. vulgatus, B. distasonis, B. fragilis are the four key species of 
intestinal Bacteroides, predominantly found following the consumption of a high-protein and 
-animal fat diet, whilst Prevotella enterotype are frequently identified in hosts consuming a 
high-carbohydrate diet (Fukuda and Ohno, 2014; Sears, 2005). Diet low in plant fibre and 
high in sugar and saturated fat causes major changes in the bacterial phyla and decrease 
their diversity significantly (Nettleton et al., 2016).  
Wu et al. (2011) found that eating energy rich high-fat, low-fibre or low-calorie, low-fat, high-
fibre diets rapidly changed GM composition and function. Despite changes, the key 
composition and overall classification of the individual’s microflora was unaltered (Wu et al., 
2011). Such fast changes in response to diet might be explained by the fact that microbes 
can double their population within an hour (Myhrvold et al., 2015). Also, gut epithelial cell 
turnover time is two to five days (Van Der Flier and Clevers, 2009). However, long-term 
11 
 
dietary behaviours remain the major influence in shaping the individual’s GM (Wu et al., 
2011; Muegge et al., 2011; De Filippo et al., 2010). 
1.3.1 Formation and development of gut microbiota 
The sterile condition in the uterus means that mammalian foetuses acquire their microbiome 
during and after birth. The GI tract undergoes rapid microbial colonisation in infants, 
eventually becoming a unique ecosystem. Delivery mode, mother’s health, hygiene, 
gestation period, and breast feeding are important factors for microbial composition. During 
the early stage of life, the facultative anaerobes are predominant in the gut whilst 
Bacteroidetes and Firmicutes overtake eventually (Nagai et al., 2016). The infant GM 
demonstrates dynamic changes, greater degree of variability among individuals and are 
less stable. By the age of 2.5 to 3 years, the composition, diversity and functional capacity 
of the child microbiota resemble those of adults (Rodriguez, 2015; Koenig et al., 2011). The 
adult GM is relatively stable until ~70 years, however, life events may perturb the 
composition (Biagi et al., 2010). 
1.3.2 The influence of diet on gut microbiota 
The regular diet is one of the most important factors that shapes GM. De Filippo et al., 
(2010) compared intestinal microbiota of a rural village in Burkina Faso with an urban area 
in Italy, finding higher microbial diversity in children in Burkina Faso. The African diet rich in 
complex carbohydrate and fibre, whilst low in fat and animal protein created distinct 
differences in phyla composition in comparison to the European diet rich in processed 
sugars and fat whilst low in fibre. Similarly, adult diets rich in animal protein and saturated 
fats were shown to increase enterotype Bacteroides, whilst diets rich in complex 
carbohydrates increased Enterotype, Prevotella (Wu et al., 2011). These indicates the 
importance of diet in shaping intestinal microbiota. 
Dietary habit also influences the composition and function of the gut microbiota (Makki et 
al., 2018; David et al., 2014). Short-term exposure to a diet composed entirely of either plant 
or animal products have the capacity to alter gut microbial community structure, implying 
the potential rapid effect of human dietary lifestyles on gut microflora (David et al., 2014). 
The ‘western or omnivorous diet’ contain refined carbohydrates, simple sugars and 
saturated fats that enhances negative alterations in microbiota leading to metabolic 
disorders (Tomasello et al., 2016). Oppositely, dietary fibres directly interact with gut 
microbial metabolism and impacts their ecology, thereby influencing host physiology and 
health (Makki et al., 2018). For example, adherence to the Mediterranean diet that includes 
high-level of cereals, fruit, vegetables, and legumes, have health benefits (De Filippis et al., 
2016). Study on a 12-month long Mediterranean diet intervention in European elderly 
subjects demonstrated specific positive alterations of the gut microbiota and reduced frailty 
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(Ghosh et al., 2019). Mediterranean diet lowered several markers of frailty and 
inflammation, as well as improved cognitive function of the subjects. The diet also enriched 
the bacterial taxa in the keystone interaction positions of the microbiome ecosystem but not 
the peripheral frailty-associated taxa. Additionally, the diet-modulated microbial metabolism 
produced more short/branch-chained fatty acids whilst less secondary bile acids, p-cresols, 
ethanol and carbon dioxide, which helps frailty (Ghosh et al., 2020). The study highlighted 
the importance of dietary intervention in promoting healthier ageing via the gut microbiota 
modulation, which implies the role of diet on GM composition and function.  
Similar protective health advantages were demonstrated when vegan diets were compared 
to vegetarian and omnivorous diets (Wu et al., 2016). Comparing the dietary intake, gut 
microbiota composition and the plasma metabolome using 16S rRNA-tagged sequencing 
along with plasma and urinary metabolomic platforms, Wu et al. (2016) showed the distinct 
difference in GM composition and metabolites of the healthy human vegans and omnivores 
in an urban USA environment. Vegan gut profile displays distinct microbiota than that of 
omnivores, although not always significantly different from that of vegetarians (Glick-Bauer 
and Yeh, 2014). The vegan diet reduce abundance of pathobionts whilst increase 
abundance of probionts, thereby lower the levels of inflammation (Tomasello et al., 2016; 
Kim et al., 2013). The vegan diet for one month could potentially decrease the disease 
activity of rheumatoid arthritis patients by changing the GM profile (Peltonen et al., 1997). 
In a study on patients with metabolic syndrome (n = 6), Kim et al. (2013) also showed that 
adherence to strict vegetarian diet for a month improved health along with reduction of 
Firmicutes-to-Bacteroides ratio. Without altering the enterotypes, the strict vegetarian diet 
led to a decrease in the pathobionts (e.g., Enterobacteriaceae) and an increase in 
commensals (e.g., Bacteroides fragilis). Therefore, the above-mentioned findings show that 
different dietary patterns hugely influence the GM which eventually impact host 
health.Beside the complete diet, food additives also impact the composition and function of 
gut bacteria. Food additives are employed for many reasons, such as to increase taste, 
aesthetic and possible food storage time (Nagai et al., 2016). Dietary emulsifiers have an 
enormous effect on GM. The US FDA approved two food emulsifiers, Carboxymethyl 
Cellulase and Polysorbate 80, as safe for health. However, their acceptable daily intake 
levels caused a reduction of the colonic mucin layer in wild-type mice (Chassaing et al., 
2015). Research showed that emulsifiers alter GM composition, increasing mucolytic 
bacteria abundance whilst decreasing Bacteroidetes, resulting in reduced SCFA 
production. Several studies have demonstrated the relation between emulsifiers and 
metabolic syndrome development (Chassaing et al., 2015). Artificial sweeteners (AS), 
widely used for reducing energy intake, are another food additive linked with microbiota-
modulating effect (Nagai et al., 2016). Several epidemiological studies have demonstrated 
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the correlation between AS consumption and the development of glucose intolerance and 
type 2 diabetes (Suez et al., 2014; Nettleton et al., 2016).  
1.4 Artificial sweeteners 
1.4.1 Sugar and sugar substitutes 
Sugar from refined cane and beet are not only expensive but also high in calorie, which has 
been linked with obesity-mediated metabolic disorders in Western countries (Cordain et al., 
2005). Diet that include sugar more than 22.5 g per 100 g or 27 g per portion of food is 
regarded as high-sugar diet (NHS, UK). High-carbohydrate diet containing more free 
sugars, specifically, more than 30 g of free sugar in the daily reference intake of 90 g total 
sugar, can cause weight gain and other health issues (NHS, UK). Continued exposure of 
the intestinal tract to a high-fat or high-carbohydrate (with free sugars) diet is associated 
with gastric permeability; where the intestinal barrier breaks down and becomes leaky 
(Payne et al., 2012; Frazier et al., 2011; Stenman et al., 2013; Damci et al., 2003; Watts et 
al., 2005). Sustained gastric permeability results in the entry of bacteria and/or antigens into 
the circulation, causing systemic inflammatory response, sepsis and multiple organ failure 
(Liu et al., 2005; Ukleja et al., 2010) (fig.1.1.3).   
As blood sugar level is a key contributor to metabolic syndrome (NHS, UK, 2019), food 
science has incorporated AS into food to provide sweetness without the effects of sugar 
(Anton et al., 2010). AS are synthetic sugar substitutes, used as food additives to provide 
the sweet taste in low-calorie foods (Suez et al., 2015; Payne et al., 2012) (fig.1.1.6).  
Chemicals eliciting sweet taste perception, namely glucose, other carbohydrates like 
fructose, AS and proteins like monellin and thaumatin vary largely in terms of their chemical 
structures (fig.1.1.6) (Keast et al., 2004). In addition, they differ in the receptor-binding 
mechanism and taste signal transduction mechanism, but all of them generate sweet taste 
perception (Keast et al., 2004; Zhao et al., 2003). AS listed in table 1.1.1 are many times 
sweeter than table sugar and are widely used in various food substances to reduce the 
energy consumption in food and beverages, and therefore, used for the present study.   
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Table 1.1. 1: Artificial sweeteners used in the study with sweetness level compared to sucrose. 
Information adapted from Rolfes et al. (2014) and Gardner et al. (2012) unless mentioned otherwise. 
*blended with aspartame; $ equivalent to 2 teaspoon sugar; # FDA approved ADI for 150-pound (68 kg) person; Bw=body weight, ADI=acceptable daily intake, 
T1R2/T1R3–the sweet taste receptor.  FDA=Food and Drug Administration (USA), EFSA=European Food Safety Authority. 
Represent the amount of sweetener if the product is exclusively sweetened with one sweetener. Very frequently more than one sweetener is used in soda 
or other products. Usually this information is proprietary and unavailable to the public; the exception is saccharin. The amount of saccharin must be listed in 
the ingredient list. The maximum amount is 12 mg/ounce fluid. 
 
 
Figure 1.1.6: Structure of sucrose and the artificial sweeteners used in the study. 
The panels represent the name, molecular structure and chemical formula of the AS. Figures adapted from PubChem, 2019.
Commercial 
name 
Artificial 
sweetener 
‘Sweetness’ 
relative to 
sucrose (the 
table sugar) 
Energy 
(Kcal/g) 
(Whitehouse et 
al., 2008) 
Concentration 
stimulate 
T1R2/T1R3 (Li 
et al., 2002) 
ADI 
(mg/kg bw) 
EFSA/ FDA 
Representative 
amount of AS in 
12-ounce Soda, 
(mg) 
Amount of 
AS in a 
packet$ (mg) 
No. of 
packets 
equal to ADI#  
Sweet n low Saccharin 300-450 0 1 mM 0-5 / 15 8* 40 8.5 
Splenda Sucralose 600 0 1 mM 0-15 / 5 68 11 30 
Equal Aspartame 160-200 4 2.5 mM 0-40 / 50 187 40 68 
E961 Neotame 7000-13000 0 0.1 mM 2 / 0.3 No consumer product in the UK 
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Eating a healthy and balanced diet is one of the important ways of preventing MD (NHS, 
UK, 2019). People often select AS to reduce calorie intake and blood sugar level (Gardner 
et al., 2012; de La Peña, 2010). In fact, AS is useful for diabetics to get sweet taste 
perception (Johnston et al., 2013; Gardner et al., 2012). The use of AS is not limited to food 
and beverages but extended to pharmaceutical and cosmetic industries (Whitehouse et al., 
2008). Therefore, the use of AS is popular and its global market still growing. The world 
consumption of AS is estimated to be ~159,000 metric tons with a market value of USD $2 
billion (Praveena et al., 2019).  However, the effect of AS remains controversial, and the 
physiological effect of AS needs to investigate further. 
1.4.2 The sweet taste receptor 
Sweet taste modality takes place by the activity of two genes (T1R2 and T1R3) of the T1R 
family. T1R2 was identified by sequencing a deducted cDNA library obtained from rat taste 
tissue in 1999. It has a distinct expression pattern and was more enriched in the 
circumvallate taste buds (reviewed by Li, 2009). The T1R3 was identified in human genome 
in 2001, which was recognised as the sac (a locus related to sweet taste sensitivity) gene 
in mice. Studies on transgenic mice introducing T1R3 gene from a taster to a non-taster 
individual confirmed that T1R3 in human is the sac gene in mice (reviewed by Li, 2009). 
Similar to sugar, AS stimulate the sweet taste receptors T1R2/T1R3; G-protein coupled 
receptors which, when stimulated, are expressed at the plasma membrane (Elliott et al., 
2011). Among the various receptors, T1R2 and T1R3 in combination are activated by sweet 
taste molecules (Assadi-Porter et al., 2010; Zhao et al., 2003). T1R has three main domains; 
the extracellular Venus-flytrap domain (VFD), the cysteine-rich domain (CRD) and the 
transmembrane domain (TMD) (Jiang et al., 2005). The VFD is a clam shell-shaped 
structure in the amino-terminal domain and is linked with the heptahelical spanning C-
terminal TMD by the CRD (Fernstrom et al., 2012; Jiang et al., 2005) (fig.1.1.7). After the 
TMD, there is a short intracellular carboxyl-terminal tail (Jiang et al., 2005).   
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Figure 1.1.7: The heterodimeric sweet taste receptor, T1R2 and T1R3.  
The receptor composed of three distinct interlinked domains and is partially embedded in the 
intracellular region with a short carboxyl-terminal tail. Figure adapted from Fernstrom et al., 2012. 
The sweet taste perception only occurs if the molecule can stimulate the relevant receptor 
T1R2/R3 (Keast, 2003). Selective elimination of T1R subunits abolishes the detection and 
perception of sweet taste modality. By incorporating the human T1R2-receptor in mice, 
Zhao et al. (2003) demonstrated a humanized sweet taste preference in the animals. 
Besides, engineered animals expressing a modified opioid-receptor in sweet cells showed 
strong attraction to a synthetic opiate. The study showed that sweet cells trigger behavioural 
outputs, however, the nature of the receptors determine the animal’s tastant selectivity 
(Zhao et al., 2003). Similarly, Damak et al. (2003) demonstrated that mice lacking T1R3 
showed no preference for AS. However, the mice had not abolished behavioural and nerve 
responses to sugars completely, rather they showed lessened responses to sweet 
molecules. Their study suggested that taste cells could have T1R3-independent sweet 
responsive receptors and/or pathway (Damak et al., 2003).   
1.4.3 AS consumption and gut physiology 
Health-conscious individuals or those trying to lose weight usually consume AS as a sugar 
substitute (Anton et al., 2010). However, the irony is that research in AS showed links to 
the development of glucose intolerance (Suez et al., 2014).  
The effect of AS on health via promoting hunger and unbalancing energy has been greatly 
debated. Research suggests that AS might cause metabolic disturbances because they are 
not physiologically inert (Wal et al., 2019). As mentioned, AS stimulate the gut sweet taste 
receptor (STR), which can interact with biochemical pathways, causing incretin release. The 
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receptors can alter appetite signalling and emptying rate through changes in osmotic load 
(Mattes and Popkin, 2008). Furthermore, taste receptor activation can stimulate the 
glucagon-like peptide, GLP-1 release (Jang et al., 2007). Activation of these pathways might 
modify glucose absorption, which in turn might participate in glucose intolerance (Shirazi-
Beechey et al., 2014). Moreover, these compounds delay gastric emptying, and alter brain 
responses indicating possibilities for negative impact on health (Meyer-Gerspach et al., 
2016). Therefore, AS consumption can directly impact intestinal epithelium and lead to MD 
development (fig.1.1.8). 
Moreover, AS have been demonstrated to alter GM diversity (Nettleton et al., 2016), thereby 
unbalancing the symbiotic conditions (Suez et al., 2014). An imbalance of microflora 
(dysbiosis) makes the host prone to a variety of MD including obesity, insulin resistance, 
cardiovascular diseases and diabetes (Nettleton et al., 2016; Fukuda and Ohno, 2014; 
Muegge et al, 2011; Suez et al., 2014).  However, the role of AS on bacterial pathogenicity 
of GM is unknown. Alterations in the GM is also associated with intestinal barrier 
permeability (fig.1.1.8). The barrier leak allows antigenic substances such as LPS to cross 
the intestinal lining, resulting in inflammation and metabolic endotoxaemia (Konig et al., 
2016). This indicates people already suffering from glucose intolerance or obesity, 
consuming AS to control sugar level, could exacerbate their situation by triggering altered 
biochemical pathways (Pepino, 2015). 
In addition, high-fat and high-carbohydrate diet alters TJ expression and distribution 
(Ulluwishewa et al., 2011). TJ alterations are linked to intestinal paracellular permeability; 
many studies link intestinal permeability and MD, but, minimal literature on the effect of AS 
on intestinal permeability (Cani et al., 2008). Kimmich et al. (1988) showed that saccharin 
(25 -130 mM) had a minimal effect on active transport of sugar from the lumen of chick IEC 
to the intracellular space, however, it inhibits passive transport from the basolateral 
boundary. Saccharin mediated inhibition of efflux allowed active system creating a 
concentration gradient of sugar. In addition, saccharin restricted transport of sugar to the 
IEC and into circulation by compromising the epithelial cells capacity to form sugar gradients 
(Kimmich et al., 1988).  
Furthermore, the investigators demonstrated the inhibitory effect of 20 mM saccharin on 
ATP driven increase in sodium ion (Na+) permeability in exogenous IEC from three-week 
old chickens. This conserved the IEC capacity for sodium dependent sugar transport. 10 
mM saccharin showed partial protection (Kimmich et al., 1989). On the other hand, 
saccharin, but not sucralose and aspartame, increased the paracellular permeability of IEC 
cell model Caco-2 (Santos et al., 2018). Saccharin decreased the transepithelial electrical 
resistance of the Caco-2 cells in a dose-dependent manner, and 10 mM caused highest 
reduction. In addition, saccharin exposure reduced the TJ protein, claudin-1, without 
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affecting the other TJ such as JAM-A, occludin-1 and ZO-1 protein content (Santos et al., 
2018). Decrease in claudin-1 protein could have negative effect on the monolayer 
permeability. 
As noted, the literature on the role of AS on intestinal permeability is limited. The above-
mentioned studies show differential results; saccharin inhibited passive sodium dependent 
sugar transport in chick IEC (Kimmich et al., 1988) while saccharin increased paracellular 
permeability and decreased TEER in IEC model (Santos et al., 2018). However, the 
downstream metabolic effect of AS consumption remained elusive. Therefore, further 
investigations are important to understand how AS impact IEC, GM, and the intestinal 
epithelium– GM axis.  
 
Figure 1.1.8: Schematic figure showing the artificial sweetener consumption and link to 
metabolic disease conditions.  
AS consumption can directly affect the intestinal epithelial cell function or via gut microbiota activity, 
thereby leading to epithelial barrier dysfunction which is a crucial reason for metabolic disease 
development. 
 
1.4.4 Metabolism of AS in the intestine 
The capacity to metabolise AS has remained controversial. AS are thought to stimulate 
sweetness via GLUT2 up-regulation in the intestine similar in mechanism to glucose (Price 
et al., 1970). However, AS might enhance natural sugar uptake (Price et al., 1970), cause 
glucose intolerance (Suez et al., 2014), and stimulate hunger thereby affecting metabolic 
pathways (Payne et al., 2012).  
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Studies are available regarding changes in microflora following AS consumption in terms of 
abundance, composition, and diversity, but research on GM associated metabolism of AS 
is limited.  Several gut bacteria were reported to have the capability to convert cyclamates 
into cyclohexylamine (Renwick, 1985), the derivative is more toxic than cyclamate, and 
metabolism of cyclohyxylamine differs in individual hosts at different times (Coates and 
Walker, 1992).  
In addition, saccharin also changes the metabolic activity of GM. In rats, saccharin inhibited 
β-glucuronidase activity and proteolysis, and enhanced carbohydrate and protein 
accumulation, leading to enlargement of rat caecum. However, these metabolic changes 
were found when consumption was higher than ‘acceptable’ daily intake (Coates and 
Walker, 1992), leading to a lack of clarity, thereby urging further investigations. 
1.4.5 Co-culture model for host-microbiota interactions 
IEC are frontline participants interacting with GM, responsible for the initiation and 
regulation of intestinal epithelial response. The in vitro co-cultivation of model gut bacteria 
and IEC represents a common approach to mimic the host responses to certain food 
component. Considering the intrinsic limitations and complexities of studying different area 
of the GI tract in vivo, Marzorati et al. (2014) developed a device named Host-Microbiota 
Interaction (HMI) module to study the eukaryote-prokaryote interplay in vitro. The HMI 
module allows relevant conditions of the GI tract, representing a GM community to be co-
cultivated microaerophilically with human IEC up to 48 hours. The device might contribute 
to the mechanistic understanding of indirect GM-host interactions in the GI tract (Marzorati 
et al., 2014).  
In vitro models simulate gut microbial processes and represent enticing alternatives to 
rapidly test hypothesis since they are cheap, flexible, scalable and offer improved 
throughput (reviewed by Fritz et al., 2013). Compared to in vivo samples, downstream high-
resolution molecular analyses of in vitro samples are simpler. An ideal in vitro model of host-
microbiota interactions is presented in fig.1.1.9. 
Obviously, findings from co-culture model cannot be directly compared to in vivo conditions. 
But the co-culture model like Caco-2 and model gut bacteria, represents benefits for 
simplicity and reproducibility (reviewed by Fritz et al., 2013). Also pursuing the role of a 
dietary component such as AS in a co-culture model provides molecular mechanisms for 
future studies which might be unmanageable to address in vivo. 
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Figure 1.1.9: Conceptualization of an ideal in vitro model of gastrointestinal host-microbiota 
interactions.  
The co-culture model should include separate chambers for microbial, human epithelial and human 
immune cell culture. The chambers should be separated by semipermeable membranes, thereby 
preventing microbes to overtake human cells while permitting molecular crosstalk between them. 
Figure taken from Fritz et al. 2013. 
 
1.4.6 Inhibition of the sweet taste receptor 
STR activity is blocked by sweet taste inhibitors (Assadi-Porter et al., 2010; Jiang et al., 
2005). Lactisole is a common inhibitor (Assadi-Porter et al., 2010) that suppresses the 
sweet taste of substrates like table sugar, intensively sweet proteins such as thaumatin and 
monellin, and ASs (Jiang et al., 2005). Lactisole is composed of a carboxyl group and a 
hydrophobic phenoxyl group, and this molecular structure is important for suppression of 
the STR (Jiang et al., 2005; Xu et al., 2004). 
In addition to Lactisole, zinc is a potent sweet taste inhibitor which suppresses the sweet 
taste perception of a number of sweeteners namely glucose, fructose, sucrose, maltose 
and AS such as sucralose, acesulfame K, aspartame, saccharin (Keast, 2003; Iwasaki and 
Sato, 1986). Although the mechanism of inhibition by zinc ions is unclear, several studies 
demonstrated that zinc sulphate (ZnSO4) inhibits perceived ‘sweetness’ of compounds in a 
dose-dependent manner (Keast et al., 2004). 
Moreover, use of taste receptor siRNA, knockout cell line (Wauson et al., 2012) or knockout 
mice could be other options to investigate the role of the receptor in sweet sense mediated 
biochemical mechanisms.  
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Aims and hypothesis 
The broad research objective for the PhD is to develop our understanding of the molecular 
mechanisms regulating key gut microbiota and gastric permeability in populations 
consuming a normal or high concentration of artificial sweeteners in their diet.  
The hypothesis for the PhD is that artificial sweeteners negatively impact gut health 
through damage to the epithelium, increased pathogenicity of two key microbiota, 
and disruption of the interplay between the epithelium and the microbiota. Studies 
will focus on the role of sweet taste sensors to address this hypothesis.  
The overall impact of this research is to demonstrate the effect of AS in the diet and how 
they can promote gut leak and pathogenicity of key microflora bacteria. Research into this 
area will extend our knowledge of the role of diet components, and particularly additives 
such as sweeteners, in regulating gut physiology. These findings can impact our 
understanding of the link between diet, microbiota and the molecular mechanisms leading 
to metabolic diseases such as diabetes.  
 
The PhD project will be studied via four specific aims: 
 
Aim I: to understand the role of artificial sweeteners (AS) on an in vitro model of the 
intestinal epithelium; 
 
Aim II: to assess whether AS affect metabolism and pathogenicity of model gut bacteria; 
 
Aim III: to establish whether AS exposure has an impact on the interactions between the 
model gut microflora and intestinal epithelium using a co-culture model;  
 
Aim IV: to determine whether the effect of AS on the intestinal epithelium and model gut 
microflora is mediated through sweet taste sensors.  
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2 Effect of artificial sweeteners on intestinal epithelial 
cells 
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2.1 Introduction 
2.1.1 Intestinal epithelium 
The gut constitutes the most critical organ for host communication with the environment, 
representing the major ground for intricate interactions between host genes and the 
extrinsic immunological impact on the body (Brandtzaeg, 2011). The intestinal epithelium is 
the single layer that separates the gut lumen from the underlying lamina propria of the 
gastrointestinal (GI) tract. These proliferative epithelial cells carry out the rapid renewal of 
the intestinal epithelium and form many specialized cell types. Epithelial cells undergo a 
renewal process of cell division, maturation and migration every 4-5 days (fig.2.1.1) 
(Bischoff et al., 2014; Van Der Flier and Clevers, 2009). The stem cells residing at the crypt 
of the epithelial invaginations continuously carry out this process of renewal and replace the 
older cells. The new cells, along with their maturation, migrate toward and out of the crypt, 
eventually apoptosis and are shed into the intestinal lumen (Yen and Wright, 2006; Weiser, 
1973). Therefore, the intestinal epithelial layer remains the same, while renewed 
continuously by new cells.  
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Figure 2.1.1: The succession of intestinal epithelial cells. 
The life span of intestinal epithelial cells is 4-5 days. This life cycle is determined by the duration 
between cell migration from their origin at the crypt base to the villus tip, from where they are shed 
into the lumen. Figure adapted from Gunther et al., 2013. 
 
Among the different types of renewable intestinal epithelial cells (IEC), more than 80% are 
the absorptive enterocytes (Van der Flier and Clevers, 2009). Enterocytes are the most 
abundant IEC that play the major function of the maintenance of epithelial barrier integrity 
(Groschwitz and Hogan, 2009). The other important types of cells include the Goblet cells 
which produce mucus and peptide (fig.2.1.2), Paneth cells secreting antimicrobial peptides, 
Microfold cells (M cells) responsible for antigen delivery and secretive enteroendocrine cells 
which produce various bioactive molecules, such as, hormones (Van der Flier and Clevers, 
2009; Yen and Wright, 2006; Turner, 2009; Trier, 1963). However, some studies overruled 
these functional partitioning and appreciated the role of different cells performing the same 
function and vice versa (Geibel, 2005; Singh et al., 2005; reviewed by Binder et al., 2005). 
The intestinal epithelial layer, therefore, plays a vital role in the food digestion, nutrient 
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absorption and protection; appropriate maintenance and function of this layer are pivotal for 
good health while dysfunction can cause various diseases (Kong et al., 2018). 
 
Figure 2.1.2: Different cells in the intestinal epithelia. 
The single epithelial layer separates the intestinal lumen and the lamina propria. Intestinal stem cells 
differentiate into different types of intestinal epithelial cells such as enterocytes, enteroendocrine 
cells, goblet cells and Paneth cells. Enterocytes perform the absorption and transportation. Goblet 
cells secrete mucin which is heavily glycosylated and polymerized into an enormous net-like structure 
and plays a key role in keeping intestinal microbes at a distance from the epithelial surface. Paneth 
cells secrete antimicrobial peptides in the mucosa reflecting its central role in immunity and protection 
against pathogens. B cell activation and proliferation leads to antigen-specific secretory 
immunoglobulin A (sIgA) production in the gut associated lymphocytes via T-cell dependent 
pathways. Figure adapted from Bischoff et al., 2014. 
 
2.1.2 Intestinal epithelial layer and permeability 
The intestinal epithelial layer plays a dual role by regulating the nutrient and fluid uptake, 
as well as maintaining barrier and tolerance to the adjacent residing microflora. The 
selective nature of this barrier is fundamentally important for absorption while resisting the 
permeation of potentially hazardous substances present in the lumen. This selective 
function in the IEC layer is called ‘intestinal permeability’ (Brandtzaeg, 2011).  
This term, in the clinical studies, refers to the IBF and has been defined as “the ability of 
medium and large-sized water-soluble compounds to passively traverse the intestinal 
epithelial layer through paracellular tight-junctional areas” (Ma et al., 2012). As such, the 
relative leakage of hydrophilic probes across the intestinal barrier regulated by the TJs or 
paracellular pathways are used for measuring intestinal epithelial permeability. Therefore, 
markers of permeability, whether for in vitro or in vivo studies, need to be water-soluble and 
26 
 
passively absorbed, chemically inert and atoxic, not metabolised and easily measurable 
(Ma et al., 2012). 
2.1.3 Paracellular leak and related diseases  
As a critical interface connecting the host to the surrounding environment, any barrier 
breach could be the initial point in the pathogenesis of many intestinal or extra‐intestinal 
inflammatory disorders. Intestinal leak could also occur as a side effect of many disease 
processes, making the host susceptible to severe complications. Breakdown of the barrier 
can be implicated in various diseases including type 1 diabetes (T1D), irritable bowel 
disease (IBD), Crohn’s disease, coeliac disease, food allergy, sepsis, asthma and many 
more (Liu et al., 2007). Understanding the significance of the intestinal barrier in the 
pathophysiology of disease processes is, therefore, crucial to find out preventive and 
therapeutic measures. 
Increased intestinal barrier permeability to antigenic compounds is the hallmark of 
inflammatory responses related to metabolic disease conditions. Leakage can occur 
between (paracellular) or through (transcytosis) epithelial cells however there is no concrete 
research to show that these leakage pathways are linked (Armstrong et al., 2012). 
Increased gastric and intestinal permeability are linked to metabolic disease development 
such as insulitis and diabetes (Meddings et al., 1999). BB diabetes-prone (BBdp) and 
control, diabetes-resistant (BBc) rats were maintained on either a control or hydrolyzed 
casein diet for 175 days. Their weight gain, gastrointestinal permeability and diabetes 
development was assessed in relation to age. While no difference was recorded for the 
weight gain among the control and diabetes prone rat groups, development of diabetes 
varied. The control groups did not have diabetes on 100-day age, however, 80% of the 
BBdp rats maintained on regular diet developed diabetes. On the other hand, only 20% of 
the BBdp rats maintained on the hydrolyzed casein diet showed incidence of diabetes. 
Moreover, within 50 days of age, the gastric and small intestinal permeability was 
significantly increased in the diabetes prone rats. Although, the small intestinal permeability 
was normalised in the BBdp rats around 100 days of age, however, the gastric permeability 
remained in the rats by this time point (Meddings et al., 1999). These findings suggest that 
increased permeability have an early role for the development of several immunological 
diseases.  
Similar studies were conducted on healthy (n=161) and type 2 diabetic (n=130) individuals 
by Cox et al. (2017) to examine relationships between intestinal permeability and T2D. Their 
study showed that known cardiometabolic risk factors such as higher average BMI, a 
predominance of dyslipidemia, impaired glucose control and low-grade inflammation were 
significantly different between the T2D and control groups. The intestinal permeability risk 
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score was assessed by measuring the combination of circulating LPS, LPS-binding protein, 
and intestinal fatty acid binding protein, and the findings supported that intestinal 
permeability has association with risk for T2D (Cox et al., 2017). 
Furthermore, intestinal barrier permeability is associated with chronic inflammatory 
gastrointestinal diseases, such as IBD (Suenaert et al., 2002) and coeliac disease 
(Vogelsang et al., 1998). Also, increased small intestinal permeability is common in patients 
with T1D (Damci et al., 2003). In addition, impaired intestinal barrier provokes immune 
system function that affects other organs by causing diseases like IgA nephropathy, multiple 
sclerosis in the brain, non-alcoholic hepatic steatohepatitis (Turner, 2009). Dysfunction of 
the intestinal barrier is also linked to many extra‐intestinal and systemic disorders. Farhadi 
et al. (2003) reviewed the incidence of increased intestinal permeability in critically ill 
patients suffering from health issues like multiple traumas, extensive burn, shock, acute 
pancreatitis. Abnormal IBF was also linked to dermatologic disorders including eczema, 
psoriasis, urticaria‐angioedema and dermatitis herpetiformis (Hamilton et al., 1985) and 
several rheumatological disorders (Farhadi et al., 2003). Furthermore, ingress of the 
antigenic substances promotes systemic inflammatory response syndrome, which can lead 
to multiple organ failure (Ulluwishewa et al., 2011).  Beside the loss of TJ integrity, damage 
and apoptosis of the IEC can cause intestinal barrier dysfunction. Discernment toward the 
commensal microbiota and the dietary components and protection against pathogens 
require intact mechanisms of the intestinal epithelial barrier. 
Different food components can influence the breakdown of IBF through affecting cell 
viability, apoptosis, or by affecting the TJ expression and distribution. Glucose, the most 
common ingredient in the diet, is known as an absorption enhancer. Also, a significant 
portion of intestinal glucose absorption takes place via TJs, but not by transcellular active 
transport. Glucose was demonstrated to increase the intestinal intercellular permeability by 
changing the distribution of the TJ in Caco-2 cell line (Lerner and Matthias, 2015).  
There is a need to study the regulation of intestinal permeability to develop therapeutic 
intervention for these conditions. Given the complexity of in vivo models (Harrison et al., 
2004), it is useful to use in vitro cell models of the intestinal epithelium to establish the effect 
of different components.  
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2.1.4 Factors affecting intestinal barrier function 
The mammalian host defence mechanisms evolved with successful confrontations with 
external factors, and the immune system have been modulated and being shaped 
depending on the gut microbial pressure and extrinsic (including dietary) impact. The major 
determinant of the homeostasis is therefore the transport via intestinal barrier (Brandtzaeg, 
2011). Many factors influence and modulate the intestinal epithelial barrier. Multiple defence 
mechanisms regulate its function (fig.2.1.3), although the mechanisms of the permeation 
control have not yet been fully understood. The defence relies mainly on the function of the 
epithelial (the mucus layer and epithelial cells) and the immunological (the epithelial 
secretions and immune cells) barrier (Pijls et al., 2013a; Pijls et al., 2013b). The structural 
element of these cells, TJs, the intraepithelial pathways altogether have a regulatory role 
on the intestinal permeability (Farhadi et al., 2003). Also, both hereditary and environmental 
factors, and their combination effect, modulate the intestinal permeability. Hereditary factors 
include the epithelial and mucosal immune system, and the environmental factors include 
diet, infectious agents, drugs and toxins. The other factors that belong to the transition of 
the hereditary and environmental factors include food allergy, bacterial flora, inflammatory 
reactions and stress (Farhadi et al., 2003).  
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Figure 2.1.3: The intestinal epithelial defense system. 
The primary layer of defence in the gut system is the mucus layer, which act as a chemical barrier to 
critically limit the contact between the microflora and epithelial cells. The second level is the single-
layer intestinal lining that consists of different epithelial cells (fig.2.1.1), and act as a physical barrier. 
The appropriate connections between the epithelial cells are facilitated by many tight junction 
proteins that seal the paracellular pathway and conduct selective gate and fence functions. The next 
level is the lamina propria which is a thin layer of connective tissue and play critical role in promoting 
strong communication between the microflora and the immune cells. Immune cells that belongs to 
the intestinal epithelial system also function in close relation with the intestinal epithelial cells to 
maintain intestinal homeostasis and to resist unwanted external substances. Figure adapted from 
Chelakkot et al., 2018. 
 
2.1.4.1 Role of cell-cell junction molecules 
The intercellular junctional complex is a crucial regulator for the maintenance of intestinal 
barrier integrity. The TJ are the multifunctional complex that helps to maintain the barrier by 
forming a seal between (sealing the paracellular space between) adjacent epithelial cells 
(fig.2.1.3). TJ types and their role has already been described in general introduction 
(section-1.2.1). However, the TJs are a dynamic structure and their expression and function 
are influenced by the external stimuli, such as the components in the diet, microbiota, 
microbial metabolites (Armstrong et al., 2012). 
2.1.4.2 Intracellular mediators 
Intracellular mediators, such as nitric oxide (NO), play various roles in regulating intestinal 
permeability. NO modulates both the epithelial cells and the microcirculation, appearing as 
a significant regulator of the normal physiology of the GI tract (Farhadi et al., 2003). 
Constitutive NO synthase-derived low-level of NO help to reduce the consequence of acute 
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inflammation, while the inducible form of nitric oxide synthase-derived NO overproduction 
is associated with prolonged inflammatory conditions as in sepsis and IBD (Alican and 
Kubes, 1996). The mechanism of NO overproduction mediated intestinal barrier dysfunction 
is complex. Both in vivo and in vitro studies indicate that increased induced NO synthase 
activity is linked to LPS as well as other inflammatory cytokines and other mediators 
(Forsythe et al., 2002). 
2.1.4.3 Inflammation (mast cells, microflora/LPS, cytokines) 
Mast cells are a keystone in modulation of intestinal permeability. Mast cell mediators are 
involved in the impaired intestinal barrier associated pathogenesis induced by food allergy, 
psychological stress and intestinal inflammatory processes. Santos et al. (2001a,b) showed 
that mast cells play an important role in colonic epithelial barrier function. Comparing the 
mast cell deficient (Ws/Ws) and positive (+/+) rats, they have demonstrated that chronic 
stress significantly increased epithelial barrier leak in mast cell positive mice compared with 
non-stressed controls, but not in mast cell deficient ones. The study suggested that mast 
cells are required for expression of stress induced epithelial transport abnormalities in the 
rat colon.  
Interactions between the commensal microflora and intestinal epithelium affect the barrier 
permeability. Garcia-Lafuente et al. (2001) demonstrated that bacterial colonization could 
modify the intestinal barrier permeability. Colonization of some bacteria such as Escherichia 
coli, Klebsiella pneumoniae and Streptococcus viridans significantly increased intestinal 
permeability in the rat, while Lactobacillus brevis had the opposite effect, reduced 
permeability (Garcia-Lafuente et al., 2001). Bacteroides fragilis did not have any effect on 
the rat intestinal permeability. However, it remained unclear whether the permeability 
changes were through direct bacterial actions or host immune system response. 
LPS is the most prominent endotoxin in the gut environment (Moreira et al., 2012). 
Considering the number of GM, the amount of LPS in the enteric reservoir can reach ≥ 1g 
(Berg, 1996). The level of LPS in the gut reservoir vary depending on diet and other factors, 
a high fat meal consumption can cause postprandial increase in LPS levels of healthy men 
between 33 and 50 g in comparison to fasted individuals (Moreira et al., 2012). Bacterial 
endotoxin LPS play an essential role in the intestinal epithelial barrier permeability 
(Patterson and Watson, 2017). Although the physiological effects of LPS in the IBF 
remained unclear, however, studies indicate it causes intestinal injury, enhances 
overproduction of NO and promotes bacterial translocation (Forsythe et al., 2002).  
Guo et al. (2013) demonstrated the effect of different concentrations of LPS (0 to 1 ng/mL) 
on the intestinal epithelial barrier function using in vitro (Caco-2 cell monolayer) and in vivo 
(mouse intestinal perfusion) intestinal epithelial model system. They showed that LPS at 
high concentrations in the mucosal surface do not affect TJ-mediated IBF. At concentrations 
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1 and 50 µg/ml in the apical surface, LPS had no effect on the Caco-2 cell transepithelial 
resistance or inulin flux (Guo et al., 2013). The increase in intestinal TJ-permeability was 
mediated by an intracellular mechanism involving an increase in TLR-4 expression in the 
enterocyte membrane, thereby increasing the co-localization of the membrane-associated 
protein CD14. In vivo, clinically relevant plasma concentrations of LPS (intraperitoneal 
injection of 0.1 mg/kg) also caused a time-dependent increase in intestinal permeability 
(Guo et al., 2013). Moreover, Mathan et al. (1988) challenged conventional and specific 
pathogen free (SPF) mice with subcutaneous C5LPS (LPS from Salmonella typhimurium 
strain C5) concentrations ranging from 0.5 to 200 µg. Their study showed no change in both 
type of mice at concentrations less than 10 µg. However, 100% conventionalized mice 
challenged with 50 and 100 µg LPS produced an intestinal microvascular lesion leading to 
fluid exudation into the lumen of the intestine and diarrhoea. On the other hand, challenging 
SPF mice with 50 µg LPS caused vascular damage in a few blood vessels in lamina propria 
but did not develop diarrhoea. However, only 200 µg LPS in SPF mice caused fluid 
accumulation and bacterial growth enhancement (Mathan et al., 1988). Taken together, 
these studies suggest that LPS-mediated injury takes place at high concentrations. Also, 
Mathan et al. (1988) challenged mice with subcutaneous LPS injection and produced injury 
at concentrations ranging from 50 and 200 µg, prompting the study of higher levels of LPS 
for this in vitro study. 
2.1.4.4 Diet 
Diet influences the intestinal barrier permeability by regulating the TJs and the GM. 
Intestinal microbiota can ferment undigested dietary components to affect the barrier 
integrity. For instance, butyrate production by the colonic bacteria facilitates TJ assembly 
and enhance the barrier integrity (Peng et al., 2007). Diet also modulates the GM with direct 
and indirect regulatory effect on barrier function, as discussed in the main introduction 
(section-1.3). 
In addition to bacteria, dietary components directly regulate the expression and distribution 
of the TJ proteins, thereby affecting the permeability. Drago et al. (2006) demonstrated 
gliadin (a glycoprotein present in wheat) induced increased barrier permeability due to 
downregulation of the TJs, ZO-1 and occludin. Both IEC6 and Caco-2 cells released zonulin 
in the cell medium when exposed to gliadin, with subsequent zonulin binding to cell surface, 
cell cytoskeleton rearrangement, drop of occludin-ZO1 protein-protein interaction, resulting 
in an increase in monolayer permeability. Similarly, ex vivo intestinal samples from human 
coeliac patients in remission expressed a sustained luminal zonulin release when exposed 
to gliadin, causing cytoskeletal rearrangement and ZO-1 reorganization and showed an 
increase in intestinal permeability. In both cases, pretreatment with the zonulin antagonist 
prevented the gliadin-mediated increased permeability (Drago et al., 2006). Thus, food 
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components have direct effect on the TJ expression and distribution, thereby regulating the 
intestinal permeability. 
Although most food components were not studied in detail for their effect on permeability, 
however, some studies mentioned the effect of diet components on enterocyte 
transepithelial electrical resistance (TEER), TJ expression and distribution, and eventual 
effect on intestinal permeability. More than 300 food-derived substances were screened for 
their effect on the intestinal permeability without having any cytotoxic effect on the Caco-2 
cell model (Konishi, 2003). So, effect of AS as a dietary component on the IEC function 
needs to be investigated. 
Surfactants are the known modulators of TJ permeability. Sucrose monoester fatty acid, a 
food-grade surfactant, was demonstrated to decrease TEER of Caco-2 cell monolayer 
resulting increased TJ permeability for a major egg white allergen, ovomucoid. The 
surfactant exposure induced shortening of microvilli, actin disbandment and structural 
separation of the TJs, thereby facilitating the paracellular uptake of food allergens (Mine 
and Zhang, 2003). In addition, synthetic surfactants that are used as food additives were 
reported to imbalance the GM (Csáki, 2011). 
Moreover, the trace elements also influence intestinal permeability. For example, dietary 
zinc has a critical contribution in maintaining the membrane function and in regulating 
inflammatory cell infiltration (Finamore et al., 2008). Zinc deficiency decreased TEER and 
altered/disorganized TJ expression and localization in Caco-2 cells. These changes led to 
the disruption of membrane barrier integrity, resulting in increased migration of neutrophils 
associated with severe inflammation.  
There are many other dietary components such as proteins, amino acids, polysaccharides, 
fatty acids and flavonoids, which have been associated with modulation of TJ and therefore 
IBF (Ulluwishewa et al., 2011). Other factors which are non-dietary, such as heredity, 
oxidative stress, psychological stress, exercise, aging and apoptosis, use of drugs and 
toxins, have also been identified to play essential roles in regulating intestinal barrier 
permeability (Farhadi et al., 2003). These factors are interdependent and intricately related, 
changes/response from one signal therefore influence the others and mediate the intestinal 
epithelial barrier function. 
2.1.5 Importance of artificial sweeteners 
There are many types of research that study the beneficial effects of AS. These sweeteners 
contribute little to no calories in comparison to approximately 25 calories in a teaspoon of 
sugar (NHS, UK). For the diabetes patients, AS made it possible to enjoy the sweetness of 
food products, since AS do not raise the blood glucose level (FDA, 2014). Also, some 
research findings demonstrate their preventive role in tooth decay (Washburn and 
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Christensen, 2012). However, long-term consumption of AS has been linked to numerous 
health problems and conditions related to MD (Ruiz-Ojeda et al., 2019; Suez et al., 2014), 
therefore, further studies are needed to investigate their impact on health.  
2.1.6 The sweet taste receptor - T1R2/T1R3 
T1R2/T1R3 acts as the intestinal sweet taste sensor and these taste elements are 
expressed in intestinal L- and K-enteroendocrine cells (Shirazi-Beechey et al., 2014; Moran 
et al., 2010). The T1R2/T1R3 heterodimer is stimulated by simple sugars (glucose, fructose 
and sucrose) acting at hundred millimolar range concentrations (300 mM, Li et al., 2002) 
and AS (acesulfame‐K, sucralose and saccharin) at very low millimolar concentrations (Li 
et al. 2002). The concentration of AS (used in the study) that stimulate the STR are given 
in table 1.1.1. 
Moran et al., (2010) demonstrated the co-expression of T1R2, T1R3 and gustducin in the 
enteroendocrine cells of piglet intestine. The endocrine cells secrete gut hormones, 
glucagon-like peptides (GLP-1, GLP-2) and glucose-dependent insulinotropic peptide (GIP) 
in response to dietary carbohydrates. In addition, type 1 G-protein-coupled receptors (T1R) 
and gustducin are co-expressed with those hormones, indicating the ability of 
enteroendocrine cells to express these taste elements (Shirazi-Beechey et al., 2014; Moran 
et al., 2010). GLP-1 and GIP enhance insulin secretion while GLP-2 increases intestinal 
growth and glucose absorption (Shirazi-Beechey et al., 2014). Stimulation of the STR and 
gustducin can also activate the signalling pathways leading to up-regulation of the active 
glucose transporter SGLT1. Moran et al. (2010) demonstrated, in rodent models, that 
supplementation of AS enhances feed palatability by increasing glucose absorption 
capacity in the gut.  Piglets’ were fed with AS combination (saccharin and neohesperidin 
dihydrochalcone), which enhanced Na+/glucose co-transporter (SGLT1) expression and 
intestinal glucose transport function (Moran et al., 2010).  
Several studies have indicated the co-localisation of taste receptors with GLP-1, GIP, 
Peptide tyrosine tyrosine (PYY) and cholecystokinin. Investigations on T1R3 knockout 
models of mice have confirmed impaired glucose-stimulated incretin secretion (Jang et al., 
2007). Steinert et al. (2011) researched healthy human subjects to assess the GI satiety 
peptides, glucose homeostasis and appetite feelings in response to sweetness-matched 
carbohydrate sugars and AS intake. Their findings showed that glucose in comparison with 
water stimulated GLP-1 and PYY release and reduced ghrelin secretion, as well as affected 
(although insignificantly) appetite with increased satiety and fullness. On the other hand, 
the equisweet AS intake compared to water did not affect GI peptide secretion with 
negligible effects on appetite (Steinert et al., 2011). Nonetheless, the cell culture-based co-
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culture experiments only mimic the human physiology, whereas, in vivo, the regulatory 
interface of the GI tract is way more complex and regulated by multiple factors. 
 At high concentration, Glucose-mediated (30–100 mm glucose) activation range of the 
heterologous T1R2/R3 expression system coincides with the mechanism of apical GLUT2 
insertion in the intestine (Li et al. 2002; Mace et al. 2007). Apical GLUT2, therefore, imparts 
the major pathway of absorption at high concentration of glucose, while AS can rapidly 
induce apical GLUT2 insertion at low glucose concentration (20 mm) (Mace et al. 2007). 
Apical GLUT2 insertion is the outcome of PKC-βII activation which is stimulated through a 
T1R2/R3–α‐gustducin–PLC-β2 pathway (fig.2.1.4) and simple sugars and AS act 
synergistically in this stimulation (Helliwell et al., 2003). These imply that AS although not 
contributing directly to calorie intake but do stimulate the biochemical pathways like glucose.  
 
 
Figure 2.1.4: Signalling by a sweet taste receptor. 
Sweet molecule (like sugar) binds to a sweet taste receptor (T1R2/T1R3) which initiates the sweet 
taste signal transduction pathway via G-proteins (α, β, and γ). Phospholipase beta2 is involved, and 
sodium and calcium ions play a role. IP3- inositol triphosphate, TRPM5- transient receptor potential 
cation channel subfamily M member 5. Figure adapted from (Cummings and Overduin, 2007). 
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AS are commonly used in foods, beverages, pharmaceuticals and cosmetics (Suez et al., 
2014). According to global AS market reports, saccharin, sucralose, aspartame, neotame, 
acesulfame potassium, and cyclamate are the widely accepted AS that will have a predicted 
global market of USD 3 billion by the end of the year 2025 (Research and markets, 2019). 
For the current study, four of the above-mentioned AS were taken under consideration; all 
of them are approved as safe by the US Food and Drug Administration (FDA, 2006). 
Saccharin is the oldest AS (Lawrence, 2003), it is heat-stable and non- metabolised in the 
GI tract, thus excreted unchanged in the faeces. Sucralose is also thermally stable and 
excreted with the faeces without being metabolized. It has a disaccharide structure like 
sucrose (fig.1.1.6), although three hydroxyl groups are replaced by chlorine which results 
in structural resemblance with an organochlorine chemical compound 
Dichlorodiphenyltrichloroethane (DDT). It is the closest to sucrose in taste (Roberts et al., 
2000). Conversely, aspartame which is an ingredient of approximately 6,000 foods and 
beverages sold worldwide (PubChem database, 2019), is unstable, changes in temperature 
and pH changes its structure. In addition, upon ingestion, aspartame breaks down into the 
comprising compounds phenylalanine, aspartic acid and methanol (Wal et al., 2019). 
Phenylalanine plays an important role in amino acid metabolism and protein structuring as 
well as in neurotransmitter regulation (Humphries et al., 2008), thereby indicating hazards 
to health. Since aspartame decomposes in liquids during storage and contains 
phenylalanine, it is the most controversially discussed AS in scientific literature. 
Nonetheless, based on toxicological and clinical studies, both FDA and European Union 
consider aspartame as safe for consumption (Scheurer et al., 2009).  
Neotame is one of the most recent sweeteners which is a dipeptide AS composed of N-
(3,3-dimethylbutyl)-L-aspartic acid and methyl L-phenylalanate units linked by a peptide 
bond. Whilst closely related to aspartame in structure (derived from aspartame), neotame 
has an additional branched hydrocarbon chain (3,3-dimethylbutyraldehyde) attached by 
replacing -NH3 group of aspartames by a -NH-alkyl group at the specific region (fig.1.1.6) 
(O’Donnell, 2006). It is 7000 to 13000 times sweeter than sucrose (BeMiller, 2018; FDA, 
2018). The ability of stimulating sweet taste perception by aspartyl-based dipeptide 
compounds are based on their conformation (“L-shaped” conformation). Neotame 
demonstrates well-oriented hydrophobic and hydrophilic regions in its solid-state 
conformation which could be responsible for the intense sweetness of this dipeptide 
compound (Prakash et al., 1999). Like aspartame, neotame is metabolized to mainly de-
esterified neotame, and other compounds namely N-(3, 3 dimethylbutyl)- L aspartic acid 
and a beta-glucuronide conjugate of 3, 3-dimethylbutanoic acid (O’Donnell, 2006; Duffy and 
Anderson, 1998).  
Similarly, eight available AS including saccharin, sucralose, aspartame and neotame, and 
five steviol glycosides were determined from 24 samples using high-performance liquid 
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chromatography and tandem mass spectrometry with electrospray ionization (Kubica et al., 
2015). The samples belonged to carbonated and non-carbonated soft drinks and 
carbonated beverages bought from the local shops in Poland with special attention to 
ensure diversity to determine the EU-authorised high-potency sweeteners. Samples (18 of 
24) were labelled with steviol glycosides, but not for aspartame or saccharin. However, 
carbonated alcoholic drink 1 contained aspartame and saccharin at a concentration 
65.56 ± 0.60 mg/L and 5.95 ± 0.34 mg/L, respectively, while carbonated alcoholic drink 2 
contained only aspartame (9.88 ± 0.17 mg/L) but no saccharin (Kubica et al., 2015). Also, 
de Queiroz et al. (2015) demonstrated the amount of AS in 11 foods and beverages using 
HPLC. They showed that light tomato and barbecue sauce contain an amount of 
acesulfame-K (115.8 ± 9.0 and 198.9 ± 30.8, respectively) which is above the legal limit of 
AS concentration to be used. Taken together, the above findings suggest that the 
concentration of AS present in different food substances in market are higher than the 
approved AS concentration to use.  
2.1.7 Intestinal epithelial cell models  
There are several transformed continuously growing IEC lines that are often used as IEC 
model such as Caco-2, HT29, T84. These in vitro differentiated human IEC monolayers are 
suitable for testing the intestinal processes like absorption and active and passive transport 
(Meunier et al., 1995).  
The Caco-2 cell line is enterocyte-based colon carcinoma cells which undergoes 
spontaneous enterocytic differentiation in culture. Once Caco-2 cells reach confluence, they 
form domes, thereby enabling transepithelial ion transport. Differentiated Caco-2 cells 
demonstrate well-defined brush border on the apical surface and have the TJ proteins. Also, 
they demonstrate the typical properties of the absorptive enterocytes, including expression 
of the enzyme activities/markers and transport systems, therefore represent an appropriate 
model for the co-culture studies (Darfeuille-Michaud et al., 1990). Importantly, this cell line 
represents the similar level of alkaline phosphatase, sucrase-isomaltase, and 
aminopeptidase activities like primary enterocytes (Lea, 2015). Having all the other 
properties in place, Caco-2 cells lack the ability to produce mucin, but TJ expression made 
them a good model for studying barrier function.  
The mucin secreting HT29 resembles the goblet cells, develop confluent monolayer, as well 
as demonstrate the TJ formation. However, HT29 do not perform spontaneous 
differentiation under standard culture conditions, although differentiation can be induced by 
adding or substituting various chemicals from the culture media. Also, HT29 can form 
enterocyte-like cells and goblet cells provided with appropriate induction (Huet et al., 1987). 
Moreover, Caco-2 cells express a higher degree of functional TJ complexes than HT29 
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(Lea, 2015). Another cell line, T84, differentiate spontaneously after confluence in culture; 
however, their brush border is not as well defined as the Caco-2, neither do the cells express 
the microvillus membrane hydrolases (Meunier et al., 1995).  
There are thus a range of potential cell types which can be utilised for in vitro studies. As 
the current study considered the effect of artificial sweeteners on IECs focusing on barrier 
function, Caco-2 was found to be particularly suitable. 
2.1.8 Examples of Caco-2 study with food components 
Many studies have utilised Caco-2 cells to mimic physiologic conditions. Due to their 
similarities with absorptive enterocytes, Caco-2 cell has been widely accepted as a primary 
tool for absorption studies of dietary components and pharmaceutical preparations. The 
Caco-2 cell line was used as in vitro digestion model for screening foods and food 
combinations for iron bioavailability before definitive human trials were used (Mahler et al., 
2009). They also reported that the qualitative assessment of iron bioavailability from Caco-
2 model correlated tightly with human data.  
Yu et al. (2013) also used Caco-2 model to investigate the effect of potential absorption 
enhancers (glucose, sodium cholate, ethanol, menthol, EDTA, and SDS) on the paracellular 
permeability of macromolecules. The tested enhancers increased the permeability of Caco-
2 cells by affecting the TJs; changing the distribution of ZO-1, claudin-1, occludin, and E-
cadherin. Ethanol at high concentrations (≥40%) also damaged epithelial barrier function by 
a direct cytotoxic effect. Lower concentrations of ethanol (0 to 10%) were demonstrated to 
have a dose-dependent decrease in cell epithelial resistance and an increase in paracellular 
permeability. Also, ethanol caused a progressive disruption of the TJ protein ZO-1, as well 
as disassembly and displacement of perijunctional actin and myosin filaments (Ma et al., 
1999). Similar to ethanol, many alcoholic beverages and fermented foods can also contain 
acetaldehyde as an additive which disrupts junctional interactions, leading to decreased 
TEER and increased TJ-permeability (Sheth et al., 2007). 
Vors et al. (2012) demonstrated the in vitro lipolysis of four dietary emulsions and used 
Caco-2 cell monolayer to assess the absorption and metabolism. The emulsions (with 
emulsifier either lecithin or sodium caseinate) were broken down with gastric and pancreatic 
enzymes and cells were exposed to the diluted (1:20) lipolysis media. They observed similar 
levels of gastric and duodenal lipolysis, which agreed with previous in vivo findings of 
Carrière et al. (2000). So, Vors et al. (2012) emphasised the possibility of Caco-2 model in 
lipid metabolism for assessing different dietary emulsions digested by gastrointestinal 
lipases. 
Taken together, these literatures demonstrate the strong impact of dietary components on 
barrier function in the intestinal epithelium, and the importance of IEC model, Caco-2 cells. 
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Food compounds which are highly consumed by the public should therefore be investigated 
in detail to understand their impact on the gut epithelium. 
2.1.9 AS consumption and changes in energy metabolism 
AS replaces sugar, however, AS might have paradoxical impact on intestinal physiology. 
There are several postulated claims that undermine the weight management effect of AS 
(reviewed by Rogers, 2018). For example, the sweet taste confusion hypothesis notes that 
AS provide sweet taste but no calorie which might impair energy intake and body weight 
regulation (Swithers, 2013).  Also, AS stimulates the sweet taste receptor and triggers the 
downstream signalling whilst there are no sweet molecules (Mathur et al., 2020; Cornier, 
2008). AS results in insulin release due to their sweet taste which might lead to decreased 
receptor activity because of insulin resistance (Mathur et al., 2020).  
While AS activate the STR, but partially stimulate the food reward pathway, and have no 
activity on the post-ingestion pathway since they lack calorie. These variations in 
downstream pathways in comparison to sugar may increase hunger, food craving and 
caloric consumption (Stice et al., 2008). These alterations might cause improper energy 
absorption and deposition leading to weight gain (Frisch, 2016). The blood glucose control 
of previously AS non-consumer healthy human subjects (n = 7) were examined upon AS 
exposure. Four out of seven volunteers at 5 to 7 days showed worse glucose tolerance of 
AS exposure in comparison to first 4 days, demonstrating the heterogeneity in the GM that 
makes some people more vulnerable after AS exposure than others (Suez et al., 2014).  
Another hypothesis claims that consumption of sweet enhances a sweet tooth (sweet tooth 
hypothesis); so, encourage increased intake of high-calorie foods and beverages which can 
ultimately contribute in weight gain (reviewed by Rogers, 2018). Consumption of AS 
increase appetite and motivate to eat more compared to controls (reviewed by Pearlman et 
al., 2017). Also, because of changes in downstream effects on digestion, absorption and 
metabolism, AS do not induce satiety in the same way that sugar does (Swithers, 2015). In 
addition, sucralose stimulated gut hormone release, such as GLP-1 and GIP, are lower than 
that of glucose indicating AS can cause faster gastric emptying and decreased satiety (Wu 
et al., 2012). These literature supports the AS interference with basic learned physiology of 
the gut. 
The conscious overcompensation hypothesis claims that consumers might consciously 
overcompensate for ‘calories saved’ by intaking AS, resulting in an overall increase in 
energy intake (Mattes and Popkin, 2008). This hypothesis can be supported by the literature 
showing AS containing beverage consuming healthy males (n = 30) had similar daily energy 
intake due to conscious overcompensation during subsequent meals (Tey et al., 2017). 
Porikos et al. (1977) more clearly showed this conscious decision of overcompensation 
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phenomenon in obese patients (n=8). Patients’ energy intake was similar or slightly higher 
than with AS diet when they were aware of consuming AS-containing foods. Interestingly, 
a 25% decrease in caloric intake in comparison to conventional diet was observed when 
the diet was secretly changed to AS-containing products (Porikos et al., 1977). Although 
these claims are yet to prove, however, effects of AS on glucose intolerance, the activation 
of T1R2/T1R3, and perturbations of the GM composition remain controversial (reviewed by 
Ruiz-Ojeda et al., 2019).  
The gut peptides also play important role in regulating digestion, absorption, disposal and 
intestinal epithelial integrity. These functions are initiated by a range of G protein-coupled 
receptors (GPCR) and mediated by direct or indirect effects on the target cells. Brubaker 
and Drucker (2004) exemplified the effect of specific GPCR glucagon-like peptides-1 and 2 
(GLP-1 and GLP-2) on regulation of signalling to cell proliferation and apoptosis. GLP-1 
promotes pancreatic β-cell survival via multiple intracellular pathways, including activation 
of Akt. Similarly, GLP-2 was demonstrated to confer resistance to cellular damage and 
enhance proliferation in different cells (Brubaker and Drucker, 2002). In vivo, animal models 
demonstrated proliferative and antiapoptotic effects upon GLP-1 and GLP-2 administration 
(Drucker, 2003). GLP-1 promoted β-cell expansion and resisted injury in diabetes models 
(Buteau, 2008; Li et al., 2003 ), while GLP-2 administration promoted the IEC regeneration 
and resisted apoptosis in intestinal disorders, suggesting the contribution of these peptides 
in protection and regeneration of particular cell types (Brubaker and Drucker, 2004). 
AS, like natural sugars, were also demonstrated to promote the secretion of GLP-1, GLP-2 
and glucose-dependent insulinotropic peptide (GIP). GLP-1 and GIP play an important role 
in insulin secretion, while GLP-2 promotes IEC proliferation as well as glucose absorption 
(Shirazi-Beechey et al., 2014). Studies on rodent models have demonstrated that AS 
inclusion in the diet enhances the Na+/glucose co-transporter (SGLT1) and increase 
glucose absorption in the gut. AS were regularly added in the piglet's diet to enhance the 
palatability of food. This has been supported by the findings on piglets, where animals 
maintained on food with AS supplementation (saccharin and neohesperidin 
dihydrochalcone combination) showed enhanced SGLT1 expression and intestinal glucose 
absorption. They also demonstrated the co-expression of GLP-1, GLP-2 and GIP with the 
T1R receptors (T1R2/T1R3) and gustducin expression in enteroendocrine cells of the piglet 
intestine.  
Chemicals eliciting sweet taste perception such as glucose, other carbohydrates like 
fructose, AS and proteins like monellin and thaumatin vary largely in their chemical 
structures (fig.1.1.6) (Keast et al., 2004). In addition, they differ in receptor-binding 
mechanism and taste signal transduction mechanism (fig.2.1.5), but all of them generate 
sweet taste perception to different degrees (Keast et al., 2004; Zhao et al., 2003). Details 
about AS was mentioned in the general introduction (section-1.4).  
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Both sugar and AS stimulates the sweet taste perception via STR. So, if the sucrose 
mediated negative effects on health is via sweet taste sensing, it is likely that AS 
consumption could also cause similar effect. Nevertheless, the receptor has different 
binding sites for different sweeteners and inhibitors. Sucralose binds to both T1R2/T1R3 
whilst aspartame and neotame bind to VFT domain of T1R2, however, if sweetener-binding 
fails to activate the receptor, sweetness perception (the downstream signalling cascade) 
does not occur (Brown and Rother, 2012). Therefore, further studies are needed to 
investigate the mechanisms of AS stimulated sweet sensing. 
 
 
Figure 2.1.5: Binding site of different sweeteners and inhibitors to the human sweet taste 
receptor (T1R2/T1R3). 
There are six agonist binding sites identified so far by different docking experiments, and the 
sweeteners represent specific binding nature. Similarly, the sweet taste inhibitors also have specific 
binding site to deactivate the stimulation. Figure adapted from DuBois, 2016. 
 
2.1.10 Sweet taste sensing and permeability 
AS were reported to induce glucose intolerance by altering the conformation and function 
of the GM (Suez et al, 2014). In mice, AS-intake was linked with dysbiosis which was 
confirmed by antibiotic treatment; antibiotics (200 mg/ml ciprofloxacin and 1000 mg/ml 
metronidazole for Gram-negative, and 500 mg/ml vancomycin for Gram-negative bacteria) 
killed the commensal microbiota and abrogated the metabolic effects (Suez et al, 2014), 
however, AS-mediated changes in gut bacteria remain largely unknown.   
In addition, Palmnäs et al. (2014) demonstrated the effect of aspartame doses in rats 
(equivalent to 5-7 mg/day, approximately 2-3 diet cola for human subjects). After 8-week 
exposure, aspartame increased the fasting glucose level, caused insulin intolerance and 
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deranged GM with an increase in abundance of Enterobacteriaceae and Clostridium 
leptum. In a human study, 4-day food intake of American adults was assessed and the 
relationship between AS (especially aspartame and acesulfame potassium) intake and 
microflora was demonstrated (Nettleton et al., 2016). No differences in the abundance of 
bacteria were noted between the AS consumers and non-consumers but a higher microbial 
diversity was observed in those consuming AS. These studies indicate that AS consumption 
causes bacterial diversity which may exert a regulatory metabolic change in the host such 
as increased endotoxin (such as LPS) in the gut. The endotoxin could be directly diffused 
into the circulatory system due to intestinal paracellular permeability or through absorption 
by enterocytes (Moreira et al., 2012). Moreover, changes in GM, increased intestinal 
permeability and metabolic endotoxemia possibly play a role in the development of a 
chronic low‐grade inflammatory state in the host that contributes to the development of 
obesity and associated chronic MD.  
Furthermore, LPS-mediated low-grade inflammation has been demonstrated to induce 
insulin resistance in adolescents (mean age 15.5 ± 0.8 year) (Herder et al., 2007). In 
addition, small intestinal bacterial overgrowth (SIBO) was linked to increased intestinal 
permeability in humans with non-alcoholic fatty liver disease (NAFLD) (Miele et al., 2009). 
Their study showed that NAFLD patients with increased gut permeability had a prevalence 
of SIBO (88.8%) greater than double (p<0.001) that of patients with normal permeability 
(29.4%). Moreover, subjects with SIBO had increased intestinal permeability (p<0.05) and 
significant increase of metabolic syndrome (p<0.001) (Miele et al., 2009) (fig.1.1.2). 
Therefore, AS alters GM which could play important role in development of MD, however, 
the mechanisms needs further investigations. 
Nonetheless, whilst the effect of AS on epithelial layer permeability has not been studied, a 
link between the taste receptor and endothelial barrier permeability has been established 
(Harrington et al., 2017). However, there are many differences between endothelial and 
epithelial permeability mechanisms. Furthermore, the AS sucralose was reported to play a 
role in the translocation and activation of the PKC substrate, myristoylated alanine-rich C-
kinase (MARCK), in MIN6 cells (Nakagawa et al., 2009). PKC activation has been linked to 
the disruption of TJ protein complexes, via activation of the ERK1/2-MAPK pathway in 
human corneal epithelial cells (Lei et al., 2014).  Therefore, it stands to reason that a similar 
effect may be seen with the intestinal epithelial layer which may lead to increased 
permeability. Perhaps PKC is a key signalling molecule in sweetener-mediated regulation 
of junctional complexes, but differences in the complexes between epithelial and endothelial 
cells cause opposing effects in permeability.  
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2.1.11 Cell apoptosis 
Homeostasis in multicellular organisms is maintained through an active and complex 
molecular programme termed apoptosis. This is primarily responsible for physiological cell 
death. Programmed cell death is a vital component of the physiological processes allowing 
the organism to properly regulate morphogenesis, tissue remodelling, development and 
functioning of the immune system, atrophy, embryonic development and overall protection 
from dangerous cells that threaten homeostasis (Elmore, 2007; Hengartner, 2000; 
Thompson, 1995; Krammer et al., 1994). Inappropriate apoptosis in humans can contribute 
to various disorders including neurodegenerative diseases, cancer, viral infections, 
autoimmune diseases and other degenerative diseases. Cell’s decision to signal apoptosis 
follows multiple independent pathways driven by a number of proteins (appendix table-
A8.10), and can be initiated and/or influenced by a wide variety of regulatory factors 
including environmental, physiological and pathological factors within or outside cells 
(Strasser et al., 2000; Kerr et al., 1972) (fig.2.1.6).  
Membrane asymmetry is an early characteristic of apoptosis; phospholipid 
phosphatidylserine (PS) translocates from the phospholipid bilayer of the inner cell surface 
to the external surface (Rysavy et al., 2014). The cells also undergo cytoplasmic blebbing 
and vacuolization, condensation of the chromatin material and nucleosomal fragmentation 
(Nandi et al., 2010). In the second stage, these apoptotic bodies are either shed off or 
absorbed by other cells, where they experience various changes and are eventually being 
degraded by the ingesting cell-derived lysosomal enzymes (Kerr et al., 1972). 
IECs continuously proliferate and differentiate in the small intestine (fig.2.1.1) (Kim et al., 
1998). For the maintenance of a sufficient number of enterocytes, apoptosis spontaneously 
occurs to counterbalance proliferation and maintain the survival and generation of cells 
(Hockenbery, 1995; Potten, 1992). Other than internal decision, external mechanical and 
chemical damage can induce cell apoptosis (Van Engeland et al., 1998). For example, 
oxidative stress from reactive oxygen species (ROS), such as hydrogen peroxide (H2O2), 
triggers apoptosis in mammalian cells (Lee et al., 2000).  
Two broad pathways play a role in activation of the apoptosis mechanisms (Sanz et al., 
2008) (fig.2.1.6). The extrinsic pathway is mediated by the external cell signals such as 
nutrient loss, X-rays, heat, hormones, and lethal factors. Conversely, the intrinsic pathway 
is triggered by internal cellular death signals such as removal of growth factors, DNA 
damage, mitochondrial damage, oxidative stress, and scarcity of energy generation (Sanz 
et al., 2008). Details of apoptosis pathway were mentioned in appendix A (section-8.1.7). 
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Figure 2.1.6: Diagram outlining the extrinsic and intrinsic pathways of apoptosis. 
Both extrinsic (death receptor) pathway and intrinsic (mitochondrial) pathways join to a common 
pathway involving the caspase-3 proteinase activation and the apoptosome formation leading to 
execution of cell death. TNF, tumour necrosis factor; Fas, fatty acid synthetase; DISC, death-
inducing signalling complex; ROS, reactive oxygen species; apaf-1, apoptotic protease activating 
factor; Bax, BCL2 associated X protein; Bid, BH3 interacting domain death agonist; cyt, cytochrome; 
ATP, adenosine triphosphate. Figure adapted from Marí et al., 2013. 
 
Previous studies have described that AS reduce epithelial cell viability and induce DNA 
damage (van Eyk, 2014).  The study showed the effects of five AS on the morphology, cell 
proliferation and DNA in cells by epithelial cells lines such as HT-29 and HEK-293. Cells 
were exposed to sodium cyclamate, sodium saccharin, sucralose and acesulfame-K (0–
50 mM) and aspartame (0–35 mM) over 24, 48 and 72 hours and colon cells were 
demonstrated to show cell morphology alteration, viability reduction and DNA fragmentation 
(van Eyk, 2014).  Horio et al., (2014) demonstrated aspartame-induced apoptosis in PC12 
cells, with cyt c content higher in the cytosol of aspartame-treated cells in comparison to 
control cells. The study observed that low concentrations of aspartame (0-8 µg/ml) induced 
cytotoxicity, whilst trace amounts (~1 ng/ml concentration) induced apoptosis-related DNA 
fragmentation in the PC12 cells. Therefore, AS can affect several biochemical processes of 
IEC that can exert negative impact on gut health, so further studies on AS effect of gut 
physiology is timely. 
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2.1.12 Sweet taste inhibitors  
Inhibitors of the STR have been studied to investigate the interference of taste mechanisms. 
Lactisole was identified as a human-specific sweet taste inhibitor by experimenting its effect 
on HEK293 cells and human/mouse T1R2 and T1R3 clones in the presence of sucrose, 
cyclamate and acesulfame K (Jiang et al., 2005) and T1R3 transmembrane domain of the 
STR subunit was reported as the Lactisole binding site (fig.2.1.5) in human (Fernstrom et 
al., 2012; Assadi-Porter et al., 2010; Xu et al., 2004). In another experiment, Lactisole was 
shown to inhibit the effect of several sweeteners such as acesulfame K, sucralose and 
glycyrrhizin on T1R-mediated insulin secretion of MIN6 cells; it was reported that Lactisole 
reduced the cytoplasmic calcium ion concentration induced by sucralose and acesulfame 
K but intracellular cAMP remained unaffected by it (Hamano et al., 2015). Lactisole is thus 
a useful tool to study AS-stimulated T1R receptor inhibition. 
While Lactisole is specific sweet taste inhibitor for humans, ZnSO4 was reported to inhibit 
the sweet taste perception of a wide range of sweet molecules without showing binding 
specificity (Keast, 2003). For example, ZnSO4 was reported to block the augmented 
contraction effect of saccharin in bladder cells (Elliot et al., 2011).  It is possible that ZnSO4 
may interact with the extracellular component of the STR (fig.1.5) to inhibit the sweet taste 
stimulated nerve response in mice and sweet taste perception in humans (Elliot et al., 2011; 
Keast et al., 2004). Interestingly, zinc has been reported to improve the maintenance of the 
intestinal barrier integrity (Ulluwishewa et al., 2011). Caco-2 cells cultured in a media 
deficient of zinc demonstrated decreased TEER as well as alterations in the expression and 
localization of the TJ proteins ZO-1 and occludin (Finamore et al., 2008). These indicates 
that zinc not only inhibits sweet taste perception but also plays an important role in intestinal 
barrier integrity. So, sweet taste signalling inhibition with this inhibitor might be linked with 
improved intestinal barrier integrity, and therefore, is a suitable sweet taste inhibitor to study. 
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Rationale of chapter 2 
AS are indigestible, but IEC are directly exposed to the synthetic AS components in the diet. 
Therefore, assessing their effect on cell viability and understanding the mechanisms are 
important to indicate the effect of AS on the intestine. Moreover, morphological observations 
can suggest AS-mediated physical injury, and whether the apoptosis pathway is involved 
via nuclear fragmentation or mitochondrial changes. In addition, cell viability interferes with 
monolayer permeability, also dietary components directly interfere with permeability through 
a variety of mechanisms including stress fibre formation (Banan et al., 2001). Consequently, 
it was important to study the stress fibres due to AS exposure. Nonetheless, AS stimulates 
sweet taste perception like natural sweeteners, so their role on AS-mediated changes in 
cells were important to investigate, with an aim to find a remedy of the AS effect via receptor 
inhibition.   
Aims and objectives 
The objective of this chapter is to determine the effect of different physiologically relevant 
concentrations of the four AS on the IEC model, Caco-2.  
The hypothesis of the current chapter is that artificial sweeteners have negative effect 
on an in vitro model of the intestinal epithelium. To address the hypothesis, the aims of 
the chapter are –  
• To understand whether AS interfere with IEC viability and to identify whether cell 
death is via apoptosis 
• To observe whether AS cause morphological changes of the cell 
• To ascertain whether AS cause cell monolayer permeability  
• To evaluate whether the effect of AS on IECs is via the sweet taste receptor 
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2.2 Materials and methods 
2.2.1 Chemicals and supplies 
Cell culture flasks and 96-well plates were purchased from Corning Life Sciences (Lowell, 
MA). EMEM (Eagle’s Minimal Essential medium) was purchased from ATCC® 30-2003 
(American Type Culture Collection). Caco-2 cells, non-essential amino acids, Foetal Bovine 
Serum (FBS), Trypsin EDTA (Ethylenediaminetetraacetate) (0.25 % (w/v) Trypsin/0.53 mM 
EDTA), Dimethyl sulfoxide (DMSO), Penicillin/Streptomycin solution, lipopolysaccharide 
(LPS), Lactisole and Cell counting kit 8 (CCK-8) were purchased from Sigma (USA). The 
AV apoptosis assay kit was purchased from BD Pharmingen (San Diego). Phosphate 
Buffered Saline (PBS) was obtained from Gibco (Life Technologies, Sigma).  
The artificial sweeteners (AS) saccharin, sucralose, aspartame and neotame were 
purchased from Sigma-Aldrich. Sterile, non-treated polystyrene 96-well plates were 
purchased from CytoOne (USA) and Transwell plates, and flat-bottom 24-well plate from 
Corning (USA). Black 96-well plates for indirect ELISA were bought from ThermoScientific 
(USA). Fluorescein Isothiocyanate (FITC) conjugated Dextran (FD) proteins 4000 and FD 
20000 were also purchased from Sigma-Aldrich, the primary (goat polyclonal IgG, both 
extracellular and intracellular) and secondary (donkey anti-goat IgG-FITC) antibody for the 
indirect ELISA were supplied by Santa Cruz Biotech, UK. The FITC Annexin V (AV) 
apoptosis detection kit was purchased from BD-PharmingenTM, EU. Other chemicals 
namely Bovine Serum Albumin, paraformaldehyde, Triton X-100 are from Sigma. DAPI 
(ProLong® Gold) was purchased from Thermo Fisher Scientific (UK), Phalloidin (Phalloidin-
iFluorTM 594 Conjugate) was from Cayman Chemical and DiOC6 was from Sigma-Aldrich. 
Zinc sulphate (ZnSO4), and the carbohydrates, glucose, fructose and sucrose, were 
supplied by Sigma.  
The AS concentrations were determined considering the amount available in the food and 
beverages, and in a sachet, as well as the achievable amount depending on the FDA 
approved ADI (table 1.1.1). A chewing gum can contain as low as 0.01 mg/kg of AS (Rasouli 
and Akbari-Adergani, 2016) whilst a soda can contain 0.5 µM (Franz, 2010) to 2 mM 
(Gardner et al., 2012), indicating that the intestine can be exposed to a range of 
concentrations. Considering the amount of AS in a sachet (e.g., 40 mg aspartame) and ADI 
of number of packets (e.g., 68 for aspartame) (table 1.1.1) shows that intestine can be 
exposed to a very high concentration of AS. If the ADI amount (AS sachet X number of 
packets) is equally split into 5 portions, the amounts of saccharin (0.068 g), sucralose (0.066 
g) and aspartame (0.520 g) (Gardner et al., 2012) are greater than the amounts used to 
prepare 50 mM of the AS in the study (table-A8.3). Also, previous studies used a range of 
neotame concentrations such as 0.75 mg/kg in CD-1 mice (Chi et al., 2018) and 10 to 50 
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mg/kg with a very high concentration of 500 mg/kg neotame in pigs (Zhu et al., 2016). 
Considering 0.081 as the conversion factor between human and mouse (Nair and Jacob, 
2016), the equivalent concentration for human is around 0.06 mg/kg bw/day which is also 
greater than the amount of neotame used in the present study (table A8.3). Zinc sulphate 
concentrations were previously used by Keast et al. (2003). 
2.2.2 Cell cultures 
Caco-2 cells were grown in an incubator (Thermo Scientific, HERA Cell 150i CO2 incubator) 
at 37 ˚C in an atmospheric condition of above 90% humidity along with 95% O2 and 5% CO2 
gas. The cells were cultured in different flasks (size and amount of chemicals for different 
surface in table-A8.1) depending on cell numbers containing EMEM with 10% FBS and 1% 
antibiotic (penicillin/streptomycin) solution. In addition, cells were grown in two other tissue 
culture media (DMEM and RPMI) and tested their growth for 3 days (fig.A8.1).  
Cell maintenance  
Cells were fed by replacing the used medium with the pre-warmed (37 ˚C) fresh medium. 
Once grown to confluence (70 – 80 %), cells were split 1:3 or 1:6 depending on necessity 
of the experiments (fig.2.2.1).  
Cell passaging and cell freezing were performed using standard tissue culture techniques 
(appendix A8.1.2). Trypsin was used to detach cells from the flasks, and cells were 
cryopreserved in freezing medium (90% complete EMEM and 10% DMSO).   
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Figure 2.2.1: Caco-2 cells of different density. 
Cells were grown in EMEM medium supplemented with FBS and antibiotics. Panel shows very high 
to low density cells; confluence was considered as over confluent (a), confluent (b), about 80% (c), 
and about 70% confluent in the study. Images were collected using phone from the microscopic view 
(×40 magnification). 
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Cell counting 
Caco-2 cell count was performed using haemocytometer, 10 µl cell suspension was placed 
to the counting chamber and the four quadrants were counted under inverted microscope 
(fig.2.2.2) (an example calculation appendix, A8.1.2.3). 
 
Figure 2.2.2: Caco-2 cell count using haemocytometer. 
Cells in the four quadrants (q1, q2, q3, and q4) were counted using inverted microscope. The cells 
in the inner side of the surrounding quadrant wall were taken under consideration. Figure taken from 
Louis and Siegel, 2011, and modified. 
 
Cell density (cells/ml) = average cell count [(q1 + q2 + q3 + q4)] × 10,000. 
Total number of cell count was performed for individual flasks. 
2.2.3 Cell viability assay 
2.2.3.1 Protocol determination 
Cell viability was measured by CCK-8 assay (fig.2.2.3). The assay relies on the formation 
of formazan from a water-soluble tetrazolium salt by dehydrogenases. The amount of 
formazan produced by the biochemical activity of living cells is directly proportional to the 
number of cells (Held, 2009). 
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Figure 2.2.3: Schematic presentation of the principle of Cell Counting Kit 8 assay. 
Cell viability is measured as absorbance. Due to the activities of the living cells, substrates 
(tetrazolium salt, WST-8) are reduced by dehydrogenases and formazan is produced. 1-Methoxy 
PMS (1-Methoxy5-methyphenazinium methyl sulfate) acts as electron mediator between NADH and 
other electron acceptors. Formazan dye is soluble in tissue culture medium, therefore is proportional 
to the dehydrogenase activity. So, the absorbance represents the number of living cells. Figure 
information adapted from Held, 2009. 
 
Caco-2 cells were plated on a 96-well plate at a density of 3×105, 1×105, to 1×102 and 
incubated for 24-, 48-, and 72-hours. Example of cell number calculation using serial dilution 
of the initial concentration was shown (fig.A8.2). Used media was replaced with fresh media 
to neutralize any effect of medium colour and CCK-8 reagent was added (1:10). The plates 
were incubated for up to 4 hours and absorbance (450 nm) was measured every 1 hour 
using a precision microplate reader (Tecan SunriseTM) with Magellan software.  
Data was calculated using a media-only control (blank) to neutralize the medium effect. For 
example, sample absorbance was (b - a); where media only absorbance was ‘a’, and 
treatment absorbance was ‘b’. 
2.2.3.2. Caco-2 cell viability assay with treatments 
Caco-2 cells were maintained on a 96-well plate (1x104 cells/well) with 100 µl of EMEM 
media. After 48-hour, the used medium was replaced with EMEM supplemented with 
different concentrations of treatments and incubated for 24 hours. The effect of different 
concentrations (calculation in Appendix A) of bacterial endotoxin, LPS; AS saccharin, 
sucralose, aspartame and neotame; the sweet taste inhibitor ZnSO4 and Lactisole; or 
vehicle were observed. Cells were incubated for 2 hours with CCK-8 (1:10) and absorbance 
was measured at 450 nm (Tecan SunriseTM).  
LPS stock solution (5 mg/ml) was prepared in ddH2O, and the used concentrations were 
prepared using serial dilution (fig.A8.2), an example calculation is given in table-A8.2.  
The calculations for the concentrations of the saccharin, sucralose, aspartame and neotame 
are given in table-A8.3. Control experiments (without cells) were run in parallel with the 
51 
 
CCK-8 assay with AS to assess any nonspecific binding. The without cell absorbance was 
deducted from the with cell absorbance to calculate the effect of AS on Caco-2 cell viability.  
ZnSO4. was dissolved in distilled de-ionized water and an example calculation for the 
different concentrations were shown in table-A8.4.  
Lactisole was dissolved in Ethanol (EtOH, 100%), and the used concentrations were 
prepared in EMEM and calculations are shown in table-A8.5. Given the established 
cytotoxic effect of the vehicle for Lactisole, ethanol (Tong et al., 2013), Lactisole was also 
studied with a different vehicle, DMSO (Dimethylsulfoxide). Examples of calculations for 
Lactisole alone, and Lactisole with AS concentrations in DMSO are shown in table-A8.5 
and table-A8.6, respectively. The without cell control experiment was performed with all the 
concentrations of Lactisole (both DMSO and ethanol) using no cells to observe the effect 
chemicals with CCK-8 reagents. These ‘without cell’ experimental data were subtracted 
from the ‘with cell’ experimental data when calculated the absorbance of cell viability. 
2.2.3.3. Apoptosis Assay 
The proportion of apoptotic cells was assessed using the AV apoptosis assay (BD 
Biosciences, BD Pharmingen, San Diego) following the manufacturer’s protocol with minor 
modifications. This assay relies on the binding of AV with the externalised 
phosphatidylserine (fig.2.2.4).  
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Figure 2.2.4: Schematic representation of the apoptosis process causing loss of membrane 
lipid asymmetry. 
Healthy cells have an asymmetric lipid bilayer composition. The Phosphatidylserine (PS) molecules 
are embedded in the inner leaflet of the membrane facing to the cytosol. These PS residues become 
exposed at the outer membrane during apoptosis. FITC-labelled Annexin V (AV) has high affinity to 
the PS bodies and readily binds with them. Instead, Propidium iodide (PI) intercalates between DNA 
bases. Viable cells exclude PI with their intact cell membrane, damaged and dead cells allow PI 
binding with DNA. Therefore, viable cells are both AV and PI negative, apoptotic cells are AV positive 
and PI negative, while necrotic cells are both AV and PI positive. The lipid bilayer was taken from 
web source (stmichaelshospitalresearch.ca), and the image was made following the information from 
BD Biosciences. 
 
Caco-2 cells were grown in T25 flasks until 60% confluence and exposed to different 
concentrations (0.1 µM - 10 mM) of AS saccharin, sucralose, aspartame, and neotame or 
H2O2 or vehicle for 24 hours. Both floating and adhered cells were harvested and washed 
(ice-cold PBS, X2) by centrifuging at 1000 rpm for 10 mins. 
The binding buffer supplied in the kit was diluted (1:10) in ddH2O. The cell pellet was re-
suspended in 100 µl binding buffer at a concentration of 1X105 cells/ml. Binding buffer (1X, 
400 µl), AV and Propidium Iodide (PI) (5 µl each) was added followed by a 5 second vortex 
and incubation in dark, at RT, to allow effective double staining of the cells. After 15 minutes 
of incubation, the cells were analysed within an hour by flow cytometry (BD Accuri™ C6, 
BD Biosciences) using BD Pharmingen software (fig.2.2.5).  
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10,000 events were counted for each sample. Control cytometry plots (BD Pharmingen 
template) were used to gate the cells and exclude debris from the counted cells. The 
template for the AV Apoptosis Detection Kit from the BD Biosciences also included a 
forward scatter (FSC) vs. side scatter (SSC) plot (fig.2.2.5.i). The flow cytometry analysis 
then separated the cells into four quadrants; live, early apoptotic, late apoptotic/ necrotic, 
and dead, as shown in figure 2.2.5.ii. Early apoptotic cells were quantified by counting only 
AV positive cells, whereas dead cells were measured as both AV and PI positive cells. The 
percentage of events in each quadrant was collected for further analysis. The scattering of 
cells (forward and side) were measured and converted to relative percentage change from 
the control. 
 
 
Figure 2.2.5: Determination of the counted cells for the flow cytometry (i) and different stages 
of cell death (ii) using BD Biosciences template. 
Panel i shows the exclusion of the low forward scattering and side scattering events from the cell 
sample by drawing a gate, which might have cell debris. Here, 30.3% cells were counted. Quadrants 
in panel ii represent A) Both Annexin V(AV)-and PI-negative quadrant where live cells were recorded, 
B) AV-positive/PI negative quadrant where apoptotic cells were counted, C) AV-negative/PI-positive 
quadrant where late apoptotic/necrotic cells were noted, and D) Both AV-and PI-positive quadrant 
where dead cells were measured. Here, the example figure shows 78.1%, 10.3%, 2.5%, and 9.2% 
cells in quadrants A, B, C, and D, respectively. 
 
2.2.4. Fluorescence Microscopy 
To determine the potential modulatory effects of AS on IECs, cell nucleus, filamentous actin 
(F-actin) and mitochondria were observed using fluorescence microscopy (example 
fig.2.2.6). Caco-2 cell nuclei were stained with Prolong® Gold antifade reagent with 4′,6-
diamidino-2-phenylindole (PG-DAPI) which is a blue-fluorescent DNA stain. Stress fibre 
were stained with Phalloidin-iFluorTM 594 Conjugate which is a high-affinity F-actin probe, 
and mitochondria were stained with 3,3'-Dihexyloxacarbocyanine Iodide (DiOC6), a green-
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fluorescent dye selective for the mitochondria. The stain preparation is mentioned in 
appendix A (8.1.6).  
Cells were seeded at 2x104 cells/well of 96-well plate with 100 µl of media and incubated 
for 24 hours. The media was replaced with 100 µl of EMEM containing 10 mM of saccharin, 
sucralose, aspartame, neotame, 100 µg/ml of LPS or vehicle (H2O). After 24 hours, the cells 
were rinsed (PBS X2), fixed (4% paraformaldehyde in PBS) for 30 minutes at room 
temperature (RT), rinsed (PBS X2) and permeabilized for 5 minutes with 0.1% Triton X-100 
(TX-100) in PBS at RT. After washing (PBS X2), cells were stained with Phalloidin (100 µl) 
for 60 minutes at RT in dark. The cells were rinsed (PBS X2) and stained with 100 µl DiOC6 
in PBS (1:1000) for 10 minutes at RT in dark. After rinsing (PBS X2), the cells were dyed 
with Prolong Gold-DAPI in PBS for 15 minutes in dark at RT. The cell monolayers were 
rinsed with PBS and covered with 100 µl of PBS and examined under fluorescence using 
the Zoe imager (exposure details in appendix table-A8.8).  
 
 
Figure 2.2.6: Fluorescence microscopy of Caco-2 cells for nucleus, stress fibre and 
mitochondria. 
 
Panel a and b represent unstressed and stressed Caco-2 cells, respectively. The merged image 
demonstrates the nuclei (1) stained with Prolong® Gold-DAPI (blue), the F-actins (2) stained using 
phalloidin-iFluorTM 594 Conjugate (red), and the mitochondria (3) stained with DiOC6 (green). Scale 
bar = 30 µM. 
 
2.2.5. FITC-Dextran permeability assay 
The permeability of the Caco-2 cell monolayer was assessed using the FITC-Dextran 
permeability assay (Monaghan-Benson and Wittchen, 2011, with modifications). FITC 
Dextran proteins FD4 (MW 4000 Da) and FD20 (MW 20000 Da) were used for the assay, 
preparation of FD stock solution is mentioned in appendix A (8.1.4.4).  
Caco-2 cells were plated onto filters in a 12-well Transwell plate at a cell density of 2 x104 
cells/well. 500 μl and 1.5 ml EMEM was added in upper and lower/basolateral chamber of 
the wells, respectively (fig.2.2.7). After 24-hour incubation, used media was aspirated gently 
and replaced with EMEM supplemented with LPS concentrations. At 24 hour, 100 μl 
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medium from insert chamber was aspirated and 100 μl of FITC-labelled Dextran was added 
(5 mg/ml) with care for light sensitivity of FD. 100 μl from each of insert- and base-chambers 
were collected at 60-, 180-, and 360- seconds in 96-well plate and immediately wrapped 
with aluminium foil. 
  
Figure 2.2.7: Schematic presentation of FITC-dextran assay to assess permeability. 
If the cell monolayer is impaired, FITC can go across the cell monolayer to the basolateral 
compartment. Figure adapted from Fang et al., 2010).  
 
To optimise the FITC-Dextran permeability assay, conditions such as cell number, 
incubation duration, and time for FD permeation were tested. The first experiment was 
performed using 2x104 cells as described. For the second and third type, 5x104 and 1x105 
cells, respectively were incubated for 48 hours before exposing to LPS. After FD addition, 
5x104 cells was maintained like before, but 1x105 cells were incubated for 1 hour before 
sample collection. Also, 100 µl of samples were collected from both the basolateral and 
insert compartment into 96-well plate.  
Plates were read using fluorescent plate reader (PerkinElmer 2030 Manager, Victor X3, UK) 
at excitation and emission wavelengths of 485 and 535 nm, respectively using HC FITC-
Dextran protocol. Data was calculated as below, 
Permeability (%) was calculated by dividing fluorescence of lower compartment with 
fluorescence of upper compartment; it was normalised with control as 100%, [(sample / 
control) × 100], for each sample. 
2.2.6 Determination of sweet taste receptor protein level  
Indirect whole cell ELISA was performed to measure the level of STR, T1R3 protein in 
response to LPS and AS (protocol modified from Xiao et al., 2003). The mechanism of which 
is shown in (fig.2.2.8).  
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Figure 2.2.8: Schematic presentation of whole-cell ELISA. 
When sweet taste receptors are expressed in cells, primary antibodies bind to them. Then the 
secondary antibody with fluorescent tags binds with the primary antibody and gives fluorescent signal 
when plates are read. 
 
Caco-2 cells were plated at 1×104 cells/well with 50 μl complete EMEM media onto 96-well 
plates. After 24 hours, cells were treated with LPS (table-A8.2) or AS (table-A8.3) or vehicle 
(dH2O).  
Cells were fixed with 1% Paraformaldehyde (PFA) (50 μl/well) at RT for 10 minutes. The 
wells were rinsed gently with PBS (twice) and incubated with 2% BSA-PBS (200μl ) at 37 
oC for 1 hour to block non-specific binding. 
For intracellular receptors cells were permeabilised with 0.1% TX-100 for 10 minutes at RT. 
Cells were directly incubated with 2% BSA for the non-permeabilised ELISA for extracellular 
ELISA. 
The wells were rinsed (dH2O X3), primary antibody (PA) (50 μl/well) was added and 
incubated at 37oC for 2-hours. The PA was prepared using anti-T1R3 antibody (either N20 
or V20 specific to the intracellular and extracellular domain respectively), at a 1:50 ratio in 
1% BSA-PBS (control 1% BSA-PBS without PA). 
The wells were rinsed (dH2O X3) and the secondary antibody (SA) was applied (50 μl/well) 
and incubated at 37 oC for 1 hour. The fluorescent-tagged SA (donkey anti-goat FITC) was 
prepared in 1% BSA-PBS (1:200) (control 1% BSA-PBS without SA). Care was taken to 
handle the light sensitive FITC in the dark. 
After 1 hour, plates were rinsed (dH2O X3), wrapped in foil and fluorescence (r.f.u.) was 
measured at excitation 485 nm and emission 535 nm using PerkinElmer. 
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2.2.7 Data analysis 
All the quantitative data in the study were collected as Excel (Microsoft Office) files. Excel 
processed data were analysed using appropriate statistics on GraphPad Prism 7.0. 
Calculation of data for each experiment are mentioned in the corresponding method section. 
The outliers were tested using the z-score calculation [Z = {(test result – average of all test 
results)/ standard deviation of all test results}]. For two groups, the variance in data sets 
was analysed using the non-parametric test followed by the appropriate T-test. For three or 
more groups, variance was assessed by using ordinary one-way ANOVA with Kruskal-
Wallis test followed by Dunn’s or Holm-Sidak’s multiple comparison test. For more than two 
groups of data with more than one variant, difference was analysed using two-way ANOVA 
followed by appropriate method for statistical hypothesis testing such as Sidak’s or Dunnet’s 
multiple comparison test. For all other data sets, differences among the means were tested 
for significance by ANOVA with different multiple comparison test. Significance was reached 
when p<0.05. The replication number was presented in the legend for each experiment.  
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2.3 Results 
2.3.1 Caco-2 cell viability assay 
2.3.1.1 Method evaluation 
To examine AS effect on IEC viability, CCK-8 assay (method fig.2.3.1) was performed on 
Caco-2 cells after 24-hour exposure to the AS. The appropriate cell number, cell 
maintenance period, and right incubation duration with CCK-8 reagent were pre-
determined. The viability of low-density cells (1×102 and 3×102 cells/well) were almost 
undetectable after 24- and 48-hour incubation, and absorbance were low after 72 hours 
(<0.5 a.u.). Conversely, the higher density cell dilutions (1×105 and 3×105 cells/well) showed 
linear growth at 24 and 48 hours but plateau at 72 hours.   
After CCK-8 addition, 1-hour incubation gave low absorbance (0.34±0.08) while 3-hour 
presented 0.85±0.18. Higher number of cells (3×105) at 2-hour gave absorbance 1.5±0.29, 
1.6±0.18, and 1.2±0.11, while the lower cell numbers (3×102) gave 0.05±0.03, 0.07±0.03, 
and 0.11±0.06  at 24, 28, and 72 hours, respectively (fig.2.3.1.i). These do not appropriately 
reflect the expected absorbance trend, indicating the potential for CCK-8 saturation which 
would result in a lack of sensitivity.  
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Figure 2.3.1: Caco-2 cell viability assay. 
(i) Different number of cells were seeded on 96-well plate, incubated for 24 (a), 48 (b), and 72 (c) 
hour, and CCK-8 assay was performed. For each time point the plates were incubated for 1 to 4 hour 
after CCK-8 addition, and viability was measured as absorbance at 450 nm using multiplate reader 
(Tecan Sunrise™) with Magellan software. Data are presented as the mean ± S.E.M., n=8.  
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3×104 cells/well density showed a linear relationship, however, the absorbance readings at 
1×104 cell density represented better consistency (remained >1 a.u.), indicating their 
suitability for detection with a plate reader (Berova et al., 2007). In addition, 48- and 72-
hour, with different CCK-8 incubation times, gave similar values. So, 48-hour cell 
maintenance and 2-hour incubation with CCK-8 reagent gave the most appropriate 
absorbance (Berova et al., 2007) (fig.2.3.1).  
At 48-hour, 1×104 and 3×104 cells showed absorbance 0.59±0.12 and 0.81±0.14, 
respectively (fig.2.3.1.ii), however, the absorbance for 3×104 cells were near the marginal 
level of consideration (fig.2.3.1.ii.b). So, cell number from 1x104 to less than 3×104 per well 
was appropriate for further experiments. 
 
Figure 2.3.1: Caco-2 cell viability assay for method evaluation.  
(ii) Cells were seeded on 96-well plates at 1×104 cells (a) and 3×104 cells (b) per well, and incubated 
for 24-, 48- and 72-hours. CCK-8 assay reagent was added and incubated for 1 to 4 hours, and cell 
viability was measured as absorbance at 450 nm using multiplate reader (Tecan Sunrise™) with 
Magellan software. Data are presented as the mean ± S.E.M., n=8. 
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2.3.1.2 Effect of Lipopolysaccharide cell viability 
Since LPS is the most prominent endotoxin in the gut environment (Moreira et al., 2012) 
and linked to barrier function (Wang et al., 2015), its effect on Caco-2 cell viability was 
measured to establish a positive control and injury model. LPS-mediated injury takes place 
at high concentration of the endotoxin (Mathan et al., 1988), therefore, a range of 
concentrations up to 100 µg/ml were chosen. Cell viability was unaffected for concentrations 
ranging from 0.01 to 5 µg/ml (fig.2.3.2). Higher concentrations (>10 µg/ml) reduced cell 
viability and a dramatic decline was observed at 100 µg/ml (by 0.2 a.u.) indicating a 
decrease in cell viability.  
 
 
Figure 2.3.2: Effect of LPS on the viability of Caco-2 cells. 
Cells were seeded in 96-well plate (1×104 cells/well) and maintained at standard tissue culture 
condition for 48 hours. Cells were exposed to different concentrations of LPS or vehicle (water) for 
24 hours and CCK-8 assay was performed. The cell viability was measured as absorbance at 450 
nm using Tecan Sunrise™ multiplate reader. Data are analysed using nonparametric test followed 
by Dunn’s multiple comparisons test and presented as the mean ± S.E.M., n=10. *p<0.05 versus 0 
μg/ml LPS. 
 
2.3.1.3 Cytotoxic effect of artificial sweeteners  
Intestinal barrier function (IBF) is affected by the viability of IECs.  The AS or their 
components may have cytotoxic effect on the IECs. So, Caco-2 cells were exposed to a 
range of concentrations (0.01 µM to 50 mM) of saccharin, sucralose, aspartame and 
neotame to assess their effect. To determine any non-specific interaction of CCK-8 with the 
sweeteners, the control experiment without cell was also performed (fig.2.3.3b). The control 
experiment explained the high absorbance reading at 50 mM of saccharin. Data showing 
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cell viability effects of AS have been calculated by subtracting values from the control 
experiment.  
At low concentrations (0-100 µM), the sweeteners did not affect cell viability (fig.2.3.3 – 
2.3.7). A significant effect of saccharin (fig.2.3.3), sucralose (fig.2.3.4), aspartame (fig.2.3.5) 
and neotame (fig.2.3.6) on Caco-2 cell viability was observed at higher concentrations (10 
and 50 mM).  
 
Figure 2.3.3: Effect of saccharin concentrations on the viability of Caco-2 cells. 
Caco-2 cells (1x104 cells/well) were maintained for 48 hours and exposed to increasing 
concentrations of saccharin or vehicle and viability was assessed by CCK-8 assay read at 450 nm. 
The sweetener concentrations and CCK-8 reagent were incubated in the same condition in presence 
of Caco-2 cells (a) to see the effect on viability, or without cells (b) to assess non-specific binding of 
the reagent with AS. The final data (c) were calculated by subtracting the without cell (b) data from 
with cell data (a) and converted into percentage. Data were calculated using Kruskal-Wallis test 
followed by uncorrected Dunn’s multiple comparison test and presented as the mean ± S.E.M., n=8 
(a and c), n=4 (b). *p<0.05 versus 0 μM/ml saccharin. 
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Figure 2.3.4: Cytotoxic effect of sucralose on the intestinal epithelial cells. 
Caco-2 (1x104 cells/well) were maintained for 48 hours and exposed to different concentrations of 
sucralose or vehicle, CCK-8 viability assay was performed, and viability was measured as 
absorbance at 450 nm. Panels represent absorbance of treated Caco-2 cells (a), control experiment 
for non-specific bindings of sucralose and CCK-8 reagent (b), and final viability data (c). Viability (%) 
(c) was calculated by deducting control absorbance (b) from the initial absorbance (a), and 
normalising with control. Data were analysed using Kruskal-Wallis test followed by uncorrected 
Dunn’s multiple comparison test and presented as the mean ± S.E.M., n=8 (a and c), n=4 (b). *p<0.05 
versus 0 μM/ml sucralose. 
 
 
64 
 
 
Figure 2.3.5: Effect of aspartame on Caco-2 cell viability. 
Cells (1x104 cells/well) in 96-well plates were maintained for 48 hours and exposed to different 
concentrations of aspartame or vehicle for 24 hours and CCK-8 assay was performed. Panels 
represent absorbance of treated Caco-2 cells (a), control experiment for non-specific bindings of 
aspartame and CCK-8 reagent (b), and final viability data (c). Cell viability (c) was calculated by 
deducting control absorbance (b) from the initial absorbance (a), and normalising with control as 
100%. Data were analysed using Kruskal-Wallis test followed by uncorrected Dunn’s multiple 
comparison test and presented as the mean ± S.E.M., n=8 (a and c), n=4 (b). *p<0.05 versus 0 μM/ml 
aspartame. 
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Figure 2.3.6: Cytotoxic effect of neotame on intestinal epithelial cell viability. 
Caco-2 cells were seeded at 1x104 cells/well of 96-well plate, maintained for 48 hours and were 
exposed to different concentrations of neotame for 24 hours. CCK-8 assay was performed, and cell 
viability was measured as absorbance at 450 nm. Panels represent absorbance of (a) treated cells, 
(b) controls of neotame concentrations and CCK-8 reagent, and (c) represents the final viability. The 
final viability percentage (c) were obtained by deducting the control absorbance (b) from initial 
absorbance (a) and normalised with vehicle. Data were analysed using Kruskal-Wallis test followed 
by uncorrected Dunn’s multiple comparison test and presented as the mean ± S.E.M., n=8 (a and c), 
n=4 (b). *p<0.05 versus 0 μM/ml neotame. 
 
The Caco-2 cell viability was not impaired at sub-physiological concentrations (0.01 to 100 
µM) of the AS. Sucralose showed the least toxicity since cell viability was >50% in the 
studied concentration range. The relative EC50 values of the AS are listed in fig.2.3.7. EC50 
is the half-maximal effective concentration of a toxicant that induce a response halfway 
between the baseline and the maximum level (Liu et al., 1999). Here, absolute EC50 could 
not be estimated, however, the relative EC50 (Appendix A, table-A8.7) was noted in 
comparison to control as 100% (Sebaugh, 2011). Neotame caused 50% viability decrease 
at lowest concentration (2.2 mM), followed by aspartame (15 mM) and saccharin (5.4 mM) 
(fig.2.3.7). 
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Figure 2.3.7: Effect of AS on viability of intestinal epithelial cells. 
Caco-2 cells were plated at 1x104 cells/well in 96-well plates with 100 µl EMEM and maintained for 
24 hours. Cells were exposed to increasing concentrations of saccharin or sucralose or aspartame 
or neotame or vehicle (medium), and cell viability was assessed by CCK-8 assay read as absorbance 
at 450 nm. Final viability (%) was calculated by deducting the absorbance of AS and CCK-8 reagent 
from the absorbance of cell, AS and CCK-8, and normalised with the vehicle. Data were tested for 
outliers (Z-score), analysed using Kruskal-Wallis test followed by Uncorrected Dunn’s test and 
presented as the mean ± S.E.M., n=8. *p<0.05 versus 0 μM/ml AS.  
 
2.3.1.4 Cytotoxic effect of sweet taste inhibitor 
Given the effect of activators of the STR, AS, on Caco-2 cell viability, the next experiment 
sought to understand the effect of the inhibitor of the STR, ZnSO4 and Lactisole. 
2.3.1.4.1 Zinc sulphate 
ZnSO4 is a potential inhibitor of the STR, which inhibits the sweet taste perception of a 
range of sweet molecules including AS (Keast, 2003). Therefore, the effect of ZnSO4 on 
Caco-2 cell viability was next assessed to check its suitability for the later experiments with 
STR inhibition. ZnSO4 significantly affected Caco-2 cell viability at very high concentrations 
(10 mM and 50 mM). Cell viability was unaffected at concentrations ranging from 0.1 to 1 
mM; the highest cell viability was measured at 1 µM (1.01 a.u.) although absorbance was 
above 0.93 a.u. for all concentrations up to 1 mM. The effect of ZnSO4 on Caco-2 cell 
viability was presented in fig.2.3.8.  
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Figure 2.3.8: Effect of Zinc sulphate on intestinal epithelial cell viability. 
Caco-2 cells (1x104 cells/well) were maintained for 48 hours and exposed to different concentrations 
of ZnSO4 or vehicle for 24 hours. CCK-8 assay was performed, and viability was measured as 
absorbance at 450 nm using multiplate reader (Tecan Sunrise™). The cell viability was not affected 
by ZnSO4 doses of 0.1 – 1 mM.  Data normalised with control as 100%, analysed using Kruskal-
Wallis test followed by Dunn’s multiple comparison test, no outliers found (ROUT; Q=1%), and 
presented as the mean ± S.E.M., n=6. *p<0.05 versus 0 μg/ml ZnSO4. 
 
ZnSO4 inhibits sweet taste perception at concentration ≥25 mM (Keast, 2003), while it 
significantly decreased cell viability at 10 mM concentration. Also, ZnSO4 is a non-specific 
sweet taste inhibitor (DuBois, 2016), therefore, more specific sweet taste inhibitor was 
tested.  
2.3.1.4.2 Lactisole 
Lactisole (sodium salt of ±2-(4-methoxyphenoxy)propanoic acid) is a broad-acting sweet 
antagonist that decrease the sweet intensity of 12 of 15 sweeteners (Jiang et al., 2005; 
Schiffman et al., 1999). Also, it is a selective sweetness inhibitor and is not equally effective 
to inhibit sweet perception of all sweeteners (Keast et al., 2004; Schiffman et al., 1999). So, 
in the next set of experiment, effect of Lactisole on Caco-2 cell viability was tested. 
Lactisole (vehicle ethanol) significantly decreased the Caco-2 cell viability (fig.2.3.9) at 
concentrations from 3 mM. Caco-2 cell viability dropped below 40% at concentrations 
starting from 1 mM.  
The non-specific binding of the Lactisole and ethanol was tested, and the absorbance was 
around 0.2 a.u. (fig.2.3.9.b). So, the viability reduction is the effect of either Lactisole or 
vehicle. Lactisole was reported to inhibit the sweet taste perception at ≈4 mM in MIN6 cells 
(Hamano et al., 2015). In addition, ethanol itself has cytotoxic effect on IECs including the 
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Caco-2 cell line, the cell viability was demonstrated to decrease significantly after exposure 
to concentrations >5% for 4 hours (Tong et al., 2013). Therefore, Lactisole was tested for 
another more intense vehicle, DMSO (CaymanChem, USA). 
 
Figure 2.3.9: Effect of Lactisole (vehicle ethanol) on Caco-2 cell viability. 
Cells were plated at 1×104 cells/well of 96-well plate and exposed to different concentrations of 
Lactisole in ethanol or vehicle for 24 hours. Cell viability was assessed by CCK-8 assay and 
absorbance at 450 nm was measured (Tecan Sunrise). (a) absorbance of Caco-2 cell, media and 
CCK-8; (b) absorbance of media and CCK-8, and (c) viability percentage was calculated by 
deducting b from a, and normalised with control (100%). Data were analysed using Kruskal-Wallis 
test followed by Dunn’s test, and presented as Mean ±S.E.M., n=6 (a, c), 4 (b). *p<0.05 versus 
vehicle. 
 
DMSO is a widely used vehicle for chemicals not soluble in water such as Lactisole 
(Brayton, 1986). Since ethanol showed high level of Caco-2 cell death in the experimental 
condition, Lactisole was dissolved in DMSO and viability was assessed using CCK-8 assay. 
Lactisole significantly reduced cell viability at concentrations ≥5 mM in comparison to 
vehicle (fig.2.3.10a,c). Cell viability was unaffected at 0.1 mM, while reduced to about one-
third and one-fifth at concentrations 1 and 3 mM, respectively. No considerable non-specific 
binding of Lactisole and CCK-8 was detected from the absorbance measurement 
(fig.2.3.10b). 
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Figure 2.3.10: Effect of Lactisole (vehicle DMSO) on Caco-2 cell viability. 
1×104 cells/well were seeded on 96-well plate and exposed to different concentrations of Lactisole in 
DMSO or vehicle for 24 hours. CCK-8 assay was performed, and viability was measured as 
absorbance at 450 nm (Tecan Sunrise). (a) absorbance of Caco-2 cell, media and CCK-8; (b) 
absorbance of media and CCK-8, and (c) viability percentage calculated by deducting b from a, and 
normalised with control (100%). Data were analysed using Kruskal-Wallis test followed by Dunn’s 
test, and presented as Mean ±S.E.M., n=5 (a, c), 4 (b). *p<0.05 versus vehicle. 
 
Lactisole did not affect Caco-2 cell viability at 0.1 mM, and at concentration 3 mM, it reduced 
cell viability, however, the effect was insignificant. In addition, all the AS except sucralose 
significantly reduced Caco-2 cell viability at 50 mM. So, the next set of experiment was 
performed to see the additive effect of the AS and Lactisole (in DMSO) on Caco-2 cell 
viability.  
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2.3.1.5 Additive effect of AS and Lactisole 
CCK-8 assay was performed to assess the additive effect of AS and Lactisole on Caco-2 
cells viability. If the viability reduction is via the STR, then addition of the inhibitor, Lactisole 
would reduce the deleterious effect.  
The results of the CCK-8 assay confirmed that at 0.1 mM of AS and Lactisole, cell viability 
was unaffected for all the sweeteners. 10 mM of AS alone significantly reduced viability for 
all cases, and highest reduction was noted for neotame (fig.2.3.14). At 3 mM Lactisole, the 
vehicle decreased viability ≈50%, and addition of 0.1 mM AS did not give much difference 
compared to vehicle. However, the viability dropped to nearly 10% for treating cells with 10 
mM AS and 3 mM Lactisole (fig.2.3.14). For saccharin (fig.2.3.11), sucralose (fig.2.3.12), 
and aspartame (fig.2.3.13), the viability reduction exacerbated (≈15%) for adding 3 mM 
Lactisole compared to AS alone.  
Taken together, these findings suggest that AS at 10 mM negatively affect IEC viability, and 
3 mM Lactisole augmented the decrease whilst Lactisole concentration interfere with sweet 
taste perception around 4 mM (Hamano et al., 2015). As there was a cytotoxic effect of 
DMSO on mammalian cells (Nasrallah et al., 2008), so use of other vehicle such as dimethyl 
formamide (20 mg/ml; CaymanChem, USA) or siRNA or T1R3 knockout cells (Wauson et 
al., 2012) could be other options for further studies. 
 
Figure 2.3.11: Cytotoxic effect of saccharin and Lactisole on the viability of Caco-2 cells. 
Caco-2 cells were plated at 1×104 cells/well of 96-well plate and maintained for 48 hours at 37 °C 
with 5% CO2. Cells were exposed to concentrations of saccharin in presence of 0.1 mM (a) or 3 mM 
(b) of Lactisole for 24 hour and CCK-8 assay was performed. 0.1 mM Lactisole affected cell viability 
in combination with 100 µM of Saccharin, but high concentration of the sweetener and Lactisole (10 
mM Saccharin and 3 mM Lactisole) almost killed the cells. Data are analysed using two-way ANOVA 
with Dunnett's multiple comparisons test and presented as the mean ± S.E.M., n=5. *p<0.05 versus 
0 μM saccharin. #p<0.05 versus 0 mM Lactisole. 
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Figure 2.3.12: Cytotoxic effect of sucralose and Lactisole on Caco-2 cell viability. 
Caco-2 cells were plated at 1×104 cells/well of 96-well plate and maintained for 48 hours at 37 °C 
with 5% CO2. Cells were exposed to two concentrations of sucralose in presence of 0.1 mM (a) or 3 
mM (b) of Lactisole for 24 hour and CCK-8 assay was performed. 0.1 mM Lactisole along with 100 
µM of sucralose did not affect the viability significantly (a), but high concentration (10 mM) of the 
sweetener sharply reduced absorbance while addition of Lactisole (10 mM sucralose and 3 mM 
Lactisole) presented the lowest absorbance (b). Data are analysed using two-way ANOVA with 
Dunnett's multiple comparisons test and presented as the mean ± S.E.M., n=5. *p<0.05 versus 0 μM 
sucralose. #p<0.05 versus 0 mM Lactisole. 
 
 
Figure 2.3.13: Additive effect of aspartame and Lactisole on Caco-2 cell viability. 
1×104 cells/well in 96-well plate were maintained for 48 hours at 37 °C with 5% CO2. Cells were 
exposed to aspartame in presence of vehicle or 0.1 mM (a) or 3 mM (b) of Lactisole for 24 hour and 
the CCK-8 assay was performed. Cell viability was measured as absorbance at 450 nm (Tecan 
Sunrise™). 10 mM Aspartame affected cell viability at both concentrations (0.1 and 3 mM) of 
Lactisole, however 10 mM Aspartame and 3 mM Lactisole dose reduced the cell viability drastically. 
Data are analysed using two-way ANOVA with Dunnett's multiple comparisons test and presented 
as the mean ± S.E.M., n=5. *p<0.05 versus 0 μM aspartame. #p<0.05 versus 0 mM Lactisole. 
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Figure 2.3.14: Cytotoxic effect of neotame and Lactisole on intestinal epithelial cell viability. 
Caco-2 cells were seeded at 1 × 104 cells/well in 96-well plate and maintained for 48 hours at 37 °C 
with 5% CO2. Cells were exposed to concentrations of neotame in presence of vehicle or 0.1 mM (a) 
or 3 mM (b) of Lactisole for 24 hour and the CCK-8 assay was performed to measure cell viability as 
absorbance at 450 nm (Tecan Sunrise™). 10 mM Neotame reduced viability of the cells in all cases. 
High concentration of Lactisole also decreased cell viability more than half. Data are analysed using 
two-way ANOVA with Dunnett's multiple comparisons test and presented as the mean ± S.E.M., n=5 
*p<0.05 versus 0 μM neotame. #p<0.05 versus 0 mM Lactisole. 
 
2.3.2 Effect of AS on Caco-2 cell apoptosis and morphology 
The distinctive morphological characteristics of apoptosis are very conservative and solely 
dependent on the cell type and the apoptotic inducer (Kerr et al., 1972). The cell viability 
was significantly affected at high concentration (≥1 mM) of AS except sucralose (fig.2.3.7), 
therefore changes in cell morphology and apoptosis in response to AS exposure was next 
to assess.  
Caco-2 cells were exposed to different concentrations of the four AS for 24 hours. Brightfield 
microscopy was performed to observe cell morphology and AV-PI flow cytometric analysis 
was performed to assess apoptosis.  
 
The intact cells showed completely healthy nuclei, cobble stone-like structure and edges; 
by contrast the 0.8 µM H2O2-treated cells have lost adherence and usual morphology while 
the percentage of cell death was obvious (fig.2.3.15).  
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Figure 2.3.15: Caco-2 cell morphology. 
Cells were exposed to vehicle (left) or H2O2 (right) for 24 hours and observed using brightfield 
microscopy (Zoe imager). 
 
AS negatively affected Caco-2 cell morphology in a concentration-dependent manner. Cells 
showed more flat appearance and became less well defined with rising concentration. They 
displayed higher degree of shrinkage, membrane disorientation and more floating cells in 
relation to the increasing concentrations of AS. AS increased Caco-2 cell adherence loss 
with increasing concentration, 10 mM of saccharin (fig.2.3.16) and neotame (fig.2.3.19) 
showed highest amount of adherence loss. Also, 10 mM of sucralose and aspartame, both 
increased gaps among cell islands at high concentrations of 1 and 10 mM (fig.2.3.17, and 
fig.2.3.18, respectively). 
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Figure 2.3.16: Effect of saccharin on the Caco-2 cell morphology. 
Caco-2 cells were grown on 24-well plate until approximately 80% confluence. Cells were exposed 
to different concentrations of saccharin for 24 hours. Cells were observed for changes in cell 
adherence, shape and edges under brightfield microscopy using the Zoe imager. Negative 
morphological changes such as loss of adherence and rounding were observed from low to high 
concentration. Panel represents the concentrations of saccharin 0.1 μM(a), 1 μM(b), 1 mM(c), and 
10 mM(d).  
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Figure 2.3.17: Effect of sucralose on the Caco-2 cell morphology. 
Cells were maintained in EMEM on 24-well plate until about 80% confluence and exposed to different 
concentrations of sucralose for 24 hours. Cells were observed for morphological changes such as 
adherence, shape and edges using brightfield microscopy (Zoe imager). Higher concentration (10 
mM) made cells more stretched especially in the edges and increased gaps among cell islands. Also, 
the vacuoles were greater in number from lower to higher concentrations of sucralose. Panel 
represents the concentrations of sucralose 0.1 μM(a), 1 μM(b), 1 mM(c), and 10 mM(d).  
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Figure 2.3.18: Effect of aspartame on the Caco-2 cell morphology. 
Cells were maintained on 24-well plate until about 80% confluence and exposed to different 
concentrations of aspartame for 24 hours. Cells were observed for morphological changes such as 
adherence, shape and edges under brightfield microscopy using the Zoe imager. Higher 
concentration of aspartame (10 mM) increased gaps among cell islands, with an increasing stretch 
on cells in the edges. Also, the number of floating cells were increased with increasing concentration 
of aspartame. Panel represents morphology of Caco-2 cells at aspartame concentrations 0.1 μM(a), 
1 μM(b), 1 mM(c), and 10 mM(d).  
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Figure 2.3.19: Effect of neotame on the Caco-2 cell morphology. 
Cells were maintained in 24-well plate until about 80% confluence and were exposed to different 
concentrations of neotame for 24 hours. Cells were observed for morphological changes such as 
adherence, shape and edges using brightfield microscopy (Zoe imager). Neotame (10 mM) caused 
loss of adherence and shape, also the number of floating cells were higher at 1 mM. Furthermore, 
vacuoles inside cells were increased with the increasing concentration of neotame. Panel represents 
the morphology of Caco-2 cells at neotame concentrations 0.1 μM(a), 1 μM(b), 1 mM(c), and 10 
mM(d).  
 
Figure 2.3.20 represents the average percentage of necrotic (late apoptotic), dead, live and 
apoptotic cells found from untreated, LPS- and H2O2-treated Caco-2 cells. H2O2 is a well-
known apoptosis inducer (Xiang et al., 2016), therefore was used as a positive control for 
the study. Caco-2 cells were exposed to a range of H2O2 concentrations (fig.A.8.3), and 0.8 
mM was used for the further experiments with AS considering the findings (highest cell 
death, 62%). The effect of LPS on cell apoptosis was tested to verify the findings from the 
viability assay, among the tested concentrations, 100 µg/ml was found to cause significant 
apoptosis (fig.A.8.4), and therefore, used in the later experiments with AS. The percentage 
of late apoptotic (necrotic) cells were very low for all cases, and therefore, was not included 
for the results.  
The positive control H2O2 caused 74% cell death (fig.2.3.20). The LPS increased cell death 
only 5%. The number of live cells was 69% for the control, which reduced by 10% for LPS 
exposure and dropped by 15% for H2O2 exposure. In addition, the number of apoptotic cells 
increased significantly (16%) for the LPS exposure of the cells. Therefore, LPS at high 
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concentration (100 µg/ml) cause Caco-2 cell apoptosis, and at the same duration (24-hour) 
of exposure 0.8 mM H2O2 cause cell death possibly via apoptosis. 
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Figure 2.3.20: Detection of apoptosis in Caco-2 cells. 
Caco-2 cells were maintained in T25 flasks with complete EMEM. At approximately 65% confluence, 
cells were treated with LPS (100 µg/ml) or H2O2 (0.8 mM) or vehicle for 24 hours. Untreated Caco-2 
cells were stained with (BD Biosciences) only annexin-V-fluoresceinisothiocyanate (AV), only 
Propidium Iodide (PI) and both, and LPS- or H2O2- treated cells were stained with both AV and PI. 
Flow cytometric analysis of the untreated and treated cells were done using the BD Accuri Flow 
cytometer with the software Annexin V BD template-FITC. Green fluorescent apoptotic cells were 
monitored in the FL1 channel (530 nm), whereas red fluorescent necrotic and dead cells were 
measured in the FL3 channel (670 nm). The plots are representing the fluorescence of cell staining 
for AV (apoptotic cells, FL1) versus the fluorescence of the cell staining for PI (necrotic and dead 
cells, FL3). In each of the quadrats, dots with AV-/PI-(Blue), AV+/PI-(green), AV-/PI+(black) and 
AV+/PI+(red) represent live healthy, early apoptotic, late apoptotic, and dead cells, respectively. 
Panel a represents untreated cells; unstained (a01), only AV stained (a02), only PI stained (a03) and 
both AV and PI stained (a04), panel b04 and a10 represents effects of LPS and H2O2 on cells, 
respectively. Variation was determined using Two-way ANOVA followed by Dunnett's multiple 
comparisons test, and are presented as the mean ± S.E.M., n=5-6. *p<0.05 of dead, #p<0.05 of live, 
and •p<0.05 of apoptotic cells versus control. 
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Compared with the vehicle-treated cell that exhibited natural death, the high concentrations 
(1 and 10 mM) of all tested AS demonstrated significant amount of cell death AV+/PI+ (dead 
cells) after 24-hour exposure (fig.2.3.21). Sucralose at 100 μM and 1 mM reduced the 
percentage of live cells (fig.3.22.b) and increased apoptotic cells (fig.2.3.23.b), the other 
concentrations of sucralose insignificantly reduced live cells and increased apoptotic cell 
percentage. Saccharin at 0.1 μM slightly increased living cells (fig.2.3.22.a) while reducing 
apoptotic cell percentage (fig.2.3.23.a). Above 10% cell death was observed for all the AS 
at 1 mM (fig.2.3.21). At 10 mM, cell death was increased by only 1% for saccharin and 
aspartame, however, neotame caused highest cell death (37%) (fig.2.3.21). 
 
Figure 2.3.21: Dead percentage of Caco-2 cells from flow cytometric analysis after AS- or 
vehicle-exposure. 
Panels represent the effect of saccharin (a), sucralose (b), aspartame (c), and neotame (d). Data are 
analysed using one-way ANOVA with uncorrected Dunn's test and are presented as the mean and 
S.E.M., n=6-8. *p<0.05 versus 0 μM of AS. 
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Figure 2.3.22: Percentage of live Caco-2 cells after AS- or vehicle-exposure. 
Cells were exposed to different concentrations of four AS, Annexin V apoptosis assay was performed 
(BD Biosciences) and analysed using flow cytometry. Panels represent the effect of saccharin (a), 
sucralose (b), aspartame (c), and neotame (d). Data are analysed using one-way ANOVA with 
uncorrected Dunn's test and are presented as the mean and S.E.M., n=6-8. *p<0.05 versus 0 μM of 
AS. 
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Figure 2.3.23: Quantitative apoptotic measurement of Caco-2 cells induced by AS. 
Approximately 65% confluent cells were exposed to different concentrations of the four AS or vehicle, 
stained with FITC-conjugated annexin V and analysed using flow cytometry (BD Biosciences). 
Panels represent the effect of saccharin (a), sucralose (b), aspartame (c), and neotame (d). Data are 
analysed using one-way ANOVA with uncorrected Dunn's test and are presented as the mean and 
S.E.M., n=6-8. *p<0.05 versus 0 μM of AS. 
 
2.3.2.1 Effect of AS on Caco-2 cell nuclei 
Apoptosis induces extensive morphological and biochemical changes. The main 
morphological changes include cell and nuclear shrinkage, chromatin condensation, 
formation of apoptotic bodies and phagocytosis by neighbouring cells (Kerr et al., 1972). 
The apoptosis findings suggest significant cell death due to AS exposure, and the highest 
death was found at 10 mM (fig.2.3.21), while apoptosis findings were not as anticipated 
(fig.2.3.23), the morphological changes in the nuclei was observed. 
AS-mediated changes in cell and nuclei were observed using Zoe imager. The cell nuclei 
showed a great variability in morphology, size, and morphological features and size of 
organelles compared to vehicle-exposed controls (fig.2.3.24 to 2.3.26). The AS- and LPS-
treated cells remained attached to the flask showed changes in cell border, distribution, and 
vacuolisation. Changes in cell shape with more stretching in the AS-treated cells were 
observed, and most cell shrinkage were found in the neotame-treated cells (fig.2.3.26 e,f).  
83 
 
High density of nuclear volume with loose chromatin structure was observed in control cells 
(fig.2.3.24 a,b). The 100 μg/ml LPS-treated cells demonstrated more flattened cells with 
less well-defined borders. In addition, LPS exposure caused nuclear condensations with 
irregular bordering, deep invaginations and blebbing (fig.2.3.24 c,d). Similar morphology 
was observed in the AS-treated cells and nuclei (fig.2.3.25, 2.3.26). Slightly curved nuclear 
border was observed for many nuclei in the sucralose-exposed cells (fig.2.3.25.d). There 
observed some small, round, blackish structures in the cytoplasm, the number of these 
small vacuoles were increased in the saccharin and aspartame treated cells (figure 2.3.25.c 
and 2.3.26.c). Nonetheless, intense vacuolisation in the cytoplasm was observed for 
neotame exposure (fig.2.3.26.e).   
 
Figure 2.3.23: Morphology of Caco-2 cells after 24-hour LPS exposure. 
Cells were seeded at 2×104 cells per well of the 24-well plate for 24 hours and treated with LPS or 
vehicle for 24 hours. Cells were fixed and stained with Prolong® Gold-DAPI (4′,6-diamidino-2-
phenylindole) to visualize nucleus, and images were taken using Zoe imager. Panels represent 
brightfield (a,c) and DAPI stained (b,d) images of vehicle (a, b) and LPS (c, d) exposed cells. 
Unexposed cells showed high density of nucleus, nuclear bordering was regular and without intense 
vacuolization in the cytoplasm. The LPS-treated nuclei (d) showed condensed (white arrow), heavily 
convoluted nuclei with invaginations (yellow arrow), and active membrane blebbing (green arrow). 
There were more small vesicles in the LPS-exposed cells (c) than control cells (a). Scale = 30 μm. 
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Figure 2.3.24: Effect of saccharin and sucralose on Caco-2 cell morphology after 24-hour 
exposure. 
Cells were seeded at 2×104 cells/well of the 24-well plate for 24 hours and treated with 10 mM of 
saccharin or sucralose or vehicle. Cells were stained with Prolong® Gold-DAPI (4′,6-diamidino-2-
phenylindole) to visualize nucleus, and observed using Zoe imager, scale = 30 μm. Panels represent 
brightfield and DAPI (blue) images of vehicle (a, b), saccharin (c, d) and sucralose (e, f) exposed 
cells. Unexposed cells showed high density in the nucleus with regular nuclear bordering. No intense 
vacuolization was observed in the cytoplasm of control cells. Small vacuoles (black arrows) and 
numerous black spots are visible in the sweetener-treated cells. Saccharin (d) caused disorganised 
nuclei with condensation (white arrow), heavily convoluted nuclei with invaginations (yellow arrow), 
and active membrane blebbing (green arrow). Nuclear condensation was also observed in the 
sucralose-exposed cells (f), and nuclei showed slight curvature in appearance. 
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Figure 2.3.25: Effect of AS on the Caco-2 cell morphology after 24-hour exposure. 
Cells were maintained on the 24-well plate and treated with 10 mM of aspartame and neotame or 
vehicle for 24 hours. Cells were stained Prolong® Gold-DAPI (4′,6-diamidino-2-phenylindole) and 
observed using Zoe imager. Panels represent brightfield and DAPI (blue) images of vehicle (a, b), 
aspartame (c, d) and neotame (e, f) exposed cells. Unexposed cells showed organised nuclei with 
smooth, regular nuclear bordering. The aspartame-treated (d) cells demonstrated different-sized 
nuclei with condensation (white arrow), heavily convoluted nuclei with invaginations (yellow arrow), 
and blebbing (green arrow). Similar nuclear changes were observed in the neotame-treated cells 
with more disorganised nuclei. There were numerous small vacuoles in the neotame-exposed cells 
(e) in comparison to the control cells (a). Scale = 30 μm. 
 
However, DNA degradation might not be the only phenomena or play the major role in 
apoptotic cell death. Schulze-Osthoff et al. (1994) demonstrated apoptosis in enucleated 
cells (with cytochalasin B), indicating that DNA degradation and nuclear signalling are not 
the must to induce apoptotic cell death. Therefore, other cellular machineries that play role 
in cell apoptosis such as mitochondria were studied. 
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2.3.2.2 Effect of AS on cell mitochondria 
Mitochondrial arrangements play an important role in cell function and apoptosis. Early 
stages of apoptotic cell death have been linked to dramatic alterations in mitochondrial 
morphology (Karbowski and Youle, 2003). Mitochondria undergo extensive fragmentation 
during apoptosis before activation of different cell death promoting protease enzymes (such 
as caspase family) (Youle and Karbowski, 2005). Since AS affected cell nuclei, 
mitochondria were also likely to be affected. So, mitochondria were stained (DiOC6) and 
morphological changes such as size, motion, and shape were observed using fluorescent 
microscopy (Zoe imager). 
Compared to control, LPS caused mitochondria interconnected and elongated with lots of 
small and large vacuoles across the threads (fig.2.3.27.b). Some cells demonstrated 
perinuclear mitochondria and the cristae were merged. Saccharin caused mitochondrial 
elongation with small vacuoles in some cells. Perinuclear mitochondria with clusters were 
also visible along with disorganised ones (fig.2.3.28.c). In addition, sucralose did not affect 
mitochondrial arrangement much in comparison to control, although there were some 
clusters. Also, few stretched and interconnected mitochondria were visible in the sucralose-
treated cells (fig.2.3.28.d). Nonetheless, short spheres were observed with perinuclear 
distribution. Aspartame caused some clustered mitochondria; few vacuoles were present, 
and the nuclei were surrounded by merged mitochondria (fig.2.3.29.e). Nevertheless, 
neotame caused massive changes in mitochondrial size and distribution. They became 
smaller and showed interrupted perinuclear arrangement. Moreover, enormous small 
vacuoles were observed in the mitochondria with fragmentation and merging (fig.2.3.29.f).  
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Figure 2.3.26: Changes in cell mitochondrial morphology by LPS exposure. 
Caco-2 cells were exposed to 100 μg/ml of LPS or vehicle for 24 hours. Mitochondria were stained 
with DiOC6 (3,3'-Dihexyloxacarbocyanine Iodide) (green), and nuclei were stained using Prolong® 
Gold-DAPI (4′,6-diamidino-2-phenylindole) (blue) and visualized by fluorescence microscopy (Zoe 
imager). Panel a and b represent control and LPS-treated cells, respectively. Mitochondria are 
elongated and interconnected (white arrow), disorganized (green arrow), cluster perinuclearly (yellow 
arrow) in panel b1 compared to typical morphology of control (a1). 1, 2, 3 and 4 indicates merge, 
brightfield, DiOC6, and DAPI images, respectively. Scale = 30 μm. 
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Figure 2.3.27: Effect of saccharin and sucralose on mitochondria. 
Caco-2 cells were exposed to 10 mM of AS for 24 hours. Mitochondria and nuclei were stained with 
DiOC6 (3,3'-Dihexyloxacarbocyanine Iodide) (green) and Prolong® Gold-DAPI (4′,6-diamidino-2-
phenylindole) (blue), respectively, and visualized by fluorescence microscope (Zoe imager). Panel c 
and d represent saccharin- and sucralose-treated cells, typical morphological features are shown in 
vehicle-treated cells (figure 3.27.a). Mitochondria are elongated and interconnected (white arrow), 
disorganized (green arrow) and clustered perinuclearly (yellow arrow) in panel c1 and d1. 1, 2, 3 and 
4 indicates merge, brightfield, DiOC6 and DAPI images, respectively. Scale = 30 μm. 
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Figure 2.3.28: Effect of aspartame and neotame on Caco-2 cell mitochondria. 
Caco-2 cells were exposed to 10 mM of AS for 24 hours. Mitochondria and nuclei were stained with 
DiOC6 (3,3'-Dihexyloxacarbocyanine Iodide) (green) and Prolong® Gold-DAPI (4′,6-diamidino-2-
phenylindole) (blue), respectively, and visualized by fluorescence microscope (Zoe imager). Panel 
‘e’ represent the aspartame and ‘f’ represent the neotame-exposed cells. Typical morphological 
features are shown in vehicle-treated cells (figure 3.27a). Mitochondria were elongated and 
interconnected (white arrow), disorganized (green arrow) and clustered perinuclearly (yellow arrow) 
in panel e1 and f1. 1, 2, 3 and 4 indicate images obtained from merge, brightfield, DiOC6 and DAPI, 
respectively. Scale = 30 μm. 
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2.3.3 FITC-Dextran permeability assay 
Several agents that alter actin cytoskeleton are also responsible for an increased TJ-
mediated permeability of IECs (Narai et al., 1997), so the effect of AS on the monolayer 
permeability was measured using FITC-Dextran permeability assay. The flux of the solute 
fluorescent marker FD from apical to basolateral compartment was measured to assess 
paracellular permeability (fig.2.3.30).  
2.3.3.1 Method validation 
FD is a metabolically inert, water-soluble molecule that is frequently used in microcirculation 
and cell permeability research (Svensjö et al., 1978; Rutili and Arfors, 1976). Both FD4 and 
FD20 proteins were used to investigate the concentrations of LPS causing Caco-2 cell 
monolayer permeability. 100 µg/ml of LPS caused Caco-2 cell viability reduction (fig.2.3.2) 
and increased apoptosis (fig.2.3.20); decrease in cell viability might increase monolayer 
permeability, therefore, lower concentrations (<100 µg/ml) were used for the permeability 
assay. 
In addition, three different cell numbers and different incubation durations were employed 
to optimise the experiment. For 1x104 cells, 1 µg/ml LPS showed significant permeability at 
60- and 180-seconds (fig.2.3.30.a). At 50 µg/ml LPS for the same number of cells, 
significant permeability was observed at 60-, 180-, and 360-seconds (fig.2.3.30.a). Also, 
FD20 showed significant permeation at 60- and 360-seconds for 0.1 µg/ml LPS, and at 60 
second for highest concentration of LPS (50 µg/ml), however, FD20 did not show significant 
permeability at 1 and 10 µg/ml of LPS (fig.2.3.30.b). 
No consistent significance was observed for 5x104 cells at tested timepoints for both FD4 
and FD20 (fig.2.3.30.c,d). The incubation duration was 48 hours for 5x104 cells before FD 
addition which might have caused cell overgrowth. This leads to overlapping of cells 
inhibiting any permeation. Although there was significant permeation of FD4 at 60 second 
(0.01 µg/ml LPS), however, no significance was found for any other concentration or 
timepoint (fig.2.3.30.c). FD20 also permeated across 5x104 cells significantly at 180 second 
for 0.01 and 0.1 µg/ml LPS but no permeability was observed for the higher concentrations 
at any timepoint (fig.2.3.30.d). Likewise, 1x105 cells and 1-hour incubation after FITC-
dextran addition, a similar level of fluorescence was measured for all LPS concentrations 
for both FD4 and FD20 and no significance was found (fig.2.3.30.e,f). 
Taken together, the above findings suggest that 2x104 cells, 1 µg/ml LPS, and FD4 
represent better conditions for the further permeability study with AS. Although 50 µg/ml 
LPS caused permeation of FD4 at all timepoints, however, this concentration might have 
additive effect on Caco-2 cells along with AS. 
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Figure 2.3. 29: FITC-Dextran permeability assay. 
Caco-2 cells were seeded at 2x104 (a, b), 5x104 (c, d), and 1x105 (e, f) on Transwell plate inserts for 
different timepoints and sampling was done differently. Fluorescein isothiocyanate-Dextran proteins 
4000 or 20000 (FD4 and FD20, respectively) were used as soluble fluorescent marker. Panel a, c, 
and e represent FD4, and b, d, f represent FD20 permeation. 2x104 cells (a and b) were maintained 
for 24 hours and exposed to lipopolysaccharide concentrations for 24 hours, FD4 (a) or FD20 (b) 
were added in the upper compartment of transwell plate (5 µg/ml). 100 µl sample was collected from 
both insert and base compartment and poured into 96-well plate at 60-, 180-, and 360-seconds. 
Plates were read at excitation and emission wavelengths of 485 – 535 nm (FITC HC protocol) using 
PerkinElmer (Victor X3). The same method was used for 5x104 cells (c and d), however cells were 
maintained for 48 hours before LPS exposure. In panel e and f, 1x105 cells were plated and treated 
like 5x104 cells however FD proteins could permeate for 1 hour at 37 °C. Data were calculated as 
base/insert ratio of the fluorescence and analysed using Uncorrected Dunn’s test. Data are 
presented as the mean ± S.E.M., n=3-4, *p<0.05 versus 0 μg/ml of LPS. 
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2.3.3.2 Effect of AS on intestinal epithelial cell monolayer permeability 
All the AS were found to interfere with the permeability of the Caco-2 cell monolayer. FITC-
dextran concentration was increased in the lower compartment of the Transwell plate after 
180- (fig.2.3.31) and 360-second (fig.2.3.32) of incubation. Saccharin and sucralose 
increased permeability at 1 mM (fig.2.3.31 a and b, respectively), while aspartame and 
neotame increased at 100 μM (fig.2.3.31 c and d, respectively) at 180 second permeation 
time. Moreover, saccharin caused leak at 10, 100 and 1000 μM concentrations when 
incubated for 360 seconds (fig.2.3.32.a). Aspartame also caused leak at 0.1 and 1 mM for 
360 second incubation (fig.2.3.32.c), however, neither sucralose nor neotame caused any 
significance in permeability at this timepoint (fig.2.3.32.b and d). 
 
Figure 2.3.30: Effect of artificial sweeteners on the Caco-2 cell monolayer permeability. 
Caco-2 cells (2x104) were exposed to different concentrations of the sweeteners or vehicle for 24 
hours. FITC-Dextran 4000 protein (FD4) could pass for 180 seconds and samples were collected 
into 96-well plate from both upper and lower compartment. Plates were read at excitation and 
emission wavelengths of 485-535 nm using PerkinElmer (Victor X3). Data shows percentage of ratio 
(base/insert), normalised with the control as 100%. Data were analysed using ordinary one-way 
ANOVA with Dunnett's multiple comparisons test and are presented as the mean ± S.E.M., n=7. 
*p<0.05 versus 0 μM of AS. 
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Figure 2.3.31: Effect of artificial sweeteners on the Caco-2 cell monolayer permeability at 360 
seconds. 
Caco-2 cells were seeded in the upper compartment of transwell plate at 2x104 cells/well. Cells were 
incubated for 24 hours and exposed to different concentrations of the AS or vehicle for 24 hours. 
Fluorescein isothiocyanate-Dextran protein 4000 (FD4) could pass the cell monolayer for 360 
seconds, samples were collected from both insert and base compartments into 96-well plates and 
read at 485-535 nm using PerkinElmer (Victor X3). Data shows percentage of ratio (base/insert), 
normalised with the control as 100%. Data are analysed using one-way ANOVA with uncorrected 
Dunn's test and are presented as the mean ± S.E.M., n=7. *p<0.05 versus 0 μM of AS. 
 
2.3.3.3 Effect of LPS and AS on cell monolayer permeability  
LPS increases Caco-2 cell monolayer permeability (Guo et al., 2013). In the gut 
environment, LPS is the most prominent endotoxin (Moreira et al., 2012), it is likely that 
IECs are exposed to AS in conjunction with LPS. So, the next set of FITC-Dextran 
permeability was assessed for Caco-2 cell monolayer exposed to both AS and LPS. 
Exposing cells to AS in presence of LPS (1 μg/ml) caused cell monolayer leak at lower 
concentrations in comparison with the baseline AS effect (fig.2.3.33 and 2.3.34). At 180 
seconds, saccharin caused leak of FD4 at 1 μM (fig.2.3.33.a) while sucralose caused leak 
at 0.1 μM in presence of LPS (fig.2.3.33.b). The transport of FD4 across the monolayer was 
also increased for all the used concentrations of aspartame (except 1 mM) and neotame 
when exposed with LPS (fig.2.3.33.c and d, respectively). 
Saccharin caused leak at concentrations 1 and 100 μM at 360 seconds in presence of LPS 
(fig.2.3.34.a), whereas no significance was observed for any concentrations of the 
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sucralose (fig.2.3.34.b). Moreover, both aspartame (fig.2.3.34.c) and neotame (fig.2.3.34.d) 
increased leak at 1 and 10 μM at 360-second permeation time. 
 
 
Figure 2.3.32: Effect of AS with LPS on Caco-2 cell monolayer permeability. 
Cells were grown to monolayer on the insert of transwell plate and treated with AS with/out LPS (1 
μg/ml) or vehicle. Permeation of FITC-dextran through cell monolayer was allowed for 180 second 
at room temperature and samples were collected in 96-well plate from both insert and base 
compartments. Absorbance was measured using excitation and emission wavelengths of 485 – 535 
nm using PerkinElmer (Victor X3). Permeability was measured as normalised (with vehicle) 
percentage of the ratio of insert/base. Data were analysed using two-way ANOVA with Tukey's 
multiple comparisons test, and presented as the mean ± S.E.M., n=7. *p<0.05 versus 0 μM of AS, 
#p<0.05 versus 1 μg/ml of LPS. 
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Figure 2.3.33: Effect of AS and LPS on Caco-2 cell monolayer permeability at 360 seconds. 
Cells were grown on the inserts of transwell plate and treated with AS with/out 1 μg/ml of LPS or 
vehicle. FITC-dextran was added in inserts and samples were collected in 96-well plate at 360 
seconds from both insert and base compartments. Absorbance was measured using excitation and 
emission wavelengths of 485 – 535 nm (PerkinElmer, Victor X3). Permeability was measured as 
normalised (with vehicle) percentage of the ratio of insert/base. Data were analysed using two-way 
ANOVA with Uncorrected Fisher's LSD test, and presented as the mean ± S.E.M., n=7. *p<0.05 
versus 0 μM of AS, #p<0.05 versus 1 μg/ml of LPS. 
 
Taken together, the above findings suggest that the AS causes Caco-2 cell monolayer 
permeability and the leak exacerbates due to combined effect of AS and LPS. The 
permeability is linked to F-actin cytoskeletal arrangements (Banan et al., 2001). Therefore, 
the effect of AS on the stress fibre formation (actin stress fibres) was observed in the next 
step. 
2.3.4 Stress fibre formation 
The epithelial barrier properties are regulated by specialized plasma membrane structures 
called apical junctions (Mooseker, 1985). These membrane structures are composed of 
different adhesive and scaffolding proteins that are anchored into different cytoskeletal 
structures including the actin filaments (Ivanov et al., 2010). Increasing research showed 
the pivotal role of actin cytoskeleton in regulating junctional integrity under physiological 
states. Reorganizations of F-actin cytoskeleton (disassembly and instability of the actin 
fibres) during inflammation drive disruption of epithelial barriers leading to permeability 
(Ivanov et al., 2010; Banan et al., 2001). Since AS exposure caused cell viability reduction 
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and monolayer permeability, therefore, it is likely that they enhance F-actin cytoskeleton 
disruption, hence, the effect of AS on the F-actin was assessed. 
Stress fibre formation was investigated after AS-exposure using phalloidin stain, as 
illustrated in figures 2.3.35 to 2.3.37. The control cells have fine, long and uniform 
distribution of actin fibres, captured only in the edges of cell islands (fig.2.3.35.a). The LPS 
exposed cells demonstrated localized dense spots of F-actin accumulation and prominent 
bead-like appearance with marked rounding of the cell cytoskeleton (fig.2.3.35.b). 
Saccharin caused some actin accumulation (fig.2.3.36.c), however, sucralose-exposed 
cells (fig.2.3.36.d) showed similar response of LPS. Aspartame- (fig.2.3.37.e) and neotame- 
(fig.2.3.37.f) treated cells developed different patterns of F-actin alteration, with much 
prominent changes in neotame-exposed cells. Other than the localized F-actin 
accumulation, neotame caused large translucent zones, marked rounding with conserved 
punctuated appearance in the centre of the cells (fig.2.3.37.f). 
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Figure 2.3.34: Stress fibre formation of Caco-2 cells following LPS exposure. 
Caco-2 cells were grown on 24-well plate, treated with 100 µg/ml of LPS or vehicle for 24 hours, and 
stress fibres and nuclei were visualized by staining for 20 minutes with phalloidin-iFluorTM594 
Conjugate and Prolong® Gold-DAPI, respectively. Panel a and b represent the control and LPS-
treated cells, respectively. 1, 2, 3 and 4 indicates merge, brightfield, phalloidin and DAPI, 
respectively. The microscopic exposure was gain (16, 34, 16), exposure (320, 360, 300), LED (28, 
50, 10), and contrast (17, 13, 46) for the brightfield, red and blue fluorescent lights, respectively. 
Scale = 30 μm. 
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Figure 2.3.35: Effect of saccharin and sucralose on the stress fibre network of Caco-2 cells. 
Cells were grown on 24-well plate for 24 hours and exposed to saccharin (c) and sucralose (d) for 
24 hours at 37°C. Under panels c and d; 1, 2, 3 and 4 indicates merge, brightfield, phalloidin and 
DAPI, respectively. Fixed and permeabilized cells were stained with phalloidin-iFluorTM594 
Conjugate and Prolong® Gold-DAPI to visualize stress fibre and nuclei, respectively. The 
microscopic exposure conditions were gain (16, 34, 16), exposure (320, 360, 300), LED (28, 50, 10), 
and contrast (17, 13, 46) for the brightfield, red and blue fluorescent lights, respectively. In 
comparison to the control (fig.3.35a), prominent bordering (green arrow) were visible in both 
saccharin- and sucralose-exposed cells while stress fibre accumulation (yellow arrow) was present 
in the latter one. 
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Figure 2.3.36: Effect of Aspartame and neotame on the stress fibre of Caco-2 cells. 
Cell monolayers were maintained in EMEM for 24 hours and exposed to aspartame and neotame for 
24 hours at 37°C. Fixed (4% paraformaldehyde) and permeabilized (0.1% Triton X-100) cells were 
labelled with phalloidin-iFluorTM594 Conjugate and Prolong® Gold-DAPI to visualize stress fibre and 
nuclei, respectively. Cells treated with aspartame (e) and neotame (f) developed different patterns of 
stress fibre distribution compared to control (fig.3.35a). Images 1, 2, 3, and 4 indicates merge, 
brightfield, phalloidin and DAPI, respectively. The microscopic exposure conditions were gain (16, 
34, 16), exposure (320, 360, 300), LED (28, 50, 10), and contrast (17, 13, 46) for the brightfield, red 
and blue fluorescent lights, respectively. The stress fibres are prominent in the borders (green arrow) 
in both aspartame and neotame treated cells. Also, fibre accumulation was common in neotame-
exposed cells (f1) (yellow arrow). Neotame promoted disorganisation of the stress fibre distribution, 
showing more prominent fibres around cell cytoskeleton than control, having more condensed and 
fragmenting nucleus. 
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2.3.5 Determination of sweet taste receptor protein level 
AS stimulates the STRs to stimulate the mechanism of sweet taste perception (Shirazi-
Beechey et al., 2014); T1R2/T1R3 dimer or a ‘standalone’ T1R3 are the only receptors 
responsible for this mechanism (Zhao et al., 2003). The Caco-2 cells have the mRNA for 
T1R3 (O’Brien and Corpe, 2016), therefore, T1R3 protein level in response to AS were 
tested.  
Method evaluation was performed using LPS, followed by measuring the T1R3 protein level 
in Caco-2 cells upon AS-exposure using indirect whole cell ELISA. 
No significant expression of the STR, T1R3 (both extracellular and intracellular) was 
observed after exposure to lipopolysaccharide (fig.2.3.38) and the AS saccharin, sucralose, 
aspartame and neotame. The findings for T1R3 protein level for saccharin and sucralose 
were presented in fig.2.3.39 and for aspartame and neotame were shown in fig.2.3.40.   
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Figure 2.3.37: Sweet taste receptor protein level in response to lipopolysaccharide. 
Caco-2 cells were (1×104 cells/well) were maintained in 96-well plate for 24 hours and exposed to 
different concentrations of LPS for 24 hours. An indirect whole cell ELISA was performed on non-
permeabilized (a) and permeabilized cells (b) and T1R3 primary antibody for extracellular domain 
(a) and both extracellular and intracellular domain (b) were used. FITC-conjugated secondary 
antibody was used to detect the primary antibody and T1R3 protein level was measured as 
fluorescence at 485–535 nm. Data were analysed using Kruskal-Wallis test followed by Dunn’s test 
(a), and Two-way ANOVA with Sidak’s multiple comparison test (b), and presented as the mean ± 
S.E.M., n=6. 
102 
 
 
Figure 2.3.38: Effect of AS on sweet taste receptor protein level in the extracellular domain. 
Caco-2 cells were seeded at 1×104 cells/well in 96-well plate and maintained for 24 hours. The cells 
were exposed to different concentrations of AS for 24 hours and indirect whole cell ELISA was 
performed on non-permeabilized cells to measure the T1R3 protein level. Protein level was 
measured as fluorescence at 485 – 535 nm (PerkinElmer). Panel shows effect of saccharin (a), 
sucralose (b), aspartame (c), and neotame (d) concentrations. Data were analysed using Kruskal-
Wallis test followed by Dunn’s test and presented as the mean ± S.E.M., n=6. 
 
 
 
 
103 
 
0
0.
01 0.
1 1 10 10
0
10
00
10
00
0
2000
2500
3000
3500
4000
Sucralose (M)
T
1
R
3
 p
ro
te
in
 l
e
v
e
l 
(r
.f
.u
)
Extracellular
Intracellular
0
0.
01 0.
1 1 10 10
0
10
00
10
00
0
2000
2500
3000
3500
4000
Saccharin (M)
T
1
R
3
 p
ro
te
in
 l
e
v
e
l 
(r
.f
.u
)
Extracellular
Intracellular
0
0.
01 0.
1 1 10 10
0
10
00
10
00
0
2000
2500
3000
3500
4000
Aspartame (M)
T
1
R
3
 p
ro
te
in
 l
e
v
e
l 
(r
.f
.u
)
Extracellular
Intracellular
0
0.
01 0.
1 1 10 10
0
10
00
10
00
0
2000
2500
3000
3500
4000
Neotame (M)
T
1
R
3
 p
ro
te
in
 l
e
v
e
l 
(r
.f
.u
)
Extracellular
Intracellular
a b
c d
Effect of AS on sweet taste receptor protein level. Caco-2 cells were seeded at 10,000 cells/well of 96-well plate and maintained 
for 24 h. The cells were treated with different concentrations of AS for 24 h. Cells were fixed and permeabilized with 0.1% Triton 
X-100. Indirect whole cell ELISA was performed with both extracellular and intracellular primary antibodies, FITC-conjugated 
secondary antibody was used to detect the T1R£ antigen, protein level was measured as fluorescence at 485 – 535 nm. Data are 
presented as mean with standard error of mean.  n = 6. 
 
Figure 2.3.39: Effect of AS on sweet taste receptor protein level. 
Caco-2 cells were seeded at 1×104 cells/well in 96-well plate and maintained for 24 hour and exposed 
to different concentrations of AS for 24 hours. Cells were fixed and permeabilized with 0.1% Triton 
X-100. Indirect whole cell ELISA was performed with both extracellular and intracellular primary 
antibodies, FITC-conjugated secondary antibody was used to detect the primary antibody, T1R3 
protein level was measured as fluorescence at 485 – 535 nm (PerkinElmer). Data were analysed 
using Two-way ANOVA with Sidak’s multiple comparison test and presented as the mean ± S.E.M., 
n=6. 
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2.4 Discussion 
The purpose of the study was to determine the effect of AS on the IEC function, with an 
emphasis on barrier function and an in vitro model (Caco-2 cell line) was used to mimic the 
IECs. Fogh et al. (1977) have established the Caco-2 cell line from a human colon 
adenocarcinoma. Initially the Caco-2 cell line was used for studying the resistance 
mechanisms and cytotoxic effect of antitumor drugs but later was recognised as a promising 
model for studying IEC functions (Lea, 2015). The cell line was demonstrated as a rational 
model for transepithelial and paracellular transport studies (Fonti et al., 1994). So, this 
intestinal enterocyte-like Caco-2 cell line was chosen for this study. 
The histological analysis of Caco-2 cell architecture resembles that of human colon 
epithelia. Caco-2 cells have many characters like typical intestinal enterocytes which can 
form an adherent monolayer, express general digestive enzymes, membrane peptidases 
and disaccharidases, and actively transport nutrients and ions. They also express the 
intercellular TJ proteins such as occuldin, ZO-1, ZO-2 (Lea, 2015; Lei et al., 2014; 
Ulluwishewa et al., 2011), limiting the barrier for the solute movement through the 
paracellular route, and therefore are an appropriate mimic of the intestinal epithelium. In 
addition, Caco-2 cells express most of the receptors similar to normal intestinal cells, 
including T1R3 for the sweet taste perception which increased their suitability for the current 
study on whether AS affect cell function via sweet taste sensing and whether inhibiting the 
receptor can help. Since Caco-2 cell line holds these morphological and functional qualities, 
therefore, they are a valid in vitro model for studying the effect of AS on IEC functions in 
this study.  
The single layer of the IECs maintains the barrier function and absorbance of essential 
molecules in the gut, therefore, any changes in these cells would affect the homeostatic 
condition. In this study, changes in cell morphology, viability, apoptosis, monolayer 
permeability, and T1R3 protein level were assessed after AS exposure. The rationale is that 
any change in these features would eventually influence the other resulting an impact on 
the barrier function, and impaired intestinal permeability is linked to conditions related to 
MD. The STR expression has an alleviating effect on the barrier permeability in endothelial 
cells (Harrington et al., 2017), therefore, studying the T1R3 protein level is justified. 
The intensely sweet AS molecules are present in many foods and beverages these days, 
leading to high and steady consumption by the people. The relevant literature mentions the 
association of AS-consumption and metabolic disease development, however, the 
mechanism remained unclear, suggesting further investigations are needed to understand 
the effects of AS on the IEC function. 
Four sweeteners were used in the present study considering their sweetness level (table-
1.1.1) and use. Saccharin, sucralose and aspartame are mid-range AS among which 
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aspartame is the lowest in sweetness level. Saccharin is the oldest sweetener while 
sucralose is very close to sucrose in terms of sweet taste, quality and time-intensity profile, 
and neotame is one of the newest and the sweetest sweetener than the others 
(Chattopadhyay et al., 2014). All these sweeteners are used in various foods and 
pharmaceuticals and often in conjunction with each other to compensate their weakness. 
Saccharin and sucralose are mostly used as tabletop sweetener and aspartame is most 
common in diet cola. In addition, saccharin, sucralose and neotame are non-caloric, while 
aspartame contributes few calories. Moreover, sucralose and neotame demonstrate 
excellent stability, whereas saccharin and aspartame show decreasing stability with 
increasing temperature. Since the current study focuses on how AS affect the IBF, 
therefore, the selected sweeteners having diverse characteristics better represent the family 
and studying them are reasonable. 
IECs have specific morphological features to serve their functional requirements, therefore, 
changes in the structure can affect their behaviour. They usually demonstrate the typical 
morphologic appearance of epithelioid cells in culture, having a large, centrally located 
nucleus, and grow as tightly packed colonies of polygonal cells (Quaroni and May, 1980). 
The morphological changes such as flatter cells, not well defined appearance, stretched 
edges, more floating cells were observed for 1 mM of saccharin and neotame, although 
similar morphological changes were observed in Caco-2 cells at >10 mM concentration of 
saccharin, sucralose and aspartame by van Eyk (2014).  Also, 10 mM of all AS caused all 
the above-mentioned changes, along with increased gaps among cell islands with an 
extended cell adherence loss at 10 mM of saccharin and neotame. The viability data and 
cell necrosis from the apoptosis assay supports these morphological features at 10 mM 
concentration, as the cell death was found highest for all AS. Also, gaps among cell islands 
could have link to increased permeability. 
In addition, DAPI staining demonstrates the changes in the nuclei such as irregular 
bordering, lobules in the nucleus, blebbing, and condensation which can represent the state 
whether the cells are going to the apoptosis stage. LPS-exposed cells showed nuclear 
condensation and lobules in the nucleus (fig.2.3.27). Also, small vacuoles are present in the 
cytoplasm which might be autophagic vesicles. Similar nuclear condensation was also 
observed in the saccharin- and aspartame-treated cells, along with irregular bordering of 
the nucleus (fig.2.3.28.a and 2.3.29.a, respectively). Fragmentation, irregular bordering and 
lobules in the nucleus are obvious in the neotame-exposed cells (fig.2.3.29.b). Also, the 
number of small vacuoles in the cytoplasm are greater in the neotame-treated cells than 
any other AS.  
Moreover, Phalloidin stain incorporates with the F-actin facilitating the visualisation of 
stretching of the cells including irregular cellular edges. Components that interact with the 
cell cytoskeletal actin filaments have been shown to induce a simultaneous increase in the 
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paracellular leak. Therefore, F-actin have direct or indirect association with TJ protein 
complexes (Madara, 1987), and changes in their distribution can have impact on the barrier 
permeability. The stress fibres were prominent only at the edges of Caco-2 cell islands in 
the LPS-treated cells, however, they are not conspicuous inside the cell cluster 
(fig.2.3.15.b). Sucralose did not cause Caco-2 cell stress fibre formation among cells in a 
cell island, although there were fibre lining in the edges like the controls (fig.2.3.16.d). 
However, saccharin and aspartame caused some fibre formation around cells (fig.2.3.16.c 
and 2.3.17.e) and more conspicuous fibres in the edges. The highest amount of stress fibre 
formation was observed in the neotame-exposed cells, both around the cells and in the 
edges of the cell islands (fig.2.3.17.f).  
The cells were stained with Phalloidin for only 20 minutes at RT, therefore, there is 
possibility that the probe attached with regions having high concentration of F-actin only. 
This justifies the vehicle-exposed cells having almost no fluorescence (fig.2.3.15.a), may 
be the actin cytoskeleton is properly spread, and there is no actin accumulation other than 
the edges. Nevertheless, with the probe used, sometimes it become highly concentrated at 
actin intact structures, whereas, when it is spread, the fluorescence is displaced. So, the 
images were presented without quantification. 
Furthermore, being the bioenergetics and metabolic centre of the eukaryotic cells, changes 
in mitochondria, e.g., enlarged or reduced in size, mitochondria with disorganised crests, 
mitochondrial hypertrophy demonstrates the cells with stress. Survival and appropriate 
functioning of the cells largely depend on a healthy mitochondrial network. However, 
mitochondrial component’s structural integrity constantly faces environmental and 
metabolic stresses in the cellular environment. The normal cycles of fission and fusion takes 
place that help mitochondria to cope with the stresses (Dorn, 2015; Friedman and Nunnari, 
2014; Archer, 2013; Youle and van der Bliek, 2012).  
Mitochondrial morphology is an important determinant of mitochondrial function (McBride 
et al., 2006). Mitochondrial dynamics are regulated by the balance between fusion and 
fission processes that occur in normal condition.  Cells with greater fusion than fission 
causes longer and fewer mitochondria. Fission has important role in physiological functions 
like apoptosis (Youle and Karbowski, 2005). The increase of fission leads to mitochondrial 
fragmentation which is important for apoptotic cell death programmes. Since mitochondria 
play an important role in integration and transmission of cell death signals due to stress, 
therefore, mitochondrial observation after AS-exposure was reasonable.  
DiOC6 staining helps visualisation of mitochondria, thereby facilitating the comparison of 
the AS-treated cells with the control. The most frequent abnormalities of mitochondria in 
response to apoptosis-inducing factors are reduction in size and a hyperdensity of their 
matrix which is referred to as ‘mitochondrial pyknosis’ (Desagher and Martinou, 2000). They 
have demonstrated the morphological changes and redistribution of mitochondria in HeLa 
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cells that overexpressing Bax. Bax-untreated cells showed worm-like mitochondria, while 
cells overexpressing Bax represented either punctiform mitochondria dispersed throughout 
the cells or mitochondria that have disappeared from the cell periphery to form aggregates 
around the nucleus (Desagher and Martinou, 2000). The later characteristic of mitochondria 
is prominent in the neotame-exposed cells, where many cells have disorganised 
mitochondria with lots of small vacuoles inside (fig.2.3.32.f). LPS-exposure caused 
stretching of the mitochondria with small vesicles, and diffused pattern is visible in few cells 
(fig.2.3.30.b). LPS may cause oxidative stress and may be that is why the DiOC6 is attached 
more. Saccharin and aspartame exposure also caused diffused pattern of cell mitochondria 
although vacuoles are not prominent (fig.2.3.31.c and 2.3.32.c, respectively). The 
disorganised cytoskeleton, small and large vacuoles, fragmented nucleus of the AS-
exposed cells demonstrate the characteristics of apoptosis and supports the cell viability 
findings. Physiological stress or physical injury could also be the reason of morphological 
changes observed in the AS-exposed cells. Phosphatidyl Serine (PS) probe could also be 
used to assess these further.  
Sweeteners affected the viability of Caco-2 cells at high concentrations only, and the effect 
was highest with neotame. The EC50 for neotame was found 2.2 mM whereas for sucralose 
it was >50 mM (fig.2.3.7). This might be because sucralose is much closer to sucrose in 
terms of taste and time intensity but neotame is extremely sweeter than sucrose 
(Chattopadhyay et al., 2014). On the other hand, saccharin, sucralose and aspartame were 
demonstrated to have no cytotoxic effect on the Caco-2 cell at 10 mM concentration (Santos 
et al., 2018). However, the AS-exposure duration was only 3.5 h in comparison to 24 h of 
the present study. In addition, Santos et al. (2018) have used 1×105 cells per well of the 96-
well plate for the MTT assay while this study has used 2×104 cells and performed the CCK-
8 assay. Nevertheless, both MTT and CCK-8 assays relies on the same biochemical 
mechanism. 
The observed morphological changes partially agree with van Eyk (2014) who found Caco-
2 cell morphology as similar size and shape as untreated control up to a concentration of 
approximately 10 mM of saccharin, sucralose and aspartame. The cells became flatter and 
the border was less well-defined although they remained attach to the flask at concentration 
>10 mM. However, the incubation time was 48 to 72 hour which is different from the current 
study period of 24 h, also the concentration was 10 mM. Furthermore, sucralose-exposure 
increased Caco-2 cell viability at lower concentrations (fig.2.3.4) which agrees with previous 
findings where similar viability increase was observed for Caco-2 and HT29 cells in 
response to lower concentrations of saccharin, sucralose and aspartame (van Eyk, 2014). 
Zinc at high concentrations have toxic effect on eukaryotic cells which negatively affect cell 
morphology and can enhance cell apoptosis (d'Heureuse, 2000). Zinc oxide (ZnO) was 
reported to significantly reduce epithelial cell viability (IEC-6) at concentrations 0.2 and 1 
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mM (Medeiros et al., 2013). Although at 1 mM, ZnSO4 did not affect Caco-2 cells, but 
significant reduction was observed at 10 mM (25%) and 50 mM (22%). Effect of ZnSO4 as 
a sweet taste inhibitor was assessed for the co-culture studies. 
Lactisole alone affected cell viability at only 1 mM dose which is below the documented IC50 
for the inhibitor by Jiang et al. (2005). At high concentration, the additive effect of 
sweeteners (10 mM) and Lactisole (3 mM) showed significant reduction of cell viability. 
However, the 0.1 mM concentration of Lactisole represented higher absorbance level than 
100 μM of all sweeteners except saccharin. But when applied in combination (100 μM AS 
+ 0.1 mM Lactisole), saccharin and neotame showed significance in cell viability reduction 
although sucralose and aspartame did not. The additive effect of the sweeteners and 
Lactisole determined that the 100 µM dose of sweetener and 0.1 µM of Lactisole can be 
used for the further experimentation. However, whether this Lactisole concentration is 
enough to inhibit the sweet taste sensing remained unresolved. Also, Lactisole is a human-
specific sweet taste inhibitor (Jiang et al., 2005), however, it does not dissolve in water 
(Brayton, 1986). The vehicles, ethanol and DMSO, both have a toxic effect on mammalian 
cells (Tong et al., 2013; Nasrallah et al., 2008). Therefore, the use of siRNA or T1R3 
knockdown cell lines could be other choices for sweet taste receptor investigation. 
In healthy condition, a balance between cell proliferation and cell death is maintained. Since 
Caco-2 cell viability is affected due to AS-exposure at high concentration, there may occur 
cell injury leading to cell death via necrosis and apoptosis. Also, cell morphology 
demonstrated characteristic apoptosis-related changes, therefore, apoptosis assay 
facilitated understanding whether cell death was via apoptotic pathway or not. Zoe imager 
showed irregular shape cells with numerous small vacuoles. In response to the apoptosis 
inducer, 0.8 mM H2O2, after 24-hour incubation the cells have lost their adherence 
(fig.2.3.15, right) and became clots of cells. Flow cytometric analysis represented about 
98% cells death after H2O2 exposure.  
 
Increased levels of inflammatory cytokines regulate the corresponding signalling pathways 
and lead to IEC apoptosis in human and mouse (Yan and Polk, 2002). They have purified 
novel proteins (MW 75 and 40 KDa) from Lactobacillus rhamnosus and demonstrated their 
role in inhibiting cytokine-induced cell apoptosis thereby preventing IEC loss. These 
proteins showed concentration-dependent Akt activation whilst inhibition of the cytokine-
induced apoptosis, suggesting the novel role of microbial products in intestinal cell survival 
(Yan et al., 2007). 
 
The cell continuously faces multiple opposing signals of death and survival and cells decide 
depending on the internal and external regulating factors (Van Engeland et al., 1998). There 
are some known factors that triggers apoptosis, such as, lack of growth factors, any kind of 
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DNA damage, Fas ligand binding, action of chemotherapeutic agents (Berke, 1995; Collins 
et al., 1994), however still lot of these apoptosis signalling and controlling remains to 
understand. Also, the lag time length between triggering the initiator of the apoptosis 
cascade and final cell death as well as morphological signs of apoptosis varies hugely 
depending on the cell type, growth conditions, type of triggers (Van Engeland et al., 1998). 
Therefore, morphological and flow-cytometric analysis in the study was essential. 
Surface exposure of the phosphatidylserine challenges the plasma membrane structure 
leading to apoptosis. The phospholipid binding protein, AV has high affinity for the PS and 
binds with the externalised PS. The FITC-labelled AV was measured using flow-cytometry 
thereby detecting the amount of exposed PS. Discrimination of the dead cells and apoptotic 
cells were maintained by using the membrane impermeable DNA stain PI. So, detection of 
live, apoptotic and dead cells by double staining with AV and PI and analyzing them using 
flow-cytometry was appropriate method for the apoptosis assay.  
 
The viability assay showed that high concentration AS-exposure caused significant cell 
death, so the apoptosis assay aimed to determine whether the death was via apoptosis. PS 
are located facing the cytoplasm in healthy normal viable cells, cells possess the ability to 
maintain the plasma membrane lipid asymmetry and translocation of PS to outer leaflet. PS 
exposition is the early stage phenomena of apoptosis which last until the late execution 
phase of breaking up cells into apoptotic bodies (Verhoven et al., 1999). AV specifically 
binds to PS in presence of calcium, labelling of AV using biotin- or FITC- labels facilitates 
the measurement of the exposed PS. AV cannot penetrate the phospholipid bilayer, 
therefore unable to bind to PS of inner leaflet, however, dead cells lose their plasma 
membrane integrity and allow the binding in the inner leaflet. 
In the current studies, a concentration dependent increase of Caco-2 cell death for AS 
exposure was observed (fig.2.3.24). For the apoptotic cells, the correlation was not well 
defined, which might be because the cells followed pathways other than apoptosis or the 
AS-exposure duration was longer. By the time apoptosis was measured, the cells had 
already undergone apoptosis and reached the death phase. Induced cell death can impair 
the IBF via reduced absorption and increased permeability, leading to inflammatory 
responses (Cox et al., 2017). 
Epithelial barrier impairment is an important factor of gastric permeability systemically linked 
with the inflammatory response that is related to MD (Lei et al., 2014). Previous studies 
represented a relationship between artificial sweetener intake and barrier function 
impairment via dysbiosis and sweet taste sensing (Suez et al., 2015; Suez et al., 2014). 
Lipopolysaccharide was also found to increase barrier permeability when secretes at high 
concentration (Wang et al., 2015; Lei et al., 2014). LPS makes up almost 80% of the Gram-
negative bacterial endotoxin and is prominent in the gut environment because of the 
110 
 
presence of trillions of microbes, and this major endotoxin can be released into lumen by 
shedding or lysis of bacteria (Guo et al., 2013). However, in healthy balanced condition, 
LPS cannot penetrate the intestinal barrier although impaired TJ allows paracellular 
permeation of endotoxins and luminal antigens (Guo et al., 2013). Previous studies on 
Caco-2 cells with LPS (0.1 to 100 µg/ml) demonstrated no effect on cell viability (Lei et al., 
2014; Guo et al., 2013) which agrees with the present findings. Obviously, the decrease of 
cell viability at high concentration (100 µg/ml) did not cause 50% cell death. 
Literature showed the important role of LPS in barrier permeability, so determining the effect 
of LPS on Caco-2 cell monolayer permeability was important. Lei et al. (2014) demonstrated 
that LPS impairs intestinal barrier integrity through the breakdown of occludin and ZO-1 in 
Caco-2 cell. Exposure of Caco-2 cells to increasing LPS concentrations showed a 
concentration-dependent decrease in TJ protein expression. LPS stimulation was also 
reported to induce barrier dysfunction in Caco-2 cell monolayer by interfering with the 
expression and distribution of occludin and ZO-1. In addition, LPS was reported to activate 
the ERK-MAPK pathway which induces TJ breakdown (Lei et al., 2014). 
The decrease in cell viability or increase in cell death as observed in the cell viability and 
apoptosis assays, can lead to impaired permeability. In addition, changes in the morphology 
such as cell appearance, nucleus, and mitochondria can interfere with its function. 
Moreover, the formation of stress fibre or disorganisation of the F-actin can directly affect 
the intestinal barrier permeability via changes in cell cytoskeleton. Furthermore, negative 
changes in F-actin directly interferes with the TJ protein expression and distribution, thereby 
affecting the paracellular permeability. Therefore, studying the effect of AS on the Caco-2 
cell monolayer permeability is reasonable. 
TJ permeability can be measured in vitro by different methods. TEER is measuring the ionic 
permeability of the cell monolayer. Also, paracellular passage of non-absorbable and non-
metabolized extracellular markers (e.g. FITC-Dextran proteins) of different sizes by the cell 
monolayer can be used. Although TEER is a useful indicator of early perturbations of the 
ionic permeability, however, it does not distinguish between membrane and paracellular 
conductance of the cell monolayer. On the other hand, paracellular marker passage is a 
more suitable way to describe time-dependent variations in the TJ-mediated permeability 
to molecules (McEwan et al., 1993). Therefore, FITC-Dextran permeability method was 
utilized in the present study to assess the effects of AS on Caco-2 cells. 
Assessing the permeability of Caco-2 cell monolayers in response to AS and LPS exposure 
requires the determination of the right experimental condition including cell number, 
appropriate FITC-Dextran protein, and incubation duration. If AS-exposure affects cell 
viability, it will eventually cause permeability. So, initial assessment of Caco-2 cell viability 
and apoptosis in response to AS and LPS concentrations were justified from the viability 
and apoptosis assay. These findings helped to determine the appropriate concentration of 
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AS to measure permeability without affecting cell viability. Likewise, Lactisole was found to 
reduce cell viability, at concentrations lower than the IC50 ≈4 mmol/l demonstrated in MIN6 
cells (Hamano et al., 2015) therefore the use of siRNA to inhibit the STR could be 
investigated further. 
Epithelial barrier functions are extremely important for nutrient absorption, ion transport and 
the influx of pathogens (König et al., 2016). Imbalanced gut permeability may cause 
pathogenic bacteria to go across the blood stream causing conditions leading to MD (Lei et 
al., 2014). LPS was demonstrated to have an enormous effect on epithelial barrier 
dysfunction in model cells from human and other animals (Lei et al., 2014; Guo et al., 2013). 
The effect of LPS on the Caco-2 cell monolayer was determined with significant findings at 
1 µg/ml concentration at both 60 and 180 second in case of FD4. The LPS-induced 
permeability was significant for the FD20 at 60- and 360 seconds and at concentration as 
low as 0.1 µg/ml. For the 5×104 cells, there observed FD4 leak at 0.01 µg/ml at 60 second, 
whereas, FD20 leaked at 0.01 and 0.1 concentrations at 360 second. Barrier integrity was 
higher at other concentrations which are theoretically incorrect, since lower concentrations 
caused leak, the higher concentrations had more probability to cause leak. On the other 
hand, no significance was found in 1×105 cells for both FD proteins. The cell density was 
high, and the marker proteins could pass through for an hour, therefore, either the cells 
were overlapped and was impermeable or most of the FD proteins passed through by the 
one-hour time. These findings were considered for setting the FITC-Dextran permeability 
experiment to investigate the effect of AS on the Caco-2 monolayer permeability.  
Considering the findings from the three different cell numbers seeded, three time points 
allowed for FD protein permeation, the molecular weight of the FD protein, 2×104 cells were 
found reasonable to use with FD4 protein to be allowed to permeate for 180 and 360 
seconds (fig.2.3.33). Permeability was significant for FD4 protein at concentrations 1, 10 
and 50 µg/ml at different time points (fig.2.3.33.a). On the other hand, FD20 permeation 
was found significant at concentrations 0.1 µg/ml at 60- and 360-seconds (fig.2.3.33.b). 
FD20 is bigger molecule than FD4 and may be stuck into the paracellular junctions or may 
be struggled to pass through the leak in the monolayer or the number of Caco-2 cells 
maintained are higher for their permeation, which is why the significance in concentrations 
and timepoints was inconsistent. 
60-second is very short time allowed for FD4 permeation, also, if FD protein passes at 60 
second timepoint, that will be in the insert at 180 seconds as well. Again, same time were 
allowed for the next sampling at 360 seconds giving an opportunity to compare. Therefore, 
considering the timepoints, 180 and 360 seconds for the conducted permeability assay was 
reasonable. 
In addition, although 5×104 cells/well is the standard seeding density for the 24-well plate 
(ThermoFisher Scientific), no significant change was observed for the seeding density in 
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the present study, and the fluorescence was low. Besides, cells were seeded only on the 
insert of the transwell plates, so these number of cells might become too confluent to 
overlap. In addition, the cells were maintained for 48 hours and exposed to AS for 24 hours 
before adding the FD protein. This might allow cells to grow on top of each other forming a 
multilayer rather than a monolayer and therefore FD protein could not pass through in the 
given amount of time. 
In 1×105 cells, the FD protein permeation was allowed for an hour, resulting approximately 
same level of fluorescence for all the concentrations and there was no significance. The FD 
proteins might have permeated the barrier within this time and made the concentration 
effect insignificant. Similar protocol for 1×105 Caco-2 cells were also used by Lei et al. 
(2014) and they have demonstrated significant increase in permeability of cell monolayer at 
100 µg/ml LPS. Since the CCK-8 assay in the present study showed cell death at this 
concentration, so this concentration was not considered for the permeability assay. Guo et 
al. (2013) however determined that 0.3 ng/ml or above concentrations of LPS can increase 
Caco-2 cell permeability via TJ integrity dysfunction which agrees with the current study. 
Considering all these facts, 2×104 cells were found appropriate to assess the effect of AS 
and AS ± LPS on the IEC permeability. 
Many conditions that interferes with the permeability of the intestinal epithelial barrier also 
cause changes in the expression and distribution of the TJ proteins and actin cytoskeleton 
(Ranaldi et al., 2002; Madara, 1987). Therefore, increase in the monolayer permeability in 
the present study corresponded with the morphological changes in F-actin (fig.2.3.37).  
All the AS caused Caco-2 cell monolayer permeability varying from concentration 1 mM for 
saccharin and sucralose to 0.1 mM for aspartame and neotame (fig.2.3.34). The cells 
showed increased leak at lower concentrations when exposed to AS with LPS (fig.2.3.36). 
Santos et al. (2018) showed that saccharin induced Caco-2 cell monolayer permeability at 
10 mM concentration. However, they have considered only one concentration and the FD4 
permeation was allowed for 1.5 hour which differs from the present study. They have also 
mentioned that the barrier permeability is not related to cytotoxicity. However, saccharin 
was found to reduce viability and increase permeability at 1 mM, considering the findings of 
Santos et al. (2018), there might have other mechanism than viability-related pathway 
affecting permeability.  
Although barrier impairment is linked to conditions leading to MD, however, regulated 
permeability might have positive use. Regulation of solute permeation across the epithelial 
barrier might represent a potential mean of improving bioavailability of orally administered 
bioactive solutes. Therefore, the AS induced permeability might have positive applications, 
provided that appropriate regulators are in place to overcome the harmful effects. 
T1R2/T1R3, the heterodimeric STR stimulation by AS was reported to have a link with 
metabolic consequences (Suez et al., 2015; Pepino, 2015). Also, an opposite link in STR 
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expression was shown in endothelial barrier permeability (Harrington et al., 2017), although 
how AS affect the epithelial barrier via sweet sensing is not clarified. Brown et al. (2010) 
also mentioned AS to be active in the GI tract affecting the intestinal STRs which might 
eventually lead to increased insulin secretion, thereby influencing weight, appetite and 
glycaemia. Therefore, detection of the STR protein level in response to AS exposure in the 
enteroendocrine cell model in this study was performed. Hence background research 
showed that amplicon for T1R2 was not detected in Caco-2 cells (O’Brien and Corpe, 2016) 
and Zhao et al. (2003) also described T1R3 as potential sweet taste transduction receptor 
in the human, so only T1R3 protein level was measured. Additionally, quantitative real-time 
PCR was performed to quantify the STR, T1R2/T1R3 expression by Swartz et al., 2011 
who reported a significant increase of this receptor in intestinal cells in the germ-free mice 
in contrast with the conventional mice. They have demonstrated that germ-free mice have 
more affinity to sucrose solutions although both mice category have a similar preference to 
saccharin solutions, and germ-free mice did not exert significant differences in sweet taste 
sensitivity which was inferred as an adaptive change in intestinal STR due to lacking 
intestinal microflora.  
No significant expression of the STR protein, neither intracellular nor extracellular, was 
observed in the present study. This might happen because the primary antibody used could 
not attach to the receptor, or unrecognised technical reasons. Moreover, Caco-2 cell have 
T1R3 receptor only (O’Brien and Corpe, 2016), whereas all these AS have binding 
recognition site at the Venus Flytrap domain of the T1R2 monomer of the STR (DuBois, 
2016). The insignificant expression of the T1R3 in the present study might have link with 
this. However, T1R3 protein forms dimer and is a ‘stand-alone’ receptor for the sweet taste 
perception (Zhao et al., 2003), which does not support the previous indication. Therefore, 
further studies are important to understand the AS-mediated sweet taste sensing in the 
Caco-2 cells. 
No positive control was found for the incomplete whole cell ELISA and therefore the 
experiment did not have the positive control. The positive allosteric modulators, SE-2 and 
SE-3 which specifically interacts with human T1R2/T1R3 and enhances sweet taste 
perception (Zhang et al., 2010) could be an alternative which could be considered in future 
studies. Neither LPS (fig.3.38) nor the AS (fig.2.3.39 and fig.2.3.40) showed significance in 
T1R3 expression in this study. So, immunofluorescence assay or quantitative real-time PCR 
for T1R3 detection might be better option for future studies. 
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2.5 Conclusion 
Low-calorie AS consumption is believed to have association with avoiding obesity and 
dental caries, leading to healthy way of life. However, the present research findings suggest 
that AS have negative impact on cell viability and monolayer permeability. Therefore, further 
studies are necessary to investigate how these intensely sweet molecules affects the IEC 
function. 
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3 An investigation into the effect of artificial sweeteners 
on two model gut bacteria 
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3.1 Introduction 
3.1.1 Gut Microbiota 
GM refers to all the microorganisms (mostly bacteria but also viruses, fungi and protozoa) 
harboured by the human GI tract (Sekirov et al., 2010). This flora has co-evolved over time 
with the host epithelium to develop an intricate and favourable mutual existence (Thursby 
and Juge, 2017). There are more than 100 trillion microbes in the gut which outnumber, 
more than tenfold, the total number of human somatic and germ cells (fig.3.1.1) (O’Hara 
and Shanahan, 2006). A continuing concert of studies, such as the Human Microbiome 
Project and Metagenomics of the Human Intestinal Tract, have recognised the contribution 
of the microbiome in providing unique protein coding genes as 360 times greater than their 
host (Qin et al., 2010; Consortium, 2012).  
 
Figure 3.1.1: Spatial and longitudinal variations in microbial numbers and composition across 
the length of the gastrointestinal tract. 
The human microbiota contains as many as 1014 bacterial cells, which is more than 10 times greater 
than the number of human cells present in the body. The number of bacterial cells present in the 
mammalian gut shows a continuum that goes from 102 to 103 bacteria per gram of contents in the 
stomach and duodenum, progressing to 104 to 107 bacteria per gram in the jejunum and ileum, and 
culminating in 109 to 1012 cells per gram in the colon. Figure taken from Konturek et al., (2015). 
 
The microbiome encodes more than three million genes and the combined microbial 
genome is 100 times greater than the human genome (Gill et al., 2006, Valdes et al., 2018). 
The development of microflora generally begins from birth with rapid colonisation in the GI 
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tract occurring during the first year, and by around 3 years of age, microbiota composition, 
diversity and functional capabilities resemble the adults (Rodriguez et al., 2015; Koenig et 
al., 2011). The microbiota is therefore a vital component of the gut ecosystem and human 
health.  
The human GI tract is a highly complex organ comprising of both the host and the resident 
microbial genetic power, encoding a large number of mechanisms regulating food digestion, 
absorption and metabolism (Payne et al., 2012; Qin et al., 2010). The intricate relationship 
between the gut flora and metabolism of components of the hosts’ diet aids several 
processes such as vitamin production and energy homeostasis (fig.3.1.2) (Nicholson et al., 
2012; Flint et al., 2008; Turnbaugh et al., 2006). In addition, the microflora-host gut 
relationship contributes to immune system development, enteric nervous system regulation, 
as well as the synthesis, protection and metabolism of drugs and toxins (Bian et al., 2017; 
Lopetuso et al., 2015; Hooper et al., 2012; Diaz Heijtz et al., 2011; Mazmanian et al., 2005). 
Collectively, the level of dietary metabolism performed by the GM is equal to that of the 
stomach (Bocci, 1992). There are therefore a significant number of studies to address this 
host-microbiota relationship and its impact on health and wellbeing.  
 
 
Figure 3.1.2: Role of gut bacteria in host physiology. 
Other than breaking down the foods and synthesizing vitamins, gut bacteria play an enormous role 
in other physiological mechanisms including resistance to infection and protection against 
autoimmunity, and regulation of intestinal architecture and barrier permeability. SCFA, short-chain 
fatty acid. Figure taken from Amon and Sanderson, 2017. 
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3.1.2 Factors affecting intestinal microbiota 
A delicate balance in GM composition is crucial in preserving host immunity and 
homeostasis, perturbation of the microbial balance could lead to devastating 
pathophysiological consequences (Bian et al., 2017; Yang et al., 2015). An imbalance in 
GM is commonly referred to as dysbiosis (Sekirov et al., 2010). Although depiction of a 
healthy microflora remains at its early stages (Turnbaugh et al., 2009), an imbalance 
commonly suggests alterations in the microbiota community such as changes in the ratio of 
Firmicutes and Bacteroidetes (Mariat et al., 2009), decrease in microbial richness, diversity 
and evenness (Yang et al., 2015), depletion of beneficial non-pathogenic gut bacteria (i.e., 
probionts) and increase of pathogenic inflammatory bacteria (i.e., pathobionts) (Kigerl et al., 
2016). Multiple factors regulate the development and maintenance of GM such as host 
geographical location, diet, lifestyle, bacterial infections, use of antibiotics, and exposure to 
heavy metals (fig.3.1.3) (Bian et al., 2017; Rodriguez et al., 2015; Tenaillon et al., 2010). 
These factors alone, or in combination, can change the ecological balance of the GM 
resulting in dysbiosis (Lopetuso et al., 2015).  
 
Figure 3.1.3: Factors influencing the composition and function of human gut microflora. 
Numerous factors have an influence on the gut microbiota. Clockwise from top left: methods of 
delivery at childbirth; whether breast or bottle fed; diet; exercise and other personal habits; presence 
of disease (e.g. intestinal inflammation); ageing; medications (especially antibiotics but also acid 
suppressants and metformin); geography. Figure taken from Quigley, 2017. 
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Dysbiosis make the host prone to a variety of MD including obesity, insulin resistance, 
cardiovascular diseases and diabetes (Nettleton et al., 2016; Fukuda and Ohno, 2014; 
Muegge et al, 2011). Bian et al., (2017) showed that Acesulfame-potassium (Ace-K) 
consumption for 4 weeks can significantly change the gut metabolic profiles in CD1 mice. 
In female mice, Ace-K treatment decreased the bacterial metabolism-related metabolites, 
such as lactic acid and succinic acid. Also, 2-Oleoylglycerol was also largely decreased in 
females. On the other hand, Ace-K significantly increased the concentration of pyruvic acid 
in the male mice in comparison with the controls. Hence pyruvic acid is a central metabolite 
of energy metabolism, this may have important role in host energy homeostasis. Also, Ace-
K exposure increased cholic acid while decreased deoxycholic acid in the feces of male 
mice (Bian et al., 2017). Moreover, Ace-K consumption increased the abundance of one 
bacterial toxin synthesis gene, thiol-activated cytolysin in both male and female mice (Bian 
et al, 2017). In particular, the consumption of AS in the diet has been linked with dysbiosis 
(Suez et al, 2014) however, the effect of AS on the pathogenicity of gut bacteria is not 
known. Despite this understanding, further studies are needed to establish the mechanism 
of how AS exposure changes the commensals into pathogens.  
3.1.3 Gut bacteria and artificial sweeteners 
Since AS are cheap, easily available and enhance food flavour, they have been 
incorporated into many food products such as baked goods, canned foods, desserts, and 
beverages such as soda, juice, coffee and tea, as well as pharmaceutical products. Several 
epidemiological studies have evidenced their beneficial role on weight loss and on people 
suffering from glucose intolerance and T2D (Gardner et al., 2012), however, there are 
studies which indicate opposing results (Bian et al., 2017). AS paradoxically increase calorie 
consumption and may also negatively impact the biological mechanisms such as 
T1R2/T1R3 receptor mediated downstream signalling, resting metabolic rate, as well as 
GM activity, as discussed in section-2.1.9. In addition to weight management, using animal 
and human studies, AS consumption has been linked with conditions leading to MD 
development (Suez et al, 2014), as mentioned in chapter 2 (section-2.1.10). 
Study on male rats showed that, consumption of Splenda, a plant-originated natural 
sweetener, containing sucralose (1.1%) for a 12-week period significantly decreased the 
number of beneficial faecal microflora (Abou-Donia et al., 2008). Sucralose intake 
decreased total anaerobes, bifdobacteria, Bacteroides, lactobacilli, Clostridia and the total 
aerobic bacteria in gut. Also, the tested sucralose concentrations (1.1 – 11 mg/kg) increased 
the stool pH and raised the expression of membrane efflux transporter P-glycoprotein and 
the cytochrome P-450, which indicates that the US FDA approved daily intake of sucralose 
(5 mg/kg) can adversely affect the beneficial faecal microflora (Abou-Donia et al., 2008). 
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Suez et al. (2014) demonstrated that saccharin consumption enhanced several biochemical 
pathways in mice including the glycan degradation pathways, sphingolipid metabolism and 
lipopolysaccharide biosynthesis. They have mentioned the importance of these altered 
biochemical pathways in energy harvest system and developing MD like diabetes mellitus 
and obesity. 
Similarly, Bian et al (2017) demonstrated that numerous pro-inflammatory mediators (such 
as LPS synthesis) were potentially produced by gut bacteria, which is associated with other 
metabolic disease conditions like diabetes and obesity, indicating the link between AS-
mediated dysbiosis and chronic inflammation. They have investigated the changes in the 
composition and functional genes of GM that contribute to inflammation. They showed that 
Ace-K enhanced the genes related to LPS synthesis in mice, with a distinct difference 
between male and female mice. In female, Ace-K increased the LPS synthesis-related 
genes, LPS-export genes, and an LPS-assembly protein. Similarly, two genes participating 
in LPS biosynthesis, glycosyltransferase and UDP-perosamine 4-acetyltransferase were 
up-regulated in the Ace-K-consuming male mice. Ace-K also increased multiple genes 
encoding flagella components in the female mice (Bian et al, 2017).  
Frankenfeld et al. (2015) also employed Ace-K on 31 healthy human adults and assessed 
the effect of AS consumption on GM using faecal samples. The subjects consumed 
aspartame (n=7) or Ace-K (n=7) or both (n=3) or other natural sweeteners. No difference in 
the bacterial median percentage or gene abundance between AS consumers and non-
consumers but overall bacterial diversity was different across the subjects (Frankenfeld et 
al., 2015). The aspartame consumption was 5.3- to 112 mg/day, with a mean of 62.7 
(SD:40.2) and Ace-K intake ranged from 1.7- to 33.2 mg/day. The study period was, 
however, too short to conclude concrete findings. Taken together, these studies indicate 
that AS consumption exert a negative impact on metabolism by changing bacterial diversity 
and potentially pathogenicity, with/out affecting GM composition which can influence host 
health. There are, however, limited studies which focus on the negative impact of AS on 
bacterial pathogenicity. 
3.1.4 The taste receptor in gut bacteria  
Although it was traditionally believed that the ability of bacteria to coordinate neighbourhood 
perception and behaviour occurred indirectly, sophisticated communication systems have 
been identified over the past few decades. Bacterial biological activities, such as growth 
and virulence factors (e.g., production of haemolysin/ cytolysin, aggregation substances, 
gelatinase, biofilm formation) (Franz et al., 2001), are therefore coordinated by the 
production and response of biochemical molecules, a process called quorum sensing (Miller 
and Bassler, 2001). These sensing are the key virulence regulators in bacteria and could 
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be a novel target for bacterial infection prevention and treatment (Sifri, 2008). Recent 
studies have demonstrated the crosstalk between bacteria and host, they are able to 
produce and detect chemical signals (e.g., N>-acylhomoserine signalling, quinolone 
signalling in Gram-negative bacteria, and modified oligopeptides called autoinducing 
peptides in Gram-positive bacteria) and react accordingly (Miller and Bassler, 2001; Hughes 
et al., 2008; Sifri, 2008).  
The Gram-negative bacteria demonstrates several quorum-sensing systems including the 
lux-type (such as elastase and rhamnolipid production) and synthesising quinolone 
compounds (4-hydroxy-2-alkylquinolines) (Sifri, 2008). Quorum sensing is the regulation of 
gene expression depending on the changes in bacterial cell density. It relies upon the 
interaction of a diffusible signal molecule with a transcriptional activator protein to link gene 
expression with cell population density. Quorum-sensing bacteria produce, release, and 
react to a small, pheromone-like biochemical signal molecules (commonly called 
autoinducers), which accumulate in the external environment as the cell population grows 
(Sifri, 2008; Surette et al., 1999). Autoinducers (e.g., N-Acylhomoserine lactones, AHLs) 
are produced by many gram-negative bacteria to maintain intercellular signals thereby 
facilitating the quorum sensing. These signal molecules, AHLs, differ in the structure of their 
N-acyl side chains (McClean et al., 1997). These allows a bacterial species to monitor its 
population density and activate specific sets of genes at sufficiently high cell numbers 
(Fuqua et al., 1996).  
Enteric E. coli produces and detects certain auto-inducers such as autoinducer 2 (furanosyl 
borate diester), autoinducer 3 (unidentified); these auto-inducers have the functional 
capability to activate gene (such as LuxS) necessary for bacterial adhesion and invasion, 
thereby facilitating intestinal colonisation and intrusion (Sifri, 2008). On the other hand, the 
domesticated non-pathogenic laboratory strain E. coli DH5α neither produce nor degrade 
autoinducer 2 (Surette and Bassler, 1998). Autoinducer 3 synthesis in enterohaemorrhagic 
E. coli depends on the presence of LuxS gene and can be stimulated by the epinephrine 
and norepinephrine host signalling system (Sifri, 2008; Sperandio et al., 2003), implying a 
potential cross-communication between bacterial quorum sensing and host signalling 
systems. Since AS consumption is involved with host sweet taste signalling and gut bacteria 
dysbiosis, there might have potential quorum sensing in bacteria via direct exposure to AS 
or from host signalling. However, there are no literature that can indicate these 
mechanisms.   
There is no considerable research on taste receptors or sensors in bacteria. In the lungs, 
studies showed the response and contribution of bacterial products in triggering host STR 
(T1R2/3) and suppressing bitter taste receptors (T2R) to play a role in the respiratory 
defence system. These studies do not, however, demonstrate the presence of bacterial 
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receptor proteins. The study showed that Staphylococcus species isolated from the 
respiratory samples secrete D-amino acids such as D-isoleucine, D-phenylalanine, and D-
leucine. These amino acids can activate the T1R2/3, whilst inhibiting the T2R-mediated 
signalling and defensin secretion (Lee et al., 2017). In the respiratory epithelium, Lee et al. 
(2017) have demonstrated that STR activation is linked to the inhibition of innate immune 
defence response. The secreted D-amino acids (D-phenylalanine and D-leucine) stimulate 
T1R2/3 and enhances epithelial cell death by suppressing the activation of the T2R-
mediated protective bitter taste signalling. Similar observations were made on sweet and 
bitter receptors of specialized sinonasal solitary chemosensory cells, as well as on T2R38 
in sinonasal ciliated cells, showing these receptors cause host susceptibility to upper airway 
infections, such as chronic rhinosinusitis (Carey and Lee, 2019).These findings suggest that 
STR activation in the airways triggers the epithelial cell vulnerability to infections, indicating 
a possibility whether AS-mediated sweet-sensing in the IECs also exerts a similar effect. 
Lactisole is a STR antagonist for the mammalian GPCR only (Fernstrom et al., 2012), 
therefore is not applicable for prokaryotes. Alternatively, zinc ions have a higher affinity to 
chemical groups like thio- and hydroxyl. Once exposed, they readily bind with protein, 
peptides and amino acids; this ability enabled zinc to interfere with sweet taste perception. 
Zinc readily binds to the STR protein and causes structural changes in the configuration 
(Keast et al., 2004). Therefore, the receptor-binding site of T1R2/3 is altered, and it cannot 
respond to sweet taste stimulants. 
3.1.5 Gut bacteria models 
The GI tract harbours between 1000 and 1150 predominant bacterial species belonging to 
above 50 microbial phyla (Payne et al., 2012). The diversity of GM varies in regions of the 
GI tract (fig.3.1.4), their importance has been mentioned in section-1.3. 
Among the diverse range of GM of mammals, enterococci are Gram-positive bacteria under 
the phylum Firmicutes that are also ubiquitously present in soil, environment and in many 
food products (Semedo et al., 2003). Enterococci are gaining increasing interest in research 
as inhabitants of the GI tract because of their potential role as both ‘good’ and ‘harmful’ 
bacteria.  
123 
 
 
Figure 3.1.4: Distribution and abundance of bacteria in human gastrointestinal tract. 
The gut microbiota contains an extraordinarily complex variety of metabolically active bacteria and 
other organisms. However, their diversity is limited in comparison to their number in the gut. Figure 
taken from Sartor, 2008. 
On the positive side, bacteriocinogenic enterococci inhibit the growth and development of 
certain pathogenic and spoilage microorganisms, thus play potential protective roles 
(Gomes et al., 2008). Some enterococci such as E. casseliflavus and E. gallinarum can 
produce bile salt hydrolases indicating prospective probiotic properties (Gomes et al., 
2008). They showed that among the 299 food enterococci isolates, 67.7% was found to 
present bile salt hydrolases activity, however, E. faecalis and E. faecium demonstrated 
either inactivity or presented low bile salt hydrolase activity. Still, strains of E. faecium and 
E. faecalis species have been applied as probiotic supplements in human (Moreno et al., 
2006; Eaton and Gasson, 2001), and E. faecalis strains have also been widely used as 
veterinary feed supplements (Moreno et al., 2006). Also, some species have potential roles 
in food preservation because of their capacity of performing proteolysis, lipolysis, citrate 
breakdown, and production of bacteriocins (Moreno et al., 2006). Conversely, they have the 
innate ability to acquire and incorporate extrachromosomal genetic elements, allowing 
expression of virulence characteristics or antibiotic resistance, and they are capable of 
interspecies transferring of the traits (Palmer et al., 2010; Eaton and Gasson, 2001; Franz 
et al., 2001; Cetinkaya et al., 2000).   
Enterococcus faecalis (E. faecalis), is a regular inhabitant of the human GI tract and solely 
responsible for about 80-90% of enterococcal infections in humans (Mohamed and Huang, 
2007; Semedo et al., 2003; Jett et al., 1994). They are non-sporulating, facultatively 
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anaerobic cocci that can tolerate extreme environments, including temperature (5–65 °C), 
pH (4.5−10.0) and a high sodium chloride concentration (6.5%) (Fisher and Phillips, 2009). 
E. faecalis is one of the bacteria that colonizes at the beginning of life and remains as a 
predominant commensal flora with a density of about 107–108 colony forming units (CFU) 
per gram in the GI tract (Huycke et al., 1998). Whilst remaining as a major bacteria, their 
detrimental characteristics such as antibiotic resistance, virulence, ability to integrate 
external genetic element, response to environmental changes and dietary components 
indicate their potential conversion into the evidently safe (‘good’) and unsafe (‘harmful’) E. 
faecalis and therefore increase their importance as a model organism for the current study.  
Enterobacteriaceae is another important family under the class γ-Proteobacteria (phylum 
Proteobacteria), which includes both beneficial and harmful symbionts (Lupp et al., 2007). 
Escherichia coli, one of the most characterized bacteria, is a prototypic example of the 
Enterobacteriaceae (Winter et al., 2013). It is a Gram-negative, non-sporulating facultative 
anaerobe and has been identified in mammalian GM (Gordon and Couling, 2003). E. coli 
receives a nutrient supply and protection from human host, in turn it induces colonization 
resistance to reduce attachment of external pathogens to the epithelium (Vollaard and 
Clasener, 1994; Hudault et al., 2001). The number of anaerobic bacteria in the GI tract is 
more than 100 times higher than E. coli numbers, however, the latter is a predominant 
aerobic organism in the intestine (Tenaillon et al., 2010). In the large intestine, specifically 
in the caecum and colon, this commensal E. coli population resides in the mucous layer, 
however they shed into the intestinal lumen along with the degraded mucous elements, and 
eventually excrete/egest in the faeces (Poulsen et al., 1994). E. coli is not only well-
distributed in the intestine of vertebrates but also a versatile pathogen responsible for 
various intestinal diseases in over two million people per year (Tenaillon et al., 2010). Since 
this study aims to investigate how enteric bacteria is altered due to AS exposure, more 
specifically, how the commensal bacteria turn into pathogenic bacteria, therefore, E. coli 
represents a perfect candidate for assessment. 
Both MGB, E. coli and E. faecalis, colonize at the very early stages of life and were isolated 
from the earliest faeces of normal healthy neonates (Jimenez et al., 2008). E. coli reaches 
very high density of colonization (>109 cfu/g of faeces) before other anaerobic microbes 
extend their colonization. After 2.5 years of age, when the gut flora resembles that in the 
adult (Koenig et al., 2011), E. coli density stabilizes (≈108 cfu/g of faeces) and remains the 
same during adulthood, although it gradually decreases in the elderly (Ouwehand et al., 
1999). 
Both bacteria have pro-carcinogenic features, and both produce DNA-damaging 
compounds (Boleij and Tjalsma, 2012). E. faecalis cause DNA damage in IECs by excreting 
extracellular superoxide. This superoxide converts into H2O2 that has potential DNA-
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damaging features (Huycke et al., 2002; Wang and Huycke, 2007). Similarly, some E. coli 
strains in the gut harbour the polyketide synthetase site, a gene encoding colibactin (a 
genotoxin), causing DNA damage or genetic mutation. Colibactin induces breaks in DNA 
single strands, enhancing the activation of DNA-damage induced signalling pathway, 
thereby increasing the mutation rate of attacked cells (Cuevas-Ramos et al., 2010; 
Nougayrède et al. 2006). Therefore, considering the commensal distribution, behaviour, 
sensitivity and pathogenic potential, selection of the MGB is rational for the present study. 
3.1.6 Importance of bacterial metabolism in host physiology 
The role of intestinal microbial metabolism is becoming increasingly important due to their 
close relation with hosts and the host’s health and wellbeing is equally dependent on 
host/microflora interactions (Wong et al., 2016). For example, the host’s predisposition to 
various MD is influenced by the array of harbouring microbiota (fig.3.1.2). Since microbes 
are exposed to AS in the gut environment, investigating their metabolism after AS-exposure 
is important in defining bacterial dysbiosis. The specific effect of AS on the intestinal 
bacterial metabolism remained elusive. GM function (e.g., SCFA production) and host 
metabolisms are intricately intertwined (Koh et al., 2016). Minor changes in the bacterial 
metabolism may result in huge alterations in the metabolic homeostasis of the host (Makki 
et al 2018). AS can directly impact intestinal bacteria, also bacterial metabolites after AS 
exposure can affect IEC function (Bian et al., 2017). In addition, the receptors in the intestine 
that sense these bacterial metabolites can influence gut physiology. Moreover, the 
signalling pathways involved either directly with AS metabolism or AS-mediated bacterial 
metabolites, play roles in manipulating host metabolism and host-microbiome interactions 
(Wong et al., 2016). Therefore, AS can directly impact gut bacteria, or bacterial metabolites 
can be changed after AS exposure.  
Claus et al. (2016) reviewed the extensive ability of GI microbiota in metabolising a range 
of environmental pollutants, xenobiotics and AS. They have described the breakdown of 
cyclamate, the carcinogenic effects of the component cyclohexamine and these studies 
have resulted in the banning of this sweetener in the UK and the US. The researchers also 
noted that Ace-K has no growth-promoting or -inhibiting effect on bacteria. Moreover, they 
have discussed the growing research on other AS, including saccharin, sucralose and 
aspartame, and urged the necessity of reassessment in appropriate gut microbial 
ecosystems. Since GI microbiota have the potential to metabolise unusual substances and 
can alter their metabolic activity due to long-term exposure, the authors emphasised that 
exposure of microbiota to chemical pollutants, especially during perinatal period and early 
childhood, may have critical impact on microbial development and host physiological 
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functions (Claus et al., 2016). Thus, it is important to study pathogenic factors of the GM 
stimulated due to AS-exposure. 
3.1.7 Bacterial pathogenic factors 
Whilst predominant E. coli and E. faecalis strains in the normal colon promote and maintain 
the stability of the intestinal microbial flora, their pathogenic states possess distinct virulence 
properties (Kaper et al., 2004). Among the virulent features of GM (fig.3.1.5), the most 
studied ones for E. coli are enterotoxin production, tissue invasion and adherence to 
enterocytes (Levine, 1987). E. faecalis are recognised as opportunistic pathogens and are 
responsible for various infections including intra-abdominal infections (Mohamed and 
Huang, 2007).  
 
 
 
Figure 3.1.5: Schematic diagram representing potential pathogenic factors in gut bacteria. 
Bacterial metabolism can directly affect intestinal epithelial cell function or can release substances 
harmful to cells. Also, they can increase number, and can influence the bacteria-intestinal epithelial 
cell interactions. Figure made using online images following Amon and Sanderson, 2017. 
 
127 
 
Enterococcal infections have become a frequent concern in the last few decades in relation 
to a wide range of human infections, such as cystic fibrosis, bacterial endocarditis, 
abdomen, biliary tract, nosocomial infections, and those affecting the central nervous 
system (Tendolkar et al., 2004; Jett et al., 1994). The virulence of E. faecalis cannot only 
be explained by their antibiotic resistance; other virulence factors may stimulate or enhance 
their pathogenicity (Toledo-Arana et al., 2001). Several virulence factors have been 
demonstrated in E. faecalis in different studies, including cytolysin, aggregation substances, 
surface carbohydrates, extracellular superoxide and surface proteins such as Ace, Efa A 
and Esp, however, these factors are highly dependent on the strains and environmental 
conditions (Toledo-Arana et al., 2001). In addition, a number of possible pathogenic 
activities of E. faecalis exist, including their ability of haemolysis and biofilm formation 
(Coburn and Gilmore, 2003, Kristich et al., 2004; Furumura et al., 2006). It is normally γ-
haemolytic but turns into β-haemolytic when virulent (Shankar et al., 2002). Since 
physiological factors such as diet have influence on the above-mentioned pathogenic 
factors in E. faecalis, and these pathogenic factors are important for host health, therefore, 
it is sensible to investigate the effect of AS on the growth, haemolysin and biofilm formation 
of this microorganism. 
Haemolysin production is frequently observed in pathogenic E. coli strains isolated from 
disease processes. For example, strains from urinary tract infection (UTI), peritonitis and 
appendicitis could produce haemolysin (Giaffer et al., 1992). Study on faecal samples of 
patients with UTI, E. coli strains were found to possess more haemolytic capacity than those 
from healthy individuals (Cooke and Ewins, 1975). The haemolytic E. coli strains were also 
associated with necrotoxin production and cytotoxicity (Cooke and Ewins, 1975). Similar 
studies demonstrated that the diffusible haemolysin production of E. coli has close 
correlation with cytotoxicity in chick embryo cell cultures. However, the same strain had no 
cytotoxic effect on monkey kidney and mouse embryo cell cultures (Chaturvedi et al., 1969). 
In addition, haemolytic E. coli strains were isolated from patients suffering with IBD along 
with either Crohn’s disease or ulcerative colitis. The research indicated equal distribution of 
the haemolytic strains in both diseases without differing according to disease activity 
(Giaffer et al., 1992). Therefore, whether bacteria produce haemolysin after AS-exposure 
needs to be investigated since this feature has link to other diseases.  
Communities of microorganisms adhered to an abiotic or a biotic surface and protected in 
a matrix composed of bacterial secretions, is called biofilms (O’Toole et al., 2000). Some 
genetic factors such as E. faecalis regulator (fsr), enterococcal surface protein (esp), 
autolysin (atn) etcetera genes have contribution in E. faecalis biofilm formation (Mohamed 
and Huang, 2007). Similarly, E. coli contains specific genes that promote biofilm formation 
upon stimulation from environmental conditions. Some cell surface components such as 
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flagella, type I fimbrae, outer membrane proteins, colonic acid, poly (β-1,6-GlcNAc) in E. 
coli K-12 have contribution in biofilm formation during static growth conditions (Reisner et 
al., 2006).  Therefore, biofilm formation may occur due to the genetic factors or response of 
bacteria to environmental changes and has significant phenomenon in studying the 
microbial development (Mohamed and Huang, 2007; O'Toole et al., 2000). 
Biofilm development is an important pathogenic phenotype associated with several chronic 
infections (Reisner et al., 2006; Mohamed and Huang, 2007). Biofilms form through a 
complex series of mechanisms (Tendolkar et al., 2004). Beside the genetic factors, nutrient 
availability and physical conditions such as available CO2, osmotic pressure, pH, and 
temperature influence biofilm formation (Mohamed and Huang, 2007). Evaluation of these 
factors in different studies on E. faecalis suggested that this organism monitors the milieu 
and modulates biofilm development (Kristich et al., 2004). Besides, being a non-pathogenic 
member of the GI tract, E. coli causes diarrhoea and a variety of other infections indicating 
their ability to form biofilm under appropriate environmental conditions (Reisner et al., 2006), 
however biofilm formation in response to AS has not been previously studied. 
Pathogenic bacteria produce different cytolytic toxins which have important virulence 
features. In both commensal and pathogenic states of E. coli, three different pore-forming 
cytolysins were identified so far; HlyA, EHEC HlyA, and ClyA stands for α-, 
enterohaemorrhagic E. coli– haemolysin and cytolysin A, respectively (Burgos and Beutin, 
2010; Ludwig et al., 2004). α-haemolysin is the most predominant cytolysin in the Gram-
negative pathogenic bacteria, E. coli strains exhibiting the phenomenon of haemolysis 
usually harbour a homologous gene clusters for the production, activation and secretion of 
α- and EHEC- haemolysin (Ludwig et al., 1999). ClyA is released in small amounts in the 
external medium and can cause complete haemolysis of erythrocytes (Ludwig et al., 2004). 
Influence of dietary carbohydrates on ClyA release was confirmed in recombinant E. coli 
DH5α; dextran (30 mM) but not sucrose (30 mM) demonstrated a protective role in ClyA-
mediated haemolysis (Ludwig et al., 1999). Moreover, Gomes et al. (2008) studied 
enterococci isolated from Brazilian foodstuff and reported that 72.4% of the E. faecalis 
developed biofilm while 13.8% showed adherence to Caco-2 cells and 12% caused β-
haemolysis. The study also described higher frequency of antibiotic resistance genes and 
traits in E. faecalis than other enterococci such as E. faecium (Gomes et al., 2008). There 
might have a connection among the biofilm formation, haemolysin production and antibiotic 
resistance in E. faecalis indicating their adherence to IECs can interact in a variety of ways.  
Food components have been determined to have enormous impact on the structure and 
behaviour of the microflora (section-1.3.2). AS came under focus as they exert unusual 
implications on gut bacteria (section-1.4.3). Background research has already indicated that 
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AS cause gut bacteria dysbiosis (Suez et al., 2014), however, there are no clear studies on 
how AS changes the commensal bacteria and how that potential might elicit pathogenic 
response in the intestine.  
  
130 
 
Rationale for chapter 3 
The changes in growth and pathogenicity of one organism may have influence on the 
response of others and the interactions among gut flora. The alterations can be attributed 
to either the effects of AS on mammalian cells, or the effect of AS on bacteria, or a 
combination of both. Research into this area will help our understanding on the effect of AS 
consumption on the bacterial metabolism and whether this food component can be used to 
regulate the bacterial pathogenicity. 
Both E. coli and E. faecalis are commensal as well as pathogens and are good 
representative of corresponding phyla. From a technical perspective, both species can be 
isolated easily, grown and maintained in laboratory and are frequently used as potential 
human faecal indicators (Wheeler et al., 2002). Considering the aim of the present study, 
investigating how the normal commensal bacteria could potentially become pathogenic in 
response to AS consumption in the gut environment, these organisms represent good 
models to study. 
 
Aims and hypothesis 
The hypothesis for the present chapter is that artificial sweeteners alter the model gut 
bacterial metabolism and increase pathogenicity.   
To address this hypothesis, the specific aims for the chapter are: 
• To determine the role of AS on metabolism of models of gut bacteria. 
• To assess whether exposure to AS increase model gut bacterial pathogenicity 
factors. 
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3.2 Material and methods  
3.2.1 Materials 
Bacterial culture plates and universal tubes were purchased from ThermoScientific (USA), 
the glassware and micropipette tips were from Fisherbrand (UK), and the micropipettes 
were from Eppendorf (UK). Bacteria Escherichia coli DH5α and Escherichia coli NCTC 
10418 were obtained from the Microbiology laboratory, Anglia Ruskin University. 
Enterococcus faecalis was bought from ATCC (ATCC® 19433™, USA). 2YT solid and liquid 
media were from Sigma. All other bacterial media, and carbohydrates glucose, fructose, 
and sucrose were purchased from Oxoid (UK). ZnSO4 and the antibiotics were purchased 
from Sigma-Aldrich (USA). Sterile, flat-bottom, polystyrene 96-well plates were purchased 
from CytoOne (USA). 
AS in the diet can easily reach to 100 µM. This sub-physiological concentration did not affect 
Caco-2 cell viability, while bacterial growth remained unchanged for a range of 
concentrations of the AS. Considering the co-culture assays in chapter 4, and the findings 
from growth data, 100 µM was found appropriate for the further assays with bacteria. Also, 
if there is an effect at sub-physiological concentration, it is likely that higher concentrations 
would also have the effect, so 100 µM concentration was used for the other assays (table-
3.2.1). Zinc sulphate, glucose, sucrose, and fructose concentrations used in the study were 
less than or equal to the concentrations previously used by Keast et al. (2003). 
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Table 3.2.1: AS and sweet taste inhibitor (ZnSO4) concentrations used in different 
experiments.  
The bacterial growth conditions were determined using model bacteria E. coli DH5α, and further 
experiments was performed on the model gut bacteria E. coli NCTC 10418 and E. faecalis ATCC 
19433. 
Assay 
performed  
Chemical name Cell type 
exposed to 
AS 
Concentration(s) (µM) 
Growth 
measurement 
AS (saccharin, sucralose, 
aspartame, neotame) 
E. coli 
DH5α 
0, 0.01, 0.1, 1, 10, 100, 
1000, 10000 
Glucose, fructose and 
sucrose 
0, 0.2, 2, 20, 200, 2000, 
20000, 200000 
ZnSO4 0, 1, 10, 50, 100, 500, 
1000, 10000 
Growth 
measurement 
AS (saccharin, sucralose, 
aspartame, neotame) 
E. coli 
E. faecalis 
0, 0.1, 1, 10, 100, 1000 
ZnSO4 100 
Biofilm Assay AS E. coli 
E. faecalis 
100  
ZnSO4 100 
Haemolysis 
Assay 
 
 
AS (saccharin, sucralose, 
aspartame, neotame), 
Sucrose 
E. coli 
E. faecalis 
100 AS, 73 mM Sucrose 
ZnSO4 100 
 
3.2.2. Bacterial cell culture 
Bacteria were grown at 37 ˚C either on solid media without shaking (LMS Cooled incubator, 
UK) for single colonies, or in liquid media with shaking (New Brunswick Scientific Co. Inc., 
G25, USA) at 150 revolutions per minute (rpm). Aseptic techniques were followed for all the 
bacterial and cell works.   
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3.2.3 Bacterial growth determination 
3.2.3.1. Method evaluation 
Measuring pH of the chemical solutions 
The stock solutions for the natural carbohydrates, AS, and ZnSO4 were prepared in water 
and pH was measured (Jenway, Model 3510, Bibby Scientific ltd, UK). The working 
solutions were prepared in 2YT for the model bacteria E. coli DH5α, and in NB and BHI for 
the MGB, E. coli NCTC 10418 and E. faecalis ATCC 19433, respectively. The pH of the 
stock solution and the working solutions are presented in Appendix B (table-B8.1).  
Determination of the culture conditions 
E. coli DH5α was used to determine the conditions such as inoculum concentration and 
shaking for bacterial growth. From the stock culture, a loopful bacteria was spread on 2YT 
plate and incubated overnight. A single colony from the overnight culture was inoculated 
into 10 ml of 2YT liquid medium (pH 6.72) and incubated overnight at 37 °C with shaking at 
150 rpm. The optical density of the culture was measured at 600 nm against 2YT media 
(blank) and was used as base culture for further dilutions. Different dilutions (1:50, 1:100, 
1:500, 1:1000, 1:5000, 1:10000) of the base E. coli DH5α culture were re-suspended in 200 
µl of the fresh 2YT liquid media in 96-well plates and plates were incubated with or without 
shaking. Bacterial growth was measured as absorbance at 600 nm using PerkinElmer 
(Victor X3) from 0 to 96 hour at interval of 0.5 hour. 
Effect of carbohydrates, AS, and ZnSO4 on model bacterial growth 
Once the bacterial concentration and growth condition was determined, the effect of 
different concentrations of the AS, natural carbohydrates glucose, sucrose, and fructose, 
and the sweet taste inhibitor, ZnSO4 was determined on the growth of E. coli DH5α. 
 
3.2.3.2 Determination of the model gut bacterial growth 
The model gut bacterial growth was assessed using the same protocol described above. 
Brain Heart infusion (BHI) medium was suggested by the supplier for the Enterococcus 
faecalis ATCC 19433 (E. faecalis) growth and maintenance. Escherichia coli NCTC 10418 
(E. coli) was grown in several liquid medium such as NB, BHI, Iso-sensitest broth, 2YT and 
Luria-Bertani to determine the appropriate medium for the study. Optical density (OD600) 
was measured using spectrophotometer (Eppendorf BioPhotometer Plus, Germany) and 
NB was selected for the E. coli growth. A single bacterial colony of E. coli or E. faecalis was 
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transferred from NA or BHI agar plates, respectively, into corresponding liquid media using 
aseptic techniques. Growth was measured as absorbance at 600 nm using 
spectrophotometers, cuvette photometer (Eppendorf BioPhotometer) or the multiplate 
reader (PerkinElmer, Victor X3). 
OD600 is the measurement of absorbance or optical density (OD) of bacterial growth. The 
bacterial scattering of the light provides a measurement of turbidity. Simply, the more turbid 
the sample, more bacteria are present to scatter the light, so less amount of light will pass 
through the sample. Use of multiplate reader (PerkinElmer) is easier and less amount of 
sample and time are needed. The machine uses fast absorbance measurement method to 
provide bacterial density. In contrast, the cuvette photometer (Eppendorf) requires more 
sample and longer time to read. It measures OD600 for calculating the bacteria density 
through measuring turbidity. The basic idea of measurement for both cuvette photometer 
and the PerkinElmer are same, other than the mode of measurement. For the convenience 
to differ cuvette and multiplate read in the study, the former is denoted as OD600 and the 
latter as A600. 
Determination of absorbance to bacterial count 
OD600 measurement differs for different bacteria due to their size, so an initial assessment 
was done to estimate the number of bacteria in relation to absorbance. The MGB were 
cultured overnight in NB and BHI, respectively and OD600 was measured. Also, CFU/ml of 
the bacterial culture was assessed using standard plate count method.  
In addition, to determine the number of bacteria in different growth cultures, the CFU for a 
range of absorbance was measured using simplification of the protocol maintained for the 
McFarland standards (Lahuerta Zamora and Pérez-Gracia, 2012) with the standard plate 
counting method. A serial dilution (up to 10-10) of the diluted base culture (table-B8.2) of the 
MGB was performed, and A600 of 100 μl of bacterial suspension was measured in 96-well 
plate. The diluted sample (100 μl) was plated for overnight at 37 ˚C for CFU. Absorbance 
index were developed by accounting the relative absorbance and the CFU unit. 
3.2.4 Effect of AS on model gut bacterial growth  
The MGB were cultured in the respective liquid medium supplemented with different 
concentrations of the AS saccharin, sucralose, aspartame and neotame (table-3.2.1) to 
assess the effect of AS on their growth. For each assay, the bacteria were grown between 
one and four days to measure the changes until complete stationary phase, and growth was 
recorded as A600 (fig.3.2.1). 
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Figure 3.2.1: Experimental process for bacterial growth measurement. 
(i) bacterial strain was streaked on solid media; (ii) single colony was inoculated into liquid media 
with/out AS; (iii) overnight culture – growth was measured and continued incubation; (iv,v) sample 
was measured in cuvette using spectrophotometer and/or 96-well plate using Perkin-Elmer (Victor™ 
X3); (vi) representative feature of a growth curve having lag phase, exponential phase, transitional 
or diminishing growth phase and plateau or stationary phase denoted by a, b, c and d, respectively. 
 
3.2.5 Biofilm formation Assay  
Biofilm formation of E. coli and E. faecalis was measured after exposure to different AS 
(fig.3.2.2) at 100 μM concentration (table-3.2.1). A single bacterial colony was inoculated 
into 10 ml of the respective liquid media supplemented with AS, 73 mM sucrose or vehicle, 
and allowed to grow overnight. The base cultures were diluted 1:200 with fresh liquid media 
with/out treatments for continuous- or pre-exposure, respectively. In addition, ZnSO4 was 
used with AS to inhibit the sweet sensing and biofilm formation was assessed for continuous 
exposure at 37 ˚C. Equal distribution of the bacterial cell number into each of the wells was 
confirmed by A600 measurement (fig.3.2.2).  
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Aliquots of 200 µl of bacterial cultures were dispensed in triplicate into wells of a sterile 96-
well flat-bottom plastic tissue culture plate. The sides of wells under consideration were 
filled with equal amount of distilled water to prevent evaporation or drying. The cultures 
were grown aerobically for 48 hours at RT or 37 °C without shaking. Comparable bacterial 
growth in each well was confirmed by measuring the A600. The supernatant was removed, 
and the wells were washed once with 200 µl of double distilled water (ddH2O). The adherent 
cells were stained with 150 µl of 0.1% Gram crystal violet (CV) for 20 minutes at RT to 
facilitate CV absorption by the biofilm-forming bacteria. The wells were washed (200 µl 
ddH2O, X3) to remove the unbound or loosely adhered CV and 30% acetic acid in water 
(200 µl) was employed to release retained CV. Plates were incubated at 37 °C for 5 minutes 
to facilitate CV release. A600 of the wells was again measured using the same protocol to 
assess the biofilm forming bacteria as a measurement of the CV retained. 
The biofilm forming unit was calculated (fig.3.2.2.vii) and were normalised to the control 
(100%) to eradicate normal growth influence on the treatment and presented as % biofilm 
formations. 
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Figure 3.2.2: Schematic diagram of the crystal violet biofilm formation assay in plastic 
microtiter plates. 
(i) bacterial inoculum preparation; (ii) 200 µl of inoculum into the 96-well plate for biofilm 
development; (iii) steps of biofilm formation; (iv) bacterial culture after 48 hour incubation; (v) staining 
with Crystal violet (CV) staining assay; (vi) measuring absorbance at 600 nm (A600) using Perkin-
Elmer (Victor™ X3) of total bacterial growth and retained CV by biofilms; and (vii) method used to 
calculate biofilm formation. 
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3.2.6 Hemolysis Assay 
Blood Agar Base with 7% Horse Blood (Thermo Scientific Oxoid) was used to investigate 
the haemolytic properties of E. coli and E. faecalis after exposure to 100 µM of the AS or 
sucrose (73 mM) or vehicle (fig.3.2.3). 
A single colony of MGB was grown in 10 ml of liquid media supplemented with the AS or 
sucrose or vehicle, in the presence or absence of ZnSO4. After 24-hour incubation at 37 °C 
with shaking at 150 rpm, A600 was measured. A cotton swab soaked with bacterial culture 
was spotted and dragged on Blood Agar Plates with and plates were incubated at 37 °C. 
Hemolysis was assessed after 24-, 48-, and 72-hours of incubation. Staphylococcus aureus 
was used as positive control for the assay (Wiseman, 1975). Images of the plates were 
taken (UVI-Tec imager, Cambridge, UK) and qualitative data was collected. 
 
Figure 3.2.3: Haemolysis assay on blood agar plate. 
A single colony was inoculated into liquid media containing AS or sucrose or vehicle with/out ZnSO4 
for 24 hours. Cotton swab soaked with overnight bacterial culture was streaked on blood agar plates 
and incubated at 37 °C for 24- to 72-hours. The plates were observed for the clearing of erythrocytes 
due to haemolysin production. Panels show three different types of haemolysis bacteria can cause. 
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3.2.7 Data analysis 
Differences among the means were tested for significance in all experiments by ANOVA 
with least significance difference test, one-way ANOVA with Holm-Sidak multiple 
comparison test, ordinary one-way ANOVA with Kruskal-Wallis test, unpaired t-test and 
non-parametric test. Significance was reached when p<0.05.   
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3.3. Results 
3.3.1 Protocol determination 
3.3.1.1 Escherichia coli DH5α growth 
E. coli DH5α were cultured at different dilutions and grown with or without shaking to 
determine the inoculum concentration and growth condition for further experiments. The 
initial lag phase and subsequent exponential growth phase lasted for 8-10 hours with 
shaking condition, followed by an extended period of late exponential phase of slow growth 
before stationary phase (fig.3.3.1). The effect of the increasing dilution on growth was 
observed in the growth curves (fig.3.3.1). The growth curve varied with different 
concentrations of bacteria as well as with shaking (fig.3.3.1.a) and without shaking 
(fig.3.3.1.b). 
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Figure 3.3.1: Growth curve of E. coli DH5α. 
Different dilutions of overnight grown base culture were plated in 96-well plates with 200 µl of 2YT 
liquid media (pH 7.2). The plates were incubated at 37 °C with shaking at 150 rpm (a) and without 
shaking (b), and absorbance was measured at 600 nm at 30-minute intervals (except for near 20 
and 40 hours, for about 10 h). Data are presented as the mean ± S.E.M., n=3. 
 
The initial lag phase lasted for about 2-4 hours, followed by an extended exponential phase 
for about 14-18 h (fig.3.3.1.b). The late exponential phase was longer (25 – 40 hour) with 
lower growth rate after which bacteria reached the stationary phase. 
The 1:50 dilution bacterial culture incubated with shaking showed very short (approximately 
1.5 hour) lag phase followed by about 16–18 hour log phase after which it has reached to 
a long stationary phase (fig.3.3.1.a). The dilution 1:500 represented almost similar growth 
pattern like 1:50 but showed a long late exponential phase. The 1 in 1000 dilution reached 
near 0.8 (a.u.) but the lag phase was longer (approximately 8 hour). Also, the curve started 
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to decline after 48 hours (fig.3.3.1). A similar decline was observed in 1:5000 dilution and 
the lag phase were prolonged (10 hour). The lowest absorbance (near 0.6) peak was 
recorded for the 1:10000 dilution with shaking incubation where the lag phase was extended 
for about 10 hour followed by an exponential phase of approximately 16 hour (fig.3.3.1.a). 
Without shaking, a similar trend of growth was observed however the growth rate was slow 
and the duration of each phase was extended (fig.3.3.1.b) than shaking. The highest 
absorbance was 0.9 for all the less diluted bacterial suspensions (1:50 to 1:1000) at 60 
hours. The less diluted cultures showed shorter lag phase while the more diluted bacterial 
suspensions undergone prolonged lag phase. On the other hand, the higher bacterial 
number presented a long stationary phase (about 10 hours for 1:50 dilution) whereas the 
lowest bacterial dilution (1:10000) started to decline just after reaching its peak. 
Taken together these findings show that bacterial concentration (1:500) and shaking 
technical approaches provide an appropriate growth curve with phases as expected and 
found feasible for the project. Also, the microvilli mediated continuous mixing and movement 
due to peristalsis represent shaking as more physiological condition. Further studies with 
MGB will therefore use this approach to grow bacteria in liquid media. 
3.3.1.2 The effect of natural sugars 
The effect of sweeteners on gut bacteria metabolism is important to determine the exact 
mechanism of how they change bacterial diversity and/or alter/drive bacteria to be 
pathogenic (Nettleton et al., 2016). In addition, effect of the carbohydrates such as glucose, 
fructose and sucrose, need to be assessed since they may have an effect on host 
metabolism and absorbance (Payne et al., 2012), also, the changes due to AS exposure 
can be compared to the natural carbohydrates. E. coli DH5α is a non-pathogenic laboratory 
strain that shows sensitivity to growth conditions (Phue et al., 2008). Therefore, the next set 
of experiments were performed with E. coli DH5α as a model organism to assess the role 
of glucose, fructose, sucrose, and AS on the bacterial growth.  
The pH of the solutions containing bacterial growth media and sweeteners, which the 
bacteria were exposed to, was measured (Jenway, Model 3510, Bibby Scientific ltd, UK) to 
keep the pH of the solutions consistent. The stock solutions (1M) for the natural 
carbohydrates, AS, and ZnSO4 were prepared in water and the working solutions were 
prepared in 2YT for the model bacteria E. coli DH5α, and in NB and BHI for the MGB E. coli 
and E. faecalis, respectively. The pH of the working solution concentrations was close to 
the vehicle and there was no statistically significant difference (appendix B, table-B8.1).  
The carbohydrates showed differential effect on the model bacteria, E. coli DH5α growth 
and the shaking condition has distinct impact, as expected. All without shake data were 
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presented in appendix B. Glucose and fructose marginally increased E. coli DH5α growth 
at lower concentrations (0.2 – 20 μM) while the higher concentrations (2 – 200 mM) reduced 
bacterial growth below the control (fig.3.2.a,b). In contrast, sucrose had no effect other than 
a marginal reduction for the highest concentration, 200 mM (fig.3.3.2.c). However, the 
shaking condition gave a growth curve like the vehicle (fig.3.3.2.c) while a 24-hour lag phase 
was observed without shake condition (fig.B8.1). A similar difference in the growth peak 
was also observed for glucose and fructose due to shaking, as anticipated. The growth 
reached at stationary phase for shaking condition after 36 hours (fig.3.3.2.a,b), whilst at 60-
hour for without shake condition (fig.B8.1.a,b). 
The higher concentrations (20 and 200 mM) of glucose and fructose had inhibitory effect on 
E. coli DH5α growth at both conditions (fig.3.3.2 and B8.1.a and b). Similar inhibition was 
also observed for the 2 mM at with shake condition until 24 hours (fig.3.3.2.a,b), although 
this was not distinct in without shake (fig.B8.1.a,b).  
These studies suggest that shaking is better for model bacterial growth as expected. Also, 
glucose and fructose have an initial inhibitory effect on E. coli DH5α growth, but sucrose 
has no effect. 
144 
 
 
Figure 3.3.2: Effect of natural carbohydrates on E. coli DH5α growth. 
Overnight culture was inoculated into liquid media (1:500) at planktonic condition and incubated at 
37 °C with shaking at 150 rpm. Plates were read at 12-hour intervals at 600 nm using PerkinElmer 
(Victor X3). All cultures plateau to a degree after 12 hours, the cultures with higher added sugar 
concentrations 20, 200 mM) of glucose (a) and fructose (b) took longer to re-enter exponential phase. 
Sucrose (c) growth curves were same for all the tested concentrations. Data are presented as the 
mean ± S.E.M., n=3, each with two replications. 
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3.3.1.3 Effect of AS 
AS did not have effect on E. coli DH5α growth (fig.3.3.3), except for the highest 
concentration (10 mM) of saccharin (fig.3.3.3.a) and neotame (fig.3.3.3.d) that reduced 
growth marginally. In addition, fig.3.3.3 and fig.B8.2 represent that shaking caused a 
difference in the growth of the bacteria.  
The AS at different concentrations presented an exponential growth for 24 hours, then a 
long late exponential growth phase with the very slow increase in absorbance (fig.3.3.3). 
The model bacteria showed its optimum growth for 100 μM of saccharin and neotame 
(≈0.72) at approximately 48 hours, whereas, for 10 mM of sucralose and aspartame (≥0.72) 
at around 60 hours. The sucralose and aspartame at all concentrations gave nearly same 
level of growth (fig.3.3.3.b,c). In without shake condition, there was no distinguishable 
differences in the growth curves for the different concentrations, neither for the different AS 
(fig.B8.2).  
These findings suggest that shaking is important for the model bacterial growth in liquid 
media in the planktonic condition. Also, AS do not have effect on E. coli DH5α growth. 
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Figure 3.3.3: Effect of artificial sweetener on E. coli DH5α growth. 
E. coli DH5α was inoculated in 200 µl of 2YT liquid media containing different doses of artificial 
sweetener saccharin, sucralose, aspartame and neotame and were incubated at 37 °C with and 
without shaking. Figure demonstrates the effect of a. saccharin, b. sucralose, c. aspartame and d. 
neotame. Data presented as the mean ± S.E.M., n=3, each with two replications. 
 
3.3.1.4 Effect of sweet taste inhibitor  
There was no literature found with indications on the STR in bacteria. ZnSO4 non-
specifically inhibits the sweet taste sensing (Keast, 2003), therefore, its effect on model 
bacterial growth was measured so that it can be used a pan-inhibitor of sweet sensing. 
ZnSO4 marginally increased E. coli DH5α growth up to 24 hours in shaking condition, except 
for the highest concentration (10 mM) (fig.3.3.4). Absorbance reached a peak at 60 hour 
and showed a concentration-dependent response in growth; (absorbance 0.57 at 0 dose, 
0.60 at 1 µM, 0.62 at 10 µM, 0.64 at 50 µM, 0.66 at 100 µM, 0.67 at 500 µM and 0.69 at 1 
mM) for the shaking condition (fig.3.3.4). An almost similar response was observed in the 
without shaking condition, except for the 10 mM concentration (fig.B8.3). 
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Figure 3.3.4: Effect of ZnSO4 on bacterial growth. 
E. coli DH5α was inoculated in 200 µl of 2YT liquid media containing different concentrations of 
ZnSO4 and was incubated at 37 °C with and without shaking. Data are presented as the mean ± 
S.E.M., n=3, each with two replications. 
 
Taken together, the above findings on the model bacteria, E. coli DH5α, show that 1:500 
base culture concentration is appropriate inoculum and growing bacteria with shaking is 
better option (fig.3.3.1). Also, the natural carbohydrates, AS and the sweet taste inhibitor 
do not have effect on the model bacterial growth at physiologically achievable 
concentrations. Glucose and fructose but not sucrose have an initial inhibition on growth at 
concentrations ≥2 mM (fig.3.3.2). In addition, saccharin and neotame reduce model 
bacterial growth at 10 mM (fig.3.3.3). Besides, E. coli DH5α is a non-pathogenic laboratory 
strain (Chart et al., 2000), therefore, this model bacteria was used to determine the culture 
conditions only, the further studies on the changes in the pathogenic potential was 
performed on the MGB. 
3.3.2 Determination of the model gut bacterial growth 
3.3.2.1 Establishing protocols 
3.3.2.1.1 Growth of E. coli NCTC 10418 in different liquid media 
E. coli was grown in several broths to determine the appropriate media for the study, and 
NB was selected. Table-B8.3 (appendix B) represent the growth of E. coli (OD600) in 
different liquid media at 24 hours. The bacteria showed growth in all the liquid media and 
growth in NB was in the mid-level (OD600, 1.5).  
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To first assess the correct conditions, the MGB E. coli and E. faecalis, were grown in NB 
and BHI medium, respectively for 12 to 96 hours at 37 ˚C with shaking (150 rpm) and the 
growth was measured as absorbance at 600 nm. These growth curves (fig.3.3.5) also 
demonstrate the difference in measurement for the two machines.  
 
Figure 3.3.5: Growth curve of E. coli NCTC 10418 (a) and E. faecalis ATCC 19433 (b). 
A single bacterial colony was inoculated into 10 ml of the Nutrient broth and Brain Heart infusion 
liquid media, respectively, and incubated at 37 ˚C with shaking at 150 rpm for four days. 1 ml of the 
sample was taken into cuvette and optical density (OD600) was measured against appropriate blank 
using spectrophotometer (EppendorfBioPhotometer). On the other side, 100 µl of the same sample 
was taken into 96-well plate and absorbance was measured at 600 nm using PerkinElmer (Victor 
X3). Growth was recorded at different time points and represent the difference of reads between 
spectrophotometers used. Data are presented as the mean ± S.E.M., n=4 (a), 3 (b). 
 
3.3.2.1.2 Determination of the absorbance to CFU 
To determine the number of bacteria in culture, a serial dilution of the base culture was 
performed, and the standard plate count method was used. The model gut bacterial 
absorbance and the number of CFU at 24-hour growth was presented in table-3.3.1. E. 
faecalis showed higher absorbance than E. coli, however, both MGB demonstrated 
absorbance-dependent increase in CFU/ml. Therefore, overnight culture of the MGB 
represented average growth of 1010 CFU/ml (OD600, 1.587) for the E. coli and 1012 CFU/ml 
(OD600, 2.169) for the E. faecalis. 
Table 3.3.1: Absorbance related CFU of model bacteria. 
Optical density of the overnight bacterial culture was measured using spectrophotometry 
(EppendorfBioPhotometer) and the standard plate count method was used to assess the CFU/ml. 
Bacteria *OD600 (Spectrophotometry) #CFU (per ml) 
E. coli NCTC 10418 1.502 5×1010 
1.589 2.8×1010 
1.599 6.2×1010 
1.656 6.4×1011 
E. faecalis ATCC 19433 1.496 1×1012 
2.134 3×1012 
2.382 3.6×1012 
2.664 4.7×1012 
*OD600 = optical density at 600 nm, #CFU = colony-forming units 
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In addition, CFU was measured for a range of absorbance (A600) following McFarland 
standards to determine the bacterial concentration in each suspension (table-3.3.2). E. 
faecalis showed higher absorbance and CFU number than E. coli.  
Table 3.3.2: Absorbance to CFU of the model gut bacteria following the McFarland standards. 
Overnight bacterial culture was diluted (according to table-B8.2) and absorbance at 600 nm was 
measured using spectrophotometry (PerkinElmer, Victor X3). The standard plate count method was 
used to assess the number of CFU/ml of the corresponding bacterial suspension and absorbance 
index was prepared. 
E. faecalis ATCC19433 E. coli NCTC10418 
*A600 #CFU A600 CFU 
0.539 2.48 x 1012 0.292 2.9 x 1012 
0.507 1.65 x 1012 0.275 1.8 x 1012 
0.467 1.37 x 1012 0.266 1.44 x 1012 
0.438 9.2 x 1011 0.249 1.25 x 1012 
0.401 8.8 x 1011 0.228 1.46 x 1011 
0.380 5.7 x 1011 0.197 4.7 x 1010 
0.316 3.4 x 1011 0.168  1.85 x 1010 
0.272 3.5 x 1010 0.152 1.45 x 1010 
0.240 2.8 x 109 0.142 1.38 x 1010 
* Absorbance at 600 nm ** Colony Forming Unit. 
 
3.3.2.2 The effect of AS on model gut bacterial growth 
The effect of AS on the MGB (E. coli and E. faecalis) growth was measured as A600. Growth 
in planktonic culture was measured every 12-hour after exposure to a range of 
concentrations of saccharin, sucralose, aspartame and neotame for 4 days.  
3.3.2.2.1 Effect of AS on E. coli NCTC 10418 growth 
None of the four AS affected E. coli growth at any of the tested concentrations and duration 
in comparison to control (fig.3.3.6). Only 1 mM saccharin inhibited E. coli growth until 18 
hours, after which it started to grow in the same manner as the vehicle (fig.3.3.6.a). There 
is a marginal increase in growth at 1 mM of sucralose from 36 to 84 hour in comparison to 
the control (fig.3.3.6.b), while a slight decrease was observed for neotame 1 mM 
(fig.3.3.6.d), however, the changes are not significant. 
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Figure 3.3.6: Effect of artificial sweeteners on E. coli NCTC 10418 growth. 
A single colony was inoculated into liquid media and was incubated for 12 to 96 hours at 37 °C with 
shaking at 150 rpm. Growth was measured as absorbance at 600 nm using PerkinElmer (Victor X3) 
at 12-hour intervals. Graphs represent effect of different concentrations (μM) of AS saccharin (a), 
sucralose (b), aspartame (c), and neotame (d). Data are presented as the mean ± S.E.M., n=3-5.    
 
3.3.2.2.2 Effect of AS on E. faecalis ATCC 19433 growth 
The AS did not exert any significant effect compared to control on E. faecalis growth at the 
given concentrations and the duration of exposure (fig.3.3.7). Sucralose and neotame 
showed a marginal increase at all the concentrations (fig.3.3.7.b and fig.3.3.7.d, 
respectively). Saccharin demonstrated a low inhibition at 1 mM (fig.3.3.7.a), while 
aspartame did not (fig.3.3.7.c).  
Therefore, the AS have no significant effect at any concentration on the MGB, E. coli and 
E. faecalis, growth. 
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Figure 3.3.7: Effect of artificial sweeteners on E. faecalis ATCC 19433 growth. 
A single colony was inoculated into liquid Brain Heart infusion media and was incubated for 12 to 96 
hours at 37 °C with shaking at 150 rpm. Samples were read at 12-hour intervals using PerkinElmer 
(Victor X3). Graphs represent effect of different concentrations (μM) of AS saccharin (a), sucralose 
(b), aspartame (c), and neotame (d) on E. faecalis growth. Data are presented as the mean ± S.E.M., 
n=3-5.    
 
There was no significant change in bacterial growth for E. coli (fig.3.3.8.a) or E. faecalis 
(fig.3.3.8.b) after AS (100 µM) exposure for 24 hours. Likewise, sweet taste inhibitor, ZnSO4 
and natural sugar, sucrose (73 mM), had no significant effect on the MGB growth. 
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Figure 3.3.8: The effect of artificial sweeteners on model gut bacterial growth. 
Bacteria were exposed to 100 µM of AS saccharin, sucralose, aspartame and neotame or vehicle 
with/out ZnSO4 and growth was measured as optical density at 600 nm at 24 hours. a) represents E. 
coli and b) represents E. faecalis growth curve. Data were analyzed using Dunn's multiple 
comparisons test and are presented as the mean ± S.E.M., n=8.   
 
3.3.3 AS enhanced bacterial biofilm formation 
The in vitro biofilm assay was performed to evaluate the influence of AS on the ability of 
MGB to form a biofilm on polystyrene plates in planktonic culture condition. Absorbance 
was measured for biofilm quantification after dissolution of biofilm-bound CV stain. Two 
model gut organisms were tested for AS with/out ZnSO4. Sucrose was used as a test 
substance to compare the effect of AS with natural carbohydrate. 
E. coli exposed to sucrose formed a biofilm at RT; short-term exposure (pre-exposure for 
24 h) caused 144% biofilm formation in comparison with vehicle while continuous exposure 
caused 630% (fig.3.3.9.a,c). However, no biofilm formation was recorded for either case 
when incubated at 37 ˚C (fig.3.3.9.b,d). Saccharin caused significant biofilm formation only 
when E. coli was continuously exposed at 37 ˚C (fig.3.3.9.d). On the other hand, sucralose 
caused E. coli biofilm formation at 37 ˚C for both the pre- and continuous exposure 
(fig.3.3.9.b,d), however, continuous sucralose exposure but not pre-exposure caused 
significant E. coli biofilm formation (360%) at RT (fig.3.3.9.a,c). Oppositely, aspartame 
exposure enhanced E. coli biofilm formation for all the given conditions, except for the pre-
exposure and at 37 ˚C (139%). Exposing E. coli to neotame for overnight or continuously 
and irrespective of the temperatures showed significant biofilm development (fig.3.3.9). 
Overall, E. coli showed higher biofilm percentage at RT than 37 ˚C, except for saccharin. 
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Figure 3.3.9: Effect of AS on E. coli biofilm formation. 
Bacteria exposed to AS for 24 hours and the culture was diluted (1:200) and sub-cultured in nutrient 
broth supplemented with (c,d) or without (a,b) AS. Biofilms were grown on polystyrene plates for 48 
hours incubating at different environmental condition, either at RT (a,c) or 37 °C (b,d). Retained 
crystal violet absorbance was measured at 600 nm using PerkinElmer (Victor X3). Data were 
analysed using one-way ANOVA with uncorrected Dunn’s test and presented as the mean ± S.E.M., 
n= 3-5. *p<0.05 versus vehicle. 
 
Analysing E. faecalis biofilm properties showed no effect of the AS on biofilm development 
for short-term or continuous exposure at the tested temperatures, other than a marginal 
increase (43%) in continuous aspartame exposure at 37 ˚C (fig.3.3.10). Effect of sucrose 
on E. faecalis biofilm formation varied largely depending on exposure duration and 
incubation temperature. Significant biofilm was observed at RT; short-term exposure 
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showed an increase of 276% (fig.3.3.10.a), whereas 141% higher biofilm formation than 
control was recorded for continuous exposure (fig.3.3.10.c). On the other hand, incubation 
at 37 ˚C decreased biofilm formation by 42% than control for the continuous exposure 
(sucrose-containing) (fig.3.3.10.d) while remaining almost unchanged for the pre-exposure 
(fig.3.3.10.b). 
Taken together, these studies represent that AS-exposure duration and temperature 
influence the model gut bacterial biofilm formation ability in vitro. E. coli is more capable to 
form biofilm because of AS-exposure than the other MGB, E. faecalis.  
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Figure 3.3.10: Quantification of biofilm development by E. faecalis after AS exposure. 
AS-exposed E. faecalis overnight culture was diluted (1:200), sub-cultured in BHI with/out AS and 
incubated at RT or 37 °C. Biofilm assay was performed at 48 hours and retained crystal violet 
absorbance was measured at 600 nm using PerkinElmer (Victor X3). Panel a and b shows pre-
exposure data at RT and 37 ˚C, respectively and panel c and d, represents the continuous exposure 
data at RT and 37 ˚C, respectively. Data are analysed using Ordinary one-way ANOVA with 
Dunnett’s multiple comparison test and presented as the mean ± S.E.M., n=3-5. *p<0.05 versus 
vehicle. 
 
All the four AS significantly increased E. coli biofilm formation (fig.3.3.11.a) when exposed 
to the sweeteners continuously at 37 ˚ C. Conversely, only aspartame significantly increased 
E. faecalis biofilm formation (fig.3.3.11.b). ZnSO4 reduced the biofilm percentage for all AS 
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to E. coli, however, aspartame and neotame effect remained significant. ZnSO4 did not 
show any effect on E. faecalis biofilm formation. 
 
Figure 3.3.11: Effect of AS and ZnSO4 on a) E. coli and b) E. faecalis biofilm formation. 
Bacteria were treated with 100 µM of sucrose or AS or AS+ZnSO4 or vehicle for 24 hours, 200 µl of 
fresh media with same treatments were aliquot with 1/200 of overnight bacterial culture on 96-well 
plate and incubated at 37 °C for 48 hours. The biofilm assay was performed using crystal violet (CV) 
staining and absorbance at 600 nm was measured. The biofilm formation was calculated by dividing 
the absorbance of retained CV with the absorbance of the total bacterial growth. Data are normalized 
with control as 100%, analysed using ordinary one-way ANOVA with Holm-Sidak multiple 
comparison test and presented as the mean ± S.E.M., n=5. *p<0.05 versus vehicle, 0 μM/ml AS and 
#p<0.05 versus ZnSO4. 
 
3.3.4 AS did not affect haemolytic activity 
The in vitro haemolysis assay was performed on blood agar plates to study the effect of AS 
on haemolytic ability of the two MGB. Exposure to each AS overnight did not affect the 
haemolysis activity (fig.3.3.12–3.3.15). E. coli treated with higher concentrations of 
saccharin (1 and 10 mM) was observed to produce α-haemolysis compared to the positive 
control S. aureus which produced β-haemolysis on the blood agar plate (fig.3.3.12). Similar 
concentrations of saccharin also did not affect the MGB, E. faecalis haemolytic feature 
(fig.3.3.13). Treating the MGB with AS (100 μM) or sugar in presence and absence of ZnSO4 
did not bring any changes in comparison with the controls, as expected. E. coli formed 
characteristic α-haemolysis and E. faecalis showed γ-haemolysis, and none of the 
treatments affected the outcomes. 
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Figure 3.3.12: Effect of 1 and 10 mM of saccharin on haemolysin production of E. coli. 
Single colony of the bacteria was exposed to 1 mM (b.) and 10 mM (c.) of saccharin for 24 hours and 
bacterial culture was streaked on blood agar plates using cotton swab. Growth was observed for 
haemolysis at 24 to 72 hours. E. coli produced α-haemolysis whilst the positive control S. aureus (a.) 
produced characteristic β-haemolysis. At 10 mM, E. coli growth was inhibited and did not form any 
colony on blood agar plates.  
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Figure 3.3.13: Effect of saccharin on E. faecalis haemolytic property. 
E. faecalis was exposed to 1 mM (b.) and 10 mM (c.) of saccharin for 24 hours and bacterial culture 
was streaked on blood agar plate using cotton swab. Plates were incubated at 37 °C for 24 to 72 
hours and were observed every 24 h interval for any clearing of the red blood cells. E. faecalis (b. 
and c.) represented 𝛾-haemolysis whilst the positive control, S. aureus (a.) showed β-haemolysis.  
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Figure 3.3.14: Effect of AS on E. coli haemolysis. 
Bacteria were exposed to vehicle (1) or 73 mM of sucrose (2) or 100 µM of saccharin (3) or sucralose 
(4) or aspartame (5) or neotame (6) in presence or absence of the sweet taste inhibitor, ZnSO4 for 
24 hours. A loopful of the overnight culture was streaked on blood agar plate and incubated for 24 to 
72 hours. Results from 48-hour incubation were presented. S. aureus which represent β-haemolysis 
was used as positive control. The used strain showed α-haemolysis irrespective of AS- exposure. In 
each plate, a. represents the positive control, b. represents only treatment effect and c. represents 
treatment plus ZnSO4 results. 
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Figure 3.3.15: Effect of AS on E. faecalis haemolysis. 
A single colony of E. faecalis was exposed to vehicle (1) or 73 mM of sucrose (2) or 100 µM of 
saccharin (3) or sucralose (4) or aspartame (5) or neotame (6) in presence or absence of ZnSO4 for 
24 hours. Single dip of cotton swab into the overnight culture was streaked on blood agar plate and 
incubated for 24 to 72 hours. At the tested concentration of AS, the organism did not show any 
haemolytic activity for the tested duration. Results from 48-hour incubation were presented. S. 
aureus which represent β-haemolysis was used as positive control. In each panel, a. represents the 
positive control, b. represents AS or vehicle effect and c. represent treatment plus ZnSO4 results. 
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3.4 Discussion 
The pivotal role of microbiota in host health and wellbeing is gaining increased interest as 
microflora are now denoted as an ‘organ’ and more studies are being conducted to 
investigate the alteration of this organ in disease states (Kau et al., 2011). Changes in the 
composition and function of gut bacteria has been linked to various MD (Cani, 2018). 
However, AS-mediated metabolic dysfunction remains largely undefined, and therefore this 
study focused on AS-mediated changes in microbiota elucidating the effect of AS on 
microbial metabolism and pathogenic factors.  
Aim II of the study was to investigate the effect of AS on the metabolism and pathogenicity 
of two MGB. The role of the GM in food processing and physiological balance is well-
established, but whether they modulate STR and transporters to alter food consumption in 
the host epithelium is not known, and little information is available on the metabolic 
machinery of GM to process natural sugars and AS (Payne et al., 2012). Swartz et al. (2011) 
reported that absence of GM alters STR expression in the small intestine which has the 
association with increased intake of nutritive sweet solutions. They investigated the 
preference of sucrose/saccharin in germ-free and conventional mice and found no 
difference for saccharin, but germ-free mice consumed 8% more sucrose solution than 
conventional mice. In another study, 8-week aspartame exposure perturbed the GM in rats 
resulting in higher fasting glucose level and disturbed insulin tolerance (Palmnäs et al., 
2014). Therefore, the gut bacteria are negatively influenced by the sweet molecules, 
however, the mechanism of microflora perturbation needs further investigations. 
Considering that GM consists of trillions of bacteria and other microorganisms (fig.3.1.1) 
(Lozupone et al., 2012), although dominated by four major phyla (Consortium, 2012), it was 
difficult to work on large number of bacteria in the study period. Therefore, with 
consideration of the available laboratory support and purpose of the study, two MGB were 
taken under consideration. These findings will provide an indication on the effect of AS on 
gut bacteria, offering a base for further studies. E. coli is one of the most common bacteria 
available in the gut (Koenig et al., 2011), readily changes from commensal to pathogenic 
state depending on external factors (Tenaillon et al., 2010), and safe to work on, so it was 
listed. In addition, E. faecalis was marked considering its facultative anaerobic nature, it is 
one of the signature organisms from the healthy microbiome found by metagenomics 
studies, colonise at the beginning of life (Huycke et al., 1998) and have both commensal 
and pathogenic state (Consortium 2012). So, the MGB were appropriate representative to 
conduct the study. 
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3.4.1 Determination of the culture conditions 
In microbiology lab settings, measuring OD is a widely accepted approach to assess 
bacterial growth (McBirney et al., 2016). OD measurement is relatively simple, faster, 
reliable and reproducible method (Biesta-Peters et al., 2010). The lag phase is the initial 
period of slow growth when cells enlarge and synthesize critical proteins and metabolites. 
Therefore, measuring OD for an extended time period was reasonable to assess the AS-
mediated changes in the bacterial population.  
In the growth experiment, different dilutions and conditions were used initially to optimise 
the protocol by growing E. coli DH5α (fig.3.3.1). For the growth experiment with natural 
sweeteners, AS and ZnSO4, 1:500 dilution of the overnight bacterial culture was considered, 
and absorbance was measured using PerkinElmer (Victor X3). The 1:50 and 1:100 dilutions 
showed fast lag phase and higher variability in the late exponential slow growing phase and 
therefore were not considered for the later experiments. The lowest dilution, 1:10000, 
conversely, represented prolonged lag phase, a fast-exponential phase and then fall quickly 
after 24- and 48 hours in with and without shake conditions, respectively. So, 1:500 and 
1:1000 bacterial concentrations were considered from which 1 in 500 dilution was used for 
the experiment with sweeteners and ZnSO4. 
Identical bacterial number was confirmed by using same absorbance of base culture. As 
the CFU was calculated for the corresponding absorbance (table-3.3.1) and for a range of 
absorbance (table-3.3.2), the number of bacteria used can also be calculated. Also, same 
growth phase was taken for all experiments considering the variation of bacterial cell size 
of the different physiological state of growth. 
The natural carbohydrates showed nearly similar effect on bacterial growth and the results 
varied a little bit depending on shaking condition (fig.3.3.2), may be because shaking made 
the nutrients more available to organisms in comparison to without shaking (fig.B8.1). 
However, the general trend of the graphs showed slightly less growth, absorbance 0.80 and 
0.91 for with and without shake (fig.3.3.1), respectively in the 1:500 dilution whereas 
absorbance was below 0.8 for all the treatments in the later experiments. 
Glucose at lower concentrations marginally increased the bacterial growth under shaking 
from the beginning (fig.3.3.2.a) and for without shaking after 18 hours (fig.B8.1.a). This 
might be because most of the organisms use glucose as primary energy source although 
the media do not contain glucose as main carbon source. But the high concentrations of 
glucose (20 mM and 200 mm) negatively affected cell growth (0.2 a.u.) which demonstrates 
that very high concentration of glucose has inhibitory effect on E. coli DH5α growth. This 
data agrees with the previous findings of Boyd and Lichstein (1951) who demonstrated that 
glucose presence in media inhibits bacterial growth; it affects the deaminases either by 
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preventing the coenzyme formation or by destroying the enzymes. Earlier work of Epps and 
Gale (1942) also found the negative effect of increased glucose concentration on cell 
growth. They showed that the formation of several deaminases is somehow inhibited or 
produced in a very low concentration in presence of glucose. Similarly, Phue et al. (2008) 
showed that E. coli DH5α growth and production was much slower when they have used 
glucose as a carbon source.  
Fructose, although is a direct dietary energy source and have a potential downstream effect, 
but it is one of the most poorly absorbed carbohydrates in human. Malabsorption of fructose 
in human was reported to be a result of microbial fructose fermentation (Gibson et al., 2007), 
meaning microbes utilise fructose which was indicated as an inherent genetic propensity of 
the intestinal microflora (Payne et al., 2012). In the present study, fig.3.3.2 and fig.B8.1.b 
shows that fructose (up to 200 µM) enhanced bacterial growth both in with/out shake 
condition and the higher concentrations (2 mM and 20 mM) also started to rise after 
prolonged incubation period which might be supported by the above-mentioned finding.   
Saccharin and sucralose enhanced E. coli DH5α growth in a concentration-dependent 
manner in shaking condition although the difference was very low, and the highest 
concentration (10 mM) showed an inhibitory effect for saccharin and neotame (fig.3.3.3). 
Overall growth for all the AS displayed an end of exponential phase after 24 hours with 
shake although this phase was prolonged for without shake (fig.B8.2). Saccharin 
metabolism has increased the relative number of intestinal aerobic bacteria in human 
(Payne et al., 2012), which might support the obtained results. They also demonstrated 
alteration (aerobic to anaerobic) of the faecal bacteria in male rats fed on 7.5% saccharin 
for ten days. 
Since zinc inhibits the sweet sensing stimulated by diverse sweetener molecules in different 
organisms (Keast et al., 2004) and also because there was no available literature on 
bacterial STR, therefore, ZnSO4 was selected to investigate whether it inhibit changes in 
bacterial metabolism induced by AS. So, the effect of ZnSO4 on E. coli DH5α was 
determined initially. ZnSO4 at high concentration (10 mM) showed an insignificant decrease 
in the bacterial growth at 24 hours but sharp increase after 48 hours (fig.3.3.4). However, 
the lower concentrations enhanced bacterial growth at 24 hour for without shaking condition 
(fig.B8.3). Although ZnSO4 inhibits enteric pathogens at 1.2 – 1.8 mg/ml including E. coli 
(Surjawidjaja et al., 2004) but such inhibition was not observed in the present study. This 
might be because the used E. coli DH5α was not pathogenic and, the bacteria might have 
adjusted with ZnSO4 after an initial inhibition.  
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3.4.2 Importance of Bacterial metabolism 
The MGB E. coli showed growth in all the liquid media (table-3.3.1). NB is a general-purpose 
medium and E. coli does not have exact nutritional requirements. E. coli growth in NB was 
≈1.5 (OD600), whilst ≥2 in 2YT and Luria-Bertani (LB) (table-B8.3). Both 2YT and LB are 
nutrient-rich media containing yeast extract and peptone, which facilitates bacterial growth.  
The variations among the pH values of medium were statistically insignificant (p>0.9999) 
(appendix B, table-B8.1). Also E. coli was shown to grow maintaining similar level of cell 
number (107) for a range of pH between 5.5 and 7.2 (Wilks and Slonczewski, 2007). E. 
faecalis, are also able to grow in range of pH 4.5 to 10 (Fisher and Phillips, 2009). 
Additionally, the gut bacteria must have the ability to grow between pH 4.5 and 9 in order 
to colonize in the gastrointestinal tract (De Jonge et al., 2003). The effect of AS was 
compared to vehicle in the study; therefore, pH did not have influence on the findings. 
Bacterial growth in the respective liquid media showed different readings for the two 
spectrophotometers used. Readings of the same sample from the PerkinElmer were lower 
than the cuvette photometer (fig.3.3.5). This difference might be due to the sample size 
taken for the measurement (PerkinElmer, 100 μl/ Cuvette photometer, 1 ml), or other 
technical matters related to measurement process. However, the growth curves generated 
using data from both spectrophotometers showed the same trend for both MGB. Also, the 
effect of treatments was counted as the relative changes with control, therefore, the 
absorbance readings from both spectrophotometers are appropriate. Moreover, the CFU 
counts of the overnight culture (table-3.3.1) represent the bacterial concentration in the 
corresponding samples.  
Furthermore, the absorbance to CFU count following McFarland standards provide a 
reference for bacterial concentrations (table-3.3.2). It represents the probable number of 
bacteria in a range of absorbance. Although the McFarland standards was not exactly 
maintained, however, the absorbance to CFU standardization provides information on the 
approximate number of bacteria in the further experiments. Nonetheless, the McFarland 
standards have frequent use in the antimicrobial studies (Lahuerta Zamora and Pérez-
Gracia, 2012). Also, the outcomes vary for conditions such as bacterial strains, growth 
medium, physical parameters including the absorbance reader (Lahuerta Zamora and 
Pérez-Gracia, 2012). The growth medium and physical conditions in the study was 
consistent for all experiments. Therefore, the absorbance to CFU data were appropriate 
and the approximate number of CFU/ml can be estimated from the absorbance 
measurements (table-3.3.2).  
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Once conditions were optimised, effect of AS on model gut bacterial growth and virulence 
factors was investigated in vitro. Using bacteria individually provided less-complex and 
more-tractable models to study the effect of AS on bacterial metabolism.  
The tested sweeteners and inhibitor did not affect growth of the MGB (fig.3.3.8), although 
there was minor insignificant increase of E. coli growth (fig.3.3.6.a) for saccharin and 
neotame. Similar response was observed in E. faecalis growth (fig.3.3.7). The relative 
number of intestinal aerobic bacteria in human was reported to increase due to saccharin 
metabolism (Payne et al., 2012). Saccharin and neotame at 1 mM slightly reduced E. coli 
growth (fig.3.3.6), almost no change was observed for same concentration of saccharin on 
E. faecalis growth although 10 mM of neotame slightly increased growth (fig.3.3.8). At high 
concentration of 10 mM, saccharin and neotame also reduced E. coli DH5α growth 
(fig.3.3.3.a,d). There were two phases in some of the growth curves (fig.3.3.2, fig.3.3.7), 
showing an initial exponential phase and plateau, then a second exponential phase and 
plateau. This might be due to the bacteria using an easy-to-access carbon source first, 
which then runs out, and they must switch to a less accessible carbon source.  
Saccharin consumption was demonstrated to alter (aerobic to anaerobic) the faecal bacteria 
in male rats fed on 7.5% saccharin for ten days. Although intestinal colon region should be 
densely colonized by obligate anaerobic bacteria, but these rats due to saccharin exposure 
represented a reduction in the number of anaerobic faecal bacteria whilst an increase in the 
aerobic bacteria (Anderson and Kirkland, 1980). Sucralose did not affect the MGB growth 
(fig.3.3.6, fig.3.3.7, fig.3.3.8), although 1.1% sucralose was demonstrated to impair rat gut 
bacterial growth (Abou-Donia et al., 2008). In the 12-week study, they found sucralose to 
suppress (≥70%) beneficial anaerobes such as Bifidobacteria, lactobacilli, and Bacteroides, 
whilst less inhibition on the harmful strains like enterobacteria. In contrast, 15 mg/kg BW 
sucralose intake (8-weeks) brought no change in the relative amounts of total faecal 
bacteria in male and female mice, although sucralose exposure decreased the relative 
amount of Clostridium cluster XIVa in a dose-dependent manner (Uebanso et al., 2017).  
In the study, AS was supplemented in the growth medium, so the organisms have all the 
required nutrients for growth. In diet, AS are used as sucrose substitute which is the source 
of energy. Similarly, substituting bacterial carbohydrate source with AS might give different 
metabolic outcomes. Young and Bowen (1990) substituted glucose with sucralose in agar 
medium and observed complete growth inhibition of ten oral bacterial strains. Opposite 
results were demonstrated where sucralose induced but saccharin inhibited growth in gut 
bacterial model, E. coli TV1061 (Harpaz et al., 2018). However, similar to the current study, 
Harpaz et al. (2018) did not replace the carbon source, therefore similar bias remains. 
Wang et al., (2018) also used E. coli as a gut bacteria model, and investigated the effect of 
saccharin, sucralose and acesulfame K on growth. E. coli HB101 was grown in LB liquid 
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and solid media supplemented with the above-mentioned sweeteners and significant 
reduction in growth was observed. Sucralose in 1.25% and 2.5% reduced growth by 17% 
and 66%, respectively in liquid culture whilst 22% and 66% in plates. These findings partially 
support the present study as E. coli DH5α growth was reduced after exposure to 10 mM of 
saccharin (fig.3.3.3.a). Also, overnight culture of E. coli to 10 mM of saccharin did not grow 
on Blood agar plates representing complete growth inhibition (fig.3.3.12). Bacteriostatic 
effect of AS might be employed through suppression of metabolic enzymes or by inhibiting 
nutrient transportation or by limiting the other processes essential for bacterial growth 
(Wang et al., 2018; Anderson and Kirkland, 1980). However, this is not clear in the present 
study and further studies are needed to answer this properly. Sucrose did not affect E. coli 
growth, however, slightly reduced E. faecalis growth 0.4 (a.u.) (fig.3.3.8). Whilst there are 
not many studies in the literature dedicated on AS and bacterial growth, studies with other 
food substances show that diet does not impact on bacteria growth. The findings in the 
present study is therefore not surprising.   
Zinc is an essential micronutrient at low concentrations but has antibacterial potential at 
high concentrations (Medeiros et al., 2013). ZnSO4 have inhibitory effect on the enteric 
bacterial growth (Faiz et al., 2011), however, the growth curve represents that the given 
concentrations of the ZnSO4 had no effect on MGB growth (fig.3.3.8). In combination with 
the AS, 0.1 mM of ZnSO4 slightly reduced bacterial growth except sucrose (73 mM) and 
sucralose (0.1 mM) for E. faecalis (fig.3.3.8.b). Zinc may have some effect in these two 
cases of growth enhancement whilst slight reduction for all other cases, however, none of 
these effects are significant on bacterial growth.  
ZnO was reported to partially inhibit enteroaggregative E. coli growth at 0.1 mM, whereas 
complete growth inhibition was recorded at 1 mM and 10 mM (Medeiros et al., 2013). They 
have mentioned similar observations for zinc acetate and ZnSO4 and suggested that to 
inhibit the human disease-associated E. coli strain 042, appropriate physiological 
concentration of ZnO is ≤0.05 mM. E. coli DH5α did not show growth inhibition at 1 mM and 
10 mM in the present study (fig.3.3.4). Also, their findings do not match with the results for 
the MGB, their growth was not inhibited at 0.1 mM concentration of the ZnSO4 (fig.3.3.8).  
3.4.3 Pathogenic factor – biofilm formation  
Competitive survival and growth of bacteria depends on their ability of adaptation in a 
densely populated environment or in limited nutrient diffusion condition. Biofilm formation 
starts with bacterial transition from planktonic lifestyle to firmly attached state on biotic or 
abiotic supports. This decision depends on many factors including genetics, nutritional 
availability and environmental factors (Mohamed and Huang, 2007; Reisner et al., 2006; 
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O’Toole and Kolter, 1998). Depending on the surroundings, bacteria communicate through 
biochemical signalling called quorum sensing. 
Considering the closeness of bacteria to molecules that can diffuse into the biofilm only 
limitedly indicates that quorum sensing may have crucial role in biofilm development. Cotter 
and Stibitz (2007) identified a small-molecule signalling system that control the conversion 
of P. aeruginosa from planktonic to biofilm growth. Bis-(3’-5’)–cyclic dimeric guanosine 
monophosphate, an intracellular second messenger, is the basis of this signalling 
mechanism. Quorum sensing was mentioned to have positive influence on biofilm formation 
with specific findings in P. aeruginosa and some other bacteria (Sifri, 2008). In a study on 
chronic bacterial infection, Hentzer and Givskov (2003) showed that molecules that have 
negative effect on bacterial quorum sensing also hinder biofilm formation in P. aeruginosa. 
However, quorum sensing does not have any influence on biofilm development by 
staphylococci (Vuong et al., 2003). 
Measuring the retained CV absorbance to quantify the biofilm-formation of the tested 
bacteria ensured the identical condition for all the wells. CV biofilm assay is biofilm biomass 
assay based on matrix staining (fig.3.2.2). This is an indirect biofilm quantification method 
that counts both living and dead cells. However, normalisation of the data with 
corresponding control removed any possibility of errors in the results. Also, the blank well 
absorbance was deducted from all the samples to guarantee the absorbance only for the 
retained CV by biofilms. Besides, the use of ddH2O in the side wells of the wells under 
consideration removed the possibility of drying or evaporation from the wells in the edge.  
As discussed earlier, diet influence the characteristics of microbiome (fig.3.1.3). 
Maltodextrin, a polysaccharide derived from starch hydrolysis, was demonstrated to 
enhance biofilm formation of E. coli associated with Crohn’s disease (Nickerson and 
McDonald, 2012). Commercially available aspartame and sucralose, containing 
maltodextrin as a bulking agent, significantly increased the E. coli biofilm formation in 
comparison with the glucose supplemented medium in their experiment. But when 
maltodextrin was removed, only aspartame and sucralose did not enhance biofilm 
formation, neither increased the level of biofilm when added to only maltodextrin ones. 
These do not agree with the current study as the E. coli biofilm development was increased 
after exposure to the sweeteners (fig.3.3.9). However, the models differ from the Crohn’s 
disease-associated strain and therefore may behaved differently.  
Besides, sucrose was found to significantly enhance biofilm development in E. coli when 
incubated at RT but not 37 °C in the present study (fig.3.3.9). Nickerson and McDonald 
(2012) demonstrated no effect of sucrose on biofilm development of the E. coli strain. In 
addition to the variation in source of organism, they have incubated the bacteria in M9 
medium at 30 °C for 24 hours for biofilm formation which might influenced the findings. 
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Regular consumption of AS-containing foods indicates a continuous exposure. Besides, the 
gut physiological temperature is approximately 37 ˚C, and previous studies showed that E. 
coli strains isolated from the gut expresses most of their virulence factors at 37 ˚C that are 
needed indeed for colonization (reviewed by Rossi et al., 2018). In addition, findings from 
the initial biofilm formation (fig.3.3.9, fig.3.3.10) represent continuous AS-exposure (37 ˚C) 
as the appropriate conditions. Therefore, the further studies with AS and ZnSO4 were 
conducted under those conditions.  
Although E. coli growth was unchanged, biofilm formation was significantly increased for 
AS exposure (fig.3.3.9) and addition of ZnSO4 reduced the effect for all AS (fig.3.3.11.a). 
Sucrose did not affect E. coli biofilm formation at 37 °C and ZnSO4 merely increased (10%) 
the biofilm (fig.3.3.11.a). Instead, sucrose reduced E. faecalis biofilm formation about 50% 
and ZnSO4 had no effect (fig.3.3.11.b). AS exposure did not increase E. faecalis biofilm 
formation except aspartame, and ZnSO4 reduced the effect (fig.3.3.11.b). Similar findings 
were demonstrated in enteroaggregative E. coli where bacterial growth was not affected by 
≤0.05 mM of ZnO, however, biofilm formation was significantly reduced (Medeiros et al., 
2013).  
Oppositely, E. faecalis biofilm formation index was reported to be just double than E. coli in 
a mixed-microbial populations study, although they did not develop any biofilm when 
cultured together (Teh et al., 2010). They have maintained 20 different strains in Mueller-
Hinton broth and screened their biofilm formation capacity in individual and combination 
culture. Considering the biofilm formation index, E. faecalis was indicated as one of the 
organisms having strong biofilm forming ability whereas E. coli was the opposite (Teh et al., 
2010). These findings are different from the present study as the E. coli was found to 
develop biofilm significantly at 37 °C with continuous exposure to the AS (fig.3.3.9) while E. 
faecalis did not (fig.3.3.10). Besides, combination culture was not performed as this study 
aimed to investigate individual bacterial response to AS. 
E. faecalis forms biofilm more frequently than other enterococci. However, this 
pathogenesis depends on genetic material as well as environmental factors (Mohamed and 
Huang, 2007). The culture media plays an immense role for the biofilm formation. For 
example, E. faecalis was exposed to different media; while the biofilm formation was 
inhibited due to media osmolarity, the growth of the bacteria remained unaffected (Kristich 
et al., 2004). In the present study, BHI was used for E. faecalis growth, and no significant 
biofilm formation agrees with the findings of Kristich et al. (2004), where they demonstrated 
that this media abruptly stops the biofilm growth of E. faecalis after 4 hours and further 
incubation decreases the density of the emerged biofilm. 
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3.4.4 Pathogenic factor – Haemolysing red blood cells 
The model bacteria, E. coli and E. faecalis are α- and γ-haemolytic, respectively in normal 
condition, however, they can turn into β-haemolytic when pathogenic (Giaffer et al., 1992; 
Shankar et al., 2002). The haemolysis assay was performed to check whether AS exposure 
impact haemolysin production. The MGB did not show haemolytic activity upon exposure 
to AS (100 μM) for 24 hours.  
Pathogenic E. faecalis from clinical samples were found to be β-haemolytic (Shankar et al., 
2002). Also, E. faecalis from foods can have haemolytic property; 52.5% of the food 
samples showed Enterococci contamination and E. faecalis was the second highest 
contributor (38.7%) with β-haemolysis (Gomes et al., 2008). As a dietary component, AS 
might have influence on bacterial conversion form non-haemolytic to haemolytic state. The 
model E. faecalis was not haemolytic in the study conditions, however, since it is able to 
incorporate external genes (Toledo-Arana et al., 2001), it may behave differently in a co-
culture condition like gut environment.  
E. coli showed α-haemolysis with no changes for ZnSO4 co-exposure (fig.3.3.14), however, 
visual observation was made only. Further investigations are needed to assess whether this 
haemolysis is caused by α-, EHEC- or ClyA- haemolysin, and to characterise the 
haemolysin protein. Besides, sucrose was non-protective to ClyA-mediated haemolysis in 
E. coli DH5α (Ludwig et al., 1999), which supports the present findings and also indicates 
a similarity in behaviour of tested AS, however, use of osmotic protectants like dextran 8 
could clarify this further (Ludwig et al., 1999). In addition, E. coli strains isolated from 
patients suffering from MD like IBD, Crohn’s disease and ulcerative colitis, irrespective of 
disease activity, were found to be haemolytic (Giaffer et al., 1992), and AS consumption 
was linked to MD development (Suez et al., 2014), therefore, there may have underlying 
mechanisms of haemolysis and disease activity. Besides, bacteria were exposed to AS for 
24 hours only in the present study, long-term AS exposure may change bacterial response 
as the GM were reported to have extensive ability of metabolising xenobiotics, including AS 
(Claus et al., 2016).  
Recent study investigated the aspartame-linked metabolic disorders and found that 
aspartame yields β-sheet-rich nanofibrils under mimicked physiological conditions that have 
cytotoxic effects. These aspartame fibrils induce haemolysis and cause DNA damage that 
leads to cell death via both apoptosis and necrosis. The investigators also mentioned that 
aspartame shows self-assembly which can cause protein aggregation and cell death 
(Anand et al., 2019).  
Blood agar plates were used which directly represent the haemolysis of red blood cells. 
Also, plates were incubated for 24 to 72 hours to note the influence of incubation duration. 
The blood agar plates do not have AS, bacteria were exposed to AS for 24 hours, so only 
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the long-lasting response was recorded. It is easier for bacteria to recover any effect when 
they are not continuously exposed. In the biofilm formation, initial exposure to saccharin 
and aspartame did not affect the E. coli biofilm whilst continuous exposure caused 
significant biofilm formation (fig.3.3.9). Besides, in the diet, there is daily intake of 
sweeteners making it more likely to be a continuous exposure. So, it is possible that AS 
might have a temporary effect which may switch on and off quickly, and do not have a long-
lasting response. Further studies are required to investigate the bacterial haemolytic 
activity. 
3.5 Conclusion 
The changes in growth and pathogenicity at species level ultimately affects the structural 
and functional stability of the whole gut ecosystem. There were no significant changes 
observed in the growth of the MGB, neither on their haemolytic behaviour. However, AS-
exposure enhanced model gut bacterial pathogenic factor (biofilm development) and 
inhibiting the sweet sensing reduced the effect. The study forms the basis for further 
research to characterize how AS modulate gut bacteria dysbiosis. Further studies using in 
vivo or artificial gut system with a range of AS might extend our knowledge in this field. 
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4 Effect of artificial sweeteners on gut microflora and 
epithelial cell co-culture model  
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4.1 Introduction 
4.1.1 Mutual existence in gut 
The human intestinal epithelium is one of the densest microbial niches and represents a 
critical interface of continuous microbial exposure (Valdes et al., 2018). Human host and 
residing microbiota have a variable relationship, that can have a beneficial or detrimental 
impact (Bian et al., 2017; Lopetuso et al., 2015). The physiological and immunological 
importance of the microflora was mentioned (section-3.1.1). The residing bacteria initially 
protect the host from exogenous pathogenic invasion by prior colonisation and by increasing 
competition for nutrients. Pathogens must out-compete the commensals to initiate 
colonisation on the intestinal epithelium (Schuijt et al., 2013). This colonisation usually 
follows three distinguishable steps initiating with migration of pathogen to the IEC surface, 
followed by navigation through the commensal microbial layer, adhesion, and finally, 
invasion of epithelial cells (Kaper et al., 2004).  
The gut bacterial profile can indicate the host disease state or vulnerability to certain 
diseases. Compared to healthy subjects, patients with IBD harbour fewer bacteria of the 
phyla Bacteroidetes and Firmicutes, whilst more from the phyla Actinobacteria and 
Proteobacteria (Frank et al., 2007). Patients with T2D have a higher ratio of Bacteroidetes 
but reduced proportion of Firmicutes (Larsen et al., 2010). Also, microbiota from infants with 
necrotizing enterocolitis was composed of bacteria from the phyla Proteobacteria and 
Firmicutes, while the healthy subject’s contain species from all the four dominant phyla 
(Wang et al., 2009). Similar studies on stool samples from human patients with colorectal 
carcinoma demonstrated that Fusobacter level could indicate colorectal cancer or risk of 
developing cancer (Meyerson and Kostic, 2014). Therefore, changes in the gut bacteria can 
be linked to whether a host is suffering or susceptible to certain diseases. 
The IEC layer is constantly exposed to various antigenic substances, including GM 
metabolites and dietary components (Kim and Jobin, 2005). Studies performed in the 1980s 
under in vitro conditions demonstrated the close associations between AS intake and 
changes in bacterial dynamics and behaviour (Abou-Donia et al., 2008; Palmnas et al., 
2014), suggestive that AS might interact with gut microbes and exert negative impacts. 
However, detailed studies with appropriate subjects and controls have not been performed 
to provide concrete evidence of the effects of AS on human GM (Daly et al., 2016). 
The pivotal contribution of the commensal microbiota to health and disease is gaining more 
appreciation. Approximately 4000 papers were published (2013–2017) emphasising 
different aspects of GM, which is 80% greater than the total publications in this area over 
the last 40 years (1977–2017) (Cani, 2018). This high volume of research highlights the 
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importance and potential of the microflora and suggests further investigations to provide a 
full understanding of the related mechanisms. Understanding the effect of AS is pivotal for 
its contribution to dysbiosis.  
In the gut, shifts in bacterial species or colonies can trigger specific disease-inducing or 
disease-protective activity. Studies on microbiome transplantation from diseased animal 
into a germ-free healthy subject have represented several disease phenotypes. The 
microbiota grafting could transfer diseases such as obesity (Turnbaugh et al., 2009), 
metabolic syndrome (Vijay-Kumar et al., 2010), ulcerative colitis (Garrett et al., 2007), which 
are characteristics of metabolic disorders and are influenced by the host’s genetics and gut 
environmental factors (Spor et al., 2011). Similarly, exposure of beneficial microbiota from 
healthy subjects showed a positive effect on host-microbial communities (Spor et al., 2011). 
In addition, the human host and GM symbiosis can trigger both local and systematic 
biological responses, which can be influenced by factors like AS in the diet. According to 
Wen et al. (2008), specific pathogen-free non-obese diabetic mice that lack an adaptor 
namely MyD88 for multiple immune receptors, do not acquire T1D. This MyD88 protein 
recognises microbial stimuli and MyD88-negative mice harbouring human-like gut bacteria 
phyla attenuated T1D. They also found that deficiency of MyD88 alters the composition of 
the distal GM and exposure of the germ-free non-obese diabetic recipients to the microbiota 
of specific pathogen-free MyD88-lacking mice attenuates T1D in the former. They 
concluded that the interaction of the microbiota with the innate immune system is a vital 
epigenetic factor that alters predisposition to T1D (Wen et al., 2008). This shows only one 
component can determine a disease state. Since AS intake has already been linked to 
conditions to diabetes (Suez et al., 2014), studying changes in microbial metabolism and 
their interactions with epithelium are important. 
4.1.2 Cytotoxic effect of AS-mediated bacterial products on IEC 
Beside the positive roles in host health, the microbiota can produce potentially dangerous 
chemicals in response to dietary components. In chapter 1, AS negatively affected the 
intestinal epithelium via reduction of cell viability (fig.2.3.7 and fig.2.3.21), which can cause 
intestinal epithelial dysfunction (Patterson and Watson, 2017). In chapter 2 AS enhanced 
model gut bacterial pathogenic feature (fig.3.3.11), which can negatively impact the 
intestinal epithelium (Nickerson and McDonald, 2012; Sifri, 2008). So, determination of the 
cytotoxic effect of the AS-mediated bacterial metabolites on IEC is an effective method of 
measuring the virulence. Lazar et al., (2010) have investigated the cytotoxic effect of 
adherent opportunistic enterobacterial strains on Caco-2 cell monolayer. They isolated 
bacterial strains from different sources, pre-tested their ability to adhere and invade 
mammalian cells and determined cytotoxic effect. Both qualitative and quantitative 
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measurements were performed using Transmission Electron Microscopy (TEM) and MTT 
assay, respectively. They found that a Citrobacter freundii strain (strain 93), isolated from 
stool culture, caused the highest level of cytotoxic effect whilst E. coli (strain 115) isolated 
from patients with acute diarrhoea, caused about 68% cytotoxicity. The investigators 
concluded that pathogenic potential of organisms is through their ability to produce and 
release cytotoxic factors into the adjacent extracellular environment and that these also 
represent pathogen’s virulence potential. The authors also highlighted the responsibility of 
the organisms in the etiology of acute infections and food-borne diseases (Lazar et al., 
2010). 
Any cellular response elicited by the interaction between gut microbes and IECs might have 
a contribution to the virulent activity of other pathogens in the gut milieu. These responses 
are related to the binding of bacterial relevant structures and/or metabolites to host cell 
receptors together with signalling pathways (Cotter and Stibitz, 2007). Attacking the host 
intestinal epithelial barrier cell cytoskeleton is the key mechanism by which pathogenic 
bacteria cause structural and functional changes (Pizarro-Cerdá and Cossart, 2006). The 
intervention of cytoskeleton organisation, signal transduction machinery, and affecting the 
cell membrane can be facilitated by enzymatic alteration by soluble toxins (Boquet et al., 
1998). This interference can also take place through the recruitment of signal transduction 
molecules related to decay acceleration and disassembly of actin network by direct 
prokaryote-eucaryote interactions (Guignot et al., 2000; Bernet-Camard et al., 1996). For 
example, adherence to human embryonic intestinal cell line (INT 407) by diffusely-adhered 
E. coli C1845 (clinical isolate) can provoke dramatic F-actin rearrangements without 
causing cell injury. The alterations in the F-actin distribution has been linked to intestinal 
permeability in chapter 2. The pathogen takes the authority of host regulatory mechanisms 
to express the cell membrane-associated decay-acceleration factors 
glycosylphosphatidylinositol, leading to alterations in the cell cytoskeleton (Peiffer et al., 
1998). Therefore, AS might stimulate the bacterial pathogenic factors directly or bacteria 
might produce metabolites that have a connection with host cell damage. 
Like the nervous system, enteric microbiota can modulate intestinal mobility and control 
diseases. Prominent human symbionts like Bifidobacteria fragilis was demonstrated to 
inhibit the pathogenic potential of another commensal bacterium, Helicobacter hepaticus in 
experimental colitis (Mazmanian et al., 2008). The former symbiont produces a beneficial 
molecule, polysaccharide A, which resists the pathogenicity of other bacteria. In addition, 
Bifidobacteria bifidum and Lactobacillus acidophilus can boost mobility, whereas, 
Escherichia species do the opposite (Rhee et al., 2009). Intestinal bacterial metabolic 
products like short-chain fatty acids or other chemotactic peptides (such as N-
formylmethionyl-leucine-phenylalanine) affect the rate of gut transit and can stimulate the 
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enteric nervous system (Barbara et al., 2005; Rhee et al., 2009). Gut bacteria imbalance 
can lead host to altered gut motility and secretions resulting in diarrhoea or constipation. In 
return, these changes influence the enteric microbiota balance (Rhee et al., 2009). 
Previous studies with different cell lines or animal models with varying measuring 
techniques have reliably and consistently demonstrated that AS affects gut bacterial 
characteristics. Qu et al. (2017) have shown that pre-treatment of E. coli BW25113 with 
sucralose increased their resistance against several antibiotics such as oxolinic acid or 
moxifloxacin and rifampicin. In addition to antibiotic resistance, sucralose elevated the 
bacterial mutation rate in a dose-dependent manner. Sucralose (62.5 mg/ml) significantly 
increased mutation frequency at 24 hours and about 50-fold at 72 hours (Qu et al., 2017).  
Since cytotoxic factors have important virulence potential (Lazar et al., 2010), it is important 
to investigate whether AS-exposure stimulates gut bacteria to exert a cytotoxic effect on 
IECs. 
4.1.3 Bacterial adhesion and invasion 
Bacterial adherence to the IECs is an essential prerequisite for microbial colonisation, 
biofilm formation and virulence manifestation (Falkow et al., 1992). In fact, the first step of 
infection is the formation of a close association between bacteria and IEC (Bernet et al., 
1994; Levine, 1987; Scaletsky et al., 2002; Lee et al., 2003). E. coli have been identified to 
demonstrate different patterns of adherence such as localized adherence, diffuse 
adherence or aggregative adherence, depending on their pathogenicity factor (Scaletsky et 
al., 2002). E. coli also shows localised adherence like (LAL) patterns of bacterial adhesion. 
Caco-2 cells were mentioned to be suitable for adhesion studies as the monolayers exhibit 
appropriate characteristic of mature enterocytes in the microvilli (chapter 1; section-2.1.7). 
In addition, irrespective of the adhesion and invasion factors of the bacteria (Kaper et al., 
2004), Caco-2 cell line was demonstrated to represent adhesion characteristics close to 
those acquired in vitro adhesion assay with human enterocytes (Darfeuille-Michaud et al., 
1990). The Caco-2 cell surface is irregular with naturally formed domes which bacteria will 
preferentially adhere to (Darfeuille-Michaud et al., 1990).  
Attachment of bacteria to Caco-2 cells is regulated by complex signalling, and specific to 
bacteria and IEC. Coconnier et al. (1993) demonstrated the adhesion and invasion potential 
of four enterovirulent organisms, Salmonella typhimurium, Escherichia coli, Yersinia 
pseudotuberculosis and Listeria monocytogenes. All these strains invaded Caco-2 cells; 
however, their adherence patterns were different. The study showed that S. typhimurium 
and enteropathogenic E. coli adhered to the brush border of differentiated Caco-2 cells in 
vitro whereas the other two strains displayed adherence to peripheral region of 
undifferentiated cells. They also demonstrated the concentration-dependent inhibitory 
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action of the Lactobacillus acidophillus strain LB which could hinder the steric human 
enterocytic pathogen receptor, thereby preventing both adhesion and invasion of these 
enterovirulent organisms to Caco-2 cells (Coconnier et al., 1993). Therefore, the adhesion 
and invasion mechanisms are not only complex but also species specific. 
IECs are the primary route of enteric pathogen invasion in the host. In response to bacterial 
intrusion, these cells upregulate the inflammatory gene regulation and expression within 1-
2 hours (Kim et al., 1998). This upregulation includes the expression of cytokines, 
interleukins (Jung et al., 1995), and an array of proinflammatory chemokines (Yang et al., 
1997; Jung et al., 1995; Eckmann et al., 1993). Additionally, bacterial invasion activates the 
expression and production of NO synthase (iNOS) and NO in human colon epithelial cells 
(Witthöft et al., 1998), these chemicals are linked to IBF (section-2.1.4.2). All these 
inflammatory mediators can induce apoptosis in IEC (Kim et al., 1998; Abreu Martin et al., 
1995; Sandoval et al., 1995) which may contribute to barrier permeability, leading to 
increased sepsis (Rajan et al., 2008; Coopersmith et al., 2002). 
The co-evolved, co-existence of prokaryotic and eukaryotic organisms are of great interest 
because human health and wellbeing are largely dependent on harbouring microflora. GM 
is now termed as the second brain and the impact of this intimate contact is of physiological 
relevance (Cani, 2018). Co-culture studies for understanding host-microbe interactions 
have been performed for only several decades, understanding of the complete relationship 
of GM and host remained in early stage urging more research (Neish, 2002). This chapter 
aimed to focus on the contact between MGB and IECs; and whether AS alters bacterial 
metabolites and influence bacterial ability of adhesion and invasion to the mammalian cell. 
At the point of contact, i.e., IEC lining in the lumen, both mammalian cell and commensal 
bacteria employ efforts to keep a normal symbiotic relationship (Neish, 2002). AS 
modulated GM composition (Suez et al., 2014) and these microbial changes affected 
human metabolic activity and immune functions (Dethlefsen et al., 2007). Although there 
are studies demonstrating the increase or decrease of some strains or phyla of bacteria due 
to AS intake, with indications of MD development, but the mechanisms through which 
microbiota affects the intestinal lining leading to diseases remained veiled. 
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Rationale of chapter 4 
Following consumption of AS-containing foods, both IEC and GM would be exposed to 
various concentrations of AS in the gut. Studies from chapter 1 demonstrate a cytotoxic and 
leak effect of sweeteners on the intestinal epithelium. Studies from chapter 2 demonstrate 
an increase in pathogenic factor such as biofilm formation, but not growth/haemolytic effect. 
However, the gut includes both cells in proximity, so co-cultivation to mimic gut physiology 
is important to understand the true effect. Assessing the effect of AS on the bacteria-
epithelial cell axis is therefore important. Moreover, use of established enterocytic cell 
model Caco-2 to assess the safety of AS is of great interest. Therefore, the study aimed to 
assess the cytotoxic effect caused by AS-mediated gut bacterial metabolites on the IEC. 
Also, adhesion and invasion assays were performed to evaluate the AS-mediated 
pathogenic factors affecting the gut bacteria-IEC interactions, which could help to explain 
the mechanism of bacterial pathogenicity upon AS exposure.  
 
Aims and objectives 
To advance our understanding of the role of AS on intestinal microbiota and resulting impact 
on function of the intestinal epithelium, the present study aimed to employ co-culture studies 
using model gut bacteria and intestinal epithelial cell.  
The hypothesis for the chapter is “Artificial sweeteners negatively affect the bacterial 
functions (metabolites and pathogenicity) leading to disrupted bacteria-epithelium 
interactions”. 
To address this hypothesis, the specific aims for the chapter are: 
• To assess the effect of AS mediated model gut bacterial metabolites on the IEC. 
• To investigate whether exposure to AS enhances model gut bacterial adhesion 
ability to intestinal epithelium. 
• To assess the effect of AS on invasiveness of model gut bacteria to the IEC. 
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4.2 Materials and methods 
4.2.1 Cytotoxicity assay 
The cytotoxicity assay was performed to assess the effect of AS-mediated bacterial 
metabolites on IEC following the protocol described by Furumura et. al. (2006) with 
modifications (fig.4.2.1). Caco-2 cells were grown on 96-well plates (1×104 cells/well) and 
incubated for 48 hours. Simultaneously, E. coli or E. faecalis was grown in 10 ml liquid 
media (fig.3.2.1, chapter 2) supplemented with 100 μM of AS (saccharin, sucralose, 
aspartame, and neotame) with/out 100 μM ZnSO4 or vehicle (H2O) for 18 hours. The 
cultures were centrifuged at 4000 rpm for 15 minutes at 4 ˚C (accuSpinTM 1R, Fisher 
Scientific) and supernatant was collected, filter-sterilized (0.22 µM membranes; Millipore, 
USA). 50 μl supernatant and 50 μl EMEM without antibiotics was added on the PBS washed 
Caco-2 cell monolayer and incubated for 18 hours.  
CCK-8 assay (section-2.2.3) and microscopic observations (section-2.2.4) were performed 
to assess viability and morphological changes, respectively.  
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Figure 4.2.1: Cytotoxic effect of AS-exposed bacterial metabolites on Caco-2 cell viability. 
Cells were seeded at 1×104 cells/well and grew for 48 hours at 37 ˚C in humidified condition. On the 
other side, a single bacterial colony was inoculated into 10 ml of the liquid media containing 
AS±ZnSO4 or vehicle and grown for 18 hours at 37 ˚ C with shaking at 150 rpm. Bacterial supernatant 
containing excreted metabolites was collected after centrifugation and cell monolayer was exposed 
to it for 18 hours. Cell viability was performed using CCK-8 assay and absorbance was measured at 
450 nm.  
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4.2.2 Adhesion and invasion assay 
An adhesion/invasion assay was performed to determine the effect of AS on the model gut 
bacterial adherence to and invasion into IEC following the previous procedure of Darfeuille-
Michaud et al. (1990) with modifications (fig.4.2.2). AS-exposed E. faecalis and E. coli were 
assessed for their ability to adhere to Caco-2 cells. The Caco-2 cells were seeded on 24-
well plates (7.5×104 cells/well) and incubated at 37 °C and 5% CO2 for 48 hours. Cells were 
exposed to concentrations of AS for 24 hours under the same conditions mentioned above. 
On the bacterial side, a single colony was inoculated into 10 ml of media supplemented with 
the AS in presence or absence of ZnSO4, or vehicle and incubated overnight at 37 °C with 
shaking at 150 rpm. Bacteria washed twice with serum-free DMEM and re-suspended in 
EMEM without antibiotics. 
Caco-2 cell monolayers were washed (500 µl PBS, X2) and EMEM (490 µl) without 
antibiotics was added to each well. The total number of adherent Caco-2 cells were 
measured by performing a cell count. Caco-2 cells were co-cultured with untreated or 
treated bacteria at multiplicity of infection (number of bacteria per mammalian cell, MOI 
1:300) (calculation shown in appendix C, 8.3.1) with an infection incubation time of 1 hour.  
After the infection period, cells were washed (PBS, X2) to remove non-attached bacteria. 
For the adhesion assay, cells were detached at this stage. For the invasion assay, cell 
monolayer was incubated with EMEM supplemented with antibiotics and incubated at 37 
°C for 30 minutes to kill the external adhered bacteria followed by washing (PBS, X2). The 
cell detachment was performed using TX-100 (500 µl, 0.5%) with mixing by pipetting up and 
down. This concentration of TX-100 had no effect on bacterial viability for more than 30 
minutes. To count the viable bacteria, the spread plate method was used after serial 
dilutions (1/10 to 1/10,000) of the cell suspensions. 
Caco-2 cells were exposed to AS in all cases, except controls, the bacteria were either 
untreated or treated with AS with/out ZnSO4. In the initial adhesion and invasion assays, 
the Caco-2 cells were exposed to a range of AS concentrations and infection was allowed 
with untreated bacteria; these findings were used to determine the concentrations of AS for 
the further assays with AS-exposed bacteria (table 4.2.1). Bacterial adhesion and invasion 
were expressed as the percentage of total bacteria attached per Caco-2 cells (fig.4.2.2).  
Initially, the effect of a range of antibiotic concentrations and incubation durations on 
bacterial growth were tested for the invasion assay. E. coli were tested for gentamicin to 
confirm that the used concentration kills the adhered bacteria in given time (Altenhoefer et 
al., 2004). E. faecalis was exposed to three antibiotics (gentamicin, ampicillin, and 
meropenem) individually and in combination (gentamicin plus ampicillin and gentamicin plus 
meropenem).  
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Caco-2 cells were also exposed to concentrations of same antibiotics and viability was 
measured using CCK-8 assay. This was to confirm that the antibiotics do not interfere 
bacterial invasiveness via cell viability.  
Table 4.2.1: The concentrations of AS, Caco-2 cells were exposed to, for the adhesion and 
invasion assay. 
Initial adhesion and invasion assay were performed with AS concentrations ranging from 0.1 to 1000 
µM, and bacteria were untreated. In the later experiments, both bacteria and Caco-2 cells were 
exposed AS. Only one concentration of each AS for Caco-2 cells, as mentioned below, was 
determined at this point using the findings from the initial experiments.  
AS (µM) Adhesion assay Invasion assay 
E. coli E. faecalis E. coli E. faecalis 
Saccharin 100 100 10 0.1 
Sucralose 10 10 0.1 0.1 
Aspartame 10 100 10 10 
Neotame 1 1 10 1000 
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Figure 4.2.2: Schematic diagram of the adhesion and invasion assay. 
(i) Caco-2 cells were grown on 24-well plates (7.5×104 cells/well) in EMEM with 10% FBS for 48 
hours; (ii) single bacterial colony was inoculated into liquid media with/out AS for 18 hours, measured 
OD, washed (PBS×2) by centrifuging at 4000 rpm for 10 minutes and re-suspended in EMEM; (iii) 
Bacteria and Caco-2 cells were co-cultivated (MOI 1:300) for an hour; (iv) gentle wash (PBS×2) 
removed non-adhered or loosely adhered bacteria; (v) antibiotic action killed the adhered bacteria in 
the invasion assay; (vi) cells were lysed with 0.5% Triton X-100, homogeneously mixed, diluted and 
spread on solid media and incubated overnight at 37 °C to count colony forming units; (vii) calculation 
of the adhesion/invasion percentage. 
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4.2.4 Data analysis 
Data for the cytotoxic effect was calculated as for the cell viability data (chapter 1). Adhesion 
and invasion assay data calculation were mentioned in each section. For two groups, the 
variance in data sets was analysed using the non-parametric test followed by the Mann 
Whitney test. For three or more groups, variance was assessed by using ordinary one-way 
ANOVA followed by uncorrected Dunn’s test, Holm-Sidak’s multiple comparison test, and 
Fisher’s LSD test. Significance was reached when p<0.05. The replication number was 
mentioned in the legend.   
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4.3 Results 
4.3.1 Cytotoxic effect of AS-mediated gut bacterial metabolites 
4.3.1.1 Method validation 
The cytotoxicity assay was performed to investigate the effect of AS-exposed bacterial 
metabolites on mammalian cell function. The Caco-2 cells were exposed to bacterial 
secretions and changes in cell morphology and viability were measured. Observation of the 
morphological changes (Zoe imager), assessed changes in cell nuclei, mitochondria, and 
stress fibre formation. Additionally, the CCK-8 assay was performed to measure the viability 
upon exposure to bacterial metabolites. 
Exposure to E. coli metabolites did not cause significant changes in cell morphology as 
observed in the brightfield images (fig.4.3.1), however, few tiny vesicles were found 
scattered throughout the Caco-2 cell culture exposed to E. coli and E. faecalis metabolites. 
E. faecalis metabolites increased the frequency of vesicles along with characteristic small, 
round, grey features throughout the microscopic field (fig.4.3.1.c).  
 
Figure 4.3.1: Intestinal epithelial cell morphology after exposure to gut bacterial metabolites. 
Caco-2 cells were exposed to E. coli and E. faecalis metabolites for 24 hours and morphological 
changes were observed microscopically (Zoe imager). Panel a represents vehicle-treated, and 
panels b and c represent untreated E. coli and E. faecalis metabolite exposed cells, respectively. 
White arrows show the vesicles on the panel b, and c, and the black arrows (c) show the small round 
features in the E. faecalis metabolites-exposed Caco-2 cells. The images were taken with gain, 16; 
exposure, 320; LED intensity, 28; and contrast, 17, scale bar = 25 µM. 
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Figure 4.3.2: Caco-2 cell morphology after exposure to vehicle-treated model bacterial 
metabolites. 
Caco-2 cells were exposed to E. coli and E. faecalis metabolites for 18 hours and changes in the (i) 
nuclei (blue), (ii) mitochondria (green) and (iii) stress fibre formation (red) were observed using the 
Zoe imager. Panel (iv) a, b and c present merge of images. Panels represent vehicle-treated Caco-
2 cells (a), and panels b and c represent E. coli and E. faecalis metabolite exposed cells. The 
conditions for the images were gain (16, 8, 34), exposure (300, 280, 360), LED intensity (10, 28, 50), 
and contrast (46, 21, 13) for the blue, green, and red fluorescence, respectively; scale bar = 25 µM.  
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Following exposure to bacterial metabolites, Caco-2 cells remained adhered to the plate 
surface without demonstrating cell rounding or monolayer disruption (fig.4.3.1.b and 
4.3.1.c). No conspicuous changes in the nuclei were observed. The mitochondria of the E. 
coli metabolites-treated cells showed some bright green spots (fig.4.3.2.b.ii), while 
numerous small vacuoles were found in E. faecalis metabolite-treated cells (fig.4.3.2.c.ii). 
In addition, no changes in the stress fibre were observed in the E. coli metabolite-treated 
cells in comparison to the vehicle-exposed cells (fig.4.3.2.c.iii). However, stress fibres were 
more prominent with uneven fused appearance of fibres in cells exposed to E. faecalis 
metabolites (fig.4.3.2.c.iii). 
IEC were exposed to AS-treated model gut bacterial supernatant and cytotoxic effect was 
assessed by CCK-8 assay. Model gut bacterial secretions did not decrease cell viability, in 
fact, media from E. coli significantly increased (241%; <0.0001) absorbance of CCK-8 
compared to the vehicle. In contrast, there was no change in viability following exposure to 
media from E. faecalis (fig.4.3.3).  
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Figure 4.3.3: Effect of bacterial metabolites on intestinal epithelial cell viability. 
Caco-2 cells were maintained on 96-well plates in EMEM supplemented with 10% FBS and 1% 
antibiotics. Model gut bacteria, E. coli and E. faecalis, were grown overnight in the respective liquid 
media and centrifuged to remove bacteria. Washed Caco-2 cell monolayer was exposed to 50 μl of 
bacterial supernatant in the presence of 50 μl of the complete EMEM media without antibiotics for 
18 hours. CCK-8 assay was performed, and the absorbance was measured at 450 nm (Tecan 
SunriseTM). Data were analysed using Ordinary one-way ANOVA with Holm-Sidak's multiple 
comparisons test and are presented as the mean ± S.E.M., n=3. *p<0.05 versus Caco-2 cell only. 
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Considering the assessment procedure, measuring the viability was found as a better 
method to assess cytotoxicity in further experiments as it gave a more sensitive and 
quantitative output. 
 
4.3.1.2 AS-mediated gut bacterial metabolites differentially affected IEC 
viability 
To evaluate cytotoxic effect of AS-mediated bacterial metabolites on intestinal epithelium, 
Caco-2 cells were exposed to AS-treated model gut bacterial metabolites and viability was 
measured. Saccharin- and sucralose-treated E. coli metabolites, in culture supernatant, 
reduced Caco-2 cell viability (21.5 ± 0.42% and 20 ± 3.1%, respectively), however, neither 
aspartame nor neotame caused any change (fig.4.3.4.a).  
E. faecalis metabolites did not cause any significant change in cell viability, although both 
sucralose and aspartame demonstrated a trend of decrease (fig.4.3.4.b). Saccharin-
exposed E. faecalis metabolites increased (10%) viability. Conversely, sucralose and 
aspartame reduced cell viability 35- and 40%, respectively. However, neotame treated E. 
faecalis excretions did not change viability at the given conditions (fig.4.3.4.b).  
188 
 
 
Figure 4.3.4: Effect of AS-exposed bacterial supernatant on Caco-2 cell viability. 
Bacteria were exposed to 100 µM of saccharin, sucralose, aspartame, or neotame or vehicle with/out 
ZnSO4. Caco-2 (1x104 cells/well) were maintained in EMEM for 48 hours, exposed to the bacterial 
supernatant for 18 hour, and CCK-8 assay was performed. The cell viability was measured as 
absorbance 450 nm (PerkinElmer). Panel represent results of (a) E. coli and b) E. faecalis 
supernatant. Data were analyzed using ordinary one-way ANOVA with Holm-Sidak’s test and are 
presented as the mean ± S.E.M., n=3. *p<0.05 versus 0 µM of AS. 
  
The images from different microscopic views of the wells could be considered to get 
quantitative data, however, these still do not represent the reaction of every cell in the wells. 
Conversely, the CCK-8 assay measures absorption and quantitative data represent the 
response of all living cells. This assay relies on the biochemical activity of cells and the 
absorbance directly represent the number of living cells.  
4.3.2 Effect of AS on bacterial adhesion  
4.3.2.1 Method validation 
Many factors are likely to influence the adhesion of gut bacteria to IECs. Some of these 
factors, such as buffer composition, incubation period and growth medium are related to the 
culture in vitro (Edwards and Massey, 2011). These factors were determined using 
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references (Dogan et al., 2006; Furumura et al., 2006) with modifications and were 
consistent for all the experiments. Bacterial concentration is another important determinant 
for adherence as expected; higher the bacterial concentration, increased the level of 
bacterial adherence (Tuomola and Salminen, 1998). The concentration of bacteria was 
tested for the study on an absorbance to CFU count. Bacterial absorbance was adjusted to 
1 (OD600) which is equivalent to 8×108 CFU/ml for E. coli (fig.4.3.5.i) and 0.5×108 CFU/ml 
for E. faecalis (fig.4.3.5.ii). The used MOI was 1:300 for both MGB. 
 
Figure 4.3.5: Determination of the bacterial number using standard colony count method. 
The base bacterial culture was serially diluted and 100 μl was plated for colony forming units (CFU). 
Panel a shows E. coli CFU for the dilutions 10-5 to 10-8, the number of bacteria from 10-7 was 
considered as the CFU was in the range of the bacterial standard count. Panel b represent the E. 
faecalis CFU for dilutions 10-4 to 10-6 and 10-8, the 10-8 dilution was considered for the further bacterial 
count. 
 
After the adhesion assay was performed, the number of CFU in the 10 μl cell lysate was 
too numerous to count (fig.4.3.6.a) for both E. coli and E. faecalis. So, a serial dilution of 
the cell lysate containing bacteria was performed and the dilution was determined using 
standard plate count method (representative fig.4.3.6). For both MGB, 10-4 dilution was 
found appropriate and was used for the further adhesion studies with AS.  
 
Figure 4.3.6: Representative plates for the bacterial colony count after serial dilution. 
Panel a represents colony formation of E. coli from the serially diluted Caco-2 cell suspension 
containing bacteria. 
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4.3.2.2 Adhesion of untreated gut bacterial adherence to AS-treated Caco-2 
cells  
Once the adherence study was optimised, the next experiment was to assess the effect of 
the AS on IEC sensitivity for model gut bacterial adhesion. Exposure of Caco-2 cells to 
saccharin significantly increased the adhesion ability of E. coli at all concentrations from 0.1 
µM to 1 mM however significance was only achieved at 1 and 100 µM (fig.4.3.7.a). 
Sucralose exposure demonstrated a dose-dependent increase in E. coli adherence up to 
10 µm (fig.4.3.7.b), although a significant increase was only observed at 10 µm and 1 mM. 
Both aspartame and neotame exposure increased E. coli adhesion at 0.1 µM (fig.4.3.7.c, 
and d, respectively); with aspartame at 0.1 and 10 µM concentrations caused similar 
adhesion on Caco-2 cells. Neotame exposure also caused significant increase in E. coli 
adhesion to Caco-2 cells at concentrations 1 µM and 1 mM however no significance was 
observed for 10 and 100 µM. 
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Figure 4.3.7: Effect of AS on the adherence of E. coli to Caco-2 cells. 
The adherence of E. coli to Caco-2 cells was assessed for saccharin (a), sucralose (b), aspartame 
(c), and neotame (d). Mammalian cells were grown up to 60% confluence and treated with sweetener 
concentrations for 24 hours. Cells were exposed to the bacteria (MOI 1:300) and infection was 
allowed for an hour. Non-adhered bacteria were washed away, and cell lysate was diluted 4 times 
before plating to count the bacterial colonies. Bacterial CFU was divided by Caco-2 cell number to 
measure the bacteria per cell and was normalised with control as 100%. Data are analysed using 
ordinary one-way ANOVA with uncorrected Dunn’s test and presented as the mean ± S.E.M., n=4. 
*p<0.05 versus vehicle. 
 
E. faecalis adherence on AS-exposed Caco-2 cells was significantly increased for saccharin 
(fig.4.3.8.a) and aspartame (fig.4.3.8.c) concentrations of 10 µM, 100 µM and 1 mM. 
Sucralose exposure significantly increased E. faecalis adherence to Caco-2 cells at 
concentrations as low as 0.1 µM, continued until 100 µM, although insignificant at 1 mM 
(fig.4.3.8.b). In addition, exposure to neotame increased E. faecalis adherence for all the 
concentrations, the percentage of adhesion increased from 0.1 µM (161%) to the highest at 
10 µM (688%) compared to vehicle. The percentage of adhesion reduced to 567% at the 
highest concentration, 1 mM, of neotame (fig.4.3.8.d). 
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Figure 4.3.8: Effect of AS on the adherence of E. faecalis to Caco-2 cells. 
Mammalian cells were treated with different concentrations of AS, saccharin (a), sucralose (b), 
aspartame (c), and neotame (d). Assays were prepared in 24-well plates, a confluent epithelial cell 
was inoculated with E. faecalis suspensions (MOI 1:300) for an hour. The supernatant with non-
adherent bacteria was removed after an hour. After washing with PBS, adherent and invaded cells 
were brought into solution by lysing Caco-2 cells with 0.1% Triton X-100. Bacteria were plated and 
total bacteria per cell was counted. Data are normalised with the control as 100% and analysed using 
ordinary one-way ANOVA with uncorrected Dunn’s test. Data are presented as the mean ± S.E.M., 
n=4. *p<0.05 versus vehicle. 
 
4.3.2.3 Adhesion of AS-treated bacteria to AS-treated Caco-2 cells 
Adhesion interaction of the MGB and IECs after exposure to the AS was assessed using 
the co-culture method. AS-treated MGB were exposed to AS-treated Caco-2 cells and 
bacterial adherence to the epithelium was measured. Except for neotame, all AS 
significantly increased E. coli adhesion (fig.4.3.9). Sucralose increased adherence 105%, 
followed by saccharin (126%), and the highest adherence was caused by aspartame 
(186.4%).  
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The adhesion pattern of the MGB on the Caco-2 cell monolayers was observed using bright-
field microscopy (representative figures in appendix C). There was no distinguishable 
change in adhesion pattern of both bacteria for AS exposure (fig.C8.1-fig.C8.4). Untreated 
E. faecalis (fig.C8.3) did not adhere prominently, although some E. coli has adhered 
(fig.C8.1). AS-treated E. coli demonstrated similarities to localized adherence like pattern 
as observed using Zoe imager (fig.C8.2.b,c). In addition, E. coli showed clusters near cell-
cell contact areas of Caco-2 islands (fig.C8.2.c) and dispersed throughout without any 
characteristic pattern. AS-exposed E. faecalis showed clusters, small chains and scattered 
bacteria throughout the microscopic field (fig.C8.4). The number of isolated E. faecalis was 
higher near the edge of cell islands although no specific pattern was observed.  
 
Figure 4.3.9: Effect of AS on E. coli adherence to Caco-2 cells. 
E. coli was treated with AS (100 μM) for 24 hours and co-cultivated for an hour (MOI 1:300) with 
Caco-2 cells pre-exposed to AS or vehicle (24 hours). Non-adhered bacteria were washed away with 
PBS and Caco-2 cells were lysed with 0.5% Triton X-100. The diluted cell lysate was plated to count 
the colony-forming units. Data were normalised as bacteria per Caco-2 cells with control (100%). 
Data are analysed using ordinary one-way ANOVA with uncorrected Dunn’s test and presented as 
the mean ± S.E.M., n=4. *p<0.05 versus vehicle. 
 
Nevertheless, all AS caused significant adherence when both E. faecalis and Caco-2 cells 
were treated (fig.4.3.10). Neotame caused adhesion increase by 708%, followed by 
aspartame (546%), saccharin (449%) and sucralose increased (407%) (fig.4.3.10). 
Therefore, exposure to AS might increase the bacterial adhesion (pathogenic potential) to 
the mammalian cells. 
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Figure 4.3.10: Adhesion level of E. faecalis to intestinal epithelial cells. 
Caco-2 cells treated with different concentrations of saccharin, sucralose, aspartame, and neotame 
or vehicle were co-cultured with 100 µM of AS-treated bacteria at the same multiplicity of infection 
(MOI 1:300) and infections were performed for an hour. Mammalian cells were washed twice to 
remove non-adhered bacteria and lysed with 0.5% Triton X-100. Colony-forming units (CFU) were 
measured using standard plate count method. Adhesion was calculated as the percentage 
(normalised with control, 100%) of CFU/cell and presented as the mean ± S.E.M., n=4. Data were 
analysed using Ordinary one-way ANOVA with Holm-Sidak multiple comparisons test. *p<0.05 
versus vehicle. 
 
4.3.3 Effect of AS on model gut bacterial invasiveness 
4.3.3.1 Method validation 
Since Caco-2 cells and bacteria were co-cultured in presence of the antibiotic, the antibiotic 
concentrations were tested to confirm bacterial extermination without affecting cell viability. 
The bacterial concentration and dilution factor for cell lysate were determined prior to the 
invasion assay with AS, to ensure the assay was effective and sensitive.  
4.3.3.1.1 Effect of antibiotics on Caco-2 cell viability 
To ensure the antibiotics used do not impact Caco-2 cell function, the cell viability assay 
was performed first. None of the antibiotics, Gentamicin (fig.4.3.11.a), ampicillin and 
meropenem (fig.4.3.11.b), affected cell viability, as observed from the CCK-8 assay. Similar 
results were observed for the combination of gentamicin and ampicillin (fig.4.3.11.c). 
Although the combination of gentamicin and meropenem reduced viability marginally (100 
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μg/ml gentamicin and 100 μg/ml meropenem), however, there was no significant differences 
in the viability of Caco-2 cells (fig.4.3.11.c).  
 
 
Figure 4.3.11: Effect of different antibiotics and their concentrations on Caco-2 cell viability. 
Caco-2 cells (1×104 cells/well) were plated on 96-well plate for 48 hours and was exposed to different 
concentrations of the antibiotics gentamicin (a), ampicillin (b) and meropenem (b). In addition, cells 
were exposed to combination of antibiotics (c), gentamicin plus ampicillin, and gentamicin plus 
meropenem for 0.5 h to 2 hours at 37 ºC with 5% CO2. The antibiotics were mentioned with the first 
letter of the name and the concentration was in μg/ml. CCK-8 reagent was added and incubated at 
the same incubation condition. Plates were read at different time points for absorbance at 450 nm. 
Cell viability remained unaffected for antibiotic concentrations and exposure duration. Data 
presented as the mean, n=2-3.  
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4.3.3.1.2 Model bacterial sensitivity to the antibiotics 
MGB E. coli was sensitive to gentamicin, and the E. faecalis was sensitive to the 
combination of gentamicin and ampicillin. Gentamicin completely inhibited E. coli growth 
(fig.4.3.12), therefore, at 1 hour the control without antibiotic started to show growth but 
antibiotic-exposed bacterial absorbance remained like blank.   
 
Figure 4.3.12: Effect of gentamicin on E. coli growth. 
All the concentrations of gentamicin inhibited E. coli growth. After 1 hour, the control started to grow 
and a difference between gentamicin treatments and the vehicle was observed at 1.5 hour. E. coli 
was grown in 96-well plate in 100 μl of Nutrient broth with gentamicin or vehicle. Growth was 
measured as absorbance at 600 nm using PerkinElmer (Victor X3). Data are presented as the mean 
± S.E.M., n=2. 
Conversely, E. faecalis strain demonstrated resistance to aminoglycoside antibiotic 
gentamicin for concentrations as high as 500 μg/ml. A dose-dependent inhibition was 
observed, and the highest concentration of 1000 μg/ml completely killed bacteria at 24 
hours (fig.4.3.13). 100 μg/ml gentamicin reduced bacterial growth (0.1 a.u., A600) at 6 hours.  
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Figure 4.3. 13: In vitro activity of gentamicin against E. faecalis ATCC 19433. 
Gentamicin concentrations are expressed in μg/ml. A concentration-dependent inhibition was 
observed although complete inhibition was found for the highest concentration (1000 μg/ml) at 24 
hours. E. faecalis was grown in 96-well plate in 100 μl of Brain Heart Infusion supplemented with a 
range of gentamicin concentrations or vehicle. Growth was measured as absorbance at 600 nm 
using PerkinElmer (Victor X3). Data are presented as the mean ± S.E.M., n=3. 
 
Ampicillin, the first ‘broad-spectrum’ penicillin inhibited E. faecalis growth at all 
concentrations, although marginal increase was found for 50 μg/ml at 1.5 hour (fig.4.3.14.a). 
Likewise, the carbapenem antibiotic meropenem also completely inhibited E. faecalis 
growth (fig.4.3.14.b). The combination of gentamicin and ampicillin/meropenem showed 
similar results like meropenem for all the concentrations (Fig.4.3.14.c,d).  
Depending on findings from MIC tests, gentamicin (100 μg/ml) was chosen for E. coli, and 
combination of gentamicin (100 μg/ml) and ampicillin (50 μg/ml) was chosen for E. faecalis 
for the invasion assay. Previous study with human epithelial cell also used a combination 
of ampicillin (200 ug/ml) and gentamicin (300 ug/ml) for invasion assay (Inaba et al., 2019). 
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Figure 4.3.14: Antibiotic activity against E. faecalis ATCC 19433 in Brain Heart Infusion. 
All antibiotics are expressed as the first letter of their names, and concentrations are in μg/ml. Both 
ampicillin (a) and meropenem (c) inhibited bacterial growth individually and in combination of 
gentamicin plus ampicillin (b), and gentamicin plus meropenem (d).  Growth was measured as 
absorbance at 600 nm (PerkinElmer, Victor X3). Data are presented as the mean ± S.E.M., n=2, 
each containing 3 replications. 
 
4.3.3.2 Effect of AS on model gut bacterial invasion into Caco-2 cell 
4.3.3.2.1 Untreated bacterial invasion to AS-exposed Caco-2 cells  
Effect of AS on gut bacterial invasion into the IECs was quantified by employing antibiotic 
protection assay, invasion percentage are presented for E. coli (fig.4.3.15) and E. faecalis 
(fig.4.3.16).  
Both saccharin and sucralose significantly increased E. coli invasion in AS-treated Caco-2 
cells at 1 µM (fig.4.3.15. a and b, respectively), whereas aspartame and neotame increased 
at the lowest concentration of 0.1 µM (fig.4.3.15. c and d, respectively). Aspartame also 
increased invasion at 100 µM concentration, however, none of the other concentrations of 
neotame caused significant E. coli invasion to Caco-2 cells. 
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Figure 4.3.15: Effect of AS on E. coli invasion to intestinal epithelial cells. 
Caco-2 cells were exposed to different concentrations of saccharin(a), sucralose(b), aspartame(c), 
neotame(d) or vehicle and co-cultivated with bacteria at multiplicity of infection (MOI 1:300) for an 
hour. Washing removed non-adhered and gentamicin (100 µg/ml) killed adhered bacteria. Cells were 
lysed (0.5% Triton X-100) and colony-forming units (CFU) were measured using standard plate count 
method. Invasion was calculated as percent CFU/cell and normalised with control (100%). Panel a 
has higher percentage value and the ‘y’ axis has higher value than other panels. Data were analysed 
using ordinary one-way ANOVA with Holm-Sidak multiple comparisons test and presented as the 
mean ± S.E.M. n=4. *p<0.05 versus vehicle. 
 
Untreated E. faecalis did not demonstrate invasion ability to a large extent (fig.4.3.16). 
Treating Caco-2 cells with saccharin and neotame did not cause E. faecalis invasion at 
concentrations ranging from 0.1 µM to 1 mM (fig.4.3.16. a and c, respectively). Sucralose 
increased invasion approximately 100% at 0.1 µm concentration (fig.4.3.16.b) and 
aspartame at 100 µm (fig.4.3.16.c), none of the other concentrations of sucralose and 
aspartame affected the model gut bacterial invasiveness.   
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Figure 4.3. 16: Effect of AS on E. faecalis invasion to intestinal epithelial cells. 
Caco-2 cells were treated with different concentrations of the artificial sweeteners saccharin (a), 
sucralose (b), aspartame (c) and neotame (d) or vehicle and were co-cultured with E. faecalis (MOI 
1:300) for an hour. Mammalian cells were washed twice to remove non-adhered bacteria and 100 
µg/ml gentamicin was used to kill surface adhered bacteria. Caco-2 cells were lysed with 0.5% Triton 
X-100 and the standard plate count method was performed to measure the colony-forming units 
(CFU). Invasion percentage of CFU/cell was measured, and data were normalised with control as 
100%. Data are analysed using ordinary one-way ANOVA followed by uncorrected Fisher’s LSD test 
and presented as the mean ± S.E.M., n=4. *p<0.05 versus vehicle. 
 
4.3.3.2.2 AS-exposed bacterial invasion to AS-exposed Caco-2 cells 
Mimicking the gut milieu, both bacteria and IEC were exposed to AS prior co-cultivation to 
assess their effect on bacterial invasion ability (fig.4.3.17 and fig.4.3.18). Saccharin 
exposure did not cause E. coli invasion to Caco-2 cells, other AS significantly increased 
(close to 150%) E. coli invasion to AS-exposed Caco-2 cells compared to vehicle 
(fig.4.3.17.a). 
The IEC-GM interactions were observed microscopically to understand the invasion pattern 
(representative images shown in appendix C). Control E. coli (fig.C8.5) and E. faecalis 
(fig.C8.7) did not show invasion, AS-treated E. coli and E. faecalis invasion patterns were 
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also indistinctive (fig.C8.6 and fig.C.8.8, respectively). The AS-exposed bacteria showed 
more invaded bacteria in comparison to the control, E. coli represented higher invasion 
ability than E. faecalis and the former was diffusely accumulated on the Caco-2 cells 
(fig.C8.6.b,c). Like adhesion, the rod-shaped invaded E. coli was dispersed into cell islands 
avoiding the large vacuoles and inter-island spaces. AS-treated E. faecalis demonstrated 
small clusters; the cocci also formed characteristic short-chains or pairs (diplococci) or 
remained isolated and scattered (fig.C8.8).  
 
Figure 4.3.17: Invasion of E. coli to intestinal epithelial cells in co-infection experiments. 
AS-treated Caco-2 cells were co-cultivated with AS-treated (100 μM) or vehicle-treated E. coli at 
multiplicity of infection (MOI), 1:300 for an hour. Surface bacteria were killed using antibiotic 
treatment for 0.5 hour, and invaded bacteria were released through lysis (0.5% Triton X-100). The 
standard plate count method was performed to measure colony-forming units (CFU). Invasions are 
expressed as percentage of CFU/cell. Data were normalised with control (100%), analysed using 
ordinary one-way ANOVA with Uncorrected Fisher's LSD test and presented as the mean ± S.E.M., 
n=4. *p<0.05 versus vehicle. 
 
All AS significantly increased treated E. faecalis invasion into Caco-2 cells (fig.4.3.18). 
Neotame caused the highest invasion (398%), nearly double of other three. Saccharin 
increased invasion (163%) followed by aspartame (127%) and sucralose (121%) 
(fig.4.3.18).  
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Figure 4.3.18: Effect of AS on the E. faecalis invasion ability to Caco-2 cells. 
AS- or vehicle-treated Caco-2 cells were co-cultivated for an hour (MOI 1:300) with E. faecalis treated 
with AS. Gentamicin was used to get rid of adhered E. faecalis, total CFU/cell were counted and data 
were normalised with control (100%). Data are analysed using ordinary one-way ANOVA followed 
by uncorrected Dunn’s test and presented as the mean ± S.E.M. n=6. *p<0.05 versus vehicle. 
 
4.3.4 Effect of sweet taste inhibitor on bacterial pathogenic factors 
ZnSO4 was used as a pan-inhibitor of sweet sensing to assess whether it can prevent model 
gut bacterial pathogenic effect on IECs. The effect of inhibition was assessed on bacterial 
cytotoxicity, adhesion, and invasion to Caco-2 cells.  
4.3.4.1 Cytotoxic effect of bacterial metabolites 
4.3.4.1.1 ZnSO4 concentrations did not affect cell viability 
Effect of ZnSO4 on Caco-2 cell viability and model gut bacterial growth was determined to 
confirm that effect is not via cytotoxicity. Cell viability was unaffected at concentrations 
ranging from 0.1 to 500 µM; absorbance was above 0.93 (a.u.) for all concentrations 
(fig.4.3.19).  
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Figure 4.3.19: Effect of ZnSO4 on Caco-2 cell viability. 
Cells were seeded on 96-well plates (1×104 cells/well) and maintained for 48 hours at standard tissue 
culture conditions. The used media was replaced with EMEM supplemented with ZnSO4 
concentrations and incubated for 24 hours. CCK-8 assay was performed, and viability was measured 
as absorbance at 450 nm (Tecan SunriseTM). Data were analysed using Uncorrected Dunn's test and 
presented as mean and S.E.M., n=6.  
 
ZnSO4 decreased E. coli and E. faecalis growth marginally in comparison to the vehicle 
(fig.4.3.20). No significant inhibition was found and difference between medians of E. coli 
results was 0.0595 (p=0.9546) and E. faecalis was 0.0825 (p=0.6009).  
 
 
Figure 4.3.20: Effect ZnSO4 on model gut bacterial growth. 
A single E. coli (a) or E. faecalis (b) colony was inoculated into 10 ml of Nutrient broth or Brain Heart 
infusion, respectively containing ZnSO4 (100 μM) or vehicle and incubated for 24 hours. The optical 
density was measured by spectrophotometry (EppendorfBioPhotometer). Data were analysed using 
the nonparametric test followed by Mann Whitney test and presented as mean and S.E.M, n=6. 
 
4.3.4.1.2 Effect of sweet taste inhibition on AS-mediated changes in bacterial 
metabolites 
To evaluate whether STR is involved in the cytotoxic effect of AS-mediated bacterial 
metabolites on mammalian cells, gut bacteria was exposed to AS in presence of ZnSO4, 
and IEC monolayer was exposed to the resultant bacterial metabolites (fig.4.3.21 and 
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fig.4.3.22). Previous studies revealed that the ZnSO4 concentration was non-toxic to Caco-
2 cells and MGB.  
ZnSO4-treated E. coli metabolites significantly reduced Caco-2 cell viability compared to 
control (without ZnSO4). As appeared in fig.4.3.21, almost no changes in viability occurred 
for E. coli metabolites for ZnSO4 co-exposure with saccharin and sucralose. Aspartame and 
neotame with ZnSO4 reduced cell viability by 18% and 15.3%, respectively. However, 
viability was increased by 12.5% (aspartame) and 15.1% (neotame) compared to the 
vehicle (with ZnSO4) (fig.4.3.21). 
 
Figure 4.3.21: Effect of ZnSO4 on AS-mediated changes in E. coli affecting Caco-2 cell 
viability. 
E. coli was exposed to AS with ZnSO4 or vehicle for 24 hours. Cells were seeded in 96-well plate 
(1×104 cells/well) and maintained for 48 hours. Cells were exposed to the bacterial culture 
supernatant for 18 hours. CCK-8 assay was performed, and viability was measured as absorbance 
at 450 nm (PerkinElmer). Data were analysed using ordinary one-way ANOVA with Holm-Sidak's 
multiple comparisons test and presented as the mean ± S.E.M., n=3. *p<0.05 versus control and 
#p<0.05 versus vehicle. 
 
AS and ZnSO4 exposed E. faecalis metabolites showed a differential effect on Caco-2 cell 
viability (fig.4.3.22). The vehicle (with ZnSO4) marginally (11.5%) increased viability. A 
similar outcome was found for sucralose and ZnSO4, viability increased by 19% compared 
to only sucralose-exposed metabolites. Other three AS-exposed E. faecalis metabolites, 
with ZnSO4 reduced cell viability, the highest reduction was observed for saccharin (37.5%), 
followed by neotame (36%), and minor reduction for aspartame (9%). However, E. faecalis 
metabolites mediated changes of Caco-2 cell viability that were insignificant for all AS 
compared to control or the vehicle (fig.4.3.22).  
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Figure 4.3.22: Viability of Caco-2 cells exposed to AS ± ZnSO4-treated E. faecalis metabolites. 
Bacteria were exposed to vehicle or AS with/out ZnSO4 for 24 hours and culture supernatant was 
collected. Simultaneously maintained Caco-2 cell monolayer was exposed to the bacterial 
supernatant for 18 hour and CCK-8 assay was performed. Cell viability was measured as absorbance 
at 450 nm (PerkinElmer) and viability was normalised with control (100%). Data were analysed using 
ordinary one-way ANOVA with Holm-Sidak's multiple comparisons test and presented as the mean 
± S.E.M., n=3. 
 
4.3.4.2 ZnSO4 decreased model gut bacterial adhesion 
ZnSO4 inhibits the sweet sensing of many sweet molecules including the AS (Keast, 2003). 
Because AS-exposure increased model gut bacterial adherence to the IECs, ZnSO4 was 
employed to investigate whether this can reduce bacterial pathogenicity, implying the 
involvement of sweet sensing with gut bacterial adherence. ZnSO4 vehicle did not change 
E. coli and E. faecalis adherence to Caco-2 cell compared to control (fig.4.3.23 and 
fig.4.3.24, respectively). 
Saccharin, sucralose and aspartame, all significantly increased E. coli adherence to Caco-
2 cells, however, ZnSO4 co-exposure reduced the effect. Also, neotame itself insignificantly 
increased E. coli adherence by 88%, and ZnSO4 co-exposure condensed the effect by 
77.5% (fig.4.3.23).  
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Figure 4.3.23: Effect of ZnSO4 on AS-mediated E. coli adherence to Caco-2 cells. 
E. coli was treated with 100 µM of AS ± ZnSO4 or vehicle and co-cultivated (MOI 1:300) with AS-
treated Caco-2 cells for an hour. Non-adhered bacteria were washed away with PBS and cells were 
lysed with 0.5% Triton X-100. The diluted cell lysate was plated to count colony-forming units. 
Invasion percent (CFU/Caco-2) was calculated and normalised with control (100%). Data were 
analysed using Holm-Sidak’s multiple comparison test, presented as the mean ± S.E.M., n=4. 
*p<0.05 versus vehicle. 
 
AS significantly increased E. faecalis adherence to Caco-2 cells and neotame caused the 
highest adherence. ZnSO4 co-exposure reduced the AS-mediated E. faecalis pathogenic 
factor/s related to adhesion, it has abridged the adherence for the AS (fig.4.3.24).  
 
Figure 4.3.24: ZnSO4 inhibition of the AS-mediated E. faecalis adherence to Caco-2 cells. 
AS-treated Caco-2 cells were co-cultivated for an hour with AS±ZnSO4-treated E. faecalis (MOI, 
1:300). Non-adhered bacteria were washed away, and both adhered and internalized bacteria were 
counted, and normalised with 100% of control. Data were analysed using ordinary one-way ANOVA 
followed by Holm-Sidak’s multiple comparison test and presented as the mean ± S.E.M., n=6(AS), 
3(AS+ZnSO4). *p<0.05 versus vehicle. 
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4.3.4.3 ZnSO4 co-exposure inhibited AS-mediated bacterial invasion 
Since AS-exposure significantly increased gut bacterial ability to invade IECs, the 
hypothesis whether inhibiting the sweet sensing interfere with invasiveness was tested. For 
that purpose, the invasion efficiency of MGB upon exposure to AS with ZnSO4 was 
determined using the antibiotic protection assays. Results of these clearly demonstrated an 
inhibitory effect of ZnSO4 on the invasiveness of the MGB E. coli (fig.4.3.25) and E. faecalis 
(fig.4.3.25). 
ZnSO4 co-exposure reduced E. coli invasion by 120% for neotame, followed by 84% and 
40% for aspartame and sucralose, respectively. Conversely, saccharin increased E. coli 
invasiveness by 63% in presence of ZnSO4 (fig.4.3.25).  
 
Figure 4.3.25: Effect of AS and ZnSO4 on the invasion level of E. coli to Caco-2 cells. 
Mammalian cells were treated with AS or vehicle, and E. coli was treated with AS ± ZnSO4 or vehicle, 
and co-culture was performed for an hour (MOI, 1:300). Adhered cells were killed using gentamicin 
and total CFU per cell was counted using standard plate count. Data were normalised with 100% of 
control. Data analysed using ordinary one-way ANOVA followed by Holm-Sidak’s multiple 
comparison test and are presented as the mean ± S.E.M., n=5. *p<0.05 versus vehicle. 
 
In the co-culture experiment of gentamicin and ampicillin protection assay for E. faecalis, 
the invasiveness of the bacteria was determined in the presence and absence of ZnSO4 
with AS (fig.4.3.26). The invasion percentage of E. faecalis into Caco-2 cells were reduced 
by 404% (neotame) and 64% (sucralose) in presence of ZnSO4. However, inhibition of E. 
faecalis invasion by ZnSO4 for the AS was insignificant (p=0.3-0.5, E. coli; and p=0.2-0.4, 
E. faecalis; multiple t-tests with Holm-Sidak’s test). 
V
eh
ic
le
S
ac
ch
ar
in
S
uc
ra
lo
se
A
sp
ar
ta
m
e
N
eo
ta
m
e
0
200
400
600
Artificial sweetener and ZnSO4
E
. 
c
o
li
 i
n
v
a
s
io
n
 (
%
)
AS
AS + ZnSO4
*
*
*
208 
 
 
Figure 4.3.26: Effect of AS and ZnSO4 on the E. faecalis invasion ability into Caco-2 cells. 
AS- or vehicle-treated Caco-2 cells were co-cultivated for an hour (MOI 1:300) with E. faecalis treated 
with AS ± ZnSO4 or vehicle. Treating bacteria with AS significantly increased their ability to invade 
Caco-2 cells, however, the use of ZnSO4 reduced invasion. Combination of gentamicin (100 μg/ml) 
and ampicillin (50 μg/ml) was used to get rid of adhered E. faecalis, total CFU/cell were counted, and 
normalised with control (100%). Data were analysed using ordinary one-way ANOVA followed by 
uncorrected Dunn’s test and presented as the mean ± S.E.M. n=3. *p<0.05 versus vehicle. 
  
Ve
hi
cl
e
Sa
cc
ha
ri
n
Su
cr
al
os
e
A
sp
ar
ta
m
e
N
eo
ta
m
e
0
200
400
600
800
Artificial sweetener and ZnSO4
E
. 
fa
e
c
a
li
s
 i
n
v
a
s
io
n
 (
%
) AS
AS + ZnSO4
* * *
*
209 
 
4.4 Discussion 
AS perturbs the homeostatic GM and interferes with bacteria-intestinal epithelium 
interaction leading to MD development (Suez et al., 2014). Therefore, AS might have the 
capacity to alter good bacteria to pathogen by stimulating virulence factors although the 
mechanisms remained unclear. This chapter aims to investigate AS- mediated changes in 
gut bacteria-enterocytes interactions.  
Interaction with the IECs is a major element of the virulent activity of the intestinal 
pathogens. AS comes in direct contact with the gut bacteria, therefore, any influence on 
bacterial quorum sensing and/or metabolism might have a cytotoxic effect on the IECs. In 
addition, adhesion of gut bacteria on the intestinal enterocytes prevents their elimination by 
the clearing mechanism of the intestine. AS can stimulate gut microbial adherence or 
increase enterocytes’ susceptibility to microbes. Besides, adhered bacteria can trigger other 
biological responses in host cell by inducing surface receptor-associated signalling 
pathways. A further hallmark of pathogenicity is the ability of intrusion of virulent gut 
microbes into non-phagocytic host cells. Many pathogens cause intense changes in host 
cell anatomy and function through a series of mechanisms mediated by exocellular factors 
and/or direct interactions between prokaryotic-eukaryotic cells (Minnaard et al., 2004; Sears 
and Kaper, 1996). So, studying pathogenic responses in gut bacteria-intestinal enterocytes 
interactions upon AS exposure is justified.  
Most intestinal microflora studies have used rodents as models or used faecal samples of 
the human host. These are easier to perform compared to humans, however, the 
extrapolated data from rodents have misleading interpretations for the physiological and 
metabolic differences between humans and rodents (Daly et al., 2016). Also, most 
published human microbiome studies have used faecal specimens since this is easier to 
collect. However, faecal samples are inappropriate representatives of non-pathogenic 
microflora of the oesophagus region. Similarly, it is a poor representative of proximal 
gastrointestinal tract and the mucosa-inhabited microflora (Hollister et al., 2014).  
Despite some limitations of the single lineage monoculture systems to represent the 
complex biological processes occur in vivo, in vitro models based on single cell types 
provide key information on a cell type’s reaction to certain treatment/microbe. In addition, 
such monocultures provide an efficient and economical way of avoiding a wide range of 
experimental variables. Therefore, considering the available technical supports, a well-
established IEC model was used for the co-culture studies. 
The intestinal epithelium has continuously renewing cell system, the cells differentiate as 
they migrate along the crypt-villus axis (Van Der Flier and Clevers, 2009). The differentiation 
of the enterocytes regulates the cell accessibility of receptors for bacterial adhesins and 
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invasins (Kerneis et al., 1992; Isberg and Leong, 1990). The confluent monolayers 
demonstrate both phenotypically and functionally the property of typical enterocytic 
differentiation due to the formation of TJs (Lea, 2015; Coconnier et al., 1994). In addition, 
invasion of atypical enteropathogenic E. coli into the HeLa cells was dependent on the actin 
filaments (Yamamoto et al., 2009). Also, disruption of TJ in the T84 cells enhanced the 
bacterial invasion efficiency (Yamamoto et al., 2009). The plasma membrane segregates 
into apical and basolateral domains, these changes mimic the IECs (Lea, 2015). So, it is 
already accepted that the enterocyte differentiation regulates the availability of cell 
receptors for bacterial adhesion and invasion (Yamamoto et al., 2009; Rosa et al., 2001). 
Therefore, using the enterocyte cell model Caco-2 for these experiments, which 
demonstrate the biological responses in bacteria-intestinal epithelium contact is 
reasonable. 
Despite their intensity and diversity, most gut bacterial species cannot be cultured in vitro, 
and co-culturing gut bacteria and human cells is even more challenging (Allen-Vercoe, 
2013). The major complication in a host-microbiome co-culture system is that above 90% 
of the gut bacteria are obligate anaerobes, while human cells depend on oxygen, the 
bacteria die rapidly on exposure to atmospheric conditions (21% O2). Maintaining both the 
eukaryotic and bacterial cell co-culture simultaneously is difficult as the growth rate of 
bacteria is much faster than that of eukaryotic cells (Kim et al., 2010). However, different 
co-culture methods were established meanwhile (Sadabad et al., 2015) to investigate the 
host-microbe interactions or the effect of compounds and drugs. Since the present study 
investigated the changes in morphology and viability of the eukaryotic cells in response to 
the bacterial secretions, therefore, the co-culture methods were different from Kim et al., 
(2010) who have used it as a screening tool for identifying the beneficial bacterial signal in 
the GI tract.  
Assessing morphological changes are a common way of investigating the cytotoxic effect; 
the changes in Caco-2 cell morphology co-cultivated with vehicle-exposed model gut 
bacterial metabolites were observed (fig.4.3.1 and fig.4.3.2). E. faecalis metabolites caused 
small vacuoles in the cell while there were prominent nods in the stress fibres in contrast 
with control (fig.4.3.2.c). The nuclei structure was similar for both E. coli and E. faecalis 
metabolite-treated Caco-2 cells in comparison to the control. However, morphology 
observation demonstrates physical damage of the cells, while the viability assay represents 
the effect on the cellular biochemical activity. Also, measuring the cell viability directly 
represents the number of living cells, which is a more straightforward, precise and better 
method to measure the cytotoxic effect. Therefore, the effect of AS-mediated bacterial 
metabolites was studied using the CCK-8 viability assay. 
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The viability measurement found from cytotoxicity assay could not be compared as no 
relevant literature was found. The background was maintained using 1:1 of mammalian cell 
culture media and bacterial media, which is reasonable, however, the control also contained 
untreated bacterial supernatant. The cytotoxic effect on cell viability could also be measured 
by FITC-AV apoptosis assay followed by flow cytometric analysis, which might represent 
exact number of viable, apoptotic and necrotic cells. However, findings from present study 
provide an idea on cytotoxic effect of AS-mediated metabolites.  
Interestingly, saccharin- and sucralose-exposed E. coli supernatant decreased Caco-2 cell 
viability and ZnSO4 addition reduced the effect (fig.4.3.21). On the other hand, E. faecalis 
supernatant did not significantly affect cell viability. Although ZnSO4 increased viability only 
11%, however, ZnSO4 with saccharin, aspartame and neotame slightly reduced viability 
(fig.4.3.22). 
Likewise, Rettig et al. (2014) also investigated the effect of an AS on metabolic activity of 
several gut flora of the phyla Bacteroides (B. fragilis, B. uniformis) and Firmicutes (E. 
faecalis, Clostridium sordelli). They have shown that sucralose caused metabolic inhibition 
on Bacteroides in a concentration-dependent manner (1.1, 3.3, 5.5, and 11 mg/kg/day), 
however, it had no significant effect compared to control group on the metabolic activity of 
the E. faecalis at any tested concentrations. These findings support the current results on 
the cytotoxic effect of E. faecalis metabolites on Caco-2 cells (fig.4.3.4.b). Oppositely, 
sucralose-mediated E. coli metabolites reduced Caco-2 cell viability in the present study. 
Previous findings from Boudeau et al. (2003) demonstrated that even though E. coli Nissle 
1917 bacteria showed a high level of adherence (p<0.001) to the IEC (Intestine-407), they 
did not induce any cytotoxic effect. The E. coli Nissle 1917 were non-pathogenic like E. coli 
NCTC 10418, which implies the AS-exposed bacterial metabolites might be responsible for 
the viability reduction (fig.4.3.4.a). 
Although AS-mediated bacterial metabolites did not affect viability, but AS differentially 
enhanced bacterial adherence to Caco-2 cells. This effect can take place in two ways; Caco-
2 cells can generate positive signals for gut bacterial adherence, or bacteria can be 
stimulated from AS exposure. Bacterial adherence, Caco-2 cell-associated bacteria 
(adhering and invading), were determined using the plate count method. This could also be 
measured using Real-Time PCR (Candela et al., 2005), however, another study using both 
techniques demonstrated no significant statistical difference between the methods (Nawaz 
et al., 2011).  
Bacterial adherence to IECs is the primary step for pathogenic colonisation of pathogens 
and eventual invasion. This ability also facilitates efficient toxin release on the cell milieu or 
its entrance into the target cells (Pizarro-Cerdá and Cossart, 2006; Cossart and Sansonetti, 
2004). A comparison between adhesion and invasion percentages does not represent 
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correlation of the pathogenic features. This indicates adhesion and invasion process might 
have different specific nature. Invasion seems to rely more on specialized receptor 
molecules, distinct from the receptors responsible for the adherence. Also, adhesion and 
invasion processes do not show much correlation with concentrations of the AS. 
Aspartame caused Caco-2 cell susceptibility to E. coli adherence at only 0.1 μM, although 
saccharin and sucralose caused at 1 and 10 μM, respectively. There might have an opposite 
connection of the sweet sensing and E. coli adherence, aspartame is the lowest in 
sweetness level, followed by saccharin and sucralose (table-1.1.1). Nonetheless, the 
response to neotame (6000) does not support this (fig.4.1.9), the intense sweetness might 
remain unrecognised by the cells for E. coli response. Likewise, the exposure of both Caco-
2 cells and E. coli to neotame did not cause any significant adherence of bacteria, which 
might have relevance with the previous statement about sweetness level. These findings 
could not be compared with other studies for limitations of literature.  
Opposite to E. coli, all concentrations of neotame significantly increased E. faecalis 
adherence to Caco-2 cells. Sucralose also caused adherence at the lowest concentration 
(0.1 μM), although the percentage is low for all concentrations. The comparatively low sweet 
molecules, saccharin and aspartame, both caused Caco-2 cell susceptibility at >10 μM 
concentrations. Other than sweet taste perception, the enterocytes might have different 
receptors for MGB which therefore differentially influence their adherence in response to 
the same AS concentrations.   
Potential adherence factors that mediate enterococcal virulence include cell surface 
carbohydrates, cell surface adhesins or their homologs, which share features with cell 
surface proteins of other Gram-positive bacteria (Lowe et al., 1995), these can act as a 
collagen adhesion or an aggregation substance (Furumura et al., 2006). However, detailed 
information on the adhesion promoting factors of E. faecalis remain unknown (Archimbaud 
et al., 2002). Besides, two different glycoproteins, β1 integrins and E-cadherin were already 
identified in the Caco-2 cells that act as receptors for bacterial entry into enterocytes 
(Mengaud et al., 1996; Isberg and Leong, 1990). Furumura et al. (2006) studied E. faecalis 
adhesion to human epithelial cell lines suggesting 50% and 40.6% adhesion of the studied 
clinical isolates to the HeLa and Hep-2 cells, respectively. This clearly indicates that 
adhesion to the epithelial cells is related to pathogenicity. 
Both E. coli and E. faecalis adhesion was significantly increased when Caco-2 cells were 
treated with different concentrations of the tested AS (fig.4.3.7 and fig.4.3.8, respectively), 
which remained same when both Caco-2 cells and bacteria were treated with the 
sweeteners (fig.4.3.9 and fig.4.3.10, respectively), except neotame-treated E. coli. 
However, treating bacteria with AS and ZnSO4 decreased both bacterial adhesion; E. 
faecalis adhesion (fig.4.3.24) was more reduced than E. coli adhesion (fig.4.3.23). Only 
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ZnSO4 did not affect any of the bacterial adherence and the percentage was like the vehicle 
(fig.4.3.23, fig.4.3.24). Since adherence to IECs is an important prerequisite for pathogenic 
gut bacterial colonisation and pathogenesis development, inhibition of their adherence 
ability decreases intestinal colonisation thereby preventing their invasion and subsequent 
pathogenicity. 
Nickerson and Mcdonald (2012) found Crohn’s disease-associated E. coli strain to be more 
adhesive to IECs when exposed to the polysaccharide, maltodextrin. This food additive 
enhanced bacterial adherence to IEC monolayer at both 3- and 6-hour time points, but E. 
coli invasion remained unaffected after maltodextrin exposure. Other than the difference in 
the bacterial source, they have used HT29 cell line whereas the present study was 
performed on Caco-2 cells, however, the study might support current findings.  
Adhesion of E. coli to Caco-2 cells closely resembles the localized adherence like pattern 
whereas the E. faecalis showed small clusters and pairs without any specific patterns as 
revealed from the images (fig.C8.1 to fig.C8.4) (Scaletsky et al., 2002; Darfeuille-Michaud 
et al., 1990). Both E. coli and E. faecalis demonstrated differences in bacterial number and 
distribution compared to control in the adhesion and invasion assays, however, the effect 
of different AS was not distinct.  
E. coli was dispersed on the cells, and some areas had higher number (fig.C8.2, fig.C8.5), 
this might occur for different maturation process of the Caco-2 cells and the resulting density 
of bacterial adherence receptors (Darfeuille-Michaud et al., 1990). On the other hand, 
adhered E. faecalis formed clusters or short-chains or pairs irrespective of the cellular area, 
with no specific pattern (fig.C8.4). Further studies with the adherence-related DNA probes 
(Scaletsky et al., 2002) or staining Caco-2 cells and bacteria (Nishikawa et al., 1994), and 
observation using transmission electron microscopy might give a better idea on the 
adhesion pattern of E. coli and E. faecalis to Caco-2 cells.  
Beside the pathogenic effect, the ability of the MGB to adhere to IEC after AS exposure 
could have a positive effect. Since adherence is one of the most important characters for 
probiotics (FAO, WHO, 2001), the potential effect of AS might be exploited for further 
research. The current data could serve as a preliminary base for screening potential factors 
that leads to adhesion, thereby opening a window of probiotic research using AS. 
Similar to adhesion, AS differentially affected model gut bacterial invasion ability into IEC. 
Bacterial attachment to IECs requires incorporation of bacteria-host receptors. This 
attachment might result in several outcomes, such as cell distortion, colonisation, bacterial 
internalization, interference with cell regulatory mechanisms and intracellular proliferation 
(Coconnier et al., 1993). Bacterial invasion in adjacent epithelial barrier induces an 
inflammatory reaction in the nearby intestinal mucosa (Jung et al., 1995). The bacteria 
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invade the epithelial cell membrane, increase their number and leads to host cell death. 
Exfoliation of these cells result in decreased mucosal surface and the presence of a greater 
number of immature enterocytes. Reduced or damaged mucosa surface therefore 
negatively affects the capacity of ion transport and nutrient digestive-absorptive functions 
(Coconnier et al., 1993).  
In the current study, the total co-culture time was an hour, allowing little or no chance for 
the bacteria to internally multiply. The percentage of bacterial invasion into mammalian cells 
was measured using gentamicin, hence antibiotic action kills non-internalized bacteria 
whilst intracellular ones are protected. A significant statistical difference was observed 
between vehicle-treated and AS-treated bacterial invasion (fig.4.3.15, fig.4.3.16). 
Sweetener with ZnSO4 reduced the invasiveness for all cases of both bacteria, and like 
adhesion, E. faecalis invasion (fig.4.3.26) was decreased more than E. coli (fig.4.3.25) due 
to ZnSO4 action. This indicates sweet sensing-mediated prokaryote-eukaryote interactions, 
which could be a matter of further studies. 
Antibiotic protection assay is used widely to study bacterial invasion to host cells. The assay 
relies on the inability of the antibiotics to kill intracellular bacteria thereby allowing a count 
of invaded bacteria only. Since gentamicin cannot diffuse into the apical domain of Caco-2 
cells (Bernet et al., 1994), so adhered bacteria to the Caco-2 cells are killed by the antibiotic 
action whilst invaded bacteria remain alive. 
E. coli is sensitive to gentamicin and the gentamicin protection assay is well-established to 
study E. coli invasion. The MIC (minimum inhibitory concentration) findings support this and 
100 μg/ml gentamicin concentration is widely used for E. coli invasion studies (Dogan et al., 
2006; Altenhoefer et al., 2004; Boudeau et al., 2003). Although some studies used lower 
concentrations of gentamicin (50 μg/ml) for E. coli (Ghosal et al., 2013; Roselli et al., 2003; 
Kim et al., 1998), however, the incubation duration with antibiotics was different. 
Conversely, some E. faecalis strains show less sensitivity to the aminoglycoside antibiotic, 
gentamicin (Wells et al., 1992; Huycke et al., 1991) and a concentration-dependent 
inhibition was observed in the MIC test (fig.4.3.13). Some of the E. faecalis strains were 
found to be insensitive to ampicillin (Ono et al., 2005; Cercenado et al., 1996; Inoue et al., 
1992), therefore, using the combination of antibiotics is better option (Fernández-Hidalgo et 
al., 2013; Gavaldà et al., 2003; Gavalda et al., 1996). However, the model gut bacterial 
strain showed sensitivity to penicillin-like antibiotic, ampicillin and the carbapenem 
antibiotic, meropenem. Also, the bacteria were sensitive to the combinations of gentamicin 
and the broad-spectrum antibiotics ampicillin or meropenem; MIC test demonstrates that 
the extracellular bacteria must be killed by the used antibiotics (fig.4.3.14). Since 
meropenem is less stable in stock solution (Mendez et al., 2008; Mendez et al., 2003), so 
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gentamicin and ampicillin combination was considered for the E. faecalis for the 
convenience of experiments.  
Besides, the temperature and duration of antibiotic exposure were determined earlier, The 
MOI was 1:300 for the final adhesion and invasion assays. Use of higher MOI was avoided 
to reduce risk of mammalian cell damage and to ensure a precise assessment of the 
bacterial ability to invade (Edwards et al., 2010). The number of bound bacteria is 
dependent not only on the number of bacteria added, but also on the binding capacity of 
IEC (Tuomola and Salminen, 1998), however, the number of bacteria added was kept 
constant in order to compare the effect. Some studies used lower MOI (1:100, 1:200), they 
might have employed techniques such as shaking, centrifugation or extended incubation 
time to facilitate invasion (Cordeiro et al., 2013; Donnenberg et al., 1989), none of these 
were employed in the current study. Also, the co-culture time is also important which was 
longer for those studies (1-4 and 3 hour/s, respectively), and was an hour in this study.  
Furthermore, the bacteria were washed prior to exposure to mammalian cells. This 
minimizes the risk of any toxin exposure limiting Caco-2 cell damage. However, bacterial 
invasion can induce apoptosis leading to interference into normal cellular functions resulting 
in cell damage. This can allow the permeation of antibiotics into the Caco-2 cells (Kim et 
al., 1998), so bacteria could be killed giving an inappropriate impression about the invasion. 
Sucralose pre-exposure was demonstrated to increase E. coli BW25113 resistance to 
several antibiotics as well as their mutation frequency (Qu et al., 2017), however, both 
bacterial strain and the antibiotics are different in the current study. Nonetheless, the 
bacterial inocula were insufficient to cause physical damage, the exposure duration was 
short (1 hour), and more importantly the cytotoxic effect on viability does not show cell 
death.  
Also, the composition of the medium in co-culture can have a significant effect on invasion 
(Edwards and Massey, 2011). However, the bacteria were washed stepwise with the used 
media and the data were normalised with the vehicle, which justifies that the findings are 
unbiased. Finally, a lower concentration of the TX-100 was used, and the handling time was 
fast which delimits lysis related interference. Besides, the used concentration of TX-100 
does not affect E. coli and E. faecalis viability for at least 30 minutes (Vieira et al., 2008), 
therefore, the invaded bacteria remained unaffected in the given amount of time. In addition, 
the serial dilution of the cell lysate was performed in the respective liquid medium instead 
of ddH2O or PBS. Bacteria was already in PBS containing TX-100, diluting them in liquid 
media reduced undue stress. Nevertheless, the steps of serial dilution and plating were 
quick (took maximum of two minutes), so the duration was too short for bacteria to increase 
their number. Nonetheless, all possible factors that can play a role in the invasion assay 
were considered and the findings were appropriate. 
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ZnSO4 is a potential sweet taste inhibitor (Keast et al., 2004), but can inhibit enteric bacterial 
growth (Faiz et al., 2011). However, the growth curve data represents that MGB growth was 
unchanged at the used ZnSO4 concentration in this study (fig.4.3.19), therefore, the reduced 
bacterial CFU in the ZnSO4 treated adhesion and invasion is not through growth 
suppression. These divalent metal cations form complexes with amino acids and interact 
through sweet taste chemosensory mechanisms (Keast et al., 2004). There may be a 
connection between sweet molecules and bacterial signalling that mediates the pathogenic 
potential. Because no studies were found on the sweet sensing in bacteria, more specifically 
on taste receptor and chemosensory activity, therefore, the current study could not 
determine whether the adhesion and invasion reduction were via any taste receptor 
inhibition. 
Medeiros et al. (2013) also demonstrated the inhibitory effect of zinc on the adherence 
property of enteroaggregative E. coli strain 042 to IEC-6 epithelial cells. ZnO at ≤0.05 mM 
did not affect the bacterial growth or epithelial cell proliferation; however, it significantly 
inhibited the adherence of E. coli strain to the IECs. These observations support the current 
findings where 0.1 mM of ZnSO4 affected neither epithelial cell viability (fig.4.3.19) nor 
model bacterial growth (fig.4.3.20), however, it reduced both E. coli and E. faecalis 
adherence to Caco-2 cells (fig.4.3.23 and 4.3.24, respectively). The inhibitory effect of zinc 
on enterotoxigenic E. coli strain’s ability to adhere and invade to IECs was also 
demonstrated by Roselli et al. (2003). Rather than antibacterial activity, ZnO prevented the 
increase of TJ mediated permeability and modulated the cytokine gene expression on the 
Caco-2 cell surface, thereby limiting the space for bacterial adherence on the cells and 
internalisation. AS increased model bacterial adherence when both Caco-2 cells and 
bacteria were treated, the adherence increased, whether this increase is through taste 
receptor or quorum sensing or any other mechanism, remains veiled. Exposing bacteria in 
presence of ZnSO4 reduced the effect, this might be because zinc reduced cell permeability 
for bacteria (Roselli et al., 2003), or because zinc altered important pathogenic properties 
of the bacteria required for adherence (Medeiros et al., 2013), or through quorum sensing, 
however, the process needs further investigation. As the untreated bacteria showed 
adherence to AS-treated Caco-2 cells, the STR may have a role in epithelial cell 
susceptibility to bacterial adhesion and invasion ability. However, Caco-2 cells were not 
exposed to ZnSO4, therefore, it is unclear whether T1R3 played a role in this occasion. 
The percentage of the invaded cells was lower than the adhered cells. Caco-2 cells were 
exposed to the same number of bacteria for adhesion and invasion. Since adhesion assay 
counts both adhered and invaded bacteria, so the number of CFU is higher in adhesion. 
However, CFU/ml was calculated, and data were normalised with the corresponding control 
converted into 100% for both the adhesion and the invasion assay. Therefore, the presented 
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data express relative changes in adhesion and invasion in response to AS exposure with 
control.  
Fascinatingly, AS increased E. faecalis adherence (fig.4.3.10) and invasion (fig.4.3.18), but 
it did not induce bacteria to secrete metabolites affecting cell viability (fig.4.4b). 
Nonetheless, untreated E. faecalis demonstrated significant adhesion for all AS in different 
concentrations (fig.4.3.8), however, it did not represent much invasion ability to AS-exposed 
Caco-2 cells at those concentrations (fig.4.3.16). On the other hand, saccharin exposed E. 
coli metabolites significantly reduced Caco-2 cell viability (fig.4.3.4.a), increased their 
adherence (fig.4.3.9), but had no effect on invasion (fig.4.3.25). This demonstrates that 
invasion is not a must for all cases of adhesion. ZnSO4 co-exposure did not improve cell 
viability reduction (fig.4.3.21) although decreased adherence (≈20%) (fig.4.3.23) while 
increasing invasion by about 62% (fig.4.3.25). These indicate that adhesion and invasion 
might follow different pathways.  
Interestingly, neotame exposed Caco-2 cells were prone to untreated E. coli adherence 
(fig.4.3.7), but neotame exposure prevented its adhesion ability (fig.4.3.9). More 
remarkably, neotame caused significant invasiveness of E. coli irrespective of the bacterial 
exposure to the AS (fig.4.3.15, 4.3.17). These findings also suggest that adhesion and 
invasion might not always follow the same signalling system, also invasion is not always 
adhesion dependent. There might be other mechanisms or receptors that facilitate invasion, 
for example, apoptosis or cellular damage (Kim et al., 1998). However, the neotame 
exposed cell-free E. coli excretions did not affect Caco-2 cell viability (fig.4.3.4.a), 
suggesting there is less chance of apoptosis facilitated invasion although it is different from 
exposure to bacteria. In addition, neotame caused changes in the cell morphology 
(fig.2.3.17.f, chapter 1), although the concentration used for the invasion assay is very low 
(0.1 μM) in comparison to the concentration causing cellular damage (10 mM). So, there 
might be other strategies involved that triggered direct or indirect interactions between 
model bacteria and IEC receptors enabling invasion which need further investigations. 
 
Since long-term diet (intake of AS) play an important role in GM transformation leading to 
metabolic disease development, alternatively, it might have a huge possibility of fighting 
against these gut disease/GM modulations via designed diet intervention to combat these 
diseases. 
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4.5 Conclusion 
To address Aim III (assessing the effect of AS and sweet taste inhibitor on microflora and 
IEC co-culture model), mammalian and bacterial cells were co-cultured to develop a 
physiological model of the gut. Adhesion and invasion assays were performed with 
exposure of IEC to AS-treated or -untreated MGB. These studies established changes in 
the pathogenic potential of bacteria and how that impacts mammalian cells. Studies also 
used ZnSO4 to assess whether sweet taste inhibition can rescue the pathogenic effect of 
sweeteners.  
Taken together, the results from this study suggest that AS triggers model gut bacterial 
pathogenic properties involved with adhesion and invasion to host cells. Also, different AS 
differentially affect bacterial metabolism following triggered pathogenicity (E. coli) or no 
effect (E. faecalis). Inhibition of the sweet sensing reduced the pathogenic effect for most 
cases indicating sweet taste perception might have a link with gut bacterial virulence. 
However, further studies are needed to investigate the AS effect on other virulence 
properties to clarify the pathogenicity. Also, inhibiting the sweet sensing might help reducing 
pathogenicity which needs further investigations. 
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5 General Discussion 
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This PhD project used various in vitro approaches to investigate the effects of AS on the 
gut to understand whether the consumption of non-nutritive sweeteners had a negative 
impact on gut health. Specifically, the studies emphasised establishing the effect of AS on 
IEC function, MGB metabolism and pathogenicity, and intestinal epithelium-gut bacteria 
interactions. Diet is one of the most important modulators of the intestinal environment and 
the gut microflora composition and function (Suez et al., 2014). The consumption of AS in 
food and beverages is common and the use is increasing, although controversy remains 
regarding their physiological effects and safety (Payne et al., 2012). Whilst it is known that 
IECs are in direct contact with AS, research in this area is very limited. Previous findings 
indicate that AS cause gut microbial dysbiosis (Fukui, 2016), however, there are no studies 
that demonstrate the direct effect of AS exposure on bacterial metabolism or pathogenic 
features. Also, whether AS consumption stimulates or enhances bacterial pathogenicity to 
IEC remains unknown. Therefore, it is timely to investigate the role of AS on gut health and 
understand whether AS consumption is safe.  
 
The studies in the thesis  used experiments on IEC, MGB, and co-culture models to 
determine whether AS exert negative effects on IEC function via interfering with viability 
and monolayer permeability, increase MGB pathogenicity, and negatively impact IEC-MGB 
interactions (table 5.1) which are associated with inflammation and metabolic diseases. At 
first, this study investigated the effects of a range of physiologically achievable 
concentrations of four common AS on IEC to understand the potential cytotoxic effect of AS 
at the cellular level. Overall, the public can consume AS in the diet at varying concentrations; 
for example, 0.01 µM in chewing gum to 2 mM in diet soda (Gardner et al., 2012). Yet, there 
is limited information on the amount of AS in the diet as well as on how much AS intestinal 
epithelial cells can see. Also, the FDA and EFSA recommended daily intake of AS is very 
high and the amount varies considerably (table 1.1.1). So, a range of concentrations was 
chosen to use from very low (0.01 µM) to sub-physiological (100 µM) concentrations, 
covering people who consume low amount, to higher concentrations (10 and 50 mM), 
maybe mimicking people who consume AS high in the diet. Previous studies also used 
similar or higher concentrations of saccharin, sucralose, and aspartame than the range 
used in the current study (van Eyk, 2014; reviewed in Brown and Rother, 2012).  So, the 
AS concentration range were well representative of the available limit in the diet to study 
their effects on IEB function.  
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Table 5.1: Summary of the key findings in the study. 
 
At the higher concentrations, saccharin, aspartame and neotame increased cell death in 
the IEC model (fig.2.3.7), may be through the apoptotic pathway (fig.2.3.21), which can 
directly impact barrier integrity. Viability loss can open the barrier to harmful antigenic 
substances causing inflammation leading to MD development (König et al., 2016). Previous 
study with a dietary factor, acrolein, also demonstrated Caco-2 cell viability reduction by 
apoptosis, which ultimately contributed to intestinal barrier dysfunction and permeability 
(Chen et al., 2017). Opposite to current findings, Santos et al. (2018) did not see viability 
reduction in Caco-2 cell upon exposure to 10 mM of saccharin, sucralose, aspartame, and 
Ace-K. The contradiction with Santos et al. (2018) findings might be for the experimental 
conditions. Oppositely, another study on Caco-2 cell found similar viability decrease at >10 
mM concentration of saccharin, sucralose and aspartame (van Eyk, 2014) which agrees 
with present findings except for sucralose. Increased epithelial cell loss or decreased 
regenerative capacity causes epithelial layer dysfunction leading to an increase in the 
intestinal barrier permeability, promoting the leakage of potentially hazardous substances 
and microorganisms into the body (reviewed by Delgado et al., 2016). So, higher 
Aims Name of experiment Artificial sweeteners response 
Saccharin Sucralose Aspartame Neotame 
Effect of 
AS on 
intestinal 
epithelial 
cells 
(IEC) 
Viability  ↓ ↓ ↓  ↓ 
Apoptosis (dead %) ↑  ↑ ↑ ↑ 
Morphological changes √ √ √ √ 
Monolayer 
Permeability 
AS ↑ ↑ ↑ ↑ 
AS + LPS ↑ ↑ ↑ ↑ 
Stress fibre formation − √ √ √ 
T1R3 receptor expression − − − − 
Effect of 
AS on  
gut 
bacteria  
Metabolism 
(growth 
measurement) 
E. coli −  −  − −  
E. faecalis - - - - 
Biofilm formation E. coli + + +  + 
E. faecalis - - + - 
Haemolysin 
production 
E. coli − − − − 
E. faecalis − − − − 
Effect of 
AS on 
co-
culture 
of IEC 
and 
model 
gut 
bacteria 
Cytotoxicity E. coli +  + − −  
E. faecalis - - - - 
Untreated 
bacterial 
adhesion 
E. coli +  + +  + 
E. faecalis +  + +  + 
AS-treated 
bacterial 
adhesion 
E. coli + + + - 
E. faecalis + + + + 
Untreated 
bacteria invasion 
E. coli + + + + 
E. faecalis - + + - 
AS-treated 
bacterial invasion 
E. coli - + + + 
E. faecalis + + + + 
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concentrations of AS in the diet interfere with IEC viability and enhance disease state by 
causing barrier dysfunction. 
 
Morphological alterations, for example in mitochondria, AS might affect the mitochondrial 
membrane permeability resulting in the activation of the apoptotic proteins (table 2.1.1). 
Also, the AS might have caused DNA damage, since the previous study on Caco-2, HT-29, 
and HEK-293 cell lines demonstrated DNA damage after exposure to the AS (van Eyk, 
2014). The study showed that sodium saccharin and sucralose caused highest level of DNA 
damage in all types of cells, suggesting that it could trigger the intrinsic apoptotic pathway 
resulting in apoptosis-mediated cell viability loss (van Eyk, 2014). Delgado et al. (2016) also 
reviewed the mitochondrial pathway of apoptosis triggered by DNA damage or genotoxic 
stress. These stimulants promote stress signals to converge at the mitochondrial 
membranes by promoting the formation of pores. These pores eventually cause the 
permeabilization of the mitochondrial outer membrane and the release of proteins from the 
intermembrane space to the cytosol with lethal consequences for the cell (reviewed by 
Delgado et al., 2016). Also, Grabinger et al. (2014) noted that DNA‐damage‐induced 
apoptosis mostly occurs in the intestinal crypts. Although proliferative intestinal stem and 
progenitor cells are more vulnerable to such apoptosis, mature, terminally differentiated 
epithelial cells in the villus can also face it (Grabinger et al., 2014). Therefore, AS cause 
morphological changes of the IEC which might have relation to the apoptosis mediated 
viability reduction, which ultimately impact the intestinal barrier funciton.  
 
Besides all AS are not physiologically inert (Wal et al., 2019), they or their derivative 
compounds might have lethal factors that trigger the extrinsic pathway of apoptosis, leading 
to activation of the procaspase-8 (Muzio et al., 1996; Boldin et al., 1996). Nonetheless, both 
extrinsic and intrinsic pathways ultimately activate the downstream effector caspases, 
subsequently causing cell death (Muzio et al., 1996). The study could not clarify the 
apoptosis pathway, however, further studies using specific apoptosis triggers such as 
caspase assay would be able to clarify this. Also, the cells were exposed for 24 hours, which 
might have missed the point of apoptosis, shorter exposure period imaging might help to 
detect the apoptotic cells. Additionally, the morphological features studied represent some 
characteristics of the apoptosis, similar morphological alterations of Caco-2 cells were also 
reported previously by van Eyk (2014).  AS caused loss of cell adherence, and observations 
were performed on cells remained on the culture plate, but not the actual representative of 
the number of cells, implying only morphological studies might misinterpret the findings. So, 
observations could be made at different time points or through continuous imaging to detect 
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morphological signs of apoptosis. However, quantitative methods, along with morphological 
studies, would be a better representative of the effects. 
While that is relevant to people who consume a large amount of AS, the vast majority of the 
population will consume a lower amount (Logue et al., 2017; Gardner et al., 2012). The 
study shows that lower concentration is still causing damage to the epithelium via a leak. A 
similar increase in barrier permeability of FD4 across Caco-2 cell monolayer was 
demonstrated upon exposure to a dietary component, acrolein (Chen et al., 2017). In 
agreement with the FD4 permeation, Chen et al. (2017) also found decreased TEER and 
downregulation and delocalization of key TJ proteins, which indicate that present in vitro 
studies could have similar outcomes. More importantly, their study found intestinal barrier 
permeability in mice after oral intake of the acrolein, which resulted in increased 
translocation of bacterial endotoxin/LPS into the blood (Chen et al., 2017).  Additionally, the 
presence of LPS significantly increased the leak (fig.2.3.33), implying in the gut environment 
where the endotoxin is common, the AS mediated leak could be exacerbated for the 
presence of LPS. Previous study showed that LPS at physiologically relevant concentration 
increased Caco-2 cell monolayer permeability through the TJ-mediated pathway in a time-
dependent manner, and a similar increase was observed in vivo (Guo et al., 2013). Another 
study with saccharin showed increased paracellular transport via decreasing claudin-1 
expression in Caco-2 cells (Santos et al., 2018). Nonetheless, their study showed no 
significant leak for 10 mM of sucralose and aspartame, which contradict with the findings 
showing sucralose at 1 mM and aspartame at 0.1 mM caused a leak (fig.2.3.31. b, c). The 
leak was not for cell viability reduction, as viability was unaffected at these concentrations 
(fig.2.3.7). This finding agrees with Santos et al. (2018), who also observed a similar effect 
of saccharin, causing permeability without affecting viability. However, aspartame did not 
cause a significant leak at 1 mM in this study, which might indicate aspartame cause leak 
at lower concentrations only and might explain Santos et al. (2018) findings. Therefore, the 
barrier integrity impairment was not through viability reduction; other pathways such as TJ-
mediated or sweet taste receptor modulation might have interactions. Altered expression 
and redistribution of the TJs increase the intestine’s paracellular permeability (König et al., 
2016; Ulluwishewa et al., 2011). It strongly suggests that the permeability caused by the 
dietary component, AS, can subsequently affect gut physiological homeostasis. Epithelial 
barrier dysfunction is one of the significant contributors in chronic inflammation (Fukui, 
2016). It can also facilitate the permeation of endotoxins and bacterial antigens into the 
circulation (Mendrick et al., 2017; Moreira et al., 2012; Ukleja et al., 2010).  Permeability 
eventually increases inflammation, which triggers insulin resistance and adipose tissue 
plasticity leading to metabolic diseases (Fukui, 2016; Serino et al., 2009). This 
pathophysiological cascade has also been linked to the development of other MD, including 
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T2D (Clemente et al., 2012; Serino et al., 2009). So, people consuming lower amount of AS 
in the diet are still at risk of having intestinal leak which have negative impact on health. 
 
Whilst the monolayer permeability was independent of cell death, it is likely to be through 
TJ-mediated pathway. The advantage of paracellular permeability is that TJ proteins can 
be annealed, so there should be a short-term leak.  Higher concentrations caused cell death 
and that will take longer to recover because the epithelium needs to grow, and the epithelial 
cell turnover time is 5-6 days (Van Der Flier and Clevers, 2009). On the other hand, claudins 
express in epithelia and form paracellular barriers and pores that determine TJ permeability 
(Günzel and Yu, 2013). Using pulse-chase-pulse analysis Van Itallie et al. (2017) 
demonstrated that claudins preferentially incorporate with newly synthesized claudins into 
break sites to reanneal. Another study showed that paracellular leaks are followed by 
temporary local activation of RhoA, or Rho flares, which concentrate TJ proteins locally 
through Rho kinase-mediated contraction of the junction (Stephenson et al., 2019). Leak 
happens and this reverse kind of a regular basis, gut will see leak at various substances’ 
regular basis. So, irrespective of lower or higher concentration consumption, there will be 
an impact on gastric permeability. Though the TJ permeability has a greater chance to seal 
promptly, however, this will need to be studied further over time. 
 
Adjacent to the intestinal epithelium, the GM is the core part which is also exposed to the 
AS in a greater degree than IEC. So, the effect of AS on GM metabolism and their 
interactions with IEC is crucial to understand the overall impact of AS consumption. It is 
difficult to determine the real magnitude of host exposure to intestinal pathogens; the 
development of infectious diseases barely happens due to pathogen-epithelium 
confrontation in homeostatic conditions (Neish, 2002; Adlerberth et al., 2000). Also, 
assessing the exact role of AS is challenging in such an environment as the organisms are 
intricately interdependent for their existence and metabolism (Cani, 2018). Other studies 
showed dysbiosis (Suez et al., 2014), but this study focussed on the possibilities of GM 
pathogenicity because increased pathogenesis of set bacteria is linked to MD (Chen and 
Devaraj, 2018; Sartor and Wu, 2017). The study focussed on two MGB, which are prevalent. 
Interestingly, there was no effect on growth and haemolysin production other than increased 
biofilm formation (fig.3.3.9). Although a previous study used much higher concentrations 
showed that high concentrations (12.5 and 25 mg/ml) saccharin, sucralose and Ace-K have 
a strong inhibitory effect on E. coli growth (Wang et al., 2018). Interestingly, Mahmud et al. 
(2019) demonstrated a concertation-dependent increase of E. coli growth upon Ace-K 
exposure up to 15 mg/ml, and similar to previous studies, they found inhibited growth at 
high concentration of 25 mg/ml. They also found aspartame (1 mg/ml) to stimulate E. coli 
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growth insignificantly like present study (fig.3.3.6.c), although they observed growth 
inhibition at concentrations ≥3 mg/ml (Mahmud et al., 2019).  
 
The host epithelial defence mechanisms ensure host protection; however, managing the 
inflammatory reactivity is a pivotal requirement to conserve the intestinal barrier integrity 
(Nagai et al., 2016). While commensals do not trigger epithelial defensive response, they 
influence the host’s immune modulation (Petersson et al., 2010). Pathogenic bacterial 
colonization may cause host cell damage, thereby stimulating the host’s response to resist 
the antigen, raising an inflammatory response (Vijay-Kumar et al., 2010). There are several 
features of the GM which can be linked to pathogenesis such as haemagglutination, 
cytolysin production, induction of proinflammatory cytokine production (reviewed by Rossi 
et al., 2018). These findings cannot be compared because there is no literature to link 
bacterial pathogenicity and AS consumption. However, biofilm formation, which is frequent 
in the gut (Rossi et al., 2018) and is often linked to pathogenic activity (Hold and Allen-
Vercoe, 2019), was increased after AS exposure (table 5.1). Therefore, AS consumption 
can increase the pathogenic factor of GM, although further studies are needed to 
understand the mechanisms. 
Intestinal pathogenic E. coli can acquire different abilities to form a biofilm, although how 
nutrient provisions in the gut affects biofilm formation is mostly unknown (reviewed by Rossi 
et al., 2018). Quorum sensing may play a role via autoinducer-1 in E. coli biofilm formation 
in the gut, but it is still elusive how autoinducer-1 is stimulated (reviewed by Rossi et al., 
2018). Nonetheless, Mahmud et al. (2019) indicated that aspartame and Ace-K might 
influence E. coli K-12 biofilm formation in the gut. They showed that Ace-K and aspartame 
upregulated several genes such as 6-phosphofructokinase I and II (pfkA and pfkB, 
respectively), Pyruvate dehydrogenase (ace), and Lipoamide dehydrogenase (lpd). These 
genes are essential for glucose metabolic pathways in E. coli (Mahmud et al., 2019), whilst 
mutations in sugar pathways affected colonization by E. coli MG1655 (Chang et al., 2004). 
Because the gut bacteria model (E. coli MG1655) use gluconate as a major carbon source 
to colonize in mouse intestine, defected pathway negatively impacts on both the initiation 
and maintenance stages of biofilm development (Chang et al., 2004). Besides, Thymidylate 
synthetase (thyA) and Thymidylate kinase (tmk) genes which are important for de novo 
synthesis of pyrimidine (ThyA and Tmk) in E. coli, were also overexpressed upon aspartame 
and Ace-K exposure (Mahmud et al., 2019). Previous study suggested that de novo 
pyrimidine synthesis is essential for Salmonella typhimurium biofilm establishment in the 
chicks (Yang et al., 2017). One bacterial biofilm might facilitate colonization of other bacteria 
or delimit the proximity of essential commensals. Therefore, AS exposure in the present 
study might have enhanced expression of certain genes in MGB or increased the metabolic 
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activity, which facilitated the increased biofilm development; however, further investigations 
are important to ascertain this. 
In addition to biofilm, saccharin- and sucralose-treated E. coli metabolites decreased Caco-
2 cell viability in the co-culture model (fig.4.3.4.a). In the gut milieu, the production of one 
metabolite may have a combined effect on the conversion of the product into other 
compounds or stimulation or suppression of other organisms (Sartor and Wu, 2017). For 
example, colonization of the Enterococcus faecium in the small intestine of the pigs was 
shown to have an inhibitory effect on the colonization of E. coli (Ushe and Nagy, 1985). 
Sucralose- and aspartame-mediated E. faecalis metabolites reduced Caco-2 cell viability 
(fig.4.3.4.b). Although the reduction was insignificant, this may induce unplanned apoptosis, 
which can affect the barrier function (Elmore, 2007). Studying the bacterial proteins using 
western blotting or mass spectrometry might answer whether exposure of Caco-2 cells to 
AS-mediated bacterial metabolites alter intestinal epithelial cells protein profile.  
 
Also, AS negatively affected the intestinal epithelium-gut bacteria interactions by increasing 
the adhesion and invasion of the MGB to the Caco-2 cells. Overall, AS caused an increase 
in the bacterial adhesion except for neotame. Previous study showed that type 1 fimbrial 
adhesin is an E. coli adhesion protein present on the tips of fimbriae of enterotoxigenic 
strains (Kukkonen et al., 1993). AS, have stimulated Caco-2 cell receptors for the bacterial 
adhesion, as untreated bacteria adhered to the AS-exposed Caco-2 cells (fig.4.3.7–4.3.8). 
Nonetheless, it is not clear whether the adhesion was mediated by mammalian cell-bacteria 
receptors, or by the release of adhesins or other means. Further investigations with 
adhesion target inhibition might clarify the AS-mediated bacterial adhesion. 
 
Notably, the decreased adhesion of neotame-exposed E. coli (fig.4.3.9) in comparison to 
untreated bacteria (fig.4.3.7.d) indicates that there might have mismatched receptor 
interactions. In contrast, neotame exposed Caco-2 cells showed significant adherence to 
untreated E. faecalis (fig.4.3.8.d); and exposure of both Caco-2 cells and E. faecalis to 
neotame increased the adhesion percentage by 179% (fig.4.3.10). Importantly, these 
findings indicate that AS can enhance enteric bacterial adhesion to intestinal epithelium 
without affecting their growth. In addition to facilitating invasion, this phenomenon could 
assist other pathogenic features such as biofilm formation (Fons et al., 2000). Also, 
adhesion of one species may influence others, i.e., mice harbouring a relatively high density 
of E. coli population in the intestine were shown to be more susceptible to Salmonella 
enterotica induced gut inflammation (Stecher et al., 2010). Consumption of Ace-K has 
increased the risk of chronic inflammation in the host via gut microflora perturbation. Ace-K 
increased the abundance of a bacterial toxin secreting gene, thiol-activated cytolysin, as 
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well as enriched the LPS synthesis-related genes, eventually upsurge the risk of 
inflammations (Bian et al., 2017). Therefore, it may be predicted that AS not only cause 
bacterial adhesion to intestinal epithelium but also could indirectly stimulate other 
pathogenic bacterial colonization in the intestinal epithelium, which can make host prone to 
various diseases.  
 
AS differentially increased model gut bacterial invasiveness into Caco-2 cells (fig.4.3.15 
and fig.4.3.16). Invading the epithelial lining by the enteric pathogens to establish an 
infection involves enzymes and toxins (Altenhoefer et al., 2004). Pathogens can invade and 
enter the bloodstream, thereby disseminating in the body through the blood flow and cause 
inflammation (König et al., 2016). Also, AS-exposure significantly increased E. faecalis 
invasion into AS-treated Caco-2 cells (fig.4.3.18) in comparison to untreated bacteria 
(fig.4.3.16). It indicates the involvement of more than one pathway in the AS-mediated 
invasion mechanism. Although cell death could open the barrier for bacteria to pass, which 
can take place as observed in the viability reduction, that is not applicable in this in vitro 
assay results. Because, if there were dead cells, that would have been removed in the 
washing steps as death cause loss of adherence. It indicates more possibilities of receptor-
mediated bacterial invasion; however, further investigations are necessary to establish the 
AS-mediated bacterial invasion pathway.  
 
Bacteria may also use the host cellular apparatus for invasion (Coconnier et al., 1993). 
Pathogens use many inducers of the inflammatory cascade, which may exacerbate the 
inflammation (Burgos and Beutin, 2010). Upon invasion, the inflammatory response persists 
for the recruitment of leukocytes (Santos and Broz, 2018). Infection with pathogenic bacteria 
results in the expression and upregulation of a specific array of inflammatory mediators 
(Heimesaat et al., 2016; Jung et al., 1995). Therefore, perpetuated inflammation leads to 
conditions leading to metabolic disease development. 
 
The STR in the mammalian cells has been shown to express (Shirazi-Beechey et al., 2014; 
Moran et al., 2010) but not shown in bacteria (Lee et al., 2017). The study has shown that 
STR is expressed in the epithelial cells, although only T1R3 in Caco-2 cells (O’Brien and 
Corpe, 2016). Whilst current study does not show the presence of STR in the gut bacteria, 
it indicates the presence of a sweet taste sensor, because of the zinc sulphate work. These 
raise question whether there are GPCRs in gut bacteria. Also, there might have quorum 
sensing linked to sweet taste, which needs further investigations. Sweet sensing in the lung 
were shown to have negative correlation with the epithelial cell viability (Lee et al., 2017; 
Carey and Lee, 2019). Although the studies did not show any GPCR or quorum sensing, 
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however, established a link between sweet taste mediated bacterial secretions and 
epithelial cell death signalling. 
The study is not purely driven by STR. AS that was more able to bind a receptor, e.g., 
neotame, it could have the worst effect and gradually less effect for saccharin, sucralose 
and aspartame. However, findings from the present study do not support this. If this was 
taste receptor driven, then the data should show that the less sweet AS would have a less 
effect, but this is not the case. For some of them, that was the case, but for most of them, 
there was no link with the sweetness perception level. The reason behind this, maybe they 
all do not bind to the STR in the same way (Fernstrom et al., 2012; Assadi-Porter et al., 
2010).  
 
There is no known literature to explain the presence of a taste receptor or such signalling 
in bacteria, AS might not bind all sweet receptors either. In addition, all AS are structurally 
quite different; they might bind differently or may bind partially (DuBois, 2016). Besides, 
there could be an indirect effect of the AS, e.g., in the gut, we do not undoubtedly know 
whether the AS are broken down (Wal et al., 2019). Moreover, does the gut bacteria 
metabolise AS or their components is unknown. The initial concept of these chemically 
derived intense sweet molecules was questioned as all of them are not physiologically inert 
(Wal et al., 2019), which indicates that sweeteners have different metabolic activities. Also, 
they or their derivatives may cause physical injury to the cells (van Eyk, 2014). 
 
The barrier permeability was not related to the sweetness perception level either (table-
1.1.1), because saccharin is half the sweetness perception of sucralose, but both caused 
leak at 1 mM. Instead, aspartame was the lowest in sweetness perception level, while 
neotame was the highest of the tested AS, but both caused leak at 0.1 mM (fig.2.3.31). 
Additionally, the permeability findings did not represent concentration dependence. 
Sucralose caused a leak at concentrations 0.1 and 1 µM when exposed with LPS, but not 
at other concentrations of more than 10 µM (fig.2.3.33). Likewise, neotame with LPS 
increased permeability for all the concentrations (fig.2.3.33). The cell monolayer 
permeability was neither correlated with the sweetness perception level, nor the 
concentration of the AS.  
While there was no correlation between sweetness perception and paracellular transport of 
FD4, the appearance of stress fibre showed the opposite, except aspartame (fig.2.3.35 – 
2.3.37). Saccharin caused almost no prominent stress fibres in the Caco-2 cells 
(fig.2.3.36.c), whereas sucralose-exposed cells represented a similar level of stress fibre 
like LPS (fig.2.3.36.d). Moreover, neotame exposed cells demonstrated the highest level of 
stress fibres compared to others (fig.3.3.37.f). Disorganisation and disassembly of F-actins 
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lead to disruption of the epithelial barrier, causing a leak (Madara, 1987). There is no 
literature demonstrating AS-mediated stress fibre alteration; hence the findings of the study 
could not be critically analysed. The stress fibres in the present study produced a basic idea 
on the effect of AS. Further studies with quantification or measurement of the actin fibres 
would generate more specific information in this regard.  
Although the study presented here shows negative impact of AS on IEC function and GM 
pathogenicity, which are new information, still, there are some limitations. These 
experiments used an in vitro approach, which is relatively simple and easily tractable, but 
limitations remain over in vivo studies. Also, Caco-2 cell line represents only primary 
enterocytes. Although above 80% of cells of the intestinal epithelium is the enterocytes (Van 
der Flier and Clevers, 2009), but the response of other intestinal epithelial cells was not 
included. Whilst studies on the effect of AS on human is important, the use of artificial gut 
system could be the next step of the investigation. Like the epithelial cell model, the MGB 
represents individual response, which might be different in vivo. Future studies with other 
MGB or their combination, more preferably whole gut microflora would represent a better 
understanding of the effect of AS. 
Besides, food and drink often contain more than one AS, but the present study investigated 
individual AS effect, although the individual findings can indicate the combined effect. Also, 
consumption of AS is commonly based on dietary information only. In contrast, consumers 
may be unaware when intake AS in many other products like toothpaste, mouthwash, 
sauces, and frozen set foods containing AS (Pearlman et al., 2017). Whilst saccharin, 
sucralose and aspartame are ubiquitously used in food and beverages in the UK, neotame 
is not commercially used in the food products. Nevertheless, use of neotame is common in 
countries in North America, South America, Africa, Asia, and Australia (Das and 
Chakraborty, 2016).  
Despite these limits, the findings raised some exciting inquiries. The effect of AS on viability 
or permeability was not via T1R3 signalling, therefore what mechanisms underlie in the AS-
mediated effect on IEC remained unclear and would be interesting to study in future. Also, 
zinc sulphate inhibition of pathogenicity of the MGB indicates some sweet sensor, but no 
T1R3 homology was invented in bacteria yet. So, the study opened a window whether 
bacteria have sweet taste receptor homology or sweet sense mediated quorum sensing or 
other signalling mechanism. 
Also, the findings are important for public health to understand the safety of AS 
consumption. The increase in diabetes and the obesity epidemic has led more and more 
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people to consume AS as a healthy alternative (Pearlman et al., 2017; Payne et al., 2012). 
The availability and naming as ‘diet’ options could influence people to select AS containing 
products too (Gardner et al., 2012). Also, the ubiquitous use of AS in food and beverages 
might passively drive people to consume AS (Pearlman et al., 2017). Besides, the food 
processors and manufacturers are liable to express the ingredient AS names, except 
saccharin, but not the amount of AS used (Mattes and Popkin, 2008). Also, there is a good 
percentage (73%) of people who prefer AS consumption to reduce calorie intake (Gardner 
et al., 2012). The number of people consuming AS-containing foods has increased from 
3.2% to 5.8% between 1989 and 2004 (Mattes and Popkin, 2008). Consumption of AS as 
a healthy option by people already having chronic inflammation or T2D could, therefore, 
exacerbate their conditions. 
In addition, the increased sugar tax may motivate people to choose AS since it is cheap 
and require less amount. Besides, to keep the food taste as before with reformulation of the 
sugar content, the food companies might be encouraged to rely on AS to avoid tax 
(Vandevijvere and Vanderlee, 2019). However, AS do not exactly taste like sucrose 
(Steinert et al., 2011). In six months of implementing the sugar tax in 2018, GBP 150 million 
in revenue was collected from the tax, which was twice as expected (Vandevijvere and 
Vanderlee, 2019). Although the initial idea of a sugar tax was to reduce sugar in products 
by 20% by 2020 (Buttriss, 2018), but the achievement of half of the target reduction in the 
average sugar content in the UK beverages was reported (Hashem et al., 2017). The 
companies might partially replace sugar or employ combinations of AS to achieve their goal, 
indicating more dependence on controversial food additive.  
When the UK government increased dietary awareness and made companies put labels 
about calorie content and sugar content on food (EU FIC, 2011), many companies felt 
pressure to reduce the numbers of calorie by replacing some sugar with AS to make their 
product appear healthier. The companies do not present the AS name on the front labelling, 
rather keep it in the ingredient list without mentioning the concentration (Mattes and Popkin, 
2008). Consumers might follow the front of package calorie information only, thereby 
consuming AS without knowledge. Since the controversy of the safety of AS remained 
(Harpaz et al., 2018), and we are still waiting for concrete findings, it would be worth adding 
AS names and concentration in the food packaging like calorie. It would help consumers to 
make their decision on intaking AS or not. In addition, in future, the FDA should test food 
additives more thoroughly before sending them to the market. 
In the current beverage industry, specially diet-cola, AS almost replaced sugar (Gardner et 
al., 2012). The rising health awareness resulted in expanded demand for low-to-zero-calorie 
foods in the packaged food sector, indicating a greater need for AS (Praveena et al., 2019; 
Whitehouse et al., 2008). So, considering the continually increasing AS market, further 
research should introduce safer AS and could find ways to overcome the negative impact 
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of the existing ones. The current study provides knowledge on the metabolic and health 
effect of four common AS and indicates a rescuing possibility. Further research could 
expand this knowledge to improve AS-mediated physiological impact and find an ideal AS. 
Nonetheless, the study suggests that consumption of AS could have potentially harmful 
effects on human health. They are sugar substitutes; however, sugar could be burnt but, 
dysbiosis of the gut microflora might have worse effects. AS are great in theory, but research 
needs to develop one that triggers sweet taste perception without inducing factors that can 
provoke inflammation. Therefore, everyone related to healthcare should educate people 
about this. The concentration of the AS in the products should be closely monitored before 
any concrete decision comes about AS use. Moreover, the AS approval process might have 
evaluations and regulations similar to pharmaceutical drugs. 
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6 Conclusion 
A large number of the population consume AS in the diet, either to reduce calorie intake or 
to reduce blood glucose levels. However, there is significant controversy around the safety 
of AS consumption which, to date, remains unresolved. The aim of the present work was 
therefore to study the effect of commonly available AS (saccharin, sucralose, aspartame, 
and neotame) on intestinal health. These studies were performed using in vitro models of 
the gut epithelium (Caco-2 cells) and the MGB (E. coli and E. faecalis). Studies in the thesis 
show that AS, at physiological concentrations, decreases intestinal epithelial cell viability, 
which is associated with increased intestinal barrier leak, as measured using a FITC-
dextran model. This increased leak can lead to antigenic substances entering the circulation 
which causes systemic inflammatory responses and metabolic diseases. In MGB, AS 
exposure increased pathogenicity (biofilm formation, adhesion and invasion to the 
epithelium) but not metabolic capacity, which is indicative of further inflammatory responses 
in those who consume AS in the diet. The results of these studies demonstrate that AS 
negatively impact the intestinal epithelium and perturbs epithelium-gut bacteria interactions. 
Further studies are, however, needed to develop a thorough understanding of how these 
physiological effects of AS can be attenuated to improve gut health. 
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8.1 Appendix A - data for chapter 2 
8.1.1 Growth of Caco-2 cells in different tissue culture medium 
Caco-2 cells were grown in three different media to assess their growth performance up to 
three days. The cells have grown in all three media with fine differences as observed using 
the inverted microscope. Approximately 75% confluence was observed at day 3 in DMEM, 
followed by about 85% confluence in RPMI, and complete monolayer in EMEM medium. In 
addition, cell adherence was found faster in EMEM as observed at day 1 compared to RPMI, 
and cell remained mostly round in DMEM at that time point. Growth of the Caco-2 cells were 
found better in EMEM, which agrees with the supplier’s suggestion (ATCC® 30-2003) and 
used for the rest of the study. 
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Figure A8. 1: Growth of Caco-2 cells in different tissue culture medium. 
Cells were seeded at same concentration into T75 flasks with DMEM (Dulbecco’s Modified Eagle 
Medium; Gibco, ThermoFisher Scientific) or EMEM (Eagle’s Minimal Essential medium; American 
Type Culture Collection 30-2003) or RPMI (Roswell Park Memorial Institute 1640 Medium; 
ThermoFisher Scientific). The media were supplemented with 10 % FBS, 1% antibiotics, and 1% L-
glutamine. The flasks were observed using inverted microscope and images were taken using 
Samsung grand prime mobile phone. Magnification was X40. 
 
8.1.2 Maintenance of Caco-2 cells  
8.1.2.1 Cell passaging 
Cells were fed by replacing the used medium with the pre-warmed (37 ˚C) fresh medium. 
Once grown to confluence (70 – 80 %), cells were split 1:3 or 1:6 depending on necessity 
of the experiments (fig.A8.2). Used culture media was discarded, and cells were washed 
gently with PBS. Cells were then exposed to Trypsin-EDTA, incubated at 37 ˚C for 2 – 5 
minutes (depending on flask size) with intermittent microscopic monitoring for cell 
detachment. Cell layer dispersion was facilitated by gentle tapping. Fresh medium was 
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added to stop Trypsin action, and cells were dissociated by pipetting up and down gently. 
Appropriate amount of cell suspensions (depending on split and vessel size) were 
transferred to new cell culture vessels. For cell culture the amount of chemicals used for 
tissue culture vessels were given in table-A8.1.  
Table A8. 1: Volume of different solutions used for different cell culture vessels. 
Flask 
size 
Surface 
area 
(cm2) 
Volume of 
media 
(ml) 
Volume of 
trypsin (ml) 
Volume of 
DPBS (ml) 
T-25 25 6  1 5 
T-75 75 12 2 10 
T-175 175 25 5 20 
 
8.1.2.2 Freezing and thawing cells 
Cells were frozen down before reaching 70% confluence (fig.2.2.1). Cells were brought in 
suspension similar to cell passaging protocol and cell counting was performed using 
Haemocytometer. The cell suspension was centrifuged at 1000 rpm for 5 min, and 
supernatant was discarded. Cell pellet was resuspended in freezing medium (90 % 
complete EMEM and 10 % DMSO) by gently pipetting up and down. Volume of 
cryopreservation medium was calculated based on the cell count; approximately 1 × 106 
cells / ml was frozen. 1 ml of the cell suspension was dispensed into freezing vials which 
was immediately immersed into the Isopropanol solution of the freezing container 
(Nalgene® Mr. Frosty™, Cat no 5100), and it was transferred into the – 80 ˚C freezer. After 
about 24 h, the freezing vials were placed into liquid nitrogen (-196 ˚C; Taylor-Wharton, 
USA). 
The thawing of the cells was quick (1 – 2 min) to improve cell recovery. The freezing vial 
from the liquid nitrogen was warmed into a water bath at 37 ˚C. The partially defrosted cell 
solution was pipetted dropwise into a universal tube containing warm (37 ˚C) medium. After 
gently resuspending cells by pipetting up and down, cell suspension was centrifuged at 
1000 rpm for 5 minutes. The cells pellet was resuspended into 2 ml of medium and 
transferred into a T75 flask containing 10 ml of the medium and kept beforehand at standard 
cell culture condition. The flask was observed using inverted microscope and placed in the 
incubator.  
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8.1.2.3 Cell counting 
Caco-2 cell count was performed using haemocytometer. 10 µl of the thoroughly mixed cell 
suspension was gently placed to the edge of the counting chamber and it was drawn in by 
capillary action. Cells in each of the four quadrants were counted under inverted microscope 
and the calculation was done as below. 
Cell density (cells / ml) = average cell counts of four quadrants [(q1 + q2 + q3 + q4)] × 
10,000 (capacity of the four quadrants is 104 / ml) 
Total cells ‘p’ ml of cell suspension = cell density × p (p = amount of total cell suspension in 
a flask). 
Therefore, total number of cell count was performed for individual flasks and the required 
number of cells were used for each experiment. 
8.1.3 Calculation for the Caco-2 cell number using serial dilution 
 
Figure A8. 2: Example of cell number calculation for the CCK-8 viability assay. 
For example, 8×106 Caco-2 cells were harvested from a T175 flask (above 80% confluent), and cell 
pellet was re-suspended into 2 ml of fresh medium. 1 ml of cell suspension was prepared for each 
cell concentrations. 750 μl of stock cell suspension was added to 250 μl of fresh medium to get the 
desired cell concentrations 3×105, and serial dilution was performed to get lower cell concentrations 
to 3×102. Similarly, 250 μl of the stock cell suspension was added to 750 μl to get 1 ml of 1×105 cell 
concentration, and the lower concentrations was prepared using serial dilution method. 
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8.1.4 Treatments and concentrations 
8.1.4.1 Lipopolysaccharide  
LPS stock solution (5 mg/ml) was prepared in ddH2O, and filter-sterilized following supplier’s 
instructions. The following calculation was used to prepare the concentrations 0 to 100 
µg/ml of LPS. The preparation for 10 ml of the concentrations are listed in table-A8.2, the 
lower concentrations were prepared using serial dilution method (fig.A8.2).  
Table A8. 2: Calculation of the LPS concentrations. 
Equation, C1V1 = C2V2 
i.e., V1 = (C2V2) / C1 
So, V1 = (100µg/ml×10000 µl)/5000 µg/ml 
V1 = 200 µl 
C1 = conc. of stock solution 5 mg/ml 
V1 = required volume of stock solution 
C2 = conc. of desired solution (100 
µg/ml) 
V2 = volume to be prepared (10 ml) 
Desired conc. 
(µg/ml) 
Stock solution 
(µg/ml) 
Volume of 
stock solution 
(ml) 
Volume of 
vehicle (water) 
(µl) 
Volume of 
media (ml) 
100 5000 0.2 0 9.8 
50 100 5 100 4.9 
10 100 1 180 8.820 
5 50 1 180 8.820 
1 10 1 180 8.820 
0.5 5 1 180 8.820 
0.1 1 1 180 8.820 
0 - - 200 9.8 
 
8.1.4.2 Artificial Sweeteners 
The employed concentrations of the saccharin, sucralose, aspartame and neotame were 0 
µM, 0.01 µM, 0.1 µM, 1 µM, 10 µM, 100 µM, 1 mM, 10 mM and 50 mM. The highest 
concentration 50 mM was prepared (vehicle EMEM medium) using equation mentioned in 
table-A8.3, which was used as stock solution for the 10 mM. The other concentrations were 
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prepared using serial dilution method (fig.A8.2). The stock solutions of the AS were 
prepared using the calculation given in table-A8.3. The required amount of the AS were 
weighed and solutions were prepared using the medium as a solvent and the solutions were 
sterile-filtered. Caco-2 cells were seeded at 1 x 104 cells/well in 96-well plates with 100 µl 
EMEM supplemented with 10 % FBS and 1 % penicillin/streptomycin and incubated for 48 
hours at 37 ˚C in the presence of 5% CO2. The used medium was replaced with AS doses 
(100 µl) and again incubated for 24 hours at the same conditions. To adjust reagent 
concentration (1:10) while minimising cell stress, 10 µl of the used medium was aspirated 
and CCK-8 reagent (10 µl) was added to the wells. Plates were incubated for 2 hours and 
viability was measured as absorbance at 450 nm using a Tecan SunriseTM microplate 
reader.  
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Table A8. 3: Calculation of the required AS for the concentrations. 
Each AS has different molecular weight (MW; g/mol), and the example calculation was used to 
determine the required amount of dried AS. Required amount of AS to prepare 1 ml of 50 mM 
concentration for other AS are mentioned as well. 
AS details Calculation of concentration 
Saccharin 
MW 183.18; Purity ≥99% 
1 Molar = 1 mole/litre (1 M × 1L) 
Required dried form of the AS, denotes as S 
Required concentration, denoted as C1 
Therefore, S = [(MW) X C1] / (1 M × 1L) 
The actual required amount was calculated using the purity 
percentage. 
Sucralose 
MW 397.63; Purity ≥98% 
0.02029 g 
Aspartame 
MW 294; Purity 99% 
0.01485 g 
For example, to prepare 1 ml of 50 mM saccharin, the 
calculation is –  
S = [(183.18g) X (50mM)] / [(1000ml) X (1000mM)] 
So, S = 0.009159 g 
The purity is 99%, so, actual amount required is,  
S = [(100g) X (0.009159g)] / (99g) 
Therefore, to prepare 1 ml of 50 mM saccharin solution, 
0.009252 g saccharin power was dissolved in 1 ml vehicle. 
Neotame 
MW 378.46; Purity ≥98% 
0.01931 g 
 
The following control experiments were run in parallel with the CCK-8 study. 90 µl of the AS 
concentrations and 10 µl of CCK-8 reagent was incubated in 96-well plates under standard 
incubation condition for 2 hours to assess any nonspecific binding. The absorbance of the 
without cell control was also measured at 450 nm (Tecan SunriseTM).  
The without cell absorbance was deducted from the with cell absorbance to calculate the 
effect of AS on Caco-2 cell viability.  
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8.1.4.3 Sweet taste inhibitor  
Zinc Sulphate  
The CCK-8 assay was also performed to assess the cytotoxic effect of the sweet taste 
inhibitor, zinc sulphate. The concentrations used were 0, 0.1 µM, 1 µM, 10 µM, 100 µM, 500 
µM, 1 mM, 10 mM and 50 mM, and the vehicle was distilled de-ionized water. Zinc sulphate 
stock solution (1M) was prepared in ddH2O and filter sterilized. Calculation for the different 
concentrations were shown in table-A8.4., gradually decreasing solutions were prepared 
using serial dilution method (fig.A8.2).  The CCK-8 viability assay was performed as 
described above. 
Table A8. 4: Preparation of the zinc sulphate concentrations. 
The highest concentration 50 mM was prepared, and the other concentrations were prepared from 
it. Calculation was shown for 10 ml of each of the concentrations. 
Zinc sulphate MW = 287.56; Purity ≥ 99.5%; 1 M stock solution was prepared using the 
calculation shown in table 8.3. The other concentrations were prepared as below 
C1V1 = C2V2 
i.e., V1 = (C2V2) / C1 
So, V1 = (50 mM × 10 ml) / 1000 mM 
V1 = 0.5 ml 
C1 = conc. of stock solution 1M 
V1 = required volume of stock solution 
C2 = conc. of desired solution (50 mM) 
V2 = volume to be prepared (10 ml) 
Desired conc. (mM) Stock solution (mM) Volume of stock 
solution (ml) + 
vehicle (µl) 
Volume of media (ml) 
50 1000 0.5 + 0 9.5 
10 50 2 + 400 7.6 
1 10 1 + 450 8.550 
0.5 1 5 + 250 4.750 
0.1 1 1 + 450 8.550 
0.01 0.1 1 + 450 8.550 
0.001 0.01 1 + 450 8.550 
Vehicle (water) - 0 + 500 9.5 
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Lactisole 
For the Lactisole, two different vehicles – DMSO (Dimethylsulfoxide) and Ethanol (EtOH, 
100%) - were used.  
Lactisole was dissolved in DMSO / Ethanol, and sterile-filtered (concentration 50 mM). 
Different concentrations of Lactisole (0 mM, 0.1 mM, 1 mM, 3 mM, 5 mM and 10 mM) were 
then prepared (calculation shown in table-A8.5) using complete EMEM media and 
employed on 24-hour pre-incubated Caco-2 cell monolayer. The Caco-2 cell number, 
experimental condition and the assay protocol was as mentioned above.   
Table A8. 5: Preparation of the Lactisole concentrations. 
The stock solution (50 mM) was prepared in DMSO or Ethanol using the calculation shown in the 
table below; calculation was shown for 10 ml of each of the concentrations. 
Lactisole MW = 218.2, purity ≥ 98%; To prepare 1 ml of 50 mM Lactisole solution,  
required amount = (218.2g X 1 ml X 50mM)/ (1000ml X 1000mM) =0.01091 g 
Considering the purity percentage, required amount = (100g X 0.01091g) / 98g = 0.011133g 
Therefore, dissolving 0.011133g of Lactisole powder in 1 ml of vehicle gave 50 mM Lactisole 
stock solution.  
Desired conc. 
(mM) 
Stock solution 
(mM) 
Volume of 
stock solution 
(ml) 
Volume of vehicle 
(ml) 
Volume of media 
(ml) 
10 20 2 0 8 
5 20 1 1 8 
3 20 0.6 1.4 8 
1 20 0.2 1.8 8 
0.1 20 0.02 1.98 8 
vehicle - 0 2 8 
 
Given the established cytotoxic effect of the vehicle for Lactisole, ethanol (Tong et al., 2013), 
Lactisole was also studied with a different vehicle. The sweet taste inhibitor was dissolved 
in ethanol, keeping the same concentrations and all experimental conditions as such, and 
the CCK-8 assay was performed with Caco-2 cells. 
The same experiment was carried out with all the concentrations of Lactisole (in both DMSO 
and ethanol) using no cells present to observe the effect of the chemicals interacting with 
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reagents. These ‘without cell’ experimental data were subtracted from the ‘with cell’ 
experimental data when calculated the absorbance of cell viability. 
To determine the additive effect of AS and Lactisole, Caco-2 cells were exposed to different 
concentrations (100 µM and 10 mM) of AS in combination with Lactisole (0.1 mM and 3 
mM) or vehicle (table-A8.6) and CCK-8 assay was performed as above. 
Table A8. 6: Calculation of AS and Lactisole combination concentrations. 
Water and DMSO were vehicle for Lactisole and AS stock solutions, respectively.   
Lactisole (L) stock solution was 50 mM in 
DMSO.  
AS stock solution was 50 mM in EMEM 
medium.  
Preparation of 10 ml intermediate stock solution is shown below 
6 mM Lactisole = 1.2 ml stock solution + 8.8 
ml medium 
0.2 mM Lactisole = 0.04 ml stock + 1.16 ml 
vehicle + 8.8 ml medium 
0 mM Lactisole = 1.2 ml vehicle + 8.8 ml 
medium 
20 mM AS = 4 ml stock + 6 ml medium 
0.2 mM AS = 0.04 ml stock + 9.96 ml medium 
0 mM AS = 0 stock + 10 ml medium 
The working solutions (10 ml) were prepared using the intermediate stock solutions 
0 AS + 0 L = 5 ml 0 mM AS + 5 ml 0 mM Lactisole 
0 AS + 0.1 L = 5 ml 0 mM AS + 5 ml 0.2 mM Lactisole 
0 AS + 3 L = 5 ml 0 mM AS + 5 ml 6 mM Lactisole 
AS + 0 L = 5 ml 0.2 mM AS + 5 ml 0 mM Lactisole 
AS + 0.1 L = 5 ml 0.2 mM AS + 5 ml 0.2 mM Lactisole 
AS + 3 L = 5 ml 0.2 mM AS + 5 ml 6 mM Lactisole 
10 AS + 0 L = 5 ml 20 mM AS + 5 ml 0 mM Lactisole 
10 AS + 0.1 L = 5 ml 20 mM AS + 5 ml 0.2 mM Lactisole 
10 AS + 3 L = 5 ml 20 mM AS + 5 ml 6 mM Lactisole 
 
8.1.4.4 Preparation of FITC-dextran stock solution 
FD4 and FD20 (Sigma) were dissolved in 5 ml sterile distilled water to a concentration of 
25 mg/ml (following manufacturer’s instructions), aliquoted and stored at -20 °C. 
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8.1.5 Cell viability assay  
The CCK-8 assay relies on the formation of formazan from WST-8 (a water-soluble 
tetrazolium salt) by dehydrogenases. This enzyme reduces the WST-8 inside cells and 
gives a yellow to an orange coloured product, the formazan. As formazan is a dye and 
soluble in the tissue culture medium, the amount produced by the biochemical activity of 
the living cells is directly proportional to the number of the living cells in respective well 
(Held, 2009). 
8.1.5.1 Effect of AS on Caco-2 cell viability 
The relative EC50 values of the AS concentrations for Caco-2 cell were mentioned in table-
A8.7. 
Table A8. 7: Concentrations of AS reducing Caco-2 cell viability by 50%. 
The relative EC50 estimation was performed from the graphs obtained from GraphPad Prism®. The 
baseline was considered as 0% while the maximum value was considered as 100%.  
Artificial sweetener Concentration causing 50 % cell death 
Saccharin 5.4 mM 
Sucralose > 50 mM 
Aspartame 15 mM 
Neotame 2.2 mM 
 
8.1.5.2 Effect of H2O2 on Caco-2 cell viability 
Hydrogen peroxide is a known apoptosis inducer (Xiang et al., 2016), therefore, Caco-2 
cells were exposed to different concentrations of H2O2 to determine the appropriate 
concentration to use as positive control for the apoptosis assay (fig.A8.3). Cell death was 
increased significantly at ≥ 0.8 mM of H2O2. The number of apoptotic and dead cells were 
increased while the number of live cells decreased with rising concentration of H2O2 in a 
dose-dependent manner. Number of apoptotic cells were significantly increased at 
concentrations 0.4 and 0.6 mM (47.5 and 49%, respectively), which implies the use of one 
of these concentrations as positive control for the study. However, after the pilot experiment 
with AS, the number of dead cell percentage at 10 mM concentration (fig. 3.21) was found 
similar or higher than 0.6 mM H2O2, therefore, 0.8 mM concentration was used as positive 
control for the study.  
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Figure A8. 3: Effect of hydrogen peroxide (H2O2) on intestinal epithelial cell apoptosis. 
Caco-2 cells (7.5X104) were maintained in T-25 flasks until about 60% confluence. Cells were 
exposed to different concentrations of H2O2 or vehicle for 24 hour and were stained with FITC 
Annexin V and Propidium Iodide according to the kit staining protocol (BD Biosciences). Cells were 
acquired using a BD Accuri C6 flow cytometer using the supplier’s kit template and analyzed using 
BD Accuri C6 software (BD Biosciences). Variation was determined using Two-way ANOVA with 
Dunnett's multiple comparisons test, and are presented as the mean ± S.E.M., n=2-3. *p<0.05 of 
dead cells, # p<0.05 of live cells, and •p<0.05 apoptotic cells versus 0 mM H2O2. 
8.1.5.3 Effect of LPS on Caco-2 cell viability 
LPS at high concentrations significantly decreased Caco-2 cell viability (fig.2.3.2), therefore, 
cells were exposed to different concentrations of LPS to understand whether the effect is 
via apoptosis (fig. 7.1.3). In addition, this test experiment aimed to pick an appropriate 
concentration of LPS to use as another control for the later experiment with AS. The number 
of living cells marginally decreased with increasing concentrations of LPS, however, at 100 
µg/ml, the number of apoptotic cell percentage increased significantly indicating apoptosis 
could be the reason for LPS mediated cell viability reduction. However, the sample number 
is too low to draw result, however, the purpose of selecting a concentration for the next step 
was served. 100 µg/ml of LPS was used as one of the controls when performed the 
apoptosis assay with AS. 
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Figure A8. 4: Effect of lipopolysaccharide (LPS) on intestinal epithelial cell apoptosis. 
Approximately 60% confluent Caco-2 cells in T-25 flask were exposed to different concentrations of 
LPS or vehicle for 24 hours. Cells were stained with FITC Annexin V and Propidium Iodide according 
to the supplier’s protocol, acquired using a BD Accuri C6 flow cytometer with the supplier’s kit 
template and analyzed using BD Accuri C6 software (BD Biosciences). Data were analysed using 
Two-way ANOVA followed by Uncorrected Fisher's LSD test, and are presented as the mean ± 
S.E.M., n=1-2. *p<0.05 versus 0 µg/ml of LPS. 
8.1.6 Fluorescence microscopy – morphological observation 
8.1.6.1 Preparation of the stains  
DAPI-Prolong Gold was purchased as ready to use. 1 µl of the Phalloidin stock solution 
(1,000× phalloidin conjugate in DMSO) was diluted into 1 ml of PBS containing 1% BSA 
(0.01 ng) to prepare the working solution and filter sterilized (0.22 µM Millex® GP;Merck 
Millipore Ltd, Cork, IRL). The DiOC6 stock solution was 1,000× in PBS, and working solution 
was prepared as 1:1000 concentration.  
8.1.6.2 Observation of stained cells 
Prolong Gold-DAPI, DiOC6, and Phalloidin stained nuclei, mitochondria, and stress fibre of 
AS-exposed Caco-2 cells were observed using Zoe imager. The exposure details of the 
fluorescence microscopy were mentioned in table-A8.8. 
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Table A8. 8: Fluorescence microscopy exposure details. 
Brightfield, blue, green and red fluorescence were used to observe the brightfield, DAPI, DiOC6, and 
Phalloidin staining. The criteria were adjusted as such. 
Criteria Brightfield Blue Green Red 
Gain 16 16 8 34 
Exposure 320 300 280 360 
LED intensity 28 10 28 50 
Contrast 17 46 21 13 
 
8.1.7 Cell apoptosis 
The difference between cell apoptosis and necrosis was first demonstrated in 1972 and cell 
apoptosis was established as a unique cell death process that time (Xiang et al., 2016; Kerr 
et al., 1972). During necrosis, cells rapidly lose membrane integrity resulting in cellular 
content outflow and eventual death (Ziegler and Groscuth, 2004). On the other hand, cells 
undergoing apoptosis represent structural changes in two distinct stages (Kerr et al., 1972). 
At the first stage, the cell undergo nuclear and cytoplasmic condensation, alteration in cell 
volume, disintegration of the cell membrane with blebbing formation and asymmetry (Nandi 
et al., 2010; Coleman et al., 2001) followed by fragmentation of the cell into a number of 
membrane-bound, well-preserved blebbing called apoptotic bodies (Kerr et al., 1972).  
As such, apoptotic cells display many morphological features that are distinct from the 
characteristics of cells undergoing death through other pathways such as pathological or 
necrotic cell death (Hengartner, 2000).  
The Extrinsic pathway activates the death receptors while the intrinsic pathway involves the 
mitochondria, however, both pathways unite to activate the caspases leading to cell death 
(Muzio et al., 1996; Boldin et al., 1996). Previous studies have mentioned that apoptosis is 
actively regulated process involving protease enzymes of the caspase family including 
Caspase-3, -6, -7, -8, and -9 (Taylor et al., 2008; Martin et al., 2012; Henry et al., 2013). 
The executioner caspase cascade with their proteolytic and DNAse properties, demolish 
the cell cytoskeleton and organelles. Among the executioner caspases, caspase-3 is a 
terminally activated protease whose presence usually indicates the late stage of apoptosis 
(Lavrik et al. 2005). 
In the extrinsic pathway, a multiprotein complex called death-inducing signalling complex 
(DISC) are formed via ligand binding which ultimately activate the procaspase-8 (Kischkel 
et al., 1995). Activated caspase-8 then triggers the downstream effector caspases (e.g., 
caspase-3) that subsequently cause cell death (Muzio et al., 1996; Boldin et al., 1996). In 
addition, p53 upregulated modulator of apoptosis (PUMA) can be transcripted from p53 to 
initiate the death signals. Furthermore, death receptor mediated (extrinsic) pathway can be 
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activated by corresponding ligand binding of FAS, TNF or TNF related apoptosis inducing 
ligands (Lin et al., 2011).   
All the stimuli for the intrinsic and extrinsic pathways alters the inner mitochondrial 
membrane resulting mitochondrial permeability through pore formation. This initiates with 
the replacement of the anti-apoptotic Bcl family from the outer membrane of mitochondria 
by the pro-apoptotic proteins such as Bax, Bak, Bid and Bim. All these eventually cause the 
cytochrome C (cytC) release from the intermediary space of the mitochondrial membrane. 
CytC binds to Apaf-1, facilitates the activation of pro-caspase-9 and form apoptosome. 
Caspase-9 activates caspase-3 causing cell death (fig.2.1.6) (Elmore, 2007).  
The names of some common proteins involved in apoptosis are listed in table-A8.9. 
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Table A8. 9: Some proteins involved in the extrinsic and intrinsic apoptotic pathways.  
Abbreviations and the protein names are adapted from Elmore, 2007. 
Extrinsic pathway Intrinsic pathway 
Abbreviation Protein name Abbreviation Protein name 
TNF-α Tumor necrosis factor 
alpha 
Smac/DIABLO Second mitochondrial activator of 
caspases/direct IAP binding protein 
with low PI 
TNFR1 Tumor necrosis factor 
receptor 1 
Apaf-1 Apoptotic protease activating factor 
FasL Fatty acid synthetase 
ligand 
Caspase-9 Cysteinyl aspartic acid-protease-9 
FasR Fatty acid synthetase 
receptor 
AIF Apoptosis Inducing Factor 
Apo3L Apo3 ligand CAD Caspase-Activated DNAse 
DR3 Death receptor 3 Bcl-2 B-cell lymphoma protein 2 
Apo2L Apo2 ligand Bcl-XL BCL2 related protein, long isoform 
DR4 Death receptor 4 Bcl-10 B-cell lymphoma protein 10 
DR5 Death receptor 5 BAX BCL2 associated X protein 
FADD Fas-associated death 
domain 
BAK BCL2 antagonist killer 1 
TRADD TNF receptor-associated 
death domain 
BID BH3 interacting domain death 
agonist 
RIP Receptor-interacting 
protein 
BAD BCL2 antagonist of cell death 
DED Death effector domain BIM BCL2 interacting protein BIM 
caspase-8 Cysteinyl aspartic acid-
protease 8 
BIK BCL2 interacting killer 
c-FLIP FLICE-inhibitory protein Puma BCL2 binding component 3 
  Noxa Phorbol-12-myristate-13-acetate-
induced protein 1 
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8.2 Appendix B - data for chapter 3 
8.2.1 Studies on model bacteria E. coli DH5α 
8.2.1.1 Effect of glucose, fructose and sucrose 
Effect of carbohydrates on E. coli DH5α at without shake incubation condition (fig.B8.1). 
 
Figure B8. 1: Effect of natural carbohydrates on E. coli DH5α growth at 37 °C without shake. 
Overnight culture (at dilution 1:500) was inoculated into 200 μl of 2YT liquid media at planktonic 
condition in 96-well plates and growth was read at 12 h intervals at 600 nm using Perkin Elmer (Victor 
X3) machine. Panel a, b, and c represent the effect of glucose, fructose, and sucrose, respectively. 
Data are presented as the mean ± S.E.M., n = 3, each with 2 replicates. Graph shows the effect of 
glucose (a), fructose (b) and sucrose (c) on E. coli DH5α growth.  
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8.2.1.2 Effect of artificial sweeteners 
Effect of AS on E. coli DH5α growth at without shake incubation condition (fig.B8.2). 
 
Figure B8. 2: Effect of AS on E. coli DH5α growth in without shake condition. 
Overnight culture was inoculated (at 1:500 dilution) into 200 µl of fresh 2YT liquid media 
supplemented with different concentrations of AS. The 96-well plates were incubated at 37 °C without 
shaking. Growth was measured as absorbance at 600 nm using Perkin Elmer Victor X3. Panel shows 
growth of E. coli DH5α exposed to saccharin (a), sucralose (b), aspartame (c), and neotame (d). 
Data are presented as the mean ± S.E.M., n = 3, each with 2 replicates. 
8.2.1.3 Effect of zinc sulphate  
E. coli DH5α growth at without shake incubation condition in presence of zinc sulphate 
concentrations were shown in fig.B8.3. 
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Figure B8. 3: Effect of zinc sulphate on E. coli DH5α growth at 37 °C without shake. 
Bacteria was exposed to 2YT liquid media supplemented with different concentrations of zinc 
sulphate in 96-well plates and incubated at 37 °C without shake. Growth was measured as 
absorbance at 600 nm using Perkin Elmer Victor X3. Data are presented as the mean ± S.E.M., n=3, 
each with 2 replicates. Graph shows the effect of glucose (a), fructose (b) and sucrose (c) on E. coli 
DH5α. 
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8.2.2 Data on model gut bacteria E. coli NCTC 10418 and E. faecalis ATCC 
19433 
8.2.2.1 Media pH 
The pH of the working solutions in the respective media of the MGB ranged between 6.39 
± 0.05 (aspartame) and 6.99 ± 0.09 (neotame) for E. coli, and between 6.94 ± 0.05 
(sucralose) and 7.10 ± 0.03 (neotame) for the E. faecalis. However, the pH of the vehicles 
was 6.78 ± 0.05 (NB) and 6.93 ± 0.01 (BHI), which were close to the pH range of the working 
solutions, therefore, it was unlikely that the pH influenced the experiments for the MGB.    
Table B8. 1: pH of the carbohydrates, AS and zinc sulphate. 
Stock solutions were prepared (1M) in double distilled water and filter sterilised. The working 
solutions were prepared in the 2YT liquid media for the model bacteria E. coli  DH5α, in Nutrient 
broth (NB) and Brain Heart infusion (BHI) for the model gut bacteria, E. coli  NCTC 10418 and E. 
faecalis ATCC 19433, respectively, and the pH of the solutions were measured (Jenway 3510, UK). 
Data are analysed using nonparametric Dunn’s multiple comparison test (no significance, p>0.9999), 
and are presented as the mean ± S.E.M., n=2-3. 
Chemicals Stock 
solution  
Working solution 
2YT for E. coli 
DH5α 
NB for E. coli 
NCTC 10418 
BHI for E. faecalis 
ATCC 19433 
Media  6.74 ± 0.02 6.87 ± 0.02 6.95 ± 0.01 
Vehicle (water) 7.08 ± 0.22 6.75 ± 0.01 6.82 ± 0.05 6.98 ± 0.04 
Sucrose 
7.393 6.68 ± 0.06 6.99 ± 0.09 7.10 ± 0.03 
Glucose 
7.125 6.65 ± 0.05 - - - - 
Fructose 
6.633 6.53 ± 0.12 - - - - 
Saccharin 
1.567 6.78 ± 0.03 6.97 ± 0.06 7.06 ± 0.00 
Sucralose 
5.823 6.62 ± 0.09 6.65 ± 0.02 7.10 ± 0.00 
Aspartame 
4.758 6.65 ± 0.02 6.82 ± 0.02 6.94 ± 0.05 
Neotame 
5.34 6.56 ± 0.08 6.39 ± 0.05 7.10 ± 0.00 
Zinc sulphate 
3.092 6.7 ± 0.02 6.85 ± 0.03 6.95 ± 0.01 
    *NB = Nutrient broth ** BHI = Brain Heart Infusion 
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8.2.2.2 Dilution calculation for absorbance to CFU calculation 
Table B8. 2: Dilutions of the base culture for absorbance to CFU determination.  
Dilutions Base culture 
(μl) 
Fresh media (μl) 
A 200 1 
B 180 20 
C 160 40 
D 140 60 
E 120 80 
F 100 100 
G 80 120 
H 0 200 
 
8.2.2.3 Growth of E. coli in different liquid media 
Table B8. 3: Growth of E. coli NCTC 10418 in different liquid media. 
A single bacterial colony was inoculated into 10 ml of the liquid media in universal tubes and growth 
was allowed for 24 h at 37 ˚C with shaking (150 rpm). The turbidity was measured as optical density 
at 600 nm (OD600) against corresponding growth medium as blank using spectrophotometer 
(Eppendorf BioPhotometer Plus, Germany). Data are presented as the Mean ± S.E.M., n=2.  
Media Absorbance (mean ± S.E.M.) * 
Nutrient broth 1.5805 ± 0.0028 
Brain Heart Infusion 1.497± 0.013 
Iso-sensitestTM broth 1.458 ± 0.01376 
2YT  1.934 ± 0.2205 
Luria Bertani 2.205 ± 0.0065 
*Each absorbance presented is the average of two independent experiments each having three 
replications 
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8.3 Appendix C - data for chapter 4 
8.3.1 Calculation for the multiplicity of infection (MOI): 
Calculation for E. coli  
An OD600 of 1 for E. coli have Colony Forming Units (CFU) of 8 × 108 CFU/ml 
So, 5 ml of bacterial growth have 4 × 109 bacteria. Bacterial culture was centrifuged at 4000 
rpm for 10 minutes at 37 °C, and the pellet was resuspended into 0.5 ml EMEM medium 
without antibiotics. Therefore, 0.5 ml bacterial suspension contained 4 × 109 E. coli, 10 µl 
was added in each of the wells containing 3 × 105 Caco-2 cells.  
10 µl E. coli suspension contains [(4 × 109 CFU × 10 µl) / 500 µl] = 8 × 107 CFU 
Therefore, MOI = [(number of Caco-2 cells, 3 × 105): (number of E. coli, 8 × 107 CFU)] = 1: 
300. 
Calculation for E. faecalis 
An OD600 of 1 for E. faecalis contain 9 × 109 CFU/ml. Bacterial suspension was centrifuged 
as above and resuspended in 1 ml complete EMEM medium without antibiotics, 10 µl was 
added in each of the wells containing 3 × 105 Caco-2 cells. 
10 µl E. faecalis suspension contains [(9 × 109 CFU × 10 µl) / 1000 µl] = 9 × 107 CFU 
Therefore, MOI = [(number of Caco-2 cells, 3 × 105): (number of E. faecalis, 9 × 107 CFU)] 
= 1: 300. 
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8.3.2 Effect of AS on co-culture models of intestinal epithelial cell and gut 
bacteria 
8.3.2.1 Effect of AS on model bacterial adhesion ability  
 
Figure C8. 1: Adhesion of E. coli to Caco-2 cell monolayer. 
Mammalian cells were incubated with the bacteria (MOI 1:300) for an hour at 37 ˚C. Loosely adhered 
and non-adhered cells washed away by PBS (×3) and cells were fixed with 4% PFA. The cells were 
observed using bright field microscopy (Zoe imager). Images were taken with lower (a) and higher 
(b) magnifications. The black circle (b) shows localized adherence like appearance of the rods. Also, 
irregular diffuse adhesion (black arrow, c) can be seen on the cells.  Bar 100 μm (a) and 25 μm (b). 
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Figure C8. 2: Representative feature of the effect of AS on E. coli adhesion to the Caco-2 cell 
monolayer. 
Mammalian cells were grown on 24-well plate for 48 h at standard tissue culture conditions and 
exposed to AS for 24 h. The bacteria were also exposed to AS (saccharin) for 24 h, washed and co-
cultivated with the Caco-2 cells at MOI 1:300 for an hour. Non-adhered cells were washed by PBS 
washing (×3) and cells were fixed using 4% PFA. Panel represent lower (a) and higher (b and c) 
magnifications. The E. coli shows localised adherence like appearance (black circles, b and c), small 
clusters of the rods (black arrows) were also observed. Bar 100 μm (a) and 25 μm (b and c). 
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Figure C8. 3: Adhesion of E. faecalis to Caco-2 cells. 
The bacteria were co-cultivated at MOI 1:300 for an hour and non-adhered or loosely adhered 
bacteria were washed away with PBS. Cells were observed using Zoe imager. Bar 100 μm (a) and 
25 μm (b). 
 
Figure C8. 4: Representative image of adhesion of AS-exposed E. faecalis to the AS-exposed 
Caco-2 cells. 
Mammalian cells were grown on 24-well plate, exposed to AS (saccharin) for 24 h and co-cultivation 
with bacteria were performed for an hour at 37 ˚ C. Cells were washed to get rid of unattached bacteria 
and observed under Zoe imager. Cells and bacteria were observed at lower (a) and higher (b) 
magnifications. Black arrows represent cluster or chains of the bacteria, and the black circle shows 
massive irregular adhesion. Bar 100 μm (a) and 25 μm (b and c). 
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8.3.2.2 Effect of AS on gut bacterial invasiveness 
 
Figure C8. 5: Invasion of E. coli NCTC 10418 into the Caco-2 cells at 1 hour co-culture. 
Mammalian cell monolayer was infected with the bacteria (MOI 1:300) at 37 ˚C. The adhered E. coli 
was killed by incubating with 100 μg/ml of gentamicin. Cells were washed and fixed and observed 
using bright field microscopy (Zoe imager). Images were taken with lower (a) and higher (b) 
magnifications. The black arrows (b) show rod-shaped E. coli on the Caco-2 cells. Bar 100 μm (a) 
and 25 μm (b). 
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Figure C8. 6: Effect of AS on E. coli invasion into the intestinal epithelial cell. 
Caco-2 cells were maintained in EMEM for 48 h and exposed to AS (saccharin) for 24 h. Culture 
media was replaced with fresh media without antibiotic. The AS-exposed E. coli was washed and re-
suspended in EMEM and infection was allowed for an hour at 37 ˚C. The non-adhered bacteria were 
removed by washing (PBS ×3) and the adhered bacteria were killed by antibiotic action. The invaded 
ones were protected by the mammalian cell membrane. Cells were partially lysed with (0.1% Triton 
X100) for <5 min and fixed using 4% PFA. Cells were observed using bright field microscopy (Zoe 
imager) with lower (a) and higher (b and c) magnifications. The E. coli shows greater numbers in 
some areas (black circles, b and c), however, individual bacteria and small clusters of the rods (black 
arrows) were also observed. Bar 100 μm (a) and 25 μm (b and c). 
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Figure C8. 7: Invasion of E. faecalis into Caco-2 cell after co-exposure in vehicle for 1 hour. 
Caco-2 cells were maintained in 24-well plate for 24 hours followed by exposure to AS for 24 hours. 
The washed cells were co-cultured with bacteria and the infection incubation was performed for an 
hour. The adhered bacteria were killed by gentamicin and ampicillin action while the invaded ones 
were protected by the Caco-2 cell membrane. The cells were washed and fixed with 4% 
paraformaldehyde and observed using brightfield microscopy (Zoe imager). Bar 100 μm (a) and 25 
μm (b). 
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Figure C8. 8: Representative feature of the effect of AS on E. faecalis invasion into Caco-2 
cell monolayer after 1 hour. 
Caco-2 cells were maintained in 24-well plate at standard tissue culture conditions. At 24 hours, cells 
were exposed to AS for 24 hour and then the co-culture with bacteria were performed for an hour. 
The adhered bacteria were killed by gentamicin and ampicillin action while the invaded bacteria were 
protected by the Caco-2 cell membrane. The cell monolayer was washed twice with PBS, fixed and 
observed using bright field microscopy (Zoe imager). The cocci formed small clusters (black circles, 
b) without any distinguished appearance. Also, short chains and pairs of E. faecalis (black arrows, 
c) as well as individual bacteria were observed (b, c). Bar 100 μm (a) and 25 μm (b and c). 
 
